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Abstract
Tissue plasminogen activator (tPA) has long been considered "the flagship product" of the biotechnology
industry. This protein is a popular treatment for heart attacks, coronary heart disease, and stroke. Genentech
has held a patent for the development of tPA-producing cells and sold it for approximately $2,000 per 100-mg
dose. Within the next few years this patent will expire and the opportunity will exist to produce a generic form
of tPA at a fraction of the cost. This design report describes a plant that can manufacture this recombinant
protein without spending $500 MM on research and development costs.
A cheap, generic form of tPA can acquire a large share of the current $300 MM tPA market. The FDA has
recently prohibited the sale Abbott Laboratories' thrombolytic drug, urokinase. The only other thrombolytic
medication available is streptokinase (SK); while it is much cheaper, SK causes more severe side effects and is
somewhat less effective than tPA. It is therefore likely that the market for a generic tPA will expand as the price
decreases. For this reason we have designed our plant to produce approximately 80 kg per year. Plant
calculations were completed by hand and with the use of the SuperPro Designer program (for the Separation
Section). Costing was completed using the economic spreadsheet created by Holger Nickisch. Purchase costs
were obtained as company quotes or estimates from the design consultants. Our pharmaceutical plant has an
investor's rate of return of 59.7% based on a total capital investment of $104 MM. Given the profitability of
this process we highly recommend construction of this plant.
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Dr. Arnold Kivnick 
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Philadelphia, P A, 19104 
Dear Prof. Diamond and Dr. Kivnick, 
Enclosed in this report is the completed design and economic analysis of the proposed 
human tissue plasminogen activator plant. The plant is designed to be implemented in 
the U.S. Northeast and will have a capacity to produce 80 kg oftPA per year or 1.28 MM 
doses per year. 
The optimum plant design has 2 individual fermentation and separation trains. The 
fermentation trains grow the cells that produce our product in a scale-up process 
consisting of three different size vessels: 40 L, 400 L and the maximum 5000 L. The 
product is sent to a separation train, which purifies and sterilizes the protein for medical 
use. The plant also contains a reverse osmosis water purification system that is designed 
to produce all of the pure, pharmaceutical quality water used to make all of the process 
liquids and clean out the unit operations during sterilization. 
An economic analysis of the plant was performed based on the design data using the 
spreadsheet provided by Holger Nickisch. The plant described within the report has an 
JRR of59.7% based on a $117 MM initial capital investment. The optimum selling price 
of the product tP A was determined using market share information provided by Prof. 
Diamond to be $500.00 per dose. The group highly recommends construction of the 
plant. 
Sincerely, 
I 
.-::-~/}~" :.-.- .. / -.t/ , ;:', , L'~/. ~- / i ?- fLr . • v.~~ 
. JLuU-L~ UkJ-j{ib 
Melissa Audette Christian Metallo Kasidit Nootong;:/' 
v 
I 

ABSTRACT 
Tissue plasminogen activator (tPA) has long been considered "the flagship 
product" of the biotechnology industry. This protein is a popular treatment for heart 
attacks, coronary heart disease, and stroke. Genentech has held a patent for the 
development of tPA-producing cells and sold it for approximately $2,000 per 100-mg 
dose. Within the next few years this patent will expire and the opportunity will exist to 
produce a generic fonn oftPA at a fraction of the cost. This design report describes a 
plant that can manufacture this recombinant protein without spending $500 MM on 
research and development costs. 
A cheap, generic fonn of tP A can acquire a large share of the current $300 MM 
tPA market. The FDA has recently prohibited the sale Abbott Laboratories' thrombolytic 
drug, urokinase. The only other tru-ombolytic medication available is streptokinase (SK); 
while it is much cheaper, SK causes more severe side effects and is somewhat less 
effective than tP A. It is therefore likely that the market for a generic tP A will expand as 
the price decreases. For this reason we have designed our plant to produce approximately 
80 kg per year. Plant calculations were completed by hand and with the use of the 
SuperPro Designer program (for the Separation Section). Costing was completed using 
the economic spreadsheet created by Rolger Nickisch. Purchase costs were obtained as 
company quotes or estimates from the design consultants. Our phannaceutical plant has 
an investor's rate of return of59.7% based on a total capital investment of$104 MM. 
Given the profitability of this process we highly recommend construction of this plant. 
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Generic tPA Introduction 
Impetus for the Project 
The emergence of the biotechnology industry has created an explosion ofnew 
products in the healthcare industry. In 1986 tissue plasminogen activator (tPA) was 
approved by the FDA for the treatment of acute myocardial infarction and was the first 
recombinant, therapeutic protein to be produced in mammalian cells. Since that time 
biotechnology and phannaceutical companies have attempted to beat competitors to the 
market with newly invented medications. In the next few years the patent ofthis popular 
"clot-busting" drug will be expiring, and competitors will be able to enter the market and 
create low-cost generic tPA. This report describes a process for the production of such a 
drug. A cheaper version oftPA can compete with expensive fonns such as Genentech's 
Activase™ and at the same time compete for market share owned by low-cost 
alternatives like streptokinase. Reduced healthcare reimbursements to U.S. hospitals and 
growing scrutiny over excessive drug prices will create a market for generic tP A in the 
U.S., and the prospect of a safer alternative to streptokinase and urokinase in foreign 
markets can potentially make it extremely profitable. 
Applications 
The function of tP A in the human body is to activate plasminogen. This helps the 
body clear arterial blockage, which is a major cause of heart disease. Cholesterol 
buildup in arteries is exacerbated by fibrin fonnations that surround the blockage. 
Shrinking arterial diameters puts undue strain on the heart, leading to a variety of health 
problems. Active plasminogen releases plasmin, an enzyme that dissolves these fibrin 
fonnations, which hold the clot in place. This in tum can reduce blood pressure and 
14 

Generic tPA Introduction 
relieve cardiac stress in individuals with heart disease. The role of tP A in plasminogen 
activation makes it an extremely effective medication for patients suffering from acute 
myocardial infarction or cardiac arrest. More recently tP A has been approved for the 
treatment of deep vein thrombosis, pulmonary embolism, and stroke. 
Production 
Production of recombinant tPA has been docwnented in both bacterial and 
mammalian cells. The use ofEscherichia coli (bacterial host cell) produces small 
amounts of protein and makes the separation process much more complicated. Our 
process utilizes mammalian Chinese Hamster Ovary (CHO) cells, which are commonly 
used for genetic engineering production and research. 
The DNA sequence from which tP A is produced is cloned from human melanoma 
cells. This sequence is then inserted into the genome of the CHO cells, and the highest 
producing strains of these tP A-CHO cells are selected and used for our process. The 
selected tP A-CHO cells are grown in a train of three fermentors, and after twenty days of 
growth in the three reactors the cell broth is harvested and sent to the Separation Train. 
During fermentation tP A is produced by the CHO cells and secreted into the liquid media 
solution. Serum-free media is used because it contains no growth proteins that would 
interfere with the purification process. 
Purification 
Purification of biologically active molecules can be very difficult and costly. The 
Separation section is usually the most expensive part of pharmaceutical processes; this 
15 
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holds true for our plant as well. The purification of our recombinant tP A exploits 
differences in density, protein size, and chemical affinity. The heart of the Separation 
trains is the Affinity Chromatography column, in which our protein is isolated from the 
thousands of proteins present in the harvest media. At the end, steps are taken to ensure 
the safety of therapeutic use in humans. Endotoxins that may be present in the solution 
are removed and the solution is sterilized in a 0.2 ).lm filter. The final product is then 
bottled in the correct dosage and lyophilized, creating a stable drug that can be shipped to 
hospitals and stored indefinitely. 
Protein Chemistry 
Proteins are chemicals in the body that interact with one another to send messages 
and complete complex enzymatic reactions. In order to retain their activity (functional 
ability) they must be treated with care under "gentle" conditions. Proteins lose activity at 
temperatures above freezing; for this reason the entire Separation section of our process 
is kept at 4°C by a refrigeration system. Any sudden change in environment can also 
damage the tP A, so our process is designed to minimize abrupt chemical changes. 
The size of tP A is about 66,000 daltons (one dalton = g/mol), the mature full­
length protein is made up of 562 amino acids. In high concentrations tP A can form 
aggregates which are difficult to separate and can be considered inactive protein. To 
circumvent this problem arginine is added to the tP A solution at a concentration of 2M. 
The product stream in our process has a 2M arginine concentration during most steps. 
Our recombinant tP A exactly resembles the protein produced in human melanoma cells 
and its ability to activate plasminogen has been demonstrated as well. 
16 
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Flowsheet Preparation 
The production method of tP A is straight forward and similar to any other 
fermentation process in the pharmaceutical industry (i .e. penicillin). The main difficulty 
lies in the creation of a batch schedule that provides for the completion of 50 batch-runs 
each year. The separation oftPA centers around affinity chromatography, for which the 
tP A containing solution must be adequately prepared. Various forms of filtration were 
investigated including micro filtration, tangential flow ultrafiltration, and gel filtration. 
Once the unit operations were chosen they were organized and scheduled to provide for 
two-week batches. In addition to the Fermentation and Separation Trains, a reverse 
osmosis water purification system is required to provide the sterile water that is needed 
throughout our plant. The final, detailed process is presented in the following sections. 
All design considerations relevant to a batch-wise, pharmaceutical process have been 
taken into account, including scheduling, sterilization, and sanitization requirements. 
17 
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Development of CHO Cell Line 
Before designing the human tissue plasminogen activator (tPA) process plant, a 
Chinese Hamster Ovary (CHO) cell line that secretes the product protein must be 
developed in the research and development laboratory. The cell line development 
process is estimated to take one year based on a suggestion by Prof. Diamond. The 
strategy for synthesizing tP A from CHO cells is a combination of transfecting the DNA 
sequence that produces tP A into the CHO cells and amplifying the gene into multiple 
plasmids. The Bowes melanoma cell line, which naturally produces tP A, is used to 
isolate the desired DNA sequence. PCR (polymerase chain reaction) is then used to 
make numerous copies of the tPA sequence that is}009 bases long. Two specifically 
designed primers are applied to isolate the tPA gene. The primers are a sequence of 
nucleotides that form base pairs with the complementary sequences located near the 
beginning and the end of the desired gene. The primers ensure that only the tP A gene is 
amplified during the PCR. The sequence can be checked using restriction enzymes to 
break it down into smaller segments and measure them using the technique of gel­
electrophoresis. 
The amplified sequence is inserted into a DHFR expression vector with the 
EcoRY blunt cut restriction enzyme. The vector is placed in a neo-tPA plasmid and 
transfected into the CHO cells. Those cells that take up the plasmid will produce 
multiple copies of the gene as they grow and divide. The presence of the gene in the cell 
will result in the production of tPA. In order to only select the cell culture strains that 
largely amplify the gene, the cells are exposed to a cytotoxic drug that will kill any cells 
that possess the DHFR vector. The tPA gene is located within the DHFR vector, so the 
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desired cultures die most readily in the presence of the drug. The cells that exhibit the 
most "favorable" response to the drug are grown up in large volumes and frozen at -70 De 
to create a cell stock. This cell stock will be used to begin every subsequent batch to 
enslffe /hal each cuh'lffe..-Ofoo'uces//lrge /l/7701U7/S o//FA. 
The eHO cellline that is usedin our process is estimated to produce 50pg oftPA 
per cell per day. Cell growth environments and the storage conditions of the cell line can 
alter the production rate of the cells, therefore the value used is a slight under estimation 
of the possible production levels of the cells. In addition to external factors, internal 
ce\\uhr mutat\ons can effect the tota\ "Qrocluct1on of tV A.. 1n an,:! 'E,l'Jen culture. Mutat\ons 
result 1n the "Qrocluct\on of cllfterent, 1nactlve "Qrotelns, or cause the cell to cease 

"Qroo.uchon 01 t'P A.. a\together. 'The research laboratory conhnuous\)1 tests the lntegnt':! the 

CHO cell line for its ability to produce tPA for the life of the process. 

Raw Materials 

Fermentation Materials 

The raw materials for the process include 100% sterile water, powdered media, 
compressed air, and CO2. The sterile water is produced in the plant with a reverse 
osmosis water purification system from water that is purchased from the municipal 
source in the area. The sterile water is mixed with HyQ PF-CHO duel powder media (see 
Appendix C, page 272) to generate the liquid media that makes up the growth medium 
for the CHO cells in the bioreactors. The Hyclone media is serum free but contains all of 
the nutrients, salts and amino acids necessary for cell growth. A serum free media was 
chosen because the presence of serum in the growth media interferes with the 
28 

Generic tPA Process Description 
recombinant protein purification by introducing other proteins to the product stream. 
Under the advice of Neil Collins from Hyclone Media Company, the media does not need 
to be supplemented with any additional proteins such as glutamine. The formulation for 
this media is not yet available due to patent protection but Mr. Collins verified the 
presence of important components such as insulin, growth factors and transferrin. 
The media also contains a sodium bicarbonate buffer to maintain a pH of7.3. 
The pH is adjusted by the continuous flow of CO2 into the fermentors. A pH control 
measures the internal conditions of the fermentor and adjusts the flow of C02 accordingly 
to change the pH. The CO2 is a part of the air stream that is pumped into the bioreactor 
to provide the oxygen needed for the cells' metabolism. The CHO cells require 0.06 to 
0.2 * 10-12 mol 02/hr * cell (Shuler pA55). The compressed air and CO2 are purchased in 
tanks from BOC gases (see Appendix C, page 275). In order to prevent any disturbance 
in the inlet stream, all of tanks for a given batch are hooked up to the fermentor and 
opened at the same time to maintain a constant pressure and flow rate for the life of the 
batch. 
Arginine 
Arginine Hydrochloride is used throughout the Separation process to prevent the 
aggregation of tP A in concentrated solutions. It is first added to the product solution in 
UF 1 Tank before concentration in UF 1. The concentration is only brought to 1 M here in 
order to reduce the waste of arginine (the majority would be immediately discarded in 
UFI filtrate). Prof. Diamond advised us that a 1M concentration would be enough for the 
short period of time between UFI and UF2 Tank. The 200 L volume in UF2 Tank is then 
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increased to 2M arginine. The final input of arginine comes in the elution of Affinity 
Column. As tPA is eluted, the concentration of the protein gets quite high in the elution 
buffer. The glycine based buffer is made to a concentration of 2AM arginine which 
results in a final product concentration of 2M in each dissolved dose. Endotoxin-free 
arginine can be purchased in bulk from Sigma-Aldrich at a price of $119/kg; we will 
require about 74,500 kg each year (see Appendix D, pages 283 and 290) . 
Glycine 
Glycine, or aminoacetic acid is the simplest amino acid and is an important 
ingredient in the Elution buffer for our Affinity Column. We follow Reagan et al. in 
using 0.5M glycine in our tPA elution. We will be using endotoxin-free glycine to ensure 
the quality of our final product. Glycine can be purchased in bulk by Sigma-Aldrich at 
$43/kg and our yearly needs are about 770 kg (see Appendix D, pages 283 and 290). 
Sucrose 
The final packaging requirements of lyophilized tPA contain a small amount of 
sucrose. This biotechnology grade sucrose will be added into the product solution in ER 
Tank. It is added before ER Column to ensure that any endotoxins introduced will be 
removed the ER Column. Approximately 3 kg/yr are required and this can be bought for 
$29 from Sigma-Aldrich (see Appendix D, pages 283 and 290). 
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PBS 

Phosphate buffer solution, or PBS, is the liquid medium for the Equilibration 
buffer used in the Affinity Column. About 117,000 L of PBS will be used in our process 
each year. This can be bought in bulk for approximately $0.80/L from Sigma-Aldrich 
(see Appendix D, pages 283 and 290). 
NaOH 
Sodium hydroxide, or NaOH is used to adjust the pH in ER Tank after elution in 
the acidic buffer, and it also acts as a cleaning agent for ER Column and Centrifuge. The 
yearly requirements are 550 kg and this can be bought in bulk form Sigma-Aldrich for 
$17.50Ikg (see Appendix D, pages 283 and 290). 
NaCI 
Sodium chloride, or NaCI is present in the Affinity Column Equilibration buffer 
in a concentration of 0.65M. This adds up to yearly requirements of about 4500 kg. 
Biotechnology grade NaCI can be purchased in bulk from Sigma-Aldrich at $18/kg (see 
Appendix D, pages 283 and 290). 
Fermentation Process 
The fermentation section of the tP A production is a batch process that consists of 
a scale-up series of 3 individual stainless steel fermentors ranging in size from 40 Liters 
to 5000 Liters. Each fermentor operates under the same growing conditions: a 
temperature of 37°C, a pressure of 14.7 psi, and a pH of7.3. The vessels contain a 6 
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blade standard Marine impel lor located in the center to mix the contents and disperse the 
air stream sparged through the bottom. The function of these fennentors is to provide an 
optimal environment for growth of a CHO cell line that excretes the product tPA protein. 
The fennentors are filled with media that is produced in a blending tank T-l (see 
specification page 100. Before the media can enter any of the bioreactors, it is heated to 
37°C and extensively filtered. Due to varying batch lengths for the three different 
fennentors, the media is held in the tank for up to 7 days at 4 °C before it is needed to fill 
a bioreactor. The cold temperature preserves the quality of the media and prevents the 
growth of any bacteria. The media is sent through filters F-l and F-2 (see specification 
pages 108 and 109) before it is heated to growth temperature. The filters are used to 
remove 99.9% of the contaminants and to sterilize the media. The purpose ofF-l is to 
protect the 0.2 micron F-2 from getting clogged too quickly. 
The media is pumped through the filters with peristaltic pumps that maintain a 
flow rate of2 gal/min and increase the pressure from 14.7 psi up to 29.7 psi. The media 
is finally pumped through a shell and tube heat exchanger that is designed to heat the 
media up to 37°C using a small temperature gradient that will not damage the organic 
material in the media. A wann water stream heats the media as it enters the shell side of 
HX-l (see specification page 99) at a temperature of 55°C and leaves at 48 0c. The 
wann water stream is a recycle stream made up of city water that is heated using a steam 
sparger. The wann media is finally pumped into the fennentors to provide the essential 
liquid environment for CHO cell growth. 
The fennentors are all outfitted with a complete computer control system as well 
as individual unit operation control units. The internal environment of the bioreactors is 
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maintained with the aid ofa conventional heating jacket on BR-I and BR-2 (see 
specification pages 96 and 97) and a 4-inch half-pipe heating jacket surrounding BR-3 
(see specification page 98). All the fermentors are also covered in 2 inches of fiberglass 
insulation to increase the efficiency of the heating jackets. The pH is regulated by a pH 
control that adjusts a valve on the inlet stream of CO2. The amount of C02 flowing into 
the reactor can change the pH of the cell broth (see Dynamic Controls page 44) . Finally 
the reactor is fed with a constant flow of compressed air, supplemented with CO2. The 
gases are supplied to the vessel by tanks that are attached to a sparger located at the base 
of the fermentor. 
In the designed process the CHO cells are grown up for a total of 20 days in the 
three fermentors . The size of the fermentor influences the length of the cell culture batch. 
BR-I only takes 5 days to achieve the desired cell density, while BR-2 takes 7 days to 
grow and BR-3 takes 8 days to achieve maximum growth. The batch schedule for each 
fermentor is designed to allow enough time to run 50 batches per year. BR-3 runs 
continuously through out the year in order to fit in 25-2 week batches in one year, but the 
smaller fermentors have some down time in between batches (see the complete schedule 
on page 171). The schedule is also designed to fit in an extra fermentation train for 
possible future expansion of the plant. 
Separation Trains 
The Separation trains accomplish the difficult task of purifying tP A from the 
complex mixture of biochemicals present in the harvest media. Throughout the life cycle 
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cells produce thousands of proteins of different size, structure, and chemical activity. 
Each of these differences must be exploited in order to obtain a pure, stable product. 
Throughout the Separation process the product solution must be kept as cold as 
possible to prevent loss of protein activity. High temperatures (room temperature is 
considered high for proteins) cause proteins to degrade and denature, basically changing 
the conformation that is essential for correct function. For this reason an air-conditioning 
system keeps the temperature of the entire Separation section at a temperature of 4°C. 
Because there are two Bioreactor production lines running, the separation train 
will be split to two trains at the outlet ofUF2. In effect, there will be two identical units 
for each of the following: Affinity Tank, Affinity SkidJPump, Affinity Column, ER 
Tank, ER SkidJPump, ER Column, MF Tank, MF Pump, MF, FD Tank, Bottler, and 
Freeze Dryer. Once the train has been split it is unwise to reintroduce the separated 
batches because cross contamination could possibly occur, resulting in a loss of both 
batches. 
The Separation Train begins with the draining of BR3. The cell broth is sent 
directly to Centrifuge (see specification page 119) for clarification unless the machine is 
down. If more time is needed the cell broth can be stored in Holdup Tank (see 
specification page 112) until the Centrifuge is ready. The broth is processed at a rate of 
400 LIhr and the resulting cell waste is sent to the EarthCare Company for disposal. 
Given a cell production rate of 50 pglcelllday, an average cell density in BR-3 of 2 MM 
cells/mL, a volume of 4000 L and a production time of 6 days, the amount of tPA 
produced in BR-3 is estimated at 2.4 kg, and this number is reduced by 10% to yield 2.16 
kg to account for variability in the cells' ability to produce the recombinant protein. We 
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assume that another 5% is lost with the cells during clarification in the Centrifuge. After 
this step the harvest media is sent to UF 1 Tank (see specification page 113). The total 
process time for Centrifuge is about 12 hours. 
The harvest media is then stored overnight and mixed with 850 kg of arginine in 
UF 1 Tank. AIM concentration is needed at this time to prevent aggregation of the tP A 
when it is concentrated. This concludes Day 1 of the separation. Day 2 consists of 
ultrafiltration in UFI (see specification page 125) and UF2 (see specification page 126). 
Water and other dissolved solids pass through the UFI membrane and a concentrated tPA 
solution is collected in the retentate. The 3500 L of harvest media can be processed in 
UFI in just over 6 hrs, and the resulting volume is 200 L. 
More arginine is added in UF2 Tank to again prevent aggregation. The solution 
must then be cleaned before application to the chromatography column because 
microscopic solids may still remain in solution and these particles can damage the 
chromatographic resins. The first method of pretreatment that we investigated was gel 
filtration. This chromatography operation is accomplished by applying a given volume 
of solution to a column and continually supplying sterile process water afterward. 
Particles of different sizes have different residence times, so one can collect a sample 
with a specific residence time that will contain the desired product. The downside of this 
operation is that the large volume of sterile water used causes drastic dilution of the 
sample, which is extremely undesirable in our purification process. 
The method we eventually chose was ultrafiltration with a larger pore size. The 
500 kDa pores ofUF2 allow tPA to pass through while removing larger debris. The 
process requires no additional water so dilution does not occur. The 200 L volume can 
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be ultrafiltered in less than one hour, and it is assumed that 5% of the tPA will not be 
recovered, leaving 1.89 kg. (For a more complete description ofultrafiltration theory see 
Unit Descriptions page 78). 
The tPA is then purified in four cycles in the Affinity Column (see specification 
page 128). tPA binds to the anti-tPA antibody which is bound to the Affinity Resin (see 
specification page 129). The protein is then "released" during elution and sent to ER 
Tank. Dividing the Affinity Column processing into four cycles allows us to cut the resin 
requirements from about 180 L to approximately 45 L, which cuts our yearly capital costs 
drastically. Two cycles can be performed each day, so the final elution cycle takes place 
on Day 4. It is assumed that 15% of the tPA will be lost in this step leaving over 1.6 kg 
to be recovered. (For a more complete description ofaffinity chromatography theory see 
Unit Descriptions page 82). 
After elution from Affinity Column the solution needs to be neutralized with 
addition of 1M NaOH to protect the tP A. The final product must also contain a certain 
amount of sucrose (see Prof. Diamond email page 289). These materials are added to the 
solution in ER Tank (see specification page 116) before processing in ER Column. 
The next step in the separation process is the removal of endotoxins, which are 
chemicals derived from bacteria that cannot be injected into humans. The first removal 
technique I investigated was anion exchange based on advice given by a representative at 
Arnersham Pharmacia Biotech. The process required a gel filtration step, followed by an 
adjustment to an acidic pH before application to an anion exchange column. About 98% 
of the endotoxins would bind to an anion exchange column (Harrison 1994), which is 
probably enough for our purposes. I was unsatisfied with this process because it was 
36 

Generic tPA Process Description 
very costly (requiring many of Amersham's more expensive products) and forced us to 
subject our protein to harsh conditions (low pH and ion exchange elution). 
My search over the internet then led me to an affinity resin made by Sterogene. 
The Acticlean Etox resin removes virtually all of the endotoxins in a sample. While it is 
somewhat expensive, the resin can be reused, can be run at a neutral pH, and will bind to 
practically none of our protein. The representative said that the resin was ideal for 
removal of small amounts of endotoxins, while anion exchange is more commonly used 
for removal of high endotoxin concentration. The ER Column (see specification page 
130) simply involves the application of our product solution to ER Resin (see 
specification page 131). The endotoxin free tPA solution can be collected directly from 
the column and prepared for lyophilization in MF Tanle The solution will be completely 
collected on Day 6. The tPA losses are conservatively estimated at 5% in the ER 
Column, leaving about 1.6 kg to be purified. (For further information on endotoxin 
removal see Unit Descriptions page 84). 
The solution volume is then increased to 400 L with addition ofWF1 in MF Tank 
in order to set the correct packaging concentrations. The contents are then sterilized by 
filtration through a 0.2 f.lm filter, MF (see specification page 127). This filtration will be 
complete in less than one hour and the filtrate will be collected in FD Tank (see 
specification page 118). tPA losses in the MF are estimated at 1 %, though the filter will 
be replaced each batch. 
FD Tank will store our final product solution overnight before the bottling and 
freeze drying cycles begin. On Day 7 the first of five bottling/freeze drying cycles will 
begin. A UV spectrophotometer is used to measure the protein concentration, and this 
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concentration is used to calculate the volume to be loaded into each vial. The Bottler (see 
specification page 132) uses this information and charges approximately 3200 100-mL 
vials with the tPA solution and loads them onto trays in the Freeze Dryer. The charging 
and loading wiB take a total of 2 hours based on comments from a representative of the 
Cozzoli Machine Company. 
Finally, the Freeze Dryer (see specification page 133) forms a solid tPA powder 
in sterile vials and seals the stoppers. The drying time for each cycle is estimated as 24 
hours, which is a conservative estimate, though we cannot be certain without 
experimentation. Given five cycles and allowing for over five hours of cleaning time 
between each cycle the Separation batch will be complete on Day 12. This is weB within 
the limits of 14 days per batch. In fact, the two Separation trains can handle 75 batches 
per year (three fermentation trains) ifthere is enough demand. Approximately 1.6 kg of 
tP A should be present after lyophilization, and this is enough tP A for 16,000 doses. Our 
yearly production is then estimated at 1.28 MM doses. 
Water Purification System 
City water from stream WI 01 is brought into the water purification system 
through pump PW-1 (see specification page 135). This water contains small organic 
molecules, salts, and various types of bacteria, so it must be purified to meet purified 
water standards. 
The water stream WI 02 is pumped through filter FW-l (see specification page 
136) to separate any particles that are larger than 10 ~m. FW-l is a tangential flow filter, 
which has the advantage over the dead-end filter such that it can generate higher 
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permeate flow. The purpose of FW-1 is not only to separate unwanted particles, but also 
to protect the membrane of the reverse osmosis system downstream from damaging large 
particles. Since FW-1 is exposed to many particles and unwanted species, it is easily 
contaminated, so we will replace it before starting each batch. After FW-1, city water will 
be pumped through FW-2 (see specification page 138), which is used to remove chlorine 
and organic molecules. Chlorine must be removed from city water at this point since it is 
quite erosive to the cation resin in water softener as well as the reverse osmosis 
membrane and 0.2 )..lm filter downstream. Organic molecules can also damage the 
reverse osmosis system membrane. After FW-2, city water is pumped directly to FW-3 
(see specification page 139) using pump PW-3 (see specification page 140). Filter FW-3 
is present to remove ions from the city water. For this particular softener, the Polystyrene 
Sulfonate cation is chosen because it binds to positive ions like magnesium and calcium, 
which are abundant in impure water. 
At this point, large particles, chlorine, organic molecules, and positive ions have 
already been separated from the city water stream. Water in stream W1 08 will now enter 
RO-1 (see specification page 142), which is considered the most important piece of 
equipment in the water purification process. The reverse osmosis system RO-1 is a high­
pressure unit that allows only water to flow through its semi-permeable membrane. The 
membrane is able to filter out any remaining ions, small particulates, organic molecules 
or bacteria. Purified water RO-l is then transferred to the storage tank TW-1 (see 
specification page 143) so that it can be allocated for various uses during the process. 
During the time that the purified water sits in TW-1, some extremely small organic 
particles and ions may be settle at the bottom and form larger particles - becoming a 
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source for bacterial contamination. To prevent this from happening, water is circulated 
through UV - I (see specifications page 145), which is capable of breaking down the 
forming particles and killing any bacteria that may be left in the water. When the water is 
needed in the fermentation or separation processes, purified water is flows through pump 
\ 
PW-5 (see specification page 146) into filter FW-4 (see specification page 147), which 
wi 11 act as the last line of protection to trap any minute particulates from contaminating 
the final purified water. Like the 10 Ilm filter, the 0.2 )..tm microfilter will be replaced 
after each batch. 
40 
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Generic tPA Dynamic Control 
Control Considerations 
The calculations for this process were performed assuming steady-state plant 
condi tions. However, the steady-state analysis is not an adequate representation of the 
plant design feasibility. The tissue plasminogen activator (tPA) production process is a 
batch process with a batch length of2 weeks. The plant runs 50 batches a year in two 
separate fermentation trains. The plant must have a reasonable control structure to 
regulate the cell growth environments and the process recycle streams. The total yearly 
production oftPA is only 80 kg/year, therefore the control scheme is important to prevent 
any disturbances that could kill a batch of cells and significantly reduce the yearly 
production. 
The control scheme designed for the tP A process is based on the suggestions 
made by Professor William Luyban from Lehigh University. Dr Lyban's nine basic rules 
of plant-wide control could not be applied to the tPA process because of the batch mode 
of operation. However, he was able to provide assistance in the design of controls over 
individual unit operations. The final control scheme was a result of a meeting with Dr. 
Lyban and Dr. Warren Seider in which he offered suggestions for an optimal structure. 
Control Objectives 
The principle objectives for the control system of a pharmaceutical process that 
uses cells to produce a product are the preservation of 100% sterile quality through out 
the entire production line and the maintenance of the growing environment of 
temperature 37°C and pH of 7.3. The principle constraint for the process is the 
sensitivity of the Chinese Hamster Ovary (CHO) cell line. A CHO cell cannot withstand 
a temperature change of more that ± 2°C or a pH change of more than ± 0.2 units. In 
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addition to growing conditions, a control system is put in place to regulate the flow rates 
of steam that is sparged into recycle streams, as well as streams that are used to fill 
vessels to very specific volumes. The control scheme expresses these specifications 
using controllers that are designated for the important design considerations. 
Control of Individual Unit Operations 
Control of pH in Fermentors 
The fermentors are filled with a media that contains a sodium bicarbonate buffer 
that is sensitive to CO2. Each vessel is equipped with a pH meter located within the cell 
broth liquid. The optimum pH for the cell culture is 7.3 with a tolerance of± 0.2 units. If 
a change in the pH is detected, the pH meter will send a signal to adjust the valve 
attached to the CO2 stream. In order to stabilize the pH to the optimum value, the C02 
forms a chemical reaction with the Sodium Bicarbonate buffer in the media. The Sodium 
bicarbonate ions and CO2 produce the following chemical reaction: 
When the cell broth solution becomes basic, more C02 is pumped into the cell broth in 
order to drive the reaction in the reverse direction to produce more H+ ions in the 
solution. The reverse process occurs if the pH becomes too acidic; the C02 flow rate is 
reduced and the reaction moves to the right in order reduce the number of H+ ions in the 
liquid. 
Level Controls 
All of the tanks and fermentors are equipped with level controls on the inlet flows 
to ensure the exact volume of water or media is added to the unit. In order to preserve the 
sterile quality of the water and the media the fluid cannot be handled manually and must 
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be pumped into the vessels through sanitary piping that is rinsed and sterilized after each 
use. The level control will measure the volume of water or media in the tank and adjust 
a valve located on the inlet flow stream. The liquid volumes must be measured with 
precision for two important reasons: maintain the proper ratio of media to water and 
provide enough void space in the fermentors. In order to provide enough room for 
mixing and air circulation, the three fermentors are only filled with 90% of their capacity 
with cell broth. Additionally, the media is purchased in sterile packages with a pre­
measured volume equaling the amount for one batch; hence the volume of water in the 
tank must correspond to the volume of media added to the tank. 
Temperature and Pressure Controls 
There are two steam spargers used to increase the temperature of warm water 
streams for use in a heating jacket and a heat exchanger. Due to the sensitivity of the 
organic media and the CHO cells, the temperature gradients of the heating streams must 
be very small. The 130°C steam produced in the plant is too hot to be used as the 
heating media in the heat exchanger or the half-pipe heating jacket around the 5000L 
fermentor. As an alternative, steam is sparged into a water stream to produce 
temperatures of 55°C and 38 °C for the Heat Exchanger and Heating Jacket respectively. 
A temperature control is placed on the outlet stream of the sparger for the heating jacket 
to ensure that the water flowing around the fermentor is an unvarying temperature of 38 
0c. The temperature control on the heat exchanger sparger measures the temperature of 
the media outlet stream to adjust the valve on the steam pipeline. Any deviance from the 
setpoint will send a signal to adjust the appropriate valve on each stream. 
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The volume of steam sparged into the water stream is extremely small in 
comparison to the volumetric flow of the water, but over time the volume would build in 
the closed loop system. Since the streams never come into contact with the cells or the 
cell media, unsterile recycle streams can be used for this process. In addition, recycle 
streams cut down on the utility requirement for the plant. Pressure controls are placed on 
the streams in to purge off the additional volume added by the steam. The pressure 
control sends a signal to adjust a valve placed on the purge stream. The flow rate of the 
purge stream is very small but it is necessary to maintain a steady flow through the units. 
The flow rate of the heating jacket water stream is regulated with a temperature 
control that measures the temperature of the cell broth in 5000 L fermentor. The interior 
environment of the fermentor must be maintained at a temperature of 37°C. If the cell 
broth fluctuates from this temperature, the flow of 38°C water in the jacket is increased 
or decreased stabilize the internal environment of the vessel. 
Ratio Flow Control 
Only one control unit is needed in the separation and purification section of the 
tPA process. A ratio flow control is used to specify the % volume of one holding tank 
that is recovered in another holding tank, after it has been passed through an ultra filter. 
The ultra filter reduces the volume of a liquid flow by removing most of the water in the 
stream. The retentate is recycled through the filter to remove as much water as possible. 
The tpa product remains in the retentate flowing off the top of the filter and is collected in 
the ultra filter 2 holding tank . A meter that sends a signal to a flow controller, attached to 
the retentate stream, measures the ratio of the retentate flow rate and the water removal 
flow rate. The flow controller adjusts the valve on the retentate stream so that the flow is 
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equal to 0.06 times the flow the water removal. The function of this control system is to 
remove 94% of the liquid entering the ultra filter and forming a concentrated retentate 
flow stream containing all of the tP A product. 
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TABLE 4: UTILITY COSTS FOR PROCESS UNITS 
Equipment Total # of Units Utility Usage Total Cost per year 
(in Plant) (per year) 1 kW*hr =$ 0.04 
BR-1 2 Electricity 17718 kW*hr $1,417.44 
BR-2 2 Electricity 59060 kW*hr $4,724.80 
BR-3 2 Electricity 177180 kW*hr $14,174.40 
T-1 2 Electricity 118120 kW*hr $9,449.60 
RFU 2 Electricity 126720 kW*hr $10,137.60 
P1 2 Electricity 2952 kW*hr $236.16 
P2 2 Electricity 2952 kW*hr $236.16 
P3 2 Electricity 2952 kW*hr $236.16 
P4 2 Electricity 2952 kW*hr $236.16 
P5 2 Electricity 2952 kW*hr $236.16 
P6 2 Electricity 2952 kW*hr $236.16 
P7 2 Electricity 23620 kW*hr $1,889.60 
Centirfuge Electricity 9000 kW*hr $360.00 
Refrigerator Electricity 87600 kW*hr $3,504.00 
Sep-Pumps Electricity 1461.37 kW*hr $58.45 
Sep-Tank Impellors Electricity 383900 kW*hr $15,356.00 
Bottler 2 Electricity 8176 kW*hr $654.08 
Freeze Dryers 2 Electricity 336530 kW*hr $26,922.40 
WP-1 Electricity 399 kW*hr $15.96 
WP-2 Electricity 260.98 kW*hr $10.44 
WP-3 Electricity 870 kW*hr $34.80 
WP-4 Electricity 130.5 kW*hr $5.22 
WP-5 Electricity 348 kW*hr $13.92 
WP-6 Electricity 435 kW*hr $17.40 
WP-7 Electricity 2610 kW*hr $104.40 
UV-1 Electricity 168 kW*hr $6.72 
RO SYSTEM Electricity 8948 kW*hr $357.92 
Total 1380966.85 kW*hr $90,632.11 
Boiler Natural Gas 1053.6 MMBTU $2,739.36 
Total 1053.6 MMBTU $2,739.36 
Water Production City Water 3000000 L $1,500.00 
Total 3000000 L · $1,500.00 
Total Yearly Cost = $95,000.00 
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Utili.ty Sunlnlary 
Electricity 
The electricity for the plant comes from the local power plant. The electricity is 
used primarily to drive the pump motors, the motors for the impellors, and the 
refrigerators to cool the tanks and the separation room. The tank impellors and the freeze 
dyers account for half of the electricity usage in the plant. The high energy costs for 
these pieces of equipment are caused by the large amount of energy needed to run a 
condenser in the freeze dyer at -55°C and the energy needed to rotate large impellors at 
high rpms in a viscous solution. All of the pump motors are run on electricity but the 
yearly requirement is so small is it negligible. The electricity is purchased at a price of 
$0.04 per kW*hr (Seider p. 376). 
City Water 
Water is purchased from a local water supply and sterilized in house to meet the 
standards required for a bioprocess production line. The HX-l and the heating jacket on 
5000L fermentor are the only two unit operations that use impure water. The remainder 
of the water used in the plant is sterilized in a reverse osmosis purification system. 
Approximately 3,000,000 liters of water are purified each year for use in the process 
streams. These large volumes of purified water are needed to make the liquid media for 
cell growth, make up the basis of the elution buffers for the separation processed, and 
rinse all of the process units to remove debris before they are steam sterilized. Due to the 
location of the plant, the water is available at a relatively moderate temperature of 20°C. 
The water is purchased at a cost of $0.0005 per gal (Seider p.376). 
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Steam 
Low-pressure steam is used through out the plant as a sterilization medium and 
source of energy to heat water streams that supply feed for the HX-l and the wann water-
heating jacket around BR-l. Because the steam is used to sterilize the process 
equipment, it must be made from the sterile water produced in the plant. A boiler heats 
up the water to a temperature of 130°C and a pressure of 39.16 psi. The boiler uses 
natural gas as fuel to produce 500 L steam per hour. The natural gas contains 92.6% C~ 
and can be purchased at a price of$2.60 per MMBTU of heating value. (Seider p. 376) 
Figure 6: Percentages of Total Utility Costs 
, 2% City Water 
3%Natural Gas / 
( 
Electricity95% 
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TABLE 5: Major Equipment Specifications 
Summary of Major Equipment 
Name Description Important Specifications 
BR-1 140 L Fermentor Capacity: 40 L 
Uptime per batch: 7 days 
Quantity required : 2 
Purchase Cost: $85,000 
BR-2 1400 L Fermentor Capacity: 400 L 
Uptime per batch : 10 days 
Quantity required : 2 
Purchase Cost:$125,OOO 
BR-3 5000 L Fermentor Capacity: 5000 L 
Uptime per batch: 14 days 
Quantity required:2 
Purchase Cost: $252,000 
Centrifuge Separates CHO cells from 
media 
Throughput rate400 Llhr 
Uptime per batch :-12 hr ," 
Quantity required : 1 
Purchase Cost: $355,000 
IAffinity 
Column & 
Skid/Pump 
Purify tPA with using anti-
PA antibody 
Bed volume: 58 L 
Resin: CNBr-activated Sepharose FF 
Superficial velocity: 100 cm/hr 
Uptime per batch:48 hr 
Quantity required:2 
Purchase Cost: $200,000 
ER Column & 
Skid/Pump 
Remove endotoxins from 
PA solution 
Bed volume:8.2 L 
Resin: Acticlean Etox 
Superficial velocity: 100 cm/hr 
Uptime per batch : 36 hr 
Quantity required: 2 
Purchase Cost: $1 06,190 
Bottler Load tPA-solution into vials 
~nd load Freeze Dryer 
rays 
Bottling/Loading time: 2 hr 
Electrical requirements: 1.5 hp 
Uptime per batch : 146 hrs 
Quantity required :2 
Purchase Cost: $865,000 
Freeze Dryer Lyophilize tPA solution in 
1OO-mL vials 
Capacity in vials : 3500 
Condenser capacity:200 L water in 24 hrs 
Electrical requirements: 46,,1 kW max 
Uptime per batch : 146 hrs 
Quantity required:2 
Purchase Cost: $640,000 
B-1 Create steam for 
sterilization and spargers 
Capacity: 500 Llhr 
Quantity required: 1 
Purchase Cost: $112,000 
I 
RO-1 Reverse osmosis system Volume of water per year: 3,000,000 L 
Quantity required: 1 
Purchase Cost: $7,500 
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Fermentors 

The Chinese Hamster Ovary (CHO) cell line, which is genetically altered to 
excrete the tissue plasminogen activator (tPA) product protein, is grown up in batches 
through a scale-up process containing a series of three fermentors of varying sizes. A 
small culture of cells is grown in a 40L bioreactor until a cell density of approximately 
3.0 *106 cells/mL is reached. The cells from the 40L fermentor are transferred to the 
400L where new media is added and the cells are allowed to grow up to the same density 
in the larger bioreactor. The final growth and production stage occurs in the 5000L 
fermentor after it has been inoculated with the cell broth from the 400L fermentor. A 
scale up process of this magnitude is required in order to produce enough cells to 
inoculate the largest fermentor with a cell density of 0.25 * 106 cells/mL. Other options 
were investigated, but was determined unreasonable and not cost efficient. Two such 
options that were explored were initially growing up large volumes of cells and freezing 
them, or growing up cells in a laboratory, but it was concluded that a laboratory would 
not have the capacity to produce enough cellular mass to inoculate the 5000 L fermentors 
50 times a year. 
40 Liter Fermentor BR-l 
The function of BR-l is to grow a culture CHO cells up to a density of 3 * 106 
cells/mL to be used to inoculate BR-2. The fermentor operates at an optimum growth 
temperature of37 °C and a pressure of 14.7 psi. The fermentor temperature must be 
regulated with a conventional heating jacket to sustain an internal temperature of 37°C. 
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The interior environment of the ferrnentor must remain constant because the CHO cell 
line is extremely sensitive to any changes. A temperature variance of ± 2°C can kill an 
entire cell culture. 
In addition to the temperature and pressure, the pH of the cell broth is maintained 
at 7.3. A continuous flow of compressed air and CO2 are pumped into the vessel through 
a sparger on the bottom of the tank. This stream of air supplies the oxygen for cellular 
metabolic consumption and carbon dioxide needed to regulate the pH. The ferrnentors 
are all filled with a complete CHO media that is designed to provide all the essential 
nutrients and proteins for CHO cell growth. The media also contains a sodium 
bicarbonate buffer that functions to maintain the pH at 7.3. The pH is adjusted by the 
percent concentration of CO2 in the air stream pumped through the bottom (see Dynamic 
Control page 44). The average flow of CO2 is 5% of the inlet air stream, but a pH control 
unit continuously measures the pH inside of the tank and adjusts the CO2 flow 
accordingly (Goswani p. 633). The compressed air and the CO2 are supplied to the 
ferrnentor from tanks purchased from BOC gases. BR-l requires approximately 0.03 
tanks of compressed air and 0.001 tanks of CO2 per batch (see calculation page 244). 
These growth conditions are deemed optimal by the Bioprocess Engineering book by 
Schuler and Kargi 
The ferrnentor is manufactured and designed by New Brunswick Scientific for the 
growth of animal cells. This ferrnentor is a BIOFLO 5000 Ferrnentor with a total volume 
of 40 L (see appendix page 225). In order to preserve an absolute sterile environment for 
the cells to grow, each vessel is made of 316 Stainless Steel with sanitary piping and 
couplings. A six blade standard marine impeller installed in the center of each bioreactor 
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disperses the air stream and mixes the cell culture. The agitation speed of the culture is 
only 30 rpm due to the sensitivity of CHO cells and the very low shear level the cells can 
endure (Shuler p.451). The agitator is run by an electric motor that requires l.5 hp of 
energy utility. The reactors are sterilized in place by a process of flushing with water to 
remove any excess solid waste and automatically steam sterilized at 130 DC for 
approximately 3-4 hours. The reactor must reach a temperature of 130 DC and remain at 
that temperature for an extended period of time in order to kill or denature anything that 
remains inside the growing environment. 
Attached to the fermentor is a ML-6l 00 controller system is that is capable of 
operating up to six process loops (see appendix page 229). The system also controls the 
sterilization and internal environment preservation. The menu-driven system is designed 
for simple control and minimal operator labor hours. The computer control system can 
be programmed to run a batch for any given amount of time. A vessel view window is 
installed into the wall of the fermentor in order to allow an operator monitor the process 
inside. The cell growth rate and the quality of the automatic sterilization are observed 
repeatedly through out the life of the batch. If a vessel is not completely clean after the 
water flush it must be manually scrubbed before steam sterilization. 
The batch length for the BR-l is 7 days. The batch schedule for the fermentor is 
the following: 
0.5 Days Fill and Inoculate 

5 Days of Cell Growth 

0.5 Days Harvest 

1 Day to Clean and Sterilize 

The times allotted for each of these processes are slightly over estimated to ensure 
enough time, in the event of a disturbance in the system, to provide enough time for the 
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next fennentor in the process train to be prepared to receive the cell broth. The tPA 
production plant contains a total of2, BR-l fennentors; one for each of the two 
fennentation trains. The quoted price from Ted Shields of New Brunswick Scientific for 
one unit with a complete control system is $85,000. (see specification page 96 and 
appendix page 225) 
400 Liter Fermentor BR-2 
The function of BR-2 is to grow a culture CHO cells up to a density of 3 * 106 
cells/mL to be used to inoculate the 5000 Liter Fennentor BR-3. The bioreactor is 
initially inoculated with a density of 0.25 * 106 cells/mL from the cell broth of the 40 L 
fennentor BR-l. The fennentor operates at an optimum growth temperature of37 DC and 
a pressure of 14.7 psi. The fennentor temperature must be regulated with a conventional 
heating jacket to sustain the 37 DC internal temperature. 
In addition to the temperature and pressure, the pH of the cell broth is maintained 
at 7.3. A continuous flow of compressed air and C02 are pumped into the vessel through 
a sparger on the bottom of the tank. This stream of air supplies the oxygen for cellular 
metabolic consumption and carbon dioxide needed to regulate the pH. The fennentor is 
filled with a complete CHO media that is designed to provide all the essential nutrients 
and proteins for CHO cell growth. The media also contains a sodium bicarbonate buffer 
to maintain the pH at 7.3. The pH is adjusted by the percent concentration of CO2 in the 
air stream pumped through the bottom. The average flow of CO2 is 5% of the inlet air 
stream, but a pH control unit continuously measures the pH inside of the tank and adjusts 
the C02 flow accordingly (see Dynamic Control page 44). The compressed air and the 
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CO2 are supplied to the fennentor from tanks purchased from BOC gases. BR-2 requires 
approximately 0.35 tanks of compressed air and 0.1 tanks of CO2 per batch(see 
calculations page 242). These growth conditions are deemed optimal by the Bioprocess 
Engineering book by Schuler and Kargi 
The fennentor is manufactured and designed by New Brunswick Scientific for the 
growth of animal cells. A fennentor this size is custom ordered and designed for the 
specific purpose of growing animal cells. New Brunswick Scientific provides the 
engineering support to aid in the design of a reactor a large as 400L (see appendix page 
231). In order to preserve an absolute sterile environment for the cells to grow, each 
vessel is made of 316 Stainless Steel with sanitary piping and couplings. A six blade 
standard marine impeller installed in the center of each bioreactor disperses the air stream 
and mixes the cell culture. The agitation speed of the culture is only 30 rpm due to the 
sensitivity of CRO cells and the very low shear level the cells can endure (Shuler p. 451). 
The agitator is run by an electric motor that requires 5 hp of energy utility. The reactors 
are sterilized in place by a process of flushing with water to remove any excess solid 
waste and automatically steam sterilized at 130°C for approximately 3-4 hours. The 
reactor must reach a temperature of 130 °C and remain at that temperature for a period of 
time in order to kill or denature anything that remains inside the growing environment. 
Attached to the fennentor is a ML-61 00 controller system is that is capable of 
operating up to sixteen process loops controls (see appendix page 229). The system also 
controls the sterilization and internal environment preservation. The menu-driven system 
is designed for simple control and minimal operator labor hours. The computer control 
system can be programmed to run a batch for any amount of time. A vessel view window 
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is installed into the wall of the fennentor in order to allow an operator monitor the 
process inside. The cell growth rate and the quality of the automatic sterilization are 
observed repeatedly through out the life of the batch. If a vessel is not completely clean 
after the water flush it must be manually scrubbed before steam sterilization. 
The batch length ofBR-2 is 9.5 days. The batch schedule for the fennentor is the 
following: 
Days Fill and Inoculate 
7 Days of Cell Growth 
0.5 Days Harvest 
1 Day to Sterilize 
The times allotted for each of these processes are over estimated to ensure enough time, 
in the event of a disturbance in the system, to provide enough time for the next fennentor 
in the process train to be prepared to receive the cell broth. The tP A production plant 
contains a total 2, BR-2 fennentors, one for each of the two trains. The quoted price from 
Ted Shields of New Brunswick Scientific for one unit with a complete control system is 
$125,000. (see specification page 97 and appendix page 231) 
5000 Liter Fermentor BR-3 
The function of the BR-3 is to grow a culture CHO cells up to a density of 3 * 106 
cells/mL and provide an environment for optimum tP A production. The fennentor 
operates at an optimum growth temperature of 37°C and a pressure of 14.7 psi. A 4-inch 
half-pipe heating jacket located around the outside of the vessel and covered in a 2-inch 
layer of fiberglass insulation is used to maintain the internal temperature at 37°C. The 
tubing is filled with flowing wann water at an average flow rate range of 0.09-0.2 kg/sec 
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(see calculations page 233). The range of flow rates is calculated using various 
environmental conditions. A recycled water stream is heated with sparged steam to 
maintain a temperature of 38°C is circulated through the jacket. Ted Shields of New 
Brunswick Scientific suggested a half pipe jacket over a dimple jacket because a dimple 
jacket is more likely to corrode under to operating conditions. 
In addition to the temperature and pressure, the pH of the cell broth is maintained 
at 7.3. A continuous flow of compressed air and CO2 are pumped into the vessel through 
a sparger on the bottom of the tank. This stream of air supplies the oxygen for cellular 
metabolic consumption and carbon dioxide needed to regulate the pH. The fermentors 
are all filled with a complete CHO media that is designed to provide all the essential 
nutrients and proteins for CHO cell growth. The media also contains a sodium 
bicarbonate buffer to maintain the pH at 7.3. The pH is adjusted by the percent 
concentration of CO2 in the air stream pumped through the bottom. The average flow of 
CO2 is 5% of the inlet air stream, but a pH control unit continuously measures the pH 
inside of the tank and adjusts the CO2 flow accordingly. The compressed air and the CO2 
are supplied to the fermentor from tanks purchased from BOC gases. BR-3 requires 
approximately 7 tanks of compressed air and 0.3 tanks of CO2 per batch (see calculations 
page 240). These growth conditions are deemed optimal by the Bioprocess Engineering 
book by Schuler and Kargi 
The fermentor is manufactured and designed by New Brunswick Scientific for the 
growth of animal cells. A fermentor this size is custom ordered and designed for the 
specific purpose of culturing animal cells. New Brunswick Scientific provides the 
engineering support to aid in the design of a reactor a large as 5000L (see appendix page 
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231). In order to preserve an absolute sterile environment for the cells to grow, each 
vessel is made of 316 Stainless Steel with sanitary piping and couplings. A six blade 
standard marine impeller installed in the center of each bioreactor disperses the air stream 
and mixes the cell culture. The agitation speed of the culture is only 30 rpm due to the 
sensitivity of CHO cells and the very low shear level the cells can endure. The agitator is 
run by an electric motor that requires 10 hp of energy utility. The reactors are sterilized 
in place by a process of flushing with water to remove any excess solid waste and 
automatically steam sterilized at 130°C for approximately 5 hours. The reactor must 
reach a temperature of 130 °C and remain at that temperature for an extended period of 
time in order to kill or denature anything that remains inside the growing environment. 
Attached to the fennentor is a ML-61 00 controller system is that is capable of 
operating up to sixteen process loops (see appendix page 229). The system also controls 
the sterilization and internal environment preservation. The menu-driven system is 
designed for simple control and minimal operator labor hours. The computer control 
system can be programmed to run a batch for any amount of time. A vessel view window 
is installed into the wall of the fennentor in order to allow an operator monitor the 
process inside. The cell growth rate and the quality of the automatic sterilization are 
observed repeatedly through out the life of the batch. If a vessel is not completely clean 
after the water flush it must be manually scrubbed before steam sterilization. 
The batch length ofBR-3 is 14 days. The batch schedule for the fennentor is the 
following: 
2 Days Fill and Inoculate 
8 Days of Cell Growth (and lag time) 
1 Day Harvest 
3 Days to Sterilize 
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The times allotted for each of these processes are over estimated to ensure enough time 
for adequate cell growth and production and provide enough time to stagger 50 batched 
between 2 fermentor trains in the course of one year. The tPA production plant contains 
a total 2, BR-3 fennentors, one for each of the two trains. The quoted price from Ted 
Shields of New Brunswick Scientific for one unit with a complete control system is 
$250,000. (see specification page 98 and appendix page 231) 
Heat Exchanger (HX-l) 
HX-l is a shell and tube heat exchanger, which heats the complete media from 4 
°C to the optimal cell growth temperature of 37°C. It is 4 ft. long with 1 tube pass and 
one shell pass. The unit had 18 tubes with a nominal outside diameter of 0.75 in. and a 
1.25 in. square pitch. The shell has a 6.6 in. inner diameter. The heat duty for this heat 
exchanger is 6.100 * 104 BTUIhr, with an overall heat transfer coefficient of 70 
BTUIF*ft2*hr. Based on these calculations, the heat transfer area of this heat exchanger 
is 12 ft2 (see calculations page 245). 
The media is passed through the tube side at a flow rate of 2 gaVmin counter­
currently to a wann water stream flowing at an approximate flow rate of9.7 gal/min (see 
calculations p 245) that enters the heat exchanger at a temperature of 55°C and exits the 
unit at 48 °C. The warm water stream cannot enter HX-l at a temperature greater than 55 
°C because the organic materials in the media will be damaged. The wann water stream 
is made up of a recycled flow of city water that is temperature controlled with a steam 
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sparger. The additional water accumulated in the stream from the addition of steam is 
regulated by a pressure control and purged off to the waste treatment facility. 
The HX-I is made from 316 Stainless Steel with sanitary piping and couplings to 
ensure sterile conditions. After each batch the unit if flushed out with water twice its 
volume and steam sterilized in place with 130 DC steam for 2 hours. The tPA production 
plant contains a total 2, Heat Exchangers, one for each of the two fermentation trains. 
The total purchase cost of one exchanger is estimated using cost table in the Process 
Design book by Dr. Warren Seider to be $6500.00. (see specification page 99 and 
appendix page 245) 
Blending Tank (T-l) 
The media blending tank is used to combine the duel powder HyQ PF-CHO 
media with 4500 L of sterile water in order to produce the complete media for use in BR­
1, BR-2, and BR-3. The tank is first filled with 90% of the total volume of water desired. 
While the water is gently stirred at 50-60 rpm, the powder media is added and mixed 
until it is dissolved. The agitation motor that drives the impellor requires 10 hp and uses 
59000 kW*hr per year energy (see calculations page 255). The water must stay at room 
temperature, 20 DC while the powder is mixed into the water in order to ensure complete 
dissolution. The volume is then brought up to 100% and the media is cooled to a 
temperature of 4 DC. Due to staggered scheduling of each batch, the three fermentors are 
filled at different times over the course of 7 days. The media remains in the tank at 4 DC 
until it is needed in the fermentors. As suggested by Dr. Kivnick the T -1 is equipped 
with a refrigeration unit and a jacket of copper tubing that is filled with flowing 
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refrigerant (freon) in order to cool the liquid inside the tank. The outside of the tank is 
covered with a 2 in. layer of fiberglass insulation to decrease the refrigeration 
requirements. The refrigerator requires 65000 kW*hr per year to cool the liquid. 
The media is prepared 2 days before its first scheduled use in order to allow 
adequate time for quality testing of the mixed media. A sample of media extracted and 
used to grow up a cell culture in the quality assurance laboratory. The results of the 
culture are analyzed for the presence contamination and the average cellular growth rate 
for the batch of media. The tank is manufactured using pharmaceutical standards of 
materials and sterile qUality. The tank and internal impeller are made from 316 stainless 
steel and the piping associated with the vessel is of sanitary grade. The unit is designed 
to be steam sterilize in place after each batch. The blending tank is flushed out with 
water twice its volume to remove any lingering debris and steam sterilized at 130°C for 
3-4 hours. A sight glass is installed on the top of the tank so operators can view the 
process inside and watch for any build up ofmaterial on the walls and impellor inside the 
vessel that would have to be manually washed before steam sterilization. 
The tP A production plant contains a total 2, T -1 tanks, one for each of the two 
fermentation trains. Walker Stainless Steel Equipment approximates the cost of this 
blending tank at $28,658.00 (see appendix page 250). Under the advice ofDr. Kivnick, 
an additional $2,000 is added to the purchase cost for the copper tubing that makes up the 
cooling jacket and the insulation. The small refrigerator attached to the tank is quoted at 
$20,000 and 8 tons of refrigerant is purchased at a price 0[$250.00Iton to provide the 
fuel for the refrigerator. (see specification page 100 and appendix page 250) 
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PUlnps 
Filter Pump P-l and P-2 
Filter Pumps P-1 and P-2 increases the pressure of the 2 gal/min liquid media 
stream from 14.7 psi up to 29.7 psi and sustains the volumetric flow rate. P-1 controls 
the steam leaving T-1 and pushes the 4 °C stream through a 2 !lm filter F-l. P-2 
increases the pressure of the same stream to overcome the pressure drop from F-1 and 
push the stream through the next filter F-2. The pumps are Randolph Austin Series 610 
vari-flow speed control peristaltic pumps that are equipped to handle a pharmaceutical 
grade product streams and maintain their sterile quality (see appendix page 256). The 
pumps are made out of stainless steel, which is sterilized in place by flushing water 
through the pump until all residues are removed and steam sterilized at 130°C for 30 
min. The power requirement for this peristaltic pump is specified by Randolph Austin 
Company at 0.25 hp. There are a total of four filter pumps in the tP A production plan, 
two for each of the two fermentation trains. The cost ofone pump is listed as $1595.00. 
(see specification page 101 and appendix page 253) 
Heat Exchanger Pump P-3 
Heat Exchanger Pump P-3 increases the pressure of the 2 gal/min liquid media 
stream leaving F-2 at 14.7 psi to 29.7 psi and sustains the volumetric flow rate. The 
pressure increase of the stream is used to flow the 4°C stream through HX-l. The pump 
is a Randolph Austin Series 610 vari-flow speed control peristaltic pump that is equipped 
to handle a pharmaceutical grade product stream and maintain its sterile quality (see 
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appendix page 256). The pump is made out of stainless steel, which is sterilized in place 
by flushing water through the pump until all residues are removed and steam sterilized at 
130°C for 30 min. The power requirement for this peristaltic pump is specified by 
Randolph Austin Company at 0.25 hp. There are a total of2 Heat Exchanger pumps (P­
3) in the tP A production plan, one for each of the two fermentation trains. The cost of 
one pump is listed as $1595.00. (see specification page 103 and appendix page 253) 
Cell Broth Pumps P-4 and P-5 
The Cell Broth pumps function to move the cell broth from one fermentor to the 
next one in the process train. The streams flow at a volumetric flow rate of2 gal/min at 
38°C and a pressure of29.7 psi. P-4 moves the cell broth from the BR-I to BR-2 and P-5 
moves the cell broth from BR-2 to the last unit of the train, BR-3. The pump increases 
the pressure of the stream from 14.7 psi to 29.7 psi to over come any pressure drop that 
occurs over the piping between the bioreactors. The pumps are Randolph Austin Series 
610 vari-flow speed control peristaltic pumps that are equipped to handle a 
pharmaceutical grade product stream and maintain its sterile quality (see appendix page 
256). The pump is made out of stainless steel, which is sterilized in place by flushing 
water through the pump unttl all residues are removed and steam sterilized at 130°C for 
30 min. The power requirement for these peristaltic pumps is specified by Randolph 
Austin Company at 0.25 hp for each. There are a total of four cell broth pumps in the 
tP A production plan, two for each of the two fermentation trains. The cost of one pump 
is listed as $1595.00. (see specification page 104 and appendix page 253) 
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Heating Jacket Water Pump P-6 
The function ofthe Heating Jacket Water Pump P-6 is to flow water through the 
half-pipe heating jacket that surrounds BR-3. The water is used to maintain an internal 
fermentor temperature of37 °C. The flow rate ofwater is dependent upon the heat loss 
from the reactor to the environment. The flow rates are calculated to range from 0.2 
kglhr to 0.09 kg/hr for different environmental conditions (see calculations page 233). 
The pump also increases the pressure ofthe stream from 14.7 psi to 29.7 psi in order to 
overcome the pressure drop that occurs along the tubing. The pump is a Randolph Austin 
Series 610 vari-flow speed control peristahic pump that is equipped to handle a 
pharmaceutical grade product stream and maintain its sterile quality (see appendix page 
256). The pump is made out of stainless steel, which is sterilized in place by flushing 
water through the pump until all residues are removed and steam sterilized at 130°C for 
30 min. The power requirement for this peristaltic pump is specified by Randolph Austin 
Company at 0.25 hp. There are a total of two heating jacket water pumps in the tP A 
production plan, one for each of the two fermentation trains. The cost ofone pump is 
listed as $1595.00. (see specification page 106 and appendix page 253) 
Heat Exchanger Water Pump P-7 
The function of the Heat Exchanger Water Pump is to flow warm water through 
the shell side ofHX-I. The water is used to heat up a stream ofmedia from 4 °C to 38 
°C. The calculated flow rate ofwater of the water is approximately 9.6 gal/min (see 
calculations page 245). The pump also increases the pressure ofthe stream from 14.7 psi 
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to 29.7 psi in order to overcome the pressure drop that occurs over the heat exchanger 
and piping. The pump is a Corcoran Model 3000D-HDl centrifugal pump that is 
equipped for small flow rates (see appendix page 260). The pump is made out of carbon 
steel and has a power requirement of2.0 hp. There are a total of two heat exchanger 
water pumps in the tP A production plan, one for each of the two fermentation trains. 
The cost of one pump is listed as $3250.00. (see specification page 107 and appendix 
page 253) 
FILTERS 

Fermentor Air Filters (F-3, F-4, F-5, F-6 F-7, and F-8) 

The air filters attached to the air inlet streams and the air purge streams of the 6 
bioreactors function to sterilize the air that is fed to the cell culture and purify the exhaust 
air from the fermentors of any biomaterial before it is released to the environment. The 
Osmonics Memtrex-FE Filters are dead-end filters that are made from PTFE membrane 
with an absolute filtration rating of0.2 flm. The filters are designed to handle inlet flows 
up to 15 cc/min per 10 inches of filtration area. Each cartridge is 2.75 inches in diameter 
and 10 inches in length. Multiple cartridges can be placed in a row to handle larger flow 
rates, but only one lOin cartridge is needed to handle the air flows for the process that 
range from 0.03-0.35 kg/hr for the three different size fermentors. The pressure drop over 
the filter is calculated by the equations provided by Osmonics to be than one bar for each 
of the filters because of the small volumetric flow rate and working pressure of29.7 psi. 
(see appendix page 267). 
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The air filters are replaced approximately every 3rd batch, but the outlet flows are 
still monitored by operators by gages on the pipes, in case a filter must be replaced before 
the end of the third batch. In between batches, the filters are flushed with water and 
sterilized with 130°C steam for 30 min. There are a total of 12 air filters in the tP A 
production plan, six for each of the two fennentation trains. The cost of each filter is 
quoted by Osmonics to be $44.00 per filter. Installation costs and piping are factored in 
to the overall construction cost of the plant in the economics flow sheet. (see 
specification page 110 and appendix page 267) 
Media Filter- 2 Jlm (F -1) 
The media filter F -1 function to sterilize the prepared media in the blending tank, 
before it is pumped into the fennentors. The 2 !lm filter is used primarily to protect the 
0.2 !lm filter F-2 from clogging to easily. The Osmonics Flotrex-AP Filters are dead-end 
filters that are made from polypropylene fiber media with an absolute filtration rating of 2 
!lm (see appendix page 263). Each cartridge is 2.75 inches in diameter and 10 inches in 
length with effective filtration area of5.2 ft2. The filter operates with a flow of2 gaVmin 
at a temperature of4°C and a pressure of29.7 psi. The pressure drop calculated using 
the equations provided by Osmonics is extremely small; therefore an estimated pressure 
drop of 15 psi was used for all design calculations. 
F-l is replaced every batch, but the outlet flows are still monitored by operators 
through the aid of gages on the pipes, in case a filter must be replaced before the end of 
the batch. During the course of one batch the filter is used three times: once to fill each of 
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the three fennentors. The filter is sterilized during down time between each media load 
with sterile water that is flushed through the filter to remove any debris and steam 
sterilized at 130°C for 30 min. There are a total of 2, F -2 filters in the tP A production 
plan, one for each of the two fennentation trains. The cost of each filter is quoted by 
Osmonics to be $32.00 per filter. Installation costs and piping are factored in to the 
overall construction cost of the plant in the economics flow sheet. (see specification page 
108 and appendix page 263) 
Media Filter- 0.2 ~m (F -2) 
The media filter F-2 function to sterilize the prepared media in the blending tank, 
before it is pumped into the fennentors. The 0.2 f!m filter removes 99.9% of all 
contaminants found in the media. The Osmonics Memtrex-FE Filters are dead-end filters 
that are made from PTFE membrane with an absolute filtration rating of 0.2 f!m. Each 
cartridge is 2.75 inches in diameter and 10 inches in length that can handle a maximum 
flow of 15 cc/min. The filter operates with a flow of 2 gal/min at temperature of 4 °C 
and a pressure of 29.7 psi. The pressure drop calculated using the equations provided by 
Osmonics is extremely small; therefore an estimated pressure drop of 15 psi was used for 
all design calculations (see appendix page 267). 
F-2 is replaced every batch, but the outlet flows are monitored by operators by 
gages on the pipes, in case a filter must be replaced before the end of the batch. During 
the course of one batch the filter is used three times: once to fill each of the three 
fennentors. F-2 is sterilized in down time between each media load with sterile water 
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that is flushed through the filter to remove any debris and steam sterilized at 130 °e for 
30 min. There are a total of2 media filters in the tPA production plan, one for each of the 
two fermentation trains. The cost of each filter is quoted by Osmonics to be $44.00 per 
filter. Installation costs and piping are factored in to the overall construction cost of the 
plant in the economics flow sheet. (see specification page i09 and appendix page 267) 
Boiler 
A small single boiler generates all ofthe plant's sterile steam. The steam is used 
to sterilize all process equipment and piping, as well as a source of energy to increase the 
temperature of four water streams. The boiler produces approximately 500 lblhr of39.16 
absolute pressure, 130 °e steam. The water used to make the steam enters the boiler 
from an in-house water purification system and is pumped in at 20 °e. The fuel for the 
boiler, 54.54 lblhr ofnatural gas, which is 94.2% methane, is fed to the boiler. The 
heating values of the natural gas stream are 23,000 BTU/lb. 
The boiler efficiency is predicted to be 85%. The plant sterilization requirement 
and the sparged streams are small compared to the capacity of the boiler, but an over 
estimate was assumed in order to account for an increased load on the system and 
provided enough capacity if the plant was expanded. The boiler is equipped with sanitary 
piping and stainless steel components in order to maintain the highest levels of sterility. 
Boiler controls include a feed-water flow control, fuel flow control, and the emission 
monitoring equipment. The Icarus Process Evaluator and Aspen Steady State Simulator 
aided in the boiler design. The approximate cost quoted by the IPE program for a boiler 
of this size is $112,000. (see specification page ili and appendix page 279) 
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Blending Tanks 
Blending tanks are used throughout the Separation section to ease batch 
scheduling and adjust the chemical composition of our product solution. The Separation 
section, including all blending tanks, is held at 4°C. Low temperatures prevent loss of 
protein activity over time, a primary concern during storage. Solutions are constantly 
being agitated during storage or blending. Electrical requirements were calculated 
assuming constant agitation over 7,920 hrs/year (large overestimate) and power needs of 
7 hp for 300-500 L tanks and 10 hp for 4000-5000 L tanks. Yearly impeller electrical 
needs for Holdup and UFl Tanks are 59,000 kW*hr. The remaining smaller tanks each 
required 29,500 kW*hr/year (see appendix page 362). All tanks are cleaned-in-place 
(CIP) after each use by flushing with two tank volumes of sterile water and sterilized-in­
place (SIP) with steam for 30 minutes. Tanks are made with 316 Stainless steel and 
pricing was completed with information from Walker Stainless Equipment. (see appendix 
page 250) 
Holdup Tank 
The function of this blending tank is to provide storage space for our product after 
removal from BRI. The capacity of this tank is 5000 L, but its use will only be necessary 
if the Centrifuge is being repaired. The cost ofHoldup Tank is estimated at $19,000 
based on information provided by Walker Stainless Equipment. (see specification page 
112 and appendix page 250) 
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UFI Tank 
The function of this tank is to blend arginine to 1M (-850 kg) in the product 
stream taken from the Centrifuge. tP A will be concentrated in the next step, so protein 
aggregation will be a concern; the arginine is added to prevent this aggregation. The 
product solution is then stored overnight until it is pumped to UFI the next morning. 
UF.! Tank also acts as a holding tank for the retentate recycled from UFI during the first 
ultra filtration step. Its capacity is 4000 L, and its cost was quoted at $17,000 by Walker 
Stainless Equipment. (see specification page 113 and appendix page 250) 
UF2 Tank 
The function of this 300 L tank is to blend arginine to 2M (-67 kg) in the 
retentate collected from UFt. All of the retentate from UF2 is recycled to UF2 Tank 
during the second ultra filtration step. The cost ofUF2 Tank was quoted at $9,000 by 
Walker Stainless Equipment. (see specification page 114 and appendix page 250) 
Affinity Tank 
The function of this tank is to store UF2 filtrate at 4°C before it is applied to 
Affinity Column. One quarter of its initial contents (-80 L) will be applied to Affinity 
Column in each of four cycles. The cost of this 400 L capacity tank is estimated at 
$10,000 based on infonnation provided by Walker Stainless Equipment. (see 
specification page 115 and appendix page 250) 
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ER Tank 
The function of this 400 L tank is to store the elution from Affinity Column at 
4°C, increase its contents' pH by addition of 1M NaOH, and add the required amount of 
sucrose. Sucrose will also be added in this tank so any endotoxins introduced with it will 
be removed in the ER Column. Approximately 80 mL of 1M NaOH is added to ER Tank 
after each Affinity Column elution is collected. This is sufficient to neutralize the 
solution (see appendix page 345). Sucrose is then added in the amount of0.03 kg. After 
water-for-injection (WFI) is added to MF Tank the concentration of sucrose will be 0.2 
rnM and the salt concentration will be well within the injection standards given by Prof. 
Diamond (see appendix page 289). Its cost is estimated at $10,000. (see specification 
page 116 and appendix page 250) 
MFTank 
Final preparation of the product solution takes place in MF Tank. WFI is added 
to increase the volume to 400 L. This sets the volume loaded into each 100 mL vial at 
approximately 25 mL. The capacity ofthis tank is 500 L and its cost is estimated at 
$11,000. (see specification page 117 and appendix page 250) 
FDTank 
The function of this tank is to store and agitate the MF filtrate at a temperature of 
4°C until it is bottled (about 6 days). A small sample ofFD Tank contents is taken to the 
control laboratory to determine the tP A concentration, which is required to set the amount 
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of solution that will be loaded in each 100-mL vial. The absorbance of light at 260 nm 
provides us with the protein concentration in our solution (the tryptophan in the protein 
absorbs light at this wavelength). The volume of solution per vial is such that 100 mg of 
tPA will be present after lyophilization (freeze drying). Bottling and freeze drying occur 
in five cycles, requiring one-fifth of the initial FD Tank (~80 L) contents to be transferred 
out every 26 hrs. FD Tank capacity is 500 L and its price is estimated at $11,000. (see 
specification page 118 and appendix page 250) 
Centrifuge 
The Centrifuge is used to remove the CHO cells from the media harvested from 
BR1. tP A is secreted from the cells after it is produced, so we can separate the intact 
cells while losing minimal protein. I assumed that 5% of the tP A present in the harvest 
media was lost during centrifugation, a large estimate. For the removal of mammalian 
cells, the CSC 4 Clarifier by Westfalia Separator has a capacity of 400-500 LIhr. A built­
in control system measures the turbidity of the clarified liquid and ejects solids when 
necessary. Cleaning and sterilization are accomplished by washing with NaOH for 30 
minutes and SIP for 30 minutes at 130°C. Given that processing time is less than 10 hrs, 
one centrifuge is capable of handling batches from both Bioreactor trains. Even if three 
5000 L Bioreactor trains were present there would be sufficient downtime for regular 
maintenance of the centrifuge. The Westfalia representative assured me that the clarifier 
is extremely reliable and breakdowns are rare. Power requirements are 9,000 
kW*hr/year. The price of the CSC 4 Clarifier with controls, CIP, SIP, and a three 
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charmel centripetal pump was quoted as $355,000. (see specification page 119 and 
appendix page 296) 
Pumps 
Since our product is produced batch-wise in relatively small volumes, peristaltic 
pumps are sufficient for us to use throughout our process. Maximum flow rates and an 
efficiency of 80% were used in calculating the power requirements and costs for each 
pump. All pumps operate at 4°C within the air-conditioned Separation section. (see 
appendix page 362) 
UFIPump 
UFl Pump is required to increase the pressure of stream P-6 solution to 40 psi 
before it is ultra filtered in UFl. The Series 750-362 Vari-flow pump from Randolph 
Austin Company can bring 830 LIhr of solution up to 40 psi from a 14.7 psi tank. 
Electrical requirements for this operations were calculated as 390 kW*hr/year. The price 
for this pump was quoted by a Randolph Austin representative as $2,656. (see 
specification page 120 and appendix page 256) 
UF2 Pump 
UF2 Pump increases the pressure of stream P-ll from 14.7 psi to 40 psi at a flow 
rate of 1350 Uhr. Again, the Series 750-362 Vari-flow pump from Randolph Austin 
Company will be used. Electrical requirements are 625 kW*hr/year, though it should be 
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much less given that the pump is used for less than an hour each batch. The price for 
UF2 Pump is also $2,656. (see specification page 121 and appendix page 256) 
MFPump 
MF Pump produces a pressure of34.7 psi in stream P-30, the inlet stream to MF. 
The pressure drop across MF is assumed to be 20 psi, though it is certainly much lower 
than that value. Increasing the pressure ofMF Tank contents from 14.7 psi to 34.7 psi at 
a flow rate of 1135.6 LIhr can be accomplished by the Series 750-362 Vari-flow pump 
from Randolph Austin Company. Electrical requirements for a year of use are 425 
kW*hr. The price is again $2,656. (see specification page 122 and appendix page 256) 
Affinity Skid/Pump 
The Affinity SkidlPump increases the pressure at the inlet of the Affinity Column. 
Its computer controls the volumes of the Load, Equilibration, Elution, and Wash steps 
(see Affinity Column description page 82). Given a superficial velocity of 100 cmlhr, the 
volumetric flow rate applied to this column is 135 LIhr. The pressure drop across the bed 
was calculated as 1.2 psi using the Ergun equation. This number was increased to 10 psi 
in determining the 25 kW*hr of electricity required each year to run the pump. Due to 
the fact that items such as this are custom-made by Amersham Pharmacia Biotech, the 
representative was unable to quote an accurate price. Prof. Diamond recommended 
$100,000, which includes all of the pumping, computer, and control equipment. (see 
specification page 123 and appendix page 256) 
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ER Skid/Pump 
The ER Skid/Pump controls flow through the ER Column and increases the inlet 
pressure to make up for the pressure drop across the packed bed. Product, Cleaning, and 
Regeneration solutions are applied to the column at 100 cmlhr or 11 LIhr (see ER 
Column description page 84). The pressure drop across the bed is 1.9 psi as calculated by 
the Ergun equation. Again, the value was increased to 10 psi in detennining the yearly 
electrical requirements of2 kW*hr. Amersham Pharmacia Biotech could not provide a 
quote for ER SkidlPump, so Prof. Diamond's recommendation of$100,000 will be used 
again. (see specification page 124 and appendix page 256) 
Tangential Flow Filtration 
Tangential flow filtration involves the flow of a feed stream through a hollow 
fiber filter in order to concentrate a product or remove solids from a stream. It is ideal for 
use in the separation of small biological molecules and organisms. 
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Ultra filters are used early in the process to concentrate the tPA solution after 
centrifugation. Following the first ultrafilter, a second is used to "clean up" the solution 
before the chromatography steps. 
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The product stream flows along the filter, and osmotic pressure is used to push water or 
dissolved solids through the filter. Proteins will either be rejected by the membrane or 
flow through it, depending on the filter's specified Molecular Weight Cut-Off (MWCO). 
If the protein's size is larger than the MWCO it remains in the retentate; if the MWCO is 
larger than the protein it will flow through as penneate. (see appendix page 303) 
UFI 
UFI is used to concentrate tPA from the Centrifuge supernatant. UFl Tank 
contains approximately 2 kg oftPA in about 3500 L ofliquid media. This volume will be 
reduced to about 250 L. The MWCO ofthe Koch Membrane HF 14-43-PM50 is 50 kDa 
(a Dalton is equivalent to one gram per mole and is commonly used in the description of 
protein sizes). The molecular weight oftPA is 66 kDa, which causes it to be rejected 
from the membrane remain in the retentate. The filtrate flux is specified for the PM50 as 
550 LIhr; given this flow rate and starting volume, 33 LIhr (or 6% of 550 LIhr) needs to 
be taken off as product retentate. The remaining retentate is recycled back to UFl Tank 
as shown in Figure 8 on page 81. A ratio-flow controller is used to control the product 
retentate flow in stream P-8. An inlet pressure of 40 psi is required, and the pressure 
drop was quoted as 10 psi. f'he membrane is made ofpoly sulfone and has an area of 14 
ftl. The Koch Membrane representative assured me that fouling would not be a problem 
and that the PM50 filter would last for at least a year. The amount of tP A lost to 
denaturing is assumed to be only 2%. This is a conservative estimate given that the pores 
are designed to prevent clogging and aggregation at the openings. Cleaning is 
accomplished by recirculation through the membrane of 10 gal diluted surfactant 
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solution, priced at $75 per concentrated bottle. The pump and blending tanks are priced 
separately, and the PM50 cartridge costs $785. Piping and equipment setup costs are 
factored in during our economic analysis. (see specification page 125 and appendix page 
303) 
UF2 
UF2 removes larger components that were not separated in the Centrifuge. The 
MWCO of the Koch Membrane HF 14-43-PM500 is 500 kDa and will remove larger 
proteins and cell debris that can potentially foul the resin in Affinity Column or ER 
Column. tPA flows through the membrane and is collected along with the entire volume 
ofUF2 Tank as filtrate. The inlet pressure is 40 psi and there is a pressure drop of 10 psi 
across the membrane. The filtrate flux is specified as 880 Llhr over the 14 ft2 
polysulfone filter, and all of the retentate is recycled to UF2 Tank. Cleaning is again 
done be recirculating the surfactant fluid through the membrane. Because the tP A flows 
through the mem~rane I increased the tP A loss to 5%, though the Koch representative 
stated that minimal protein would get caught. The price of the PM500 cartridge was 
quoted at $950 and it will be replaced yearly. (see specification page 126 and appendix 
page 303) 
MF (Microfiitration) 
MF performs a final sterilization of the product stream before it is bottled and 
freeze dried. The 9 ft2 PTEF membrane has a pore size of 0.2 microns. Unlike the UF1 
and UF2 above, MF is a dead-end filter, where all of the fluid passes through the 
membrane and is collected as filtrate. The pressure drop over MF is generously assumed 
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to be 20 psi, and the maximum flow rate is 1140 Llhr. Filter cartridges will be replaced 
after each batch and they are quoted at $44 each by Osmonics. (see specification page 
127 and appendix page 267) 
Affinity Column and Resin 
Affinity Column is the most important separation unit in our process. It utilizes 
affinity chromatography to select for tP A. Affinity chromatography involves the binding 
of a protein or other biologically active molecule to a resin or other biologically active 
molecule. This process utilizes the binding of a monoclonal antibody to tP A. A 
monoclonal antibody simply means that will only bind with our protein. The anti-tP A 
antibody is bound to the Affinity resin where it remains indefinitely. A protein solution 
is loaded onto the column and as it flows through, the active protein (tPA in our case) 
binds to the antibody that is attached to the resin. After the Loading is complete, the 
column is washed,or equilibrated with Equilibration buffer. Finally, the column is eluted. 
Elution takes place in a high salt or acidic solution; these conditions cause the protein to 
break its bond with the antibody. The Elution only contains the active protein and any 
salts or amino acids present in the Elution buffer. The column is then washed with 
Equilibration buffer and can be reused (the antibody remains attached to the resin 
throughout the process). 
Our 58 L 316 Stainless steel column is completely filled with CNBr-activated 
Sepharose 4 Fast Flow resin. The resin is made up of agarose beads with an average 
diameter of90 microns, and our anti-tPA antibody forms a bond with the CNBr that is 
attached to the resin. The contents ofAffinity Tank are run through the Affinity Column 
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in four cycles. After the first Load is applied to Affinity Column (through the Affinity 
SkidlPump), 2.5 bed volumes ofEquilibration buffer is applied to the column (a bed 
volume is the volume of resin in the column, or 58 L). 1.3 bed volumes of Elution buffer 
then flows through the column, and this tP A-containing solution is collected and sent to 
ER Tank. The column is then washed with 5 bed volumes of Equilibration buffer and 
cycle repeats itself three more times until the entire batch has been eluted. After each 
batch the resin will be stored in 20% ethanol. 
Amersham Pharmacia Biotech recommends flow through the column at 100 
cmlhr superficial velocity or 135 LIhr in our 70 cm diameter column (15 cm height). The 
pressure drop across the packed bed was calculated at 1.2 psi using the Ergun equation. 
The buffer solutions used were the same as those used by Reagan et al. Equilibration 
buffer contains is 0.65M NaCl in PBS at a pH of 6.8, and an acidic elution buffer is used, 
which contains 0.5M glycine and 204M arginine at a pH of2.85. In calculating the resin 
requirements I used the value of 12.3 mg antibody/mL resin from Reagan et al. I 
assumed that only 85% of the resin would be utilized and then provided enough resin to 
bind all of the protein applied to the column (0.5 kg per cycle). Even with the increased 
amount of resin I am assuming a loss of 15% of the tPA applied to the column based on 
the recommendations by Prof. Diamond. 
Bioprocess Stainless steel chromatography columns are custom-made by 
Amersham Pharmacia Biotech, so we are using Prof. Diamond's recommendation of 
$100,000. The anti-tP A antibody will be produced in our facility, but no data is available 
on its production so Prof. Diamond advised us to use an estimate of$2,000Ig antibody. 
We require 710 grams each the column so we accounted for 750 grams of antibody in our 
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economic evaluation. The Sepharose resin can be bought in bulk from Amersham 
Pharmacia Biotech at $2,81 OIL. Both the resin and antibody will need to be replaced 
each year. (see specification page 128 and appendix page 314) 
ER Column and Resin 
The ER Column is used to remove endotoxins from the tP A solution. Endotoxins, 
or pyrogens, are biochemicals that come from the cell wall of bacteria. If an endotoxin 
containing solution is injected into a human, it will cause a feverish reaction and make 
the person feel sick. Our process does not utilize bacteria in any way, but endotoxins will 
still be present in low, but significant amounts. Endotoxins may enter our process in the 
chemicals or materials we use, such as the media, PBS, sucrose, or NaCI (other chemicals 
are bought endotoxin free). Endotoxins cannot be removed or "killed" with steam 
sterilization, so they may remain on equipment even after a SIP cleaning. NaOH 
application can remove pyrogens, but this would destroy our protein. 
For the removal of endotoxins in our process we will use the Actic1ean Etox resin 
from Sterogene. This resin binds endotoxins while allowing a protein to flow through 
unaffected. The binding capacity of this resin ranges from 200 EU(endotoxin units)/mL 
resin to 20000 EU/mL resin. Prof. Diamond advised us to assume our product solution 
had 5 EU/mL. Our final endotoxin level must be below the detectable level of 0.05 
EU/mL. Given these specifications, 8.2 L of the Actic1ean Etox resin will suffice in 
rendering our product safe for injection. The 200/500 Bioprocess glass column from 
Amersham Pharmacia Biotech can hold 8.2 L of resin and provides a large bed height to 
increase contact time. The bed height is 26 cm (column height is 50 cm) and the column 
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diameter is 20 cm. Flow through the column takes place at a neutral pH and 100 cmlhr 
(11 LIhr). I am assuming a 5% loss oftPA, though Sterogene references experiments 
where 99% of the protein is recovered. After our product solution is loaded and 
collected, the resin needs to be washed with 1M NaOH for two hours. The resin is then 
regenerated with WFI and stored at a neutral pH of 7.0. Amersham Pharmacia Biotech 
quoted the column at $6,190, and the resin was quoted at a bulk price of$4,320/L by 
Sterogene. The resin is replaced each year, and costing is completed assuming a 
purchase of 10Llyear. (see specification page 130 and appendp. page 329) 
Bottler 
The bottler loads a designated amount of the final tPA solution in 100 mL vials, 
stoppers them, and loads them into the freeze dryer. The Cozzoli Machine Company 
provides machines that interact with one another to complete these tasks. The VR 840S 
can load approximately 3200 100-mL vials with 25 mL of fluid in about an hour. A 
concentration meter is required to set the amount oftPA solution that will be loaded in 
each vial. The BT15 Tray Loader can load these vials into the freeze dryer in one hour, 
and the A W160 Automatic Washer can clean and sterilize the VR 840S and BT15 after 
each cycle. The freeze dryer needs to be loaded and unloaded five times per batch, so the 
total uptime for the Bottler is about 146 hrs, though it is idle for most ofthat time. Each 
machine requires 0.5 hp, and the total yearly electrical requirements are 8,200 kW*hr. 
The total cost quoted by Cozzoli Machine Company is $1,265,000. (see specification 
page 132 and appendix page 346) 
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Freeze Dryer 
The freeze dryer removes WFI from the final tP A solution, creating a stable solid 
product. The final product is lyophilized (freeze dried) because it can remain active 
indefinitely; the solid simply needs to be redissolved inWFI. The exact time it takes to 
lyophilize a protein can only be determined experimentally. Since we are unable to 
perform these tests we will be assuming a drying time of 24 hrs. The condenser capacity 
of the Virtis Benchmark 6000 SQ Stoppering Lyophilizer is 220 L ofwater in 24 hours. 
Each cycle will only contain about 80 L of solution, making our estimate of 24 hrs very 
reasonable. The freeze dryer first freezes the solution in a vacuum, causing the solid 
solution to sublimate (water vapor can escape the partially stoppered vials). After this 
primary drying is complete, the remaining water molecules are removed by slowly 
introducing heat. This must be done gradually because any extreme temperature changes 
can cause the protein to lose activity. All heating and cooling is done by way of a silicon 
fluid. The silicon heat transfer medium flows through the baffled trays and back to the 
condenser, where it is again heated or cooled and returns to the vials. I chose the SQ 
(square) version as opposed to the Plus (circular) on a recommendation from the Virtis 
representative. He claimed there is a theory that a square lyophilizer is better for freeze 
drying (it is also $100,000 more expensive). The freeze dryer requires 6 gaVmin of 
cooling water, and the maximum power requirement is 46.1 kW, quoted in a phone 
conversation with a Virtis representative. The equipment uptime for each batch is about 
146 hours. The yearly electrical usage is 340,000 kW*hr. Virtis quoted the Benchmark 
6000 SQ, SIP and CIP capable with full controls at S640,000. The fina1 rate of 
Generic tPA Unit Descriptions 
production of tP A is about 1.6 kglbatch or 16,000 doses. (see specification page 133 and 
appendix page 350) 
Refrigerator 
A refrigerator or air-conditioning system is required to keep the Separation trains 
at.4°C year-round. Prof. Diamond helped up estimate the total area of the Separation 
sections as 4,000 ft2. Rich Metallo at Baltimore AirCoil provided "rules of thumb" for 
the air-conditioning requirements. It is assumed that 1.25 tons of refrigerant are required 
per 300 ft2 of space to be cooled. The power requirement for one ton of refrigerant is 1 
kW, but a load factor of0.6 is included in the calculation to account for the fact that 
outside temperature varies throughout the year (not as much cooling is necessary during 
the winter). Given these estimates, 17 tons ofrefrigerant are required for the Separation 
refrigeration, and the cost ofrefrigerant is $250/ton. The yearly electrical consumption 
ofthis system is 87,600 kW*hr. Prof. Diamond recommended we estimate the purchase 
cost of such a refrigeration system as $10,000. (see specification page J34 ) 
Initial Pump (PW -1) 
City water from stream WI 0 1 is brought into the water purification system 
through pump PW-1. PW-I increases the pressure of stream WIOI from 14.7 psi to 34.7 
psi in order to compensate the pressure drop in filter FW -1. PW -1 is a peristaltic pump 
that is constructed from 316 stainless steel and has speed and flow controls. The pump is 
capable ofproducing a flow rate of35 lit/min at 25°C. According to the data in the 
Randolph Austin Company website, the power requirement is 1 hp. The actual cost of the 
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pump is $5,250 quoted from Mr. Mike Milson, a representative from Randolph Austin 
Company. (see specification page 135 and appendix page 387) 
10 gm MicrofiIter (FW -1) 
The purpose ofFW-l is to remove large particles from original city water of 
stream WI 01 before it enters the water purification process. The city water is brought 
into the process at 25°C and will flow through FW-1, which will remove dissolved 
particles larger than 10 j..!m. The flow rate of water and the pressure drop across the filter 
are 18 Llmin, and 10 psi, respectively. The membranes are constructed from high-purity 
polypropylene, which is an FDA-acceptable material as are all other parts ofthe filter. 
The FW-1 cartridge will be replaced after each batch to ensure the sterilization. The 
actual cost of the filter is $44 per cartridge according to Mr. James Lewis, the application 
engineer at Osmonics. (see specification page 136 and appendix page 389) 
Carbon Filter Pump (PW -2) 
The function ofpump PW-2 is to increase the pressure in stream WI03 from 14.7 
psi to 26.7 psi in order to compensate the pressure drop in filter FW-2. PW-2 is a 
peristaltic pump constructed from 316 stainless steel with speed and flow control. The 
pump is capable ofproducing the flow rate of 18 Llmin at 25°C. According to the data in 
the Randolph Austin Company's website, the power requirement is 0.25 hp. The actual 
cost ofthe pump is $2,656 quoted from Mr. Mike Milson, a representative at Randolph 
Austin Company. (see specification page 137 and appendix page 387) 
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Carbon Filter (FW -2) 
The function of filter (FW -2) is to remove chlorine and organic molecules from 
stream WI 04 since chlorine can degrade the membranes of the reverse osmosis system 
(RO-I) and filter (FW-4). The filter can produce 76 Llmin (20 gal/min) at 25°C, and is 
able to work at a maximum temperature of 50 °c. The maximum pressure drop across the 
filter is 12 psi recommended by the manufacturer, Ameriwater Company. The carbon 
filter utilizes 1000 lbs ofbituminous coal as the absorbent. In addition, the manufacturer 
is also recommends a minimum contact time of 5.3 min based on a bed density of28 
Ib/ft3. The actual cost of the filter according to Ms. Diane Dolan, a sale manager at 
Ameriwater Company, is $1515. (see specification page 138 and appendix page 389) 
Water Softener Pump (PW-3) 
After FW-2, water in stream WI05 will proceed directly to pump PW-3, which­
will increase pressure in stream W105 from 14.7 psi to 24.7 psi to compensate the 
pressure drop in filter FW-3. PW-3 is a peristaltic pump is constructed from 316 stainless 
steel with speed and flow controls. The pump is capable ofproducing the flow rate of 76 
Llmin ofwater at 25°C. According to the data in the Randolph Austin Company's 
website, the power requirement is 1 hp. The actual cost of the pump is $5,250 quoted 
from Mr. Mike Milson, a representative Randolph Austin Company. (see specification 
page 140 and appendix page 387) 
Water Softener (FW-3) 
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The water softener (FW-3) is used to remove the cations such a calcium and 
magnesium salts from the city water. Stream W106 flows through the FW-3 at a rate of 
76 Llmin, with a pressure drop of 10 psi. The inner shell ofFW-3 is constructed from 
polyethylene, while the outer surface is made from fiberglass to provide strength of up to 
150 psi. The amount ofresin required is approximately 7 ft3, according to from Ms. 
Diane Dolan, the sale manager at Ameriwater Company. The resin used for this particular 
softener is polystyrene sulfonate cation, which can operate at a maximum temperature of 
140°C and has a standard flow rate of 4 gall(min ft3). The life of the resin is 10 years, 
while the price is $60/ft3, according to Mr. Dally, a representative ofSybron Chemical, 
Inc, the manufacturer of the resin. Ms. Diane Dolan quotes the total cost of the FW-3 
including resin at $4537. (see specification page 139 and appendix page 377) 
Reverse Osmosis Pump (PW -7) 
The water from stream WI07 is drawn into the reverse osmosis system through 
the reverse osmosis pump (PW-7). PW-7 increases the pressure of stream WI07 from 
14.7 psi to 34.7 psi in order to compensate the pressure drop in reverse osmosis system. 
PW-7 is a Randolph Austin Mode1880 Vari-Flow peristaltic pump that is constructed 
from 316 stainless steel with speed and flow controls. The pump produces a flow rate of 
76 Llmin at 25°C, and has a power requirement of 1 hp. The purchase cost of the pump 
is $5250 quoted by Mr. Mike Milson, a representative from Randolph Austin Company. 
(see specification page 141 and appendix page 387) 
Reverse Osmosis System (RO-I) 
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The reverse osmosis system RO-I is a high-pressure membrane filter that is used 
to separate low molecular weight molecules out of the feed stream. Sa salts, bacteria, and 
other organic molecules are removed from the water stream WI08 that enters RO-I 
system at 25°C, The water is produced at a rate of 13800 gal/day. The reverse osmosis 
system is capable of working in the pH range from 4-11 and a temperature range of 1-45 
0C, The pressure drop across the system is 20 psi. In addition, the system is also 
equipped with a 1.5 hp pump and a 5 Jlm filter - to facilitate the flow within the system 
and to protect it form large particles that could damage the membrane. RO-l is 
constructed from thin film composite. In the model we are using, there are 6 membranes 
that are each 4 x 40 inches. The electricity requirements of the system are 220 V, and 7.5 
maximum Amps. The total power requirements per year for the system is 4474 kW*hr. 
According to Ms. Diane Dolan, the sales manager at Ameriwater Company the purchase 
cost is approximately $22500. (see specification page 142 and appendix page 374) 
Storage Tank (TW-l) 
Water from RO-I is stored in the Storage tank (TW-I) for future use in the 2 
process trains. The horizontal tank is constructed from 4000 polyethylene, and has the 
capacity of 50000 L The purchase cost for TW -1 is approximately $3554 as quoted by 
Ms. Diane Dolan, the sales manager at Ameriwater. Note that this price does not include 
freight. (see specification page 143) 
Ultraviolet Light System Pump (PW-4) 
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The function ofultraviolet light system pump PW -4 is to increase the pressure in 
stream W 11 0 from 14.7 psi to 19.7 psi in order to compensate the pressure drop in UV-1. 
PW-4 is a Randolph Austin Model 780 Vari-flow peristaltic pump that is constructed 
from 316 stainless steel and has speed and flow controls. The pump is capable of 
producing a flow rate of23 Llmin (6 gal/min) at 25°C and has a power requirement of 
0.25 hp. The purchase cost of the pump is $2656 as quoted by Mr. Mike Milson, the 
salesperson at Randolph Austin. (see specification page 144 and appendix page 387) 
Ultraviolet Light System (UV -1) 
In order to prevent contamination of any of the process trains, the water in TW-1 
is recirculated through an ultraviolet light system that continuously purifies the water. 
Water from stream WIll enters the purifier and flows into the annular space between the 
quartz sleeve and the outside chamber wall. Within the chamber, water is exposed to 
intense germicidal UV radiation. UV-l can produce 23 Llmin (6 gal/min) ofpurified 
water with a pressure drop at this flow rate of 5 psi. The Atlantic Ultraviolet Corporation 
recommends that the maximum operating pressure of the lamp should not exceed 100 psi. 
The power consumption ofthe UV lamp is 21 W. It also has the effective life of 
10000 hours, and maximum rated output at 254 nanometers. The purchase cost of UV-l 
as quoted by Ms. Diane Dolan of Ameriwater Company is $1567. (see specification page 
145 and appendix page 384) 
0.2 gm Microfilter Pump (PW -5) 
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The function of 0.2 !lm micro filter pump PW-5 is to increase the pressure in 
stream WI 13 from 14.7 psi to 24.7 psi in order to compensate the pressure drop in FW-4. 
PW-5 is a Randolph Austin model 780 Vari flow peristaltic pump is constructed from 
316 stainless steel with speed and flow controls. The pump is capable of producing 30 
Llmin (8 gal/min) flow rate at 25°C and has a power requirement of 0.25 hp. The 
purchase cost ofthe pump is $2656 as quoted by Mr. Mike Milson, the salesperson of 
Randolph Austin Company. (see specification page 147 and appendix page 387) 
0.2 fJ,m MicrofiIter (FW-4) 
The 0.2 jlm Microfilter FW-4 is used to remove particles that may be left in water 
of stream Wl14 before it enters the fermentors. Water in storage tank can settle out 
particles and ions that must be removed before it enters the process. Therefore, FW-4 acts 
as the last line ofprotection to ensure that the water produced is uncontaminated. The 
size ofthe filter pore is 0.2 jlm. The flow rate through the filter is 18 Llmin (5 gal/min) 
and the pressure drop is 10 psi. The filter is constructed from high-purity polypropylene. 
The filter will be replaced after every batch and costs $44 per filter cartridge. (see 
specification page 147 and appendix page 389) 
Final Pump (PW-6) 
After FW-4, purified water in stream Wl15 will flow through final pump (PW-6) 
to increase the pressure from 14.7 psi to 34.7 psi in order to compensate the pressure drop 
along the pipe. PW-6 is a Randolph Austin Model 880 Vari flow peristaltic pump that is 
constructed from 316 stainless steel with speed and flow controls. The pump is capable of 
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producing a flow rate of 18 Llmin (5 gal/min) flow rate at 25°C and has a power 
requirement of 1 hp. The purchase cost of the pump is $5250 as quoted by Mr. Mike 
Milson, the salesperson at Randolph Austin. (see specification page 148 and appendix 
page 387) 
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40L FERMENTOR (BR-l) 
FUNCTION: 	Batch reactor used to grow CHO Cells up to a density of3.0 '" 106 cells/mL to be used to 
inoculate BR-2. 
TYPE: New Brunswick Scientific BioFlo 5000 Fennentor with Conventional Heating Jacket 
MATERIALS HAl'IlDLED: 
Component Quantity per batch 
Complete Media 30 L 
Cellular Material 3.5 kg 
Compressed Air 0.3 kglbatch (3% ofone tauk) 
CO2 0.025 kglbatch (0.1 % of one tauk) 
CHARACTERISTICS: 
Diameter: 0.3m 
Height: 0.6m 
Volume: 40L 
Working Capacity: 30L 
Material: 316 Stainless Steel 
Agitator: 6-Blade Stainless Steel standard Marine Blade 
Insulation: 2 in of Fiberglass Insulation 
OPERATING CONDITIONS: 
Temperature: 

Pressure: 

pH: 

Compressed Air Flow Rate: 

C02 Flow Rate (% of total air flow): 

Agitator Speed: 

Power Requirements: 

Utility Cost/year 

Sterilization: 

37°C 
14.7 psi 
7.3 
0.003 kglhr 
0.0002 kglhr (5%) 
10-30 rpm 
1.5 hp 
$355.00 
Flush with water and Steam in Place at 130°C for 2 
hours 
PURCHASE COST: $85,000.00 
REFERENCE PAGES: 54,225-230,232,244,254 
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400L FERMENTOR (BR-2) 
FUNCTION: 	 Batch reactor used to grow CHO Cells up to a density of3.0 * 106 cells/mL to be used to 
inoculate BR-3. 
TYPE: New Brunswick Scientific custom-built 400 L bioreactor with Conventional Heating Jacket 
MATERIALS HANDLED: 
Component Quantitv per batch 
Complete Media 300 L 
Cellular Mass 35.0 kg 
Compressed Air 4.5 kglbatch (50% of one tank) 
CO2 0.33 kglbatch (2% of one tank) 
CHARACTERISTICS: 
Diameter: 

Height: 

Volume: 

Working Capacity: 

Material: 

Agitator: 

Insulation: 

0.6m 
1.2 m 
400L 
300L 
316 Stainless Steel 
6-Blade Stainless Steel Marine Blade 
2 inch Fiberglass Insulation 
OPERATING CONDITIONS: 
Temperature: 

Pressure: 

pH: 

Compressed Air Flow Rate: 

C02 Flow Rate (% of total): 

Agitator Speed: 

Power Requirements: 

Utility Cost/year 

Sterilization: 

37°C 
14.7 psi 
7.3 
0.3 kg Ihr 
0.02 kglhr (5%) 
10-30 rpm 
5 hp 
$1180.00 
Flush with water and Steam in Place at 130°C 
for 5 hours 
PURCHASE COST: $125,000.00 
REFERENCE PAGES: 57,231,232,243,254 
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5000 L FERMENTOR (BR-3) 
FUNCTION: Batch reactor used to grow a CHO Cell-Line that produces the product protein tPA. 
TYPE: New Brunswick Scientific custom-built 5000 L bioreactor with 4" half pipe Heating Jacket 
MATERIALS HANDLED: 
Component Quantity per batch 
Complete Media 4000L 
Cellular Mass 460 kg 
Compressed Air 69.5 kg/batch (7 tanks) 
CO2 5.5 kg/batch (0.25% of one tank) 
CHARACTERISTICS: 
Diameter: 

Height: 

Volume: 

Working Capacity: 

Material: 

Harvest Pump: 

Agitator: 

Insulation: 

1.5 m 
3.0m 
5000 L 
4000 L 
316 Stainless Steel 
Peristaltic Harvest Pump 
6-Blade Stainless Steel Marine Blade 
2 inch Fiberglass Insulation 
OPERATING CONDITIONS: 
Temperature: 

Pressure: 

pH: 

Compressed Air Flow Rate: 

C02 Flow Rate (% of total air flow): 

Agitator Speed: 

Agitator Power Requirements: 

Pump Power Requirements: 

Utility Cost/year 

Sterilization: 

37°C 
14.7 psi 
7.3 
0.3 kg lhr 
0.025 kglhr (5%) 
10-30 rpm 
10 hp 
5 hp 
$3543.00 
Flush with water and Steam in Place at 130°C 
for 5 hours • 
PURCHASE COST: $225,000.00 
REFERENCE PAGES: 59,231,232,233-242,254 
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HEAT EXCHANGER (HX-l) 
FUNCTION: 	Bring the temperature of the Media from 4 °C up to 38°C using warm water on the shell 
side. 
TYPE: Shell and Tube 
MATERIALS HANDLED: 
Component 
Water 
Flow Rates 
2.2* 103 kglhr 
Complete Media 455 kglhr 
CHARACTERISTICS: 
Heat Transfer Coefficient: 

Heat Transfer Area: 

No. of Tube Passes: 

No. of Shell Passes: 

Number ofTubes: 

Nominal Outside Diameter: 

Pitch: 

Flow Direction: 

Material: 

75 BTUIhr*ft2*F 
11.5 if 
1 
1 
18 
0.75 in 
1.25 in, Square 
Countercurrent 
316 Stainless Steel 
OPERATING CONDITIONS: 
SHELL SIDE: 
Pressure: 
Temperature In: 
Temperature Out: 
TUBE SIDE: 
Pressure: 
Temperature In: 
Temperature Out: 
Heat Duty: 
Sterilization: 
29.7 psi 
55°C 
48°C 
29.7 psi 
4°C 
38 °C 
6.2* 104 BTUIhr 
Flush with water and Steam in Place at 130°C for 2 
hrs. 
PL"RCHASE COST: $6500.00 
REFERENCE PAGES: 62, 245-249 
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BLENDING TANK (T-l) 
FUNCTION: Mix Powdered Media and Sterile water for use in BR-l, BR-2, and BR-3. 
TYPE: Walker Stationary Blending Tank with 6-blade Rushton agitator 
MATERIALS HANDLED: 
Component Quantity per batch 
Sterile Water 4500 L 
Media (powder) Powder equivalent to make 4500L of liquid media 
CHARACTERISTICS: 
Diameter: 
Height: 
Volume: 
Capacity: 
Retention Time: 
Material: 
Cooling Coils: 
Refrigerator: 
1.5 m 
3.0m 
5000L 
4500 L 
7 Days 
316 Stainless Steel 
2 in Copper Tubing 
Standard freon refrigeration unit 
OPERATING CONDITIONS: 
Inlet Water Temperature: 

Outlet Water Temperature 

Pressure 

Outlet Flow: 

Agitator Speed: 

Cooling duty: 

Agitation Motor Power Requirements: 

Refrigerator Energy Requirements: 

Utility Cost per year (total): 

Sterilization: 

20°C 
4°C 
14.7 psi 
2 gal/min 
50 rpm 
8 tons (95386 BTU/hr) 
10 hp 
63360 kW*hr 
$4896.00 
Flush with water and Steam in Place at 130°C for 2 
hrs. 
PURCHASE COST: $40,658.00 
REFERENCE PAGES: 62, 250-252, 254-255 
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FILTER PUMP (P-l) 
FUNCTION: To pump the media from the blending tank through the 2.0J,t filter. 
TYPE: Peristaltic 
MATERIALS HANDLED: 
Component Quantity per batch 
Complete Media 4500L 
CHARACTERISTICS: 
Material: 316 Stainless Steel 
Length: 17 % in. 
Width: 13 3/8 in. 
Height: 7314 in. 
OPERATING CONDITIONS: 
Temperature: 

Pressure In: 

Pressure Out: 

Volumetric Flow Rate: 

Pump Efficiency: 

Power Requirement: 

Utility Cost/yr: 

Sterilization: 

4°C 
14.7 psi 
29.7 psi 
2 gal/min 
80% 
0.25 hp 
$59.00 
Flush with water and Steam in Place at 130°C for 30 
min 
PURCHASE COST: $1595.00 
REFERENCE PAGES: 65, 253, 256-259 
10 
• 
Generic tPA Unit Spec Sheets 
FILTER PUMP (P-2) 
FUNCTION: To pump the media from F-l through F-2. 
TYPE: Peristaltic 
MATERIALS HANDLED: 
Component Quantity per batch 
Complete Media 4500 L 
CHARACTERISTICS: 
Material: 316 Stainless Steel 
Length: 17 y. in. 
Width: 13 3/8 in. 
Height: 73/4 in. 
OPERATING CONDITIONS: 
Temperature: 

Pressure In: 

Pressure Out: 

Volumetric Flow Rate: 

Pump Efficiency: 

Power Requirement: 

Utility Costlyr: 

Sterilization: 

4°C 
14.7 psi 
29.7 psi 
2 gal/min 
80% 
0.25 hp 
$59.00 
Flush with water and Steam in Place at 130°C for 30 
min 
PURCHASE COST: $1595.00 
REFERENCE PAGES: 65,253,256-259 
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HEAT EXCHANGER PUMP (P-3) 
FUNCTION: To pump the media through the heat exchanger and into the three bioreactors. 
TYPE: Peristaltic 
MATERIALS HANDLED: 
Component Quantity per batch 
Complete Media 4500L 
CHARACTERISTICS: 
Material: 316 Stainless Steel 
Length: 17 Y4 in. 
Width: 13 3/8 in. 
Height: 7 Y. in. 
OPERATING CONDITIONS: 
Temperature: 

Pressure In: 

Pressure Out: 

Volumetric Flow Rate: 

Pump Efficiency: 

Power Requirement: 

Utility Costlyr: 

Sterilization: 

37°C 
14.7 psi 
29.7 psi 
2 gal/min 
80% 
0.25 hp 
$59.00 
Flush with water and Steam in Place at 130 °c for 30 
min 
PURCHASE COST: $1595.00 
REFERENCE PAGES: 65, 253, 256-259 
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CELL BROTH PUMP - 1 (P-4) 
FUNCTION: To pump the cell broth from BR-l to BR-2. 
TYPE: Peristaltic 
MATERIALS HANDLED: 
Component 2!!!!ntity per batch 
Cell Broth 30 L 
CHARACTERISTICS: 
Material: 316 Stainless Steel 
Length: 17 y.. in. 
Width: 13 3(8 in. 
Height: 7314 in. 
OPERATING CONDITIONS: 
Temperature: 

Pressure In: 

Pressure Out: 

Volumetric Flow Rate: 

Pump Efficiency: 

Power Requirement: 

Utility Costlyr: 

Sterilization: 

37°e 
14,7 psi 
29,7 psi 
2 gal/min 
80% 
0.25 hp 
$59.00 
Flush with water and Steam in Place at 130°C for 
30 min 
PUR,CHASE COST: $1595.00 
REFERENCE PAGES: 66, 253, 256-259 
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CELL BROTH PUMP - 2 (P-5) 
FUNCTION: To pump cell broth from BR-2 to BR-3. 
TYPE: Peristaltic 
MATERIALS HANDLED: 
Component Quantity per batch 
Cell Broth 300 L 
CHARACTERISTICS: 
Material: 316 Stainless Steel 
Length: 17 lj., in. 
Width: 13 3/8 in. 
Height: 73/4 in. 
OPERATING CONDITIONS: 
Temperature: 

Pressure In: 

Pressure Out: 

Volumetric Flow Rate: 

Pump Efficiency: 

Power Requirement: 

Utility Cost/yr: 

Sterilization: 

37°C 
14.7 psi 
29.7 psi 
2 gal/min 
80% 
0.25 hp 
$59.00 
Flush with water Steam in Place at 130°C for 30 
min 
PURCHASE COST: $1595.00 
REFERENCE PAGES: 65, 253, 256-259 
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WATER JACKET PUMP (P-6) 
FUNCTION: To pump water through a half pipe heating jacket surrounding BR-3. 
T1"PE: Peristaltic 
MATERIALS HANDLED: 
Component Flow Rate 
Water 0.2 0.09 kg/sec 
CHARACTERISTICS: 
Material: 316 Stainless Steel 
Length: 17 ~ in. 
Width: 13 3/8 in. 
Height: 7314 in. 
OPERATING CONDITIONS: 
Temperature: 

Pressure In: 

Pressure Out: 

Volumetric Flow Rate: 

Pump Efficiency: 

Power Requirement: 

Utility Costiyr: 

Sterilization: 

38°C 
14.7 psi 
29.7 psi 
0.2 • 0.09 kg/sec 
80% 
0.25 hp 
$59.00 
Flush with water and Steam in Place at 130°C for 30 
min 
PURCHASE COST: $1595.00 
REFERENCE PAGES: 67, 253, 256-259 
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HEAT EXCHANGER WATER PUMP (P-7) 
FUNCTION: To pump water through a recycle stream that passes through the shell side of the HX-l. 
TYPE: Corcoran Company mode13000D-HDI centrifugal pump 
MATERIALS HA.1'\lDLED: 
Component Flow Rate 
Water 17 gal/min 
CHARACTERISTICS: 
Material: 316 Stainless Steel 
Length: 1.5 feet 
Height: I foot 
OPERATING CONDITIONS: 
Temperature: 

Pressure In: 

Pressure Out: 

Volumetric Flow Rate: 

Pump Efficiency: 

Power Requirement: 

Utility Costlyr: 

40°C 
14.7 psi 
29.7 psi 
17 gal/min 
80% 
2 hp 
$59.00 
PURCHASE COST: $3250.00 
REFERENCE PAGES: 67, 253, 260-261 
107 

Generic tPA 	 Unit Sheets 
MEDIA FILTER (2~) F-l 
FUNCTION: 	Filter out particles larger than 2 f.I in the prepared media and prevent clogging 
of the 0.2 )l filter F-2. 
TYPE: Osmonics Flotrex-AP Filter with 2 f.I absolute rating 
MATERIALS HANDLED: 
Component Quantity per batch 
Complete Media 4500L 
CHARACTERISTICS: 
Material: Polypropylene Fiber 
Pore Size: 2.0 !l 
Diameter: 2.75 in 
Length: 10 in 
Filtration Area: 5.2 m 2 
OPERATING CONDITIONS: 
Temperature: 

Pressure In: 

Pressure Out: 

Pressure Drop: 

Volumetric Flow Rate: 

Filters per Batch 

Sterilization: 

4°C 
29.7 psi 
14.7 psi 
15 psi 
2 galfmin 
1 
Flush with water and Steam in Place at 130°C for 30 
min 
PURCHASE COST: S32.00/carteriage 
REFERENCE PAGES: 69, 262, 263-266 
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MEDIA FILTER (O.2J.l) F-2 
FUNCTION: Filter out particles larger than 0.2 "'" in the prepared media. 
TYPE: Osmonics Memtrex-FE Filter with 0.2 "'" absolute rating 
MATERIALS HANDLED: 
Component Quantity per batch 
Complete Media 4500L 
CHARACTERISTICS: 
Material: PTFE Membrane 
Pore Size: 0.2 "'" 
Diameter: 2.75 in 
Length: 10 in 
OPERATING CONDITIONS: 
Temperature: 

Pressure In: 

Pressure Out: 

Pressure Drop: 

Volumetric Flow Rate: 

Filter Cartridge Life: 

Sterilization: 

4"C 
29.7 psi 
14.7 psi 
15 psi 
2 gal/min 
1 batch 
Flush with water and Steam in Place at 130 "C for 30 
mm 
PURCHASE COST: $44.00/carteriage 
REFERENCE PAGES: 70,262,267-270 
109 

Generic tPA Unit Sheets 
FERMENTOR AIR FILTERS (O.2g) F -3 - F -8 
FUNCTION: Filter out particles larger than 0.2 J.l in the compressed air and CO2 that is sparged into the 
base of the fermentors and filter the exhaust gasses from the bioreactors .. 
TYPE~ Osmonics Memtrex-FE Filters with 2 J.l absolute rating 
MATERIALS HANDLED: 
Component Quanti!YJ!~!:.batch 
Compressed Air 0.03 - 6.65 tanks 
CO2 0.001 0.015 tanks 
CHARACTERISTICS: 
Material: PTFE Membrane 
Pore Size: 0.2 J.l 
Diameter: 2.75 in 
Length: lOin 
OPERATING CONDITIONS: 
Temperarure: 4°C 
Pressure Drop 2 psi 
Flow Rate: 0.025 - 0.35 kg/hr 
Life Span of Filter 113 batch 
Sterilization: Flush with water and Steam in Place at 130°C for 
30 min 
PURCHASE COST: $44.00 per filter 
REFERENCE PAGES: 68, 262,267-270 
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STEAM BOILER (B-1) 
FUNCTION: Produce the Steam from sterile water for use in the entire plant. 
TYPE: Standard Natural Gas fueled boiler with sanitary piping and fIxtures 
MATERIALS HANDLED: 
Component Amount Heated per Hour 
Sterile Water 500 LIhr 
CHARACTERISTICS: 
Capacity: 500 LIhr 
Material: 316 Stainless Steel 
OPERATING CONDITIONS: 
Inlet Water Temperature: 20°C 
Outlet Steam Temperature: 130 °C 
Pressure 39.16 psi 
Natural Gas Consumption: 54.5lblhr 
Boiler Efficiency: 85% 
PURCHASE COST: $112,000 
REFERENCE PAGES: 71,279-281 
111 

Generic tPA Unit Sheets 
HOLDUP TANK 
FUNCTION: Provide a place to keep bioreactor effluent if Centrifuge is down. 
TYPE: Vertical blending tank, CIP, SIP; Walker Stainless Equipment 
MATERIALS HANDLED: 
Component Quantity per batch 
CHO cells 457 kg 
Media 3565 L 
TPA 2.16 kg 
CHARACTERISTICS: 
. . 
Capacity: 5000 L 
Height: 3m 
Diameter: Um 
Material: 316 Stainless Steel 
OPERATING CONDITIONS: 
Pressure: 14.7 psi 
Temperature: 22°C 
Storage time: Only when Centrifuge is down. 
CIP by flushing with a vessel volume of water, followed by a SIP cycle. This unit will probably never be 
used because the centrifuge was quoted as very reliable. We included this tank because it is important to 
remove 4000L Bioreactor contents promptly to eliminate process down time if something happens to go 
wrong with the Centrifuge. 
PURCHASE COST: $19,000 

REFERENCE P AGE~-=. 72, 365 
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UFITANK 
FUNCTION: Blend arginine to a concentration of 1M and store at 4°C until needed. Act as a recycling 
tank for UFI. 
TYPE: Vertical blending tank, CIP, SIP; Walker Stainless Equipment 
MATERIALS HANDLED: 
Component Quantity per batch 
Media 3565 L 
Arginine 850 kg 
Tpa 2.05 kg 
CHARACTERISTICS: 
Capacity: 4000L 
Height: 2.7m 
Diameter: 104m 
Material: 316 Stainless Steel 
OPERATING CONDITIONS: 
Pressure: 14.7 psi 
Temperature: 4°C 
Arginine input: 850 kg 
Storage time: Approx. 14 hrs. (overnight) 
CIP by flushing with a vessel volume of water, followed by a SIP cycle. 
PURCHASE COST: $17,000 
REFERENCE PAGES: 73, 365 
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UF2TANK 
FUNCTION: Blend arginine to a concentration of 2M and store at 4°C until needed. Act as a recycling 
tank for UF2. 
TYPE: Vertical blending tank, CIP, SIP; Walker Stainless Equipment 
MATERIALS HANDLED: 
Component Quantitv per batch 
Media 200L 
Arginine 115 kg 
Tpa 1.94 kg 
CHARACTERISTICS: 
Capacity: 400 L 
Height: l.3m 
Diameter: 0.6m 
Material: 316 Stainless steel 
OPERATING CONDITIONS: 
Pressure: 14.7 psi 
Temperature: 4°C 
Arginine input: 67.4 kg 
Storage time: Negligible unless UF2 is down 
CIP by flushing with a vessel volume of water, followed by a SIP cycle. 
PURCHASE COST: $10,000 

REFERENCE PAGES: 73,365 
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AFFINITY TANK 
FUNCTION: 	Store UF2 filtrate at 4 "C before it is run through Affmity column. Each batch is split into 
four equal volumes and applied to the column. 
TYPE: Vertical blending tank, CIP, SIP; Walker Stainless Equipment 
MATERIALS HANDLED: 
Component Quantity per batch 
Media 196 L 
Arginine 112.9 kg 
tPA 1.89 kg 
CHARACTERISTICS: 
Capacity: 400 L 
Height: 1.3m 
Diameter: 0.6m 
Material: 316 Stainless steel 
OPERATING CONDITIONS: 
Pressure: 14.7 psi 
Temperature: 4°C 
Storage time: 48 hrs 
CIP by flushing with a vessel volume of water, followed by a SIP cycle. 
PURCHASE COST: $10,000 
REFERENCE PAGES: 73, 365 
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ERTANK 
FUNCTION: 	Store Affinity column elution at 4°C, increase pH to 7.0 with NaOH, and input 0.0258 kg 
sucrose. 
TYPE: Vertical blending tank, CIP, SIP; Walker Stainless Equipment 
MATERIALS HANDLED: 
Component Quantity per batch 
WFI 219L 
Arginine 175 kg 
Glycine 8.7 kg 
Sucrose 0.026 kg 
1M NaOH 0.33 L 
tPA 1.6 kg 
CHARACTERISTICS: 
Capacity: 400L 
Height: 1.2 m 
Diameter: 0.6m 
Material: 316 Stainless steel 
OPERATING CONDITIONS: 
-_.... 
Pressure: 14.7 psi 
Temperature: 4°C 
NaOH input: 0.33 L 
Sucrose input: 0.026 kg 
Storage time: Negligible unless UF2 is down 
CIP by flushing with a vessel volume of water, followed by a SIP cycle. 
PURCHASE COST: $10,000 

REFERENCE PAGES: 74, 365 
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MFTANK 
FUNCTION: Input 59 L WFI and store contents at 4°C. 
TYPE: Vertical blending tank, CIP, SIP; Walker Stainless Equipment 
MATERIALS HANDLED: 
Component 
WFI 
Arginine 
tPA 
NaOH 
Glycine 
Sucrose 
Quantity per batch 
278 L 
175 kg 
1.6 kg 
0.013 kg 
8.7 kg 
0.026 kg 
CHARACTERISTICS: 
Capacity: 500 L 
Height: 1.4 m 
Diameter: 0.7m 
Material: 316 Stainless steel 
OPERATING CONDITIONS: 
Pressure: 14.7 psi 
Temperature: 4°C 
WFI input: 59 L 
Storage time: Negligible unless UF2 is down 
CIP by flushing with a vessel volume ofwater, followed by a SIP cycle. 
PURCHASE COST: $11,000 
REFERENCE PAGES: 74, 365 
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FDTANK 
FUNCTION: 	Store MF filtrate at 4 °C before bottling. Each batch is split and bottled in five equal 
volumes and freeze dried in the bottles in five batches. 
TYPE: Vertical blending tank, CIP, SIP; Walker Stainless Equipment 
MATERIALS HA!~DLED: 
Component Quantity per batch 
WFI 278 L 
Arginine 175 kg 
tPA 1.6 kg 
NaOH 0.013 kg 
Glycine 8.7 kg 
Sucrose 0.026 kg 
CHARACTERISTICS: 
Capacity: 500L 
Height: 1.4 m 
Diameter: 0.7m 
Material: 316 Stainless steel 
OPERATING CONDITIONS: 
Pressure: 14.7 psi 
Temperature: 4°C 
Storage time: 146 hrs 
CIP by flushing with a vessel volume ofwater, followed by a SIP cycle. 
PURCHASE COST: $11,000 

REFERENCE PAGES: 74, 365 
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CENTRIFUGE 
FUNCTION: Separate CHO cells from harvest media. 
TYPE: CSC 4 Clarifier, In-steam sterilizable from Westfalia Separator 
MATERIALS HANDLED: 
Component Quantity per batch 
CHO cells 457 kg 
Media 3565 L 
TPA 2.16 kg 
CHARACTERISTICS: 
Bowl Volume: 1.8L 
Bowl Speed: approx. 10,000 rev/min 
Weight: approx. 230 kg 
Material: Cr-Ni-Mo stainless steel 
OPERATING CONDITIONS: 
Rated capacity: 400 LIhr 
Maximum pressure: approx. 73.5 psi 
Entering cell broth temperature: 37°C 
Centrifuge temperature: 4°C (room is at 4 0c) 
Cell removal: 100% 
Equipment uptime per batch: <10hr 
tPA lost per run 5% 
To be cleaned after each run with NaOH solution for 20-30 minutes. Followed by SIP. 
PURCHASING COST: $355,000 
REFERENCE PAGES:_75, 297-302, 367 
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UFI PUMP 
FrNCTION: Increase pressure ofUFI Tank contents to 40 psi. 
TYPE: Peristaltic, Series 750-362; Randolph Austin Company 
MATERIALS HAl~DLED: 
Component Quantity per batch 
Media 3565 L 
Arginine 850kg 
tPA 2.05 kg 
CHARACTERISTICS: 

Material: 316 Stainless steel 

OPERATING CONDITIONS: 
Pressure in: 

Pressure out: 

Temperature: 

Volumetric flow rate: 

Efficiency: 

Power Requirement: 

Equipment uptime per batch 

Utility CostJyr 

14.7 psi 
40 psi 
4°C 
828 LIhr 
80% 
49W 
6.09 hr 
$16 
PURCHASE COST: $2,656 
REFERENCE PAGES: 76, 256-259, 366 
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UF2PUMP 
FUNCTION: Increase pressure ofUF2 Tank contents to 40 psi. 
TYPE: Peristaltic, Series 750-362; Randolph Austin Company 
MATERIALS HANDLED: 
Component Quantity per batch 
Media 200L 
Arginine 115 kg 
tPA 1.94 kg 
CHARACTERISTICS: 
Material: 316 Stainless steel 
OPERATING CONDITIONS: 
Pressure in: 

Pressure out: 

Temperature: 

Volumetric flow rate: 

Efficiency: 

Power Requirement: 

Equipment uptime per batch: 

Utility Costlyr 

14.7 psi 
40 psi 
4°C 
1325 LIhr 
80% 
79W 
<1 hr 
$25 
PURCHASE COST: $2,656 
REFERENCE PAGES: 77, 256-259, 366 
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MFPUMP 
FUNCTION: Increase pressure ofMF Tank contents to 34.7 psi. 
TYPE: Peristaltic, Series 610-362; Randolph Austin Company 
MATERIALS HANDLED: 
Component Quautity per batch 
WFI 278 L 
Arginine 175 kg 
tPA 1.6 kg 
NaOH 0.013 kg 
Glycine 8.7 kg 
Sucrose 0.026 kg 
CHARACTERISTICS: 
Material: 316 Stainless steel 
OPERATING CONDITIONS: 
Pressure in: 

Pressure out: 

Temperature: 

Volumetric flow rate: 

Efficiency: 

Power Requirement: 

Equipment uptime per batch: 

Utility Costlyr 

14.7 psi 
34.7 psi 
4°C 
1140 LIhr 
80% 
53.27W 
0.25 hr 
$17 
PURCHASE COST: $2,656 
REFERENCE PAGES: 77, 256-259, 366 
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AFFINITY SKID/PUMP 
FUNCTION: Increase pressure ofAffinity column inputs to 15.9 psi and control the volume of 
equilibration and elution buffers used. 
TYPE: Peristaltic pump with computer 
MATERIALS HANDLED: 
Component Quantity per batch 
Media 196 L 
WFI 285 L 
Arginine 126 kg 
Glycine 11.3 kg 
PBS 1710 L 
NaCI 66 kg 
tPA 1.89 kg 
CHARACTERISTICS: 

Material: 316 Stainless steel 

OPERATING CONDITIONS: 
Pressure in: 

Pressure out: 

Temperature: 

Volumetric flow rate: 

Efficiency: 

Power Requirement: 

Equipment uptime per batch: 

Utility Costlyr 

15.9 psi 
14.7 psi 
4°C 
135 LIhr 
80% 
0.4 W 
12 hr 
$1 
PURCHASE COST: $100,000* 
REFERENCE PAGES: 77,256-259,366 
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ER SKID/PUMP 
FUNCTION: Increase pressure of ER Tank contents to 16.6 psi. 
TYPE: Peristaltic pump with computer 
MATERIALS HANDLED: 
Component ~antity per batch 
WFI 266 L 
Arginine 9.96 kg 
Glycine 8.7kg 
1M NaOH 193 L 
tPA 1.6 kg 
CHARACTERISTICS: 

Material: 316 Stainless steel 

OPERATING CONDITIONS: 
Pressure in: 

Pressure out: 

Temperature: 

Volumetric flow rate: 

Efficiency: 

Power Requirement: 

Equipment uptime per batch: 

Utility Costlyr 

14.7 psi 
16.6 psi 
4°C 
11 LIhr 
80% 
0.3 W 
32 hr 
negligible 
PURCHASE COST: $100,000* 
REFERENCE PAGES: 77, 256-259, 366 
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UFI 
FUNCTION: Concentrate tPA to a volume of approximately 200 L. 
TYPE: Tangential flow filter, PM50 Hollow fiber cartridge; Koch Membrane Systems 
MATERIALS HANDLED: 
Component Quantity per batch 
Media 3565 L 
Arginine 850 kg 
tPA 2.05 kg 
CHARACTERISTICS: 
Diameter: 3 in. 
Length: 25 in. 
Membrane area: 14 ftz 
MWCO; 50kDa 
Material: Polysulfone 
OPERATING CONDITIONS: 
Pressure in: 40 psi 
Pressure out: 30 psi 
Pressure drop: 10 psi 
Temperature: 4°C 
Mean flux (filtrate flow rate): 550 LIhr 
Split ratio (retentate/filtrate): 0.06 
Filter cartridge life: One year 
tPA lost per run 2% 
Retentate stream is split and recycled to UFI Tank where it again flows through the filter. Flow is 
controlled using a ratio-flow controller. 
PURCHASE COST: $785/cartridge 

REFERENCE PAGES: 79, 303-313 
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UF2 
FUNCTION: Remove remaining components larger than 500 kDa that could damage or inhibit flow 
through the affinity column. 
TYPE: Tangential flow filter, PM500 Hollow fiber cartridge; Koch Membrane Systems 
MATERIALS HANDLED: 
Component Quantitv per batch 
Media 200L 
Arginine 115 kg 
tPA 1.94 kg 
CHARACTERISTICS: 
Diameter: 3 in. 
Length: 25 in. 
Membrane area: 14 ft2 
MWCO: 500 kDa 
Material: Poly sulfone 
OPERATING CONDITIONS: 
Pressure in: 40 psi 
Pressure out: 30 psi 
Pressure drop: 10 psi 
Temperature: 4°C 
Mean flux (filtrate flow rate): 880 LIhr 
Filter cartridge life: One year 
tP A lost per run 5% 
Retentate stream is recycled to UF2 Tank where it again flows through the filter. Entire volume ofUF2 
Tank is collected as filtrate. 
PURCHASE COST: $950/cartridge 

REFERENCE PAGES: 81, 303-313 
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MF 
FUNCTION: Filter and sterilize final product stream before freeze drying. 
TYPE: Tangential flow filter, 0.2 11m filter; Osmonics 
MATERIALS HANDLED: 
Component Quantity per batch 
WFI 278 L 
Arginine 175 kg 
tPA 1.6 kg 
NaOH 0.0l3 kg 
Glycine 8.7 kg 
Sucrose 0.026 kg 
CHARACTERISTICS: 
Diameter: 2.75 in. 
Length: 10 in. 
Membrane area: 9 ft2 
Pore size: 0.2 11m 
Material: PTEF Membrane 
OPERATING CONDITIONS: 
Pressure in: 
Pressure out: 
Pressure drop: 
Temperature: 
Max flow rate: 
Filter cartridge life: 
tPA lost per run 
40 psi 
20 psi 
20 psi 
4°C 
1140 LIhr 
One batch 
1% 
PURCHASE COST: $44!cartridge 

REFERENCE PAGES: 81,267-270 
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AFFINITY COLUMN 
FUNCTION: Separate tPA from Affinity tank contents. 
TYPE: Bioprocess stainless steel column; Amersham Pharmacia Biotech 
MATERIALS HA."lULED: 
Component 
Media 
WFI 
Arginine 
Glycine 
PBS 
NaCI 
tPA 
Quantity per batch 
196L 
285 L 
340 kg 
11.3 kg 
1709 L 
66.2 kg 
1.89 kg 
CHARACTERISTICS: 
Column volume: 

Bed volume: 

Bed Height: 

Diameter: 

Resin: 

Void volume: 

Materials: 

58 L 
58 L 
15 cm 
70cm 
CNBr-activated Sepharose 4 Fast Flow 
20.2 L 
316 Stainless steel 
OPERATING CONDITIONS: 
Superficial velocity: 

Volumetric flow rate: 

Pressure drop: 

Temperature: 

Load volume: 

Equilibration volume: 

Elution volume: 

Wash volume: 

tP A lost per run: 

Equipment uptime per batch: 

100 cmlhr 
135 LIhr 
1.2 psi 
4°C 
One quarter of Affinity tank contents 
2.5 bed volumes (145 L) 
1.3 bed volumes (75 L) 

5 bed volumes (289 L) 

15% 

48 hrs 

PURCHASE COST: $100,000* 
REFERENCE PAGES: 82, 314-328 
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AFFINITY RESIN 
FUNCTION: Provide matrix to hold anti-tPA antibody. 
TYPE: CNBr-activated Sepharose 4 Fast Flow; Amersham Pharmacia Biotech 
MATERIALS HANDLED: 
Component 
Media 
WFI 
Arginine 
Glycine 
PBS 
NaCI 
tPA 
Quantity per batch 
196 L 
285 L 
340 kg 
11.3 kg 
1709 L 
66.2 kg 
1.89 kg 
CHARACTERISTICS: 
Bed volume: 58 L 
Height: 15 cm 
Diameter: 70 cm 
Bead size: 90 )lm 
Void volume: 20.2 L 
Materials: Highly cross-linked 4% agarose, spherical 
OPERATING CONDITIONS: 
Superficial velocity: 

Volumetric flow rate: 

Pressure drop: 

Temperature: 

Antibody binding: 

Resin utilization: 

Equipment uptime per batch: 

Store in 20% ethanol between batches. 
PURCHASE COST: $350,000/year 

REFERENCE PAGES: 82, 314-328 

100 cmlhr 
134.6 LIhr 
1.2 psi 
4 DC 
12.3mg AB/mL resin 
85% 
48 hrs 
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ERCOLUMN 
FUNCTION: Remove endotoxins from Affinity column elution. 
TYPE: Bioprocess glass column 200/500; Amersham Pharmacia Biotech 
l\'lATERIALS HANDLED: 
Component Quantity per batch 
WFI 266 L 
Arginine 175 kg 
Glycine 8.7 kg 
Sucrose 0.026 kg 
1M NaOH 193 L 
tPA 1.6 kg 
CHARACTERISTICS: 
Column volume: 15.7 L 
Bed volume: 8.2 L 
Bed Height: 26cm 
Diameter: 20cm 
Resin: Acticlean Etox 
Void volume: 2.9 L 
Materials: 316 Stainless steel 
OPERATING CONDITIONS: 
Superficial velocity: 

Volumetric flow rate: 

Pressure drop: 

Temperature: 

Load volume: 

Cleaning: 

Regeneration volume: 

tP A lost per run: 

Equipment uptime per batch: 

100 cmlhr 
11.0 LIhr 
1.9 psi 

4°C 

Entire volume of ER Tank contents 

1M NaOH for 2 hrs 

2 bed volumes (75 L) 

5% 

36hrs 

PURCHASE COST: $6,190 
REFERENCE PAGES: 84, 329-345 
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ERRESIN 
FUNCTION: Bind endotoxins while allowing tPA to flow through undamaged. 
TYPE: Actic1ean Etox; Sterogene 
MATERIALS HANDLED: 
Component Quantity per batch 
WFI 266 L 
Arginine 175 kg 
Glycine 8.7 kg 
Sucrose 0.026 kg 
1M NaOH 193 L 
tPA 1.6 kg 
CHARACTERISTICS: 
Bed volume: 8.2 L 
Height: 26cm 
Diameter: 20cm 
Bead size: 110!ID1 
Void volume: 2.9 L 
Materials: Actigel ALD; Sterogene 
OPERATING CONDITIONS: 
Superficial velocity: 

Volumetric flow rate: 

Pressure drop: 

Temperature: 

Endotoxin binding: 

Cleaning: 

Equipment uptime per batch: 

Store in WFI between batches. 
100 cmlhr 
11.0 LIhr 
1.9 psi 
4°C 
200 - 20,000 EU/mL resin 
1M NaOH for 2 hrs 
36 hrs 
PURCHASE COST: $87,OOO/year 

REFERENCE PAGES: 84,329-345 

131 

Generic tPA Unit Spec Sheets 
BOTTLER 
FUNCTION: Load approximately 25 mL final product solution into 100 mL vials and partially stopper 
them. Load vials onto freeze dryer trays. 
TYPE: Model VR 840S, BT15, A W160; Cozzoli Machine Company 
MATERIALS HANDLED: 
Component Q!Jantitv per batch 
WFI 278 L 
Arginine 175 kg 
tPA 1.6 kg 
NaOH 0.013 kg 
Glycine 8.7 kg 
Sucrose 0.026 kg 
CHARACTERISTICS: 
Vials volume: 100mL 
Materials: 316 Stainless steel 
CIP and SIP capability. 
OPERATL1'IJG CONDITIONS: 
Pressure: 

Temperature: 

Bottling time/3200 100 mL vials: 

Volume loaded per vial: 

Tray loading time: 

Power requirements: 

Equipment uptime per batch: 

Utility costlyr: 

14.7 psi 
4°C 
1hr 
-25 mL (depends on tPA conc. in FD Tank) 
1hr 
1.5 hp total 
146 hrs 
$330 
PURCHASE COST: $1,265,000 
REFERENCE PAGES: 85, 346-349,367 
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FREEZE DRYER 
FUNCTION: Remove \VFI from tPA and form a stable, solid product that can be dissolved and injected. 
TYPE: Virtis Benchmark 6000 SQ Stoppering Lyophilizer 
MATERIALS HANDLED: 
Component Quantitv per batch 
WFI 278 L 
Arginine 175 kg 
tPA 1.6 kg 
NaOH 0.013 kg 
Glycine 8.7 kg 
Sucrose 0.026 kg 
CHARACTERISTICS: 
Shelves: 9 
100 mL vials per shelf: 396 
Heat transfer medium: Silicon fluid 
Condenser Capacity: 220 liters H20 in 24 ills 
Material: 316 Stainless steel 
OPERATING CONDITIONS: 
Liters per cycle: 

100 mL vials per batch: 

Cycle time: 

Standard shelf temperature: 

Cooling water requirements: 

Power requirements: 

Equipment uptime per batch: 

Utility costlyr 

SIP for 30 minutes after each cycle. 
-80L 
-3200 (depends on tPA conc. in FD tank) 
24 ills 
-55 c C 
6 gal/min 
Max 46.1 kW 
146 ills 
$13,500 
PURCHAS~ COST: $640,000 
REFERENCE PAGES: 85,350-361,367 
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REFRIGERATOR 
FUNCTION: Keep entire Separation Process at 4°C at all times. 
TYPE: Air conditioning system 
MATERIALS HANDLED: 
Component Quantity required: 
Refrigerant 16.67 tons 
CHARACTERISTICS: 
Refrigerant requirements: 1.25 tons refrigerant'300 ft2 of cooled space 
Area to be cooled: 4,000 ft2 for two separation trains 
Power rating: 1 kW/ton refrigerant for Jow temperature cooling* 
Load factor: 0.6* 
OPERATING CONDITIONS: 
Cooling time/yr 8760 hrs 
Power requirements: lOkW 
Utility cost'yr: $3,504 
PURCHASE COST: $10,000* 

REFERENCE PAGES: 87, 356 
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INITIAL PUMP (PW-l) 
FUNCTION: To bring city water into the water purification process 
TYPE: Peristaltic Pump model No. 880-300 varied flow, speed control from Randolph Austin Company 
MATERIALS HANDLED: 
Component Quantity per Day 
City Water: 50000 L 
CHARACTERISTICS: 
Dimension L x W x H: 29x 17x21 (inch) 
Material: 316 Stainless Steel 
Motor Horse Power: 1 hp 
Pump Speed: 190 RPM 
OPERATING CONDITIONS: 
Pressure in: 14.7 psi 
Pressure out: 34.7 psi 
Temperature: 25°C 
Flow Rate: 35 Llmin 
PURCHASE COST: $5,250 
REFERENCE PAGES: 87, 369, 387-388 
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10 f.lM MICROFILTER (FW-1) 
FUNCTION: To separate particles in feed water before it enters the reverse osmosis system, and to 
prevent unwanted particles from damaging the reverse osmosis system membrane. 
TYPE: Tangential flow filter model Flotrex™-AP Filters Polypropylene Microfiber from Osmonics. 
MATERIALS HANDLED: 
Component Quantity per Day 
City Water: 50000 L 
CHARACTERISTICS: 
Cartridge Dimension: 2.75 inch (outside diameter) 
Cartridge Dimension: 1.25 inch (inside diameter) 
Length: 
Membrane Area: 
10 inches 
6.7 ft2 
Pore Size: 10 JlIll 
Membrane Material: Polypropylene 
OPERATING CONDITIONS: 
Temperature: 25°C 
Water Flow Rate: 18 Llmin 
Filter cartridge life: One Batch 
Pressure in: 34.7 psi 
Pressure out: 14.7 psi 
PURCHASE COST: $44 per cartridge per 10 inches equivalent 
REFERENCE PAGES: 88,376,389-390 
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CARBON FILTER PUMP (PW-2) 
FUNCTION: To compensate pressure drop in the carbon filter. 
TYPE: Peristaltic pump model No. 750-362 varied flow, speed control from Randolph Austin Company 
MATERIALS HANDLED: 
Component Quantity per Day 
City Water: 50000 L 
CHARACTERISTICS: 
Material: 316 Stainless steel 
Pump Horse Power: 0.25 bp 
Pump Speed: 12-500 RPM 
OPERATING CONDITIQNS: 
Pressure in: 14.7 psi 
Pressure out: 26.7 psi 
Temperature: 25°C 
Volumetric Flow Rate: 18 Llmin 
Efficiency: 80% 
PURCHAS:E: COST: $2,656 
REFERENCE PAGES: 88, 369-370, 387-388 
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CARBON FILTER (FW-2) 
FUNCTION: To remove chlorine and organic particles from feed water stream and to protect water 
softener's resin, micro filter, and reverse osmosis system from degradation. 
TYPE: Model WTTS16C Carbon Filter from Ameriwater. 
MATERIALS HANDLED: 
Component Quantity per Da~' 
Municipal City Water: 50000 Llday 
CHARACTERISTICS: 
Material: Polyethylene 
Diameter: 42 inches 
Height: 87 inches 
Absorbent: Bituminous Coal 
Absorbent Weight: 1000lbs 
OPERATING CONDITIONS: 
Flow Rate: 76 Llmin 
Water Temperature: 25°C 
Pressure in: 26.7 psi 
Pressure out: 14.7 psi 
Max Contact Time: 5.3 min 
Empty bed contact time at design flow and a bed density of28 Ib/ft3. 
PURCHASE COST: $1,515 
REFERENCE PAGES: 88 
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WATER SOFTENER (FW -3) 
FUNCTION: To remove to unwanted ions from the feed water before it enters the reverse osmosis system. 
TYPE: Model WTMD 16 meter initiated system from Ameriwater 
MA TERIALS HANDLED: 
Component Quantity per Day 
City Water: 50000 L 
CHARACTERISTICS: 
Resin Type: Polystyrene Sulfonate Cation 
Life of Resin: 10 years 
Flow Rate: 4 gallon I(min ft3) 
Amount of Resin filled: 7 fe 
Outer Tank Shell Material: Fiberglass 
Inner Tank Shell Material: Polyethylene 
OPERATING CONDITIONS: 
Pressure in: 24.7 psi 
Pressure out: 14.7 psi 
Temperature: 25°C 
Flow Rate: 76 Umin 
PURCHASE COST: $4,537 
REFERENCE PAGES: 89, 377-383 
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WATER SOFTENER PUMP (PW-3) 
FUNCTION: To compensate pressure drop in the water softener 
TYPE: Peristaltic Pump model No. 880-300 varied flow, speed control from Randolph Austin Company 
MATERIALS HANDLED: 
Component Quantitv per Day 
City Water: 50000 L 
CHARACTERISTICS: 
Material: 316 Stainless steel 
Dimension L x W X H: 29 x 17 x 21 (inch) 
Pump Speed: 190 RPM 
Pump Horse Power: 1 hp 
OPERATING CONDITIONS: 
Pressure in: 14.7 psi 
Pressure out: 24.7 psi 
Temperature: 25°C 
Flow Rate: 76 Llmin 
Efficiency: 80% 
PURCHASE COST: $5,250 
REFERENCE PAGES: 89, 370, 377-378 
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REVERSE OSMOSIS PUMP (PW-7) 
FUNCTION: To compensate the pressure drop across the reverse osmosis system. 
TYPE: Peristaltic Pump model No. 880-300 varied flow, speed control from Randolph Austin Company 
MATERIALS HANDLED: 
Component Quantity per Day 
City Water: 50000 L 
CHARACTERISTICS: 
Material: 316 Stainless steel 
Pump Speed: 190 RPM 
Pump Horse Power: 1 hp 
OPERATING CONDITIONS: 
Pressure in: 14.7 psi 
Pressure out: 34.7 psi 
Temperature: 25°C 
Flow Rate: 76 Llmin 
Efficiency: 80% 
PURCHASE COST: $5,250 
REFERENCE PAGES: 90, 373, 387-388 
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REVERSE OSMOSIS SYSTEM (RO-I) 
FUCTION: 	The reverse osmosis system separates salts, organic molecules, and bacteria from feed water 
stream. 
TYPE: Model IR06 Open Skid Style System from Ameriwater. 
MATERIALS HANDLED: 
Component Quantitv per day 
City Water: 50000 L 
CHARACTERISTICS: 
Membrane Size: 4 x 40 (inch) 
Membrane Type: Thin Film Composite 
Number of Membranes: 6 
Pump Horse Power: 1.5 hp 
Electricity: 220 V 7.5 Maximum Amp 
Dimension H x W x D: 72 x 24 x 35 (inch) 
OPERATING CONDITIONS: 
Rated Capacity: 

Production per Day: 

Temperature: 

Operating pH Range: 

Pressure in: 

Pressure out: 

Pressure Feed Range (psi): 

Cleaning pH Range: 

Prefiltration: 

36 Llmin 
52000 L 
25°C 
4-11 
34.7 psi 
14.7 psi 
20-80 
2-11.5 
5 flm 
PURCHASE COST: $22,500 
REFERENCE PAGES: 90, 371, 393-395 
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STORAGE TANK (TW-l) 
FUNCTION: To store excess purified water for various uses through out the plant. 
TYPE: 4000 Polyethylene, horizontal holding tank. 
MATERIALS HANDLED: 
Component Quantity per Dav 
Purified Water: 50000 L 
CHARACTERISTICS: 
Capacity: 50000 L 
Height: 140 inches 
Diameter: 94 inches 
Material: 4000 Polyethylene 
OPERATING CONDITIONS: 
PURCHASE COST: $3,554 
REFERENCE PAGES: 91 
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UV SYSTEM PUMP (PW-4) 
FUNCTION: To compensate the pressure drop in the Ultraviolet Light system 
TYPE: Peristaltic pump model 750-362 vari-flow speed control from Randolph Austin Company 
MATERIALS HANDLED: 
Component Quantity per Day 
Purified Water: 50000 L 
CHARACTERISTICS: 
Material: 316 Stainless steel 
Pump Horse Power: 0.25 hp 
Pump RPM: 12-500 RPM 
OPERATING CONDITIONS: 
Pressure in: 14.7 psi 
Pressure out: 19.7 psi 
Temperature: 25°C 
Volumetric flow rate: 23 Llmin 
Efficiency: 80% 
PURCHASE COST: $2,656 
REFERENCE PAGES: 91, 372, 387-388 
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ULTRAVIOLET LIGHT SYSTEM (UV-l) 
FUNCTION: To prevent bacterial growth and to destroy particles fonned in the Storage tank. 
TYPE: UV Lamp Model ~1inipure-MIN6, and Lamp No. 05-1370 from Atlantic Ultraviolet Corporation. 
MATERIALS HANDLED: 
Component Quantity per Day 
Purified Water: 50000 L 
CHARACTERISTICS: 
Material for chamber and hardware: 
Lamp Power Consumption: 
Rated Effective Life: 
Dimension L x W x H: 
304 Stainless steel 
21 Watts 
10000 Hours 
23 x 5 x 6 (inch) 
Maximum rated output at 254 nanometers 
OPERATING CONDITIONS: 
Pressure Drop at Max Flow Rate: 5 psi 
Pressure in: 19.7 psi 
Pressure out: 14.7 psi 
Max Operating Pressure: 100 psi 
Flow Rate: 23 Llmin 
PURCHASE COST: $1,567 
REFERENCE PAGES: 92, 384-386 
• 
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0.2 gM MICROFILTER PUMP (PW-5) 
FUNCTION: To compensate the pressure drop in 0.2 !lI11 microfilter. 
TYPE: Peristaltic pump model 750-362 vari-flow speed control from Randolph Austin Company 
MATERIALS HANDLED: 
Component Quantity per Day 
Purified Water: 50000 L/min 
CHARACTERISTICS: 
Material: 316 Stainless Steel 
Pump Horse Power: 0.25 hp 
Pump Speed: 12-500 RPM 
OPERATING CONDITIONS: 
Pressure in: 14.7 psi 
Pressure out: 24.7 psi 
Temperature: 25°C 
Flow Rate: 30 Umin 
Efficiency: 80% 
PURCHASE COST: $2,656 
REFERENCE PAGES: 92, 373,387-388 
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0.2 MICRON FILTER (PW-4) 
FUNCTION: To separate newly formed particles before the purified water enters the process. 
TYPE: Model Memtrex™-FE-S by Osmonics 
MATERIALS HANDLED: 
Component Quantitv per Dav 
Purified Water: 50000 L 
CHARACTERISTICS: 
Material: Polypropylene Membrane 
Cartridge Dimension: 2.75 inch (outside diameter) 
Cartridge Dimension: 1.25 inch ( inside diameter) 
Length: 10 inch 
Membrane Area: 9 ft' 
Pore Size: 0.2 micron 
OPERATING CONDITIONS: 
Pressure in: 24.7 psi 
Pressure out: 14.7 psi 
Temperature: 25°C 
Flow Rate: 18 Llmin 
PURCHASE COST: $44 per cartridge per 10 inches equivalent. 
REFERENCE PAGES: 93,391-392 
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FINAL PUMP (PW-6) 
FUNCTION: To adjust the pressure within pipes so that the desired flow rate can be achieved. 
TYPE: Peristaltic Pump model No. 880-300 varied flow, speed control from Randolph Austin Company 
MATERIALS HANDLED: 
Component Quantity per Day 
Purified water: 50000 L 
CHARACTERISTICS: 
Material 316 Stainless Steel 
Horse Power Required 1 hp 
Pump Speed 190 RPM 
Dimension L x W x H: 29 x 17 x 21 (inch) 
OPERATING CONDITIONS: 
Water Temperature: 25°C 
Flow Rate: 18 Llmin 
Pressure in: 14.7 psi 
Pressure out: 34.7 psi 
Efficiency: 80% 
PURCHASE COST: $5,250 
REFERENCE PAGES: 93, 373, 387-388 
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Economic Evaluation 
Generic tissue plasminogen activator (tPA) has the potential to take a large 
portion of the thrombolytic therapy market. Genentech's Activase™ and streptokinase 
are currently the primary treatment methods for heart disease and related illness. 
Genentech sells their product for about $2,000 per dose, while streptokinase is priced at 
about $200 per dose. We aim to enter the market at about $500 per dose, and this will 
allow us to sell to consumers for whom cost is not an issue and also to those who cannot 
afford premium medications. Activase™ is so expensive because Genentech must make 
up for the billions of dollars spent on research and clinical trials for its products; we will 
not have to worry about those expensives in production of generic tP A. 
Genentech currently sells about $300 MM a year of tP A in the U.S. The rest of 
the world, primarily Europe and Japan, use much less tPA and relies upon the less 
expensive streptokinase. We are estimating that the total worldwide sales oftPA are 
$400 MMlyr. When patents run out, pharmaceutical companies can lose half of their 
market share to generic versions of their drug. Given that we will be selling our drug for 
a quarter of the Activase ™ price, we are estimating that we can acquire half of the tP A 
sales worldwide. 
Many studies have been completed that compare the effectiveness oftPA and 
streptokinase for the treatment of heart-related illnesses. When taking into account 
quality oflife, one-year mortality, and long-term medical costs tPA was concluded to be 
much a more cost-effective treatment compared to streptokinase, even with the large 
difference in price (Kalish et aI, 1995). This study used data from a widely published 
study entitled the Global Utilization of Streptokinase and Tissue Plasminogen Activator 
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for Occluded Coronary Arteries (GUSTO). A questionnaire from the GUSTO-l trial was 
also used in an analysis ofpatient preferences for thrombolytic therapy. When costing 
was not an issue, tP A was preferred overall due to its lower mortality and fewer 
occurrences of side effects. When costing was introduced to the decision, especially 
under self-pay circumstances streptokinase became more preferred (Stanek et aI, 1997). 
Obviously the high cost oftPA causes it to lose market share to streptokinase, so 
lowering the price would increase its use in hospitals in less wealthy areas. Streptokinase 
is used much more widely overseas, so we estimate U.S. sales to be approximately $50 
MM/year and worldwide sales to be $150 MM/year, based on a discussion with Prof. 
Diamond. Cost and availability are the primary reasons streptokinase is used instead of 
tPA in the world; so selling it at the comparable price of$500/dose would allow us to 
gain two-thirds of the streptokinase. Calculating half of the tPA market and two-thirds of 
the streptokinase market leads us to a production number of about 76,000 doses each 
year, or 76 kg/yr. This yields about $380 MMiyear in sales, and given our production 
and start-up costs, generic tPA can be very profitable. A detailed description ofour costs 
is presented in the next sections. 
Capital C~sts 
Capital costs for our plant are just over $100 MM. These include the purchase of 
equipment, installation and construction, working capital, and accounts receivable. The 
cost of purchasing all of our equipment is about $5.4 MM; over 75% of this comes from 
the Separation Trains, in particular the Bottlers, Freeze Dryers, and chromatography 
columns (see Figure 9 on page 153). The remaining costs are derived from the 
Fermentors and Centrifuge. A list of equipment costs is presented in Table 6 on page 
151 
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152. Installation costs are set at 200% of the total equipment costs ($10.8 MM), a high 
estimate because we are using sanitary piping throughout the plant. Other capital costs 
are derived from cost factors recommended by Prof. Seider for the cost spreadsheet 
created by Holger Nickisch (see page 160). These factors can be viewed in the Input 
Summary on page 160. The final large portion ofour capital costs comes from total 
Accounts Receivable. This cost results from the fact that it takes time to collect 
payments from customers, and this revenue is needed in advance to pay for yearly fixed 
and variable costs. The number is so large because our sales sum to $360 MM/yr. 
TABLE 6: Unit Purchase Costs 
Unit Purchase Costs 
Name Description Purchase Cost Quantity Total 
BR-1 40 L Fermentor $85,000· 2 $170,000 
BR-2 400 L F ermentor $125,000* 2 $250,000 
BR-3 5000 L Fermentor $250,000* 2 $500,000 
HX-1 Heat Exchanger $6,456t 2 $12,911 
T-1 Blending Tank $28,658* 2 $57,316 
CTI Copper tubing and insulation $2,000* 2 $4,000 
RFU Refrigeration Unit for media tank $20,000* 2 $40,000 
RF Refrigerant for media $250* 16 $4,000 
P1 Peristoltic Pump $1,595* 2 $3,190 
P2 Peristoltic Pump $1,595* 2 $3,190 
P3 Peristoltic Pump $1,595* 2 $3,190 
P4 Peristoltic Pump $1,595* 2 $3,190 
P5 Peristoltic Pump $1,595* 2 $3,190 
P6 Peristoltic Pump $1,595* 2 $3,190 
P7 Centrifugal Pump $3,250* 2 $6,500 
Holdup Tank Tank after BR3 $19,000* 1 $19,000 
Centrifuge Centrifuge $355,000* 1 $355,000 
UF1 Tank Recycle tank for UF1 $17,000* 1 $17,000 
LlF1 Pump Pump for UF1 $2,656* $2,656 
UF2 Tank Recycle tank for UF2 $9,000* $9,000 
UF2 Pump Pump for UF2 $2,656* 1 $2,656 
UF Cleaning Cleaning solution • $75* 1 $75 
Affinity Tank Tank for Affinity Column $10,000* 2 $20,000 
Affinity Column Affinity chromatography column $100,OOOt 2 $200,000 
Affinity Skid/Pump Controller/pump for Affinity Column $100,OOOt 2 $200,000 
ER Tank Tank for ER Column $10,000* 2 $20,000 
ER Column Endotoxin removal column $6,190* 2 $12,380 
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Name Descrietion Purchase Cost Quantit~ Total 
ER Skid/Pump Controller/pump for ER Column $100,000t 2 $200,000 
MFTank Tank for MF $11,000* 2 $22,000 
MF Pump Pump for MF $2,656* 2 $5,312 
FD Tank Tank before Bottler $11,000· 2 $22,000 
Bottier BottlerlTray Loader $865,000* 2 $1,730,000 
Freeze Dryer Freeze Dryer $640,000· 2 $1,280,000 
Refrigerant AC refrigerant $250* 17 $4,250 
Refrigerator Air-conditioning system $10,000· 1 $10,000 
B-1 Boiler $112,000# 1 $112,000 
RO-1 Reverse osmosis system $7,500* 1 $7,500 
Water Softener Ion removal $4,537* 1 $4,537 
WP-1 Initial pump $5,250* 1 $5,250 
WP-2 Pump for Carbon filter $2,656* 1 $2,656 
WP-3 Pump for Water Softener $5,250· 1 $5,250 
WP-4 Pump for UV lamp $2,656· 1 $2,656 
WP-5 Pump for microfilter $2,656· 1 $2,656 
WP-6 Final pump $5,250* 1 $5,250 
WP-7 Pump for RO-1 $5,250· 1 $5,250 
WT-1 Holding tank for sterile water $15,000* 3 $45,000 
WT-2 Holding tank for waste $10,000· 2 $20,000 
Total: $5,410,000 
Key for the Table 
Symbol Price origin 
* Quote from vendor 
# IPE calculation 
t Quote from Prof. Diamond or Dr. Kivnick 
t Estimation from cost charts 
FIGURE 9 
Freeze Dryers 

(24%) 
 Bottlers (32%) 
Columns (11%) Water 
treatment «10/0) 
Centrifuge ___~~ 

(6.5%) 
 Boiler (2%) 
Refrige ration Fermentors 
(1%) (17°/0) 
Pumps (1%) 
\ 
l Tanks (4.5 0/0) 
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Variable Costs 
The variable costs for our process are made up of raw materials and utilities costs. 
The raw materials account for almost all ofthe variable costs, primarily because most of 
the materials we use are of the highest quality and purity. The powdered media is 
extremely expensive; for this is essentially the "feed," and our reactors are the cells, 
which require the best ingredients to yield the highest "conversion." Chemicals 
introduced in the Separation section are also of the highest purity because we cannot 
afford to introduce more contaminants or impurities (such as endotoxins). An enormous 
amount of arginine is also required for the process because this keeps our protein "intact" 
by preventing aggregation. More than half ofthe cost due to raw materials comes from 
the purchase of arginine. 
Other variable costs included are filters, which can be very expensive and are 
replaced fairly often. The chromatography columns also increase our variable costs. The 
resins used in our columns are extremely expensive; though they last an entire year. The 
Affinity Resin costs $2,81 OIL, and the ER Resin costs $4,320/L. Finally, about 750 kg of 
anti-tPA antibody are required for our Affinity Columns. This antibody will actually be 
produced in our plant, but time constraints prevented us from designing the antibody 
production (a design project in and of itself). Prof. Diamond recommended we use a cost 
of$2,000/g of antibody for our calculations. 
The waste disposal is also considered a raw material; one that we are buying for a 
"negative price" in a sense. A phenomenal amount ofwaste is produced during 
production and cleaning of our plant. This disposal is contracted out to EarthCare for a 
price of$0.211gal, though we used $1.00/gal in our calculations to provide for 
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transportation and excess waste. A list of the raw materials used in our plant is provided 
below in Table 7. 
The majority of our variable costs arise from expenses such as research, 
management compensation, and administrative expenses. Factors from Prof. Seider's 
Process Design Principles were used to detennine these costs. Direct and allocated 
research factors were increased significantly to account for research and development for 
our process. Pharmaceutical and biotechnology companies invest a significantly larger 
portion of their profits toward research because it can be so costly and fruitless in some 
instances. These other variable costs account for almost 80% of the $82 MM in variable 
costs (see page 166). 
TABLE 7: Raw Material Costs 
Raw Materials 
Item Purchllse Cost (1 unit) Quantity/yr Yearly Cost 
Affinity Resin $2,910* 120L $349,200 
ER Resin $4,320* 20L $86,400 
UF2 filters $950* 1 unit -$950 
UF1 filters $785* 1 unit $785 
Arginine $119* 74500kg $8,865,500 
Glycine $43* 770kg $32,879 
PBS $5* 117000L $566,982 
NaCI $18* 4500kg $81,000 
Sucrose $1* 3kg $2 
NaOH $18* 550kg $9,625 
Powdered Media $20* 250000L $5,000,000 
anti-tPA antibody $2,000 t 750g $1,500,000 
Waste $1* 660400gal $660,400 
Tank Compressed Air $172* 360tank $61,920 
Carbon filter $1,515* 1 unit $1,515 
10 micron filter $32* 50 unit $1,564 
2 micron filter $32* 50unit $1,564 
0.2 micron filter $44* 170unit $4,400 
Total: $16,500,000 
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FIGURE 10 
-Media (29%) 
Arginine (51.5%)' 
I 
I 

PBS (3.5%) 

Antibody (9%) 
Waste disposalAffinity Resin 
(4%)(2%) 
Fixed Costs 
Fixed costs for our plant were also calculated using the economic spreadsheet 
provided by Holger Nickisch (see page 165). Salaries and wages for operators and 
maintenance personnel contribute the majority ofour fixed costs. These figures were 
again calculated using Prof. Seider's recommendations in Process Design Principles. 
Key differences lie in wages for our operators, which are significantly higher than those 
for chemical plants. According to Prof. Diamond, most operators in biotechnology plants 
have PhD's and require higher pay; for this reason our wages and benefits accounted for 
$100,000 for 6 operators. There are many different unit operations that each requires 
significant expertise to master, for example the affinity chromatography steps. 
In addition to these costs we included $500,OOO/yr for a control laboratory. This 
molecular biology laboratory is responsible for completing quality control tests 
throughout the process (see Other Considerations page 174). This laboratory will require 
expensive instrumentation, though some of this will certainly be available from the 
156 

Generic tPA Economic Evaluation 
laboratory that derived our cell line. The $500,000/yr estimate was recommended by 
Prof. Diamond in our design meeting, and the total fixed costs sum to $11.4 MM/yr. 
Profitability Analysis 
The production of generic tPA has the potential to be a very profitable venture. 
The capital investment required from our plant is just over $104 MM, and the annual 
costs required to run the plant are over $88 MM (see page 167). Fortunately, our product 
is expensive enough to place our annual sales at $360 MMlyr. This value is derived from 
a production rate of 80 kg/yr. The table below demonstrates that the market share we 
predict will be available for generic tP A priced at $500/dose. Our calculations were 
completed at a 90% production rate (72 kglyr), so our production works well with the 
estimate market of 76 kg/yr. 
TABLE 8: Market Share Analysis 
US market ($/yr) 

Europe/Japan market ($/yr) 

World market ($/yr) 

% of market share taken 

Competitor price ($/dose) 

pur price ($/dose) 

lYearly sales from tPA & SK ($/yr) 

Our total yearly sales ($/yr) 

Production Rate 

Production Rate (1 OOmg/dose) 

tPA SK 
$300,000,000 $50,000,000 

$100,000,000 $150,000,000 

$400,000,000 $200,000,000 

50 66 
$2,000 $200 
$500 
$50,000,000 $330,000,000 
$380,000,000 
760,000 doses/year 
76kg/year 
Calculations obtained from the Nickisch spreadsheet provide and investor's rate 
of return (IRR) at 59.7% and a return on investment (ROI) of 145.8% (see page 167). 
These numbers make our plant extremely profitable. The payback period is less than two 
years for our company, given that we allowed for three years ofconstruction. This was 
done to allow time for the production of a viable cell line by our research facility. After 
eight years ofproduction the net present value (NPV) ofour plant is approximately $1 
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billion. While these numbers are high, we feel confident that our numbers are 
reasonable. Ifwe were unsure of any estimated costs, we made certain that they were 
overstated. Our annual sales will be very sensitive to price, so a more detailed estimate 
on the effect of price is presented below. 
As the selling price ofour generic tP A is lowered we will acquire a greater 
percentage of both the SK and Activase™ markets. A decrease in price will also 
decrease annual sales and revenue, so there will be a maximum in annual sales that we 
can achieve for the range of selling prices from $200/dose to $2000/dose. The following 
plot is presented to demonstrate the effect of price on sales. The percentage of SK and 
Activase ™ market share that we can attain was roughly estimated based on discussions 
with Prof. Diamond. In order to determine the ideal selling price a comprehensive 
marketing report would need to be completed, but Figure lIon page 169 is shown to 
give a general idea of the strong effect that pricing can have on market share. 
It is possible that there would not be such a large market for generic tPA; if so, 
our plant would not run at capacity. In addition to the calculations presented above, we 
have also performed calculation for our plant given an annual production of40 kg/yr, or 
half the previous value of 80 kg/yr. This cut in production only affects the variable costs 
and annual sales: both ofwhich are cut in half. Even with a $180 MM decrease in 
annual sales our plant in still extremely profitable. The IRR is now 41 % and the ROI is 
80.25%, very good values for a chemical process. The NPV after ten years of production 
is $782 MM (see page 169). 
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Annual sales per Year vs. Seiling Price 
$400~----------------~--------------~ 
$300 +--.. ,L-~-- ------".--...--..---...---...---..-­
il ..-.~.---\---- ...­
"C 
~:IE ---1 
:IE 
tit
-II)
.!! $200 ..~.---...-----j 
I'CI 
II) 
iO 
~ $100 +-------....~- --...--~-.---.--~~~~.~~~~.--...~ 
c: 
« 
$0 
$200 $700 $1,200 
-­
$1,700 
FIGURE 11 
Selling price ($/dose) 
Our calculations demonstrate that the production of generic recombinant tPA is a 
very profitable and worthwhile venture. All cost estimates are either direct quotes from 
company representatives or conservative estimates from Prof. Diamond and Dr. Kivnick. 
Given the final values in our profitability analysis, it would not be surprising to see 
generic tP A enter the market three or four years from now. 
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Generic tPA Economic Summary 
Input Summary 
April 21, 2000 
General Information 
Title of Process: Human Tissue Plasminogen Activator 
Plant Site: U.S. Northeast 
Starting Year: 2000 
Years of DesIgn: 1 
Years of Construction: 3 
Years ofPlant Life: 12 
First Year of Production: 2004 
Product Information 
_.__.__._._.____--'!:tIe proce~yields..! sin~:1'.r.?ducl_:_.~_.. _ ....__.t!'~_. __._ .._.....__... 
Capacity 
Operating Hours per Year: 8,400 
. The Process will Yield: 0.01 hour or 80 oftPA 
Market Price 
_ ..__.._._.__---....!he Price per kg oftPAi~_~ __~_~____._~000!l.!l0.0.!l ______.__._.._._.__._'_.__..__. 
Equipment Costs 
Equipment Tvpe Cost 
Fennentation Section $1,075,000 
WaterIWaste Treatment $106,000 
Separation Section $4,132,000 
Steam Production $112,000 
Cell Line Research $1,000,000 
Percentage ofPurchased Costs for Installation Materials: 200.00 % 
Percentage ofPurchased Costs for Labor: 150.00 % 
Percentage of Purchased Costs for Freight, Insurance and Taxes : 15.00 % 
Percentage ofPurchased Costs for Construction Overhead: 150.00 % 
of Purchased Costs for 130.00 % 
Total Capital Investment 
Percentage ofTotal Bare Module Costs for Site Preparation and Service Facilities: 10.00 % 
Allocated Utility and Related Facility Costs (see Table 9.4): $ 
Percentage ofDirect Pennanent Investment for Contingencies: 15.00 % 
Land: Enter either a dollar value or a percentage ofTotal Depreciable Capital: 2.00 % 
Percentage ofTotal Depreciable Capital for Royalties: % 
Percentage ofTotal Depreciable Capital for Start·Up: 20.00 % 
Site Factor 1.10Table 
Working Capital 
Inventory will be kept of the following Materials: 
Arginine: 
Glycine: 
Sucrose: 
PBS: 
NaOH: 
NaCI: 
Powdered Media: 
Compressed Air: 
10 micron filter: 
2 micron filter: 
0.2 micron filter: 
Accounts Receivable: 
-~~.----.---. ---._-._--­
Raw Materials 
kg Arginine per kg tPA: 
kg Glycine per kg IPA: 
kg Sucrose per kg tPA: 
L PBS per kg IPA: 
kg NaOH per kg tPA: 
kg NaCl per kg IPA: 
14 days 
14 days 
14 days 
14 days 
14 days 
14 days 
14 days 
14 days 
14 days 
14 days 
14 days 
30 
931.0430000 
9.6158000 
00290000 
1452.9300000 
6.5500000 
56.3000000 
Cost ($) per kg Arginine: 
Cost ($) per kg Glycine: 
Cost ($) per kg Sucrose: 
Cost ($) per L PBS: 
Cost ($) per kg NaOH: 
Cost (S) per kg NaCl: 
3,160 
33 
0 
4,931 
22 
191 
10,606 
16 
2 
2 
II 
kg 
kg 
kg 
L 
kg 
kg 
L 
tank 
unit 
unit 
umt 
119.0000000 
42.7100000 
4.8500000 
0.7990000 
17.5400000 
18.0500000 
Generic tPA Economic Summary 
L Powdered Media perkg tPA: 
tank C02 per kg tPA: 
tank Compressed Air per kg tPA: 
g anti-tPA antibody per kg tPA: 
unit [0 micron filter per kg tPA: 
unit 2 micron filter per kg tPA: 
unit 0.2 micron filter per kg tPA 
L Affinity Resin per kg tPA: 
L ER Resin per kg tPA: 
unit Carbon Filter per kg tPA: 
unit UF I /liter per kg tPA: 
unit UF2 filter per kg tP A: 
.........~~____._._.~~_W~a~s.te_p!~~tP~: 
Utilities 
3125.0000000 Cost ($) per L Powdered Media: 
0.3750000 Cost ($) per tank C02: 
4.7500000 ost($) per tank Compressed Air: 
9.3750000 Cost ($) per g anti-tPA antibody: 
0.6250000Cost ($) per unit 10 micron filter: 
0.6250000 Cost ($) per unit 2 micron filter: 
3.3750000 ost ($) per unit 0.2 micron filter: 
1.5000000 Cost ($) per L Affinity Resin: 
0.2500000 Cost ($) per L ER Resin: 
0.0125000 Cost ($) per unit Carbon Filter: 
0.0125000 Cost (S) per unit UF! !liter: 
0.0125000 Cost ($) per unit UF2 filter: 
8255.0000000 Cost ($)pergal W~te: 
20.0000000 
1428000000 
171.6300000 
2000.0000000 
320000000 
32.0000000 
44.0000000 
2809.6000000 
4320.0000000 
2000.0000000 
785.0000000 
950.0000000 
05000000 
gal Process Water per kg tPA: 17,014.5000000 Cost per gal Process Water: 0.0005000 
MMBTU Natural Gas per kg tPA: 13.1700000 Cost per MMBTU Natural Gas: 2.6000000 
kW*hr Electricity per kg tPA: 17,300.0000000 Cost per kW*hr Electricity: 0.0400000 
tPA: 0.0125000 Cost per yr Anti-body License: 12000000 
Other Variable Costs 
SellingfTransfer Expense: 

Direct Research: 

Allocated Research: 

Administrative Expense: 

Management Incentive Compensation: 

Packaging 

Labor: 

Materials: 

1.00 % of sales 
10.00 % of sales 
2.00 % of sales 
2.00 % ofsales 
1.25 % of sales 
0.00 per kg tPA 
2000.00 per kg tP A 
Fixed Costs 
Operations 

Number ofOperators per Shift: 

Annual Wages per Operator: 

Direct Salaries and Benefil~: 
Operating Supplies and Services: 
Technical Assistance to Manuf.: 
Control Laboratory: 
Maintenance 
Wages: 
Salaries and Benefits: 
Materials and Services: 
Maintenance Overhead: 
Operating Overhead 
General Plant Overhead: 
Mechanical Department Services: 
Employee Relations Department: 
Business Services: 
Property Taxes and Insurance 
Property Taxes and Insurance 
Depreciation 
Direct Plant 
Allocated Plant 
Financial Information 
6 (assuming 5 Shifts) 
$100,000 Including Benefits 
15 
6 
$52,000 
$500,000 
3.50 
25.00 
100.00 
5.00 
7.10 
2.40 
5.90 
7.40 
1.50 
8.00 
6.00 
% of wages 
%ofwages 
per labor year 
per labor year 
% ofTotal Depreciable Capital, 
% of Maintenance Wages and Benefits 
% of Maintenance Wages and Benefits 
% of Maintenance Wages and Benefits 
Including Benefits 
% of Maintenance and Operations Salaries, Wages and Benefits 
% of Maintenance and Operations Salaries. Wages and Benefits 
% of Maintenance and Operations Salaries, Wages and Benefits 
% of Maintenance and Operations Salaries, Wages and Benefits 
% ofTotal Depreciable Capital 
% of Total Depreciable Capital 
% of Allocated Costs 
Cost of Capital: ~o 
General Inflation Rate: % 
Income Tax Rate: 37.00 % 
MACRS Tax-Basis Depreciation Schedule Distribution of Investment 
YEAR I 10.00% DESIGN I 25% 
YEAR 2 18.00% CONSTRUCTION I 25% 
YEAR 3 14.40% CONSTRUCTION 2 25% 
YEAR4 11.52% CONSTRUCTION 3 25% 
YEAR 5 9.22% 
I t> \ 

Economic Summary Generic fPA 
YEAR 6 7.37% 

YEAR 7 6.55% 

YEARS 6.55% 

YEAR9 6.56% 

YEAR 10 6.55% 

YEAR II 3.2S% 

Generic tPA Economic Summary Venture Guidance Appraisal 
Human Tissue Plasminogen Activator 
April 21, 2000 
TOTAL 
Equipment 
I. fermentalion Section 
WaterlWaste Treatment 
Materials for Installation: S12,850,000 
Total Direct l\1alerlalS: $19,275,000 
'Total Direct Labor: ===== $9,638,000 
~Total Direct Project Expenses S28,913,000 
Working Capital 
Inventory 
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Generic tPA Economic Summary 
Fixed Costs 
Human Tissue Plasminogen Activator 
April 21, 2000 TOTAL 
Op,eration 
....--- $3,000,000: Wages and Benefits 
.~~. $450,000 1iDirectSalaries and Benefits 
Maintenance 
Operating Overhead 
General Plant Overhead ~.-~~-~.~ $43j,00~ 
~~anicalJ:)epartment Services ...~ .~.__~___ $146,~00 
i~mployee~elatiol1s Department . _____ ......__.~.__..... $360,000 
-
b~ 
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Generic tPA Economic Summary 
Variable Costs 
Human Tissue Plasminogen Activator 

April 2 I , 2000 TOTAL 

Raw Materials 
IPA 
IPA 
'Sucrose 14.07¢ per klk tPA 
iPBS tPA 
Byproducts 
Other Variable Costs 
\ b~ 

~I ~I 

Generic tPA Economic Summary 
Input Summary 
April 21, 2000 
General Information 
Title of Process: Human Tissue Plasminogen Activator 

Plant Site: t:.S. Northeast 

Starting Year: 2000 

Years ofDesign: 1 

Years ofConstruction: 3 

Years ofPlant Life: 12 

First Year ofProduction: 2004 

------ ......... ........._-­_ 
Product Information 
........ ___ ~ ______._ ........ The process yields a single product: 
Capacity 
Operating Hours per Year: 8,400 
The Process will Yield: 0.00 hour or 40 oftPA 
Market Price 
____T_h_e_P~ice p~Ekg oftPAis: 5000000.00 
-------- ........_----_._-­
Equipment Costs 
Equipment Type Cost 
Fennentation Section $1,075,000 
WaterlWaste Treatment $106,000 
Separation Section $4,132,000 
Stearn Production $112,000 
Cell Line Research $1,000,000 
Percentage of Purchased Costs for Installation Materials: 200.00 % 

Percentage of Purchased Costs for Labor: 150.00 % 

Percentage of Purchased Costs for Freight, Insurance and Taxes: 15.00 % 

Percentage ofPurchased Costs for Construction Overhead: 150.00 % 

ofPurchased Costs for Contractor F'nninp.prin 130.00 % 

Total Capital Investment 
Percentage ofTotal Bare Module Costs for Site Preparation and Service Facilities: 10.00 % 
Allocated Utility and Related Facility Costs (see Table 9.4): $ 
Percentage ofDirect Pennanent Investment for Contingencies: 15.00 % 
Land: Enter either a dollar value or a percentage ofTotal Depreciable Capital: 2.00 % 
Percentage ofTotal Depreciable Capital for Royalties: % 
Percentage ofTotal Depreciable Capital for Start-Up: 20.00 % 
Site Factor 1.10Table 
Working Capital 
Inventory will be kept of the following Materials: 
Arginine: 
Glycine: 
Sucrose: 
PBS: 
NaOH: 
NaCI: 
Powdered Media: 
Compressed Air: 
10 micron !ilter: 
2 micron filter: 
0.2 micron filter: 
Accounts Receivable: 
Raw Materials 
14 days 
14 days 
14 days 
14 days 
14 days 
14 days 
14 days 
14 days 
14 days 
14 days 
14 days 
30 
1,580 kg 
16 kg 
o kg 
2,466 L 
II kg 
95 kg 
5,303 L 
8 tank 
2 unit 
2 unit 
II unit 
kg Arginine per kg tPA: 931.0430000 Cost ($) per kg Arginine: 1190000000 
kg Glycine per kg tPA: 9.6158000 Cost ($) per kg Glycine: 42.7100000 
kg Sucrose per kg tPA: 0.0290000 Cost ($) per kg Sucrose: 4.8500000 
L PBS per kg tPA: 1452.9300000 Cost ($) per L PBS: 0.7990000 
kg NaOH per kg tP A: 6.5500000 Cost ($) per kg NaOH: 17.5400000 
kg NaCl per kg tPA: 56.3000000 Cost ($) per kg NaCI: 18.0500000 
~I 
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Scheduling 
The most important consideration is running a batch process is proper scheduling 
of each batch. The tissue plasminogen activator (tPA) process consists of two individual 
fermentation trains and two separation trains that share a common centrifuge and set of 
ultra filters. Batch scheduling had to be designed to fit 50 batches into one year without 
any overlap at the common unit operations. As shown in Figure 12 on page 172, a new 
batch is begun every 7 days in the 40 L fermentors and remains in the fermentation train 
for a total of27 days. 
The batch schedule is designed to run the 5000 L continuously over the course of 
the year. In other words, once a batch is harvested from the vessel the bioreactor is 
sterilized and filled with media for the next cell culture. Extra time was added into the 
schedule during the cleaning and sterilization portion of the batch to ensure enough time 
is available for routine maintenance or repairs. Each batch is properly scheduled to 
stagger the inoculation of the 40 Land 400 L fermentors so they can be harvested when 
the next fermentor in line is ready to start a new batch. The 40 L and the 400 L 
fermentors have a down time of7 and 4 days respectively. 
Another important consideration of the batch schedule is common equipment 
used by each train. The centrifuge and the ultra filters begin the purification process of 
the product protein. Cell cultures are sent immediately to the centrifuge after they are 
harvested. Precise timing of the batches in each train, staggers the harvest of the two 
5000 L fermentors every seven days. Subsequently, the centrifuge and the ultra filters are 
used only every seven days. The large down time of these two pieces of equipment 
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Figure 12 • Plant Widlt$cheduljngf9J 3 Fermentati91l Trains and 2 Separation Trains. 
Unit Operaticm 
DAY 
A40 L 
A400L 
A 5000 L 
Affinity Chromo 
ERColumn 
Micro Filter 
Bottler/Freeze Dry 
B 40L 
B400l 
B5000 l 
Affinity Chrorn. 
ERColumn 
Micro Filter 
Bottler/Freeze Dry 
A40l 
A400l 
A 5000 l 
Centrifuge 
UF1IUF2 
Affinity Chrom 
ERColumn 
Micro Filter 
BottierlFreeze Dry 
B40l 
B400L 
B 5000 l 
Centrifuge 
UF1/UF2 
Affinity Chromo 
ERColumn 
Micro Filter 
Bottler/Freeze Dry 
A40l 
A400l 
ASOOO l 
Centnfuge 
UF1/UF2 
Affinity Chromo 
ERColumn 
Micro Filler 
Bottler/Freeze Dry 
B40l 
B400 L 
B 5000 L 
Centrifuge 
UFlIUF2 
Micro Filter 
Bottler/Freeze Dry 
- 1 centnfuge and 1 Set 01 Ultra Filters for the whole plant 
- 2 Complete Separation Trains and freeze dryers 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45464748 49 50 51 52 53 54 55 56 57 58 59 60 61 6263 64 65 66 67 68 69 70 71 72 73 
....._-_. 
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Generic (PA Other Considerations 
prevents any bottlenecks from forming and allows enough time for maintenance and 
repairs if they are needed. 
The centrifuge and the ultra filters is the only area that bottlenecking could occur, 
but the scheduling design prevents this from occurring. The rest of the fermentation 
trains and the separation trains do not contain any other problematic areas. In fact, the 
plant design contains many holding tanks in between unit operations to retain material in 
the event of a shut down some where on the process line. Once the cells have been 
harvested the tP A protein can be held at 4 °C for a long period of time. 
The holding tanks are also part of a design for future expansion of the plant. In 
order to fulfill the entire problem statement, the plant was designed to handle a yearly 
production of 100 kg. The plant designed described in this report only has two 
fermentation trains, but a study of a three fermentation train plant was also explored. It 
was determined that the market was not large enough to sell 100 kg oftPAproduct, but 
the market may expand in the future. The plant would contain three fermentation trains 
and only 2 separation trains. Because of smaller batch lengths for the separation verse 
the fermentation processes, only two separation trains would be more than adequate. 
Quality Testing 
Before, during, and after each batch begins, tests must be run in order to confirm 
that we are making functional tPA and using good materials. It is always possible that 
the media is no good or that a batch will be infected. Contamination is a great concern 
given that our batches are worth approximately $15 MM each. In order to control for 
quality throughout the process we will need to perform tests on the media, take cell 
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samples from each reactor, and estimate tP A productivity at the beginning of the 
Separation train. This information is also invaluable to process development researchers 
who are working to optimize the production of tP A in our plant. 
To prevent an entire batch from being lost because of low quality media, a sample 
will be taken from the packaging when it is opened. This small sample ofmedia will be 
used to run a small, bottle-scale fermentation experiment to make sure the cells can grow 
in that particular batch ofmedia. Ordinary non-recombinant CRO cells will be used for 
this so as to avoid wasting the precious stock oftPA producing cells. For quality testing 
purposes they will be sufficient. 
Bacteria and viruses can contaminate mammalian cells very easily, so samples 
will be taken from each bioreactor to verify that the tP A-CRO cells are surviving and 
flourishing. In pharmaceutical plants such as this less than 1 percent of all batches are 
lost due to contamination. The loss of any batches is unacceptable in a process such as 
this given the shear value of the product being produced. Again, process development 
researchers can use this growth information to improve the cells and techniques used to 
grow them. 
Our plant's primary goal is to produce tPA, so testing for tP A production 
throughout the process is also very important. Unfortunately, it is quite difficult to 
measure the concentration of a particular protein when it is mixed with all of the other 
proteins produced in the cell's metabolism. The most effective test of protein presence or 
concentration is a Western blot, which can be run by our molecular biology control 
laboratory. The dead time of a Western blot is at least a day, so the results will serve as 
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research tools and to save money on the latter steps in the separation sequence if the 
batch is no good. 
Finally the activity of the final product will need to be tested. Random doses are 
used to test for functional tPA, i.e., the ability to activate plasminogen (see Introduction 
page 14). At this point the batch is ready for shipment to hospitals throughout the world. 
A relatively small molecular biology laboratory can easily complete all ofthe 
required testing. This lab will also be responsible for determining the final concentration 
of tP A in FD Tank and calculating the volume required per 100 mL viaL The price of 
such a lab, including salary and equipment, is estimated at $500,000 based on 
recommendations by Prof. Diamond. 
Sterilization 
Current Good Manufacturing Processes (cGMP's) require production of 
therapeutic medications to take place in a sterile environment. As a result, all equipment 
in our plant is capable of being cleaned-in-place (CIP) and sterilized-in-place (SIP). All 
vessel-like equipment (blending tanks and bioreactors) contains stainless steel pipes with 
nozzles that are lowered into the tank section. Sterile water is then sprayed out radially to 
wash away any remaining cell or media waste. Approximately two vessel volumes of 
water will be used during each cleaning. This step is then followed by SIP with 130°C 
steam for 30 minutes or longer. Other units have their own cleaning and sterilizing 
mechanisms and utilize caustic solution in some cases. The Centrifuge and ER Column 
require application of NaOH, and UFI and UF2 are cleaned with a 0.01% caustic 
cleaning solution. 
175 

Generic tPA Other Considerations 
In addition, sanitary piping is used throughout our process. This requires all pipes 
to contain inlets and drains for sterile cleaning water. The sanitary pipes can also be 
easily disconnected and scrubbed manually if necessary. These sterilization procedures 
take place after each batch or after each cycle in the case of the Bottler and Freeze Dryer. 
In following cGMP's we will minimize batch losses and produce a clean, functional 
medication. 
Start-Up 
There are many steps needed to take the plant from its completed construction to a 
full-scale operational plant. The steady-state operation of the plant, as designed in the 
project, can only be obtained through careful start-up procedure. All of the plant 
equipment and piping will have to be brought up to proper sterile conditions. The unit 
operations will be rinsed with water and steam sterilized before the process begins. The 
vessels can be pressurized through the use ofpumps, while various utility streams can 
help to control the temperature of the units. 
Before the plant can become fully operational, the water recycle streams that 
provide the warm water for used in HX-l and BR-3 must be charged. These two streams 
are made up of city water that is heated with sparged steam. The initial load of water on 
the system is necessary to bring the recycle stream up to steady state before any of the 
process liquids are added to the system. 
The final consideration for start-up is the purchase and application the 
monoclonal anti-tP A antibody for the affinity chromatography column. We have 
licensed a hybridoma cell line that produces this antibody for $100,000 (see Problem 
Statement page 189). The antibody will be produced in our plant, using equipment 
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purchased for tP A production. A detailed process for the antibody production cannot be 
completed with the given information, so Prof. Diamond advised us to use a costing value 
of$2,000/gram. Approximately 750 grams of antibody is necessary for each Affinity 
Column (see Appendix D page 314). The antibody will be bound to the Affinity Resin 
using the protocol provided by Amersham Pharmacia Biotech (see specification page 
314) and will remain intact for a year; after which both the resin and antibody will be 
replaced. 
Sanitization/W aste Removal 
The FDA has strict standards for the use and disposal of genetically modified 
organisms and cell waste in generaL Any materials that come into contact with our 
microorganisms must be disposed ofproperly. Our process will be producing an 
enormous amount of this waste. Solid waste removed in the Centrifuge, water waste 
from UFl, and the volumes not collected from Affinity Column and ER Column are all 
process waste streams that need to disposal. In addition to process waste, all water that is 
used for sterilization and cleaning is also considered hazardous biological waste. Given 
these amounts it is estimated that 670,000 gal of waste will be produced each year. The 
number has been rounded up because extra waste is certain to arise during the course of a 
year. The simplest way of accomplishing this task is by contracting the disposal out to a 
waste disposal company. The EarthCare Company can eradicate this waste at a cost of 
$O.2l1gal (see Appendix E page 395). This price is rounded to $lIgal to account for 
transportation and disposal charges. 
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Generic tPA Conclusions and Recommendations 
The analysis of our process indicates that production of generic human tissue 
plasminogen activator (tP A) can be an extremely profitable venture. Economic 
calculations yielded an investor's rate of return (IRR) of 59.7% and a net present value 
(NPV) of $1.7 billion after ten years. This study was completed for the sale of 
approximately 80 kg/yr, which was based on marketing estimates provided Prof. 
Diamond. A more conservative economic analysis was also conducted, estimating sales 
of only 40 kg/yr while holding our capital costs constant. This venture is also extremely 
profitable, with an IRR of 41.0% and a NPV of almost $800 MM. 
This is the first time the patent for a recombinant protein produced in mammalian 
cells will be expiring. The price for the original product is extremely high due to the 
large amount of research costs accumulated during its discovery and development. In 
following the expired patent we will avoid these costs and produce an expensive 
medication at cost. 
The introduction of a cheap, generic version of tP A should cause a tremendous 
increase in the market for recombinant thrombolytic agents. Streptokinase (SK), the only 
other major anti-clot drug on the market is only preferred for its cheaper price. In 
decreasing the price difference between tP A we will obtain a large share of the SK 
market, which is quite sizable overseas. 
Our production methods are fairly straightforward. Research in the form of a 
pilot plant will be required in order to determine growth kinetics and optimal conditions 
for the separation processes. Genentech obtained a cell production rate of 50 pg/celllday 
in patent 4,766,075. Molecular biology techniques have improved significantly in the 
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past fifteen years, so it is likely that our cells could attain higher production rates, further 
increasing our profits. 
Biological processes can be very unpredictable and there is no data published on 
the downstream processing of tPA. A great deal of data would need to be obtained to 
determine exact purification protocols. In order to account for these research needs an 
extra year of construction (three years total) was included in our economic calculations. 
The expiration of the patent for a recombinant tP A-producing cell line opens the 
door to an extremely profitable venture. This is one of the first opportunities for 
"horizontal growth" the biotechnology industry. We feel that generic tPA production 
provides a tremendous opportunity for a company to enter the pharmaceutical market. 
The profits gained from this venture could provide capital for research in other products. 
It would not be surprising for a large pharmaceutical company to undertake a venture 
such as this due to its growth potential and value. In conclusion, we strongly urge 
construction of a generic tP A production plant in the near future. 
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Generic Recombinant Human Tissue Plasminogen Activator (tPA) 
(Recommended by Dr. Scott L. Diamond, University ofPennsylvania) 
Setting: 
Plasminogen activators are powerful enzymes that trigger the proteolytic degradation of 
blood clots that cause strokes and heart attacks. Genentech owns the patent for tPA, and 
currently sells 100 mg doses of recombinant tPA (activase) for about $2000. The annual 
sales for tP A are about $300MMlyr. However, the patent for tP A will be expiring soon. 
In response, Genentech has developed a next generation, FDA-approved, Plasminogen 
activator called "TNK-tPA", which is slightly easier and safer for clinician to use. 
While a generic form of tPA may not compete well against TNK-tPA in the U.S., there 
may exist the opportunity to market a low-cost generic tPA in foreign markets, where 
urokinase and streptokinase are low-cost (-$200/dose) alternatives that are associated 
with increased bleeding risks. Additionally, reduced healthcare reimbursement to U.S. 
hospitals may allow a generic tPA to compete against TNK-tPA or activase. 
Process: 
Produce recombinant tP A using CHO cells. Since Genentech will not license their CHO 
cell, your group will be responsible for cloning the human tP A gene and creating a stably 
expressing cell line for your process. 
Constraints: 
1. The product must be sold as lyophilized, sterile powder (100 mglbottle). 
2. The product must be free of endotoxin contamination. 
3. Affinity chromatography will be necessary. 
4. Your separation system will operate as a batch system. 
S. Your annual production will need to range from 30 to 100 kg/yr. 
Determine: 
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1. 	 Compare the cost of batch and CSTR (4 month per run) bioreactor operations. 
2. 	 Design reverse osmosis/deionized water purification system to supply all process 
water. 
3. 	 Determine the steam requirements for sterilization of the bioreactor. 
4. 	 Does an economic opportunity exist for the production of generic tPA? Assume that 
Genentech is your only competitor. 
5. 	 Estimate the actual production cost per 100 mg/dose for Genentech to make tPA. 
Assumptions: 
1. 	 Your reactor will use serum-free growth medium. 
2. 	 Your have licensed the use of a hybridoma cell line that secretes tP A monoclonal 
antibody for the development of your affinity columns (life of column is 3 years). The 
license costs $120000/yr. 
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BEST AVAILABLE COpy 
United States Patent 
Gceddel et aI. 
[19] [llJ 
(45] 
Patent Number: 
Date of Patent: 
4,766,075 
Aug. 23, 1988 
[54) 	 HUMAN TISSUE PLASMINOGEN 

ACTIVATOR 

[75] 	 Inventors: D..,hl V. GoKdtl, Hillsborough; 
WWIIIII J. Kollr. San Mateo; Diu, 
Peaalea. Fosler Cit)'; Gonloa A. 
v'Dar, San Carlos, III of CaliC. 
(73) 	 Assianee: One.tlCli. IIIC.. South San 
FrancilCO. CaliC. 
[211 	 Appl. No.: 483,051 
(221 	 Filed: Apr.1,19&3 
R.lat&d U.s. AppllcalioD Data 
(63J 	 Conlinuation·in,pln or Ser. No. 393.003. luI. 14. 1911. 
and I conlinuadon.in.part or Ser. No. 314.160. MIY 5. 
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ABSTRACT 
Human !illue phuminolen activator (t.PA) i~ pro­
duced in useful quantities using recombinant DNA 
techniques. The invention disclosed thus enables the 
production o( t-PA (rce of contaminants with which it 
is ordinarily wociated in its native cellular environ· 
ment. Methods. expr_ion vehicles and various hosl 
cells useful in its production are alia disclosed . 
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GTTCTGAGCACAGGGCTGGAGAGAAAACCTCTGCGAGGAAAGGGAAGGAGCAAGCCGTGA 
-35 -30 
met ISP ala .et I'SI~g gly leu 
ATTTAAGGGACGCTGTGAAGCAATC ATG GAT GCA AT' AAG AGA GGG CTC 
-20 
cY' 	 cys vel leu leu leu cys Illy al. v.l phe VII ser pro ser 
TGC 	 TGT GTG eTG eTG CTG TGT GGA GCA GTe TTC GTT TCG cce AGC 
-10 	 1 ~'" 	 ~Iu lIe his .1& erg phe .~, .~g gly II ••rg SER TYA GLH 
AG GAA ATC CAT GCC eGA TTC AGA AGA GGA GCC AGA TCT TAC CAA 
10 
VAL ILE eyS ARG ASP GLU LYS THIt GLH MET IlE TYII GLH Gllf HIS 
GTG ATC TGC AGA GAT GAA AAA ACG CAG ATG ATA TAC CAG CAA CAT 
30 
GLII SEA TRP LEu ARG PliO VAL LEU AAG SEA ASH AIIG VAL GLU TVR
20 
CAG TCA TGG CTG CGC CCT GTG CTC AGA AGe AAe eGG GTG GAA TAT 
40 
CVS 	 TAP CYS ASH SEll GLV AIIG ALA GLH CYS HIS SEA VAL PRO VAL 
TGC TGG TGC AAC AGT GGC AGG GCA CAG TGC CAC TCA GTG CCl GTC 
SO 60 
lVS 	 SEA CVS SEA GLU PRO ARG evs PHE ASH GLY GlV THA CVS GLH 
AAA 	 AGT TGC AGC GAG CCA AGG TGT TTC AAC GGG GGe Ace TGe CAG 
10 
GLH ALA LEU TYA PH£ SEA ASP PH£ VAL eys GLH eys PRO GLU GlV 
CAG GCC CTG TAC TTC TCA GAT TTC GTG TGC CAG TGC eee GAA GGA 
80 	 gO 
PHE ~LA GLY lYS eys CYS GLU ILE ASP THA AAG ALA THR CVS TVR 
TTT GCT GGG AAG TGC TGT GAA ATA GAT ACC AGG GCC ACG TGC TAC 
100 
GLU ASP GLH GLY HE $fR HA AAG GLV THIt TRP SEA THR ALA GLU 
GAG GAC CAG GGC ATC AGC TAC AGG GGC AeG TGG AGC ACA GCG GAG 
110 	 120 
SER 	 GLV ALA GLU eys THA ASH TRP ASH SER SEA ALA LEU AlA GLH 
AGT 	 GGC GCC GAG TGC Ace AAe TGG AAC AGC AGC GCG fTG GCC CAG 
130 
LVS 	 PRO TVA SER GLY A~G ARG PAO ASP ALA ILE ARG L£U GLV LEU 
AAG 	 cce TAC AGC GGG CGG AGG eCA GAe Gce ATC AGG CTG GGC CTG 
140 150 
GL v ASH HIS ASH HR CVS 	 AAG ASH PRO ASP ARG ASP SEA US PAO 
GGG AAC CAe AAC TAC TGC 	 AGA AAC CCA GAT CGA GAC TCA AAG CCC 
160 
TRP OS TVA VAL PHE LVS ALA GL Y l YS TYR SEA S£A GLU PHE eys
TGG TGC TAC GTC TTT AAG GCG GGG AAG TAe AGC TCA GAG TTC TGC 
170 	 180 
SEll THR PRO ALA OS SER GLU GLV ASH SEA ASP CVS TYI! PHE GLV 
AGe Ace CCT GCC TGC TCT GAG GGA AAC AGT GAC TGC TAC TTT GGG 
Fk].SA. 
I q 	~ 
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190 
ASH 	 GLY SEA ALA nR ARG GL Y THR HIS SER LEU THR GLU SER GLY 
AAT 	 GGG TeA Gee TAe eGT GGe AeG CAC AGC eTC ACC GAG TCG GGT 
200 210 
ALA 	 SER en LEU PRO TAP ASH SEA MET I LE LEU ILE GL Y LYS VAL 
Gce Tec TGC CTe ceG TGG 	 AAT Tee UG ATC CTG ATA GGC AAG GTl 
220 
TVR 	 THR ALA GLH ASH PRO SEA ALA 6LH ALA LEU GLY LEu GL Y LYS 
TAe 	 ACA GeA CAG AAe CCC AGT Gce eAG GeA CTG GGe eTG GGe A4A 
230 240 
HIS ASH TYA eys ARG ASII PRO ASP GLY ASP ALA LYS PRO TAP eys 
CAT AAT TAe TGC CGG AAT CCT GA T GGG GAT Gee UG eee TGG TGe 
250 
HIS VAL LEU LYS ASH ARG AAG LEU THA TRP GLU nil .eys ASP VAL 
CAe GTG eTG AAS AAC CGC AGG eTG ACG TGG GAG TAe TGT GAT GTG 
160 	 270 
PRO 	 SEA CY$ SER THR OS GLV LEU AAG GLII TYA SER GLH PRO GtH 
eec 	 Tce TGe ree Ace Tr.e GGe eTG AGA CAG TAC AGe CAG eCT CAG 
lAO 
PHE AI! G It ELY S GLY GLY LEU PHE ALA ASP ILE ALA SEA HIS PRO 
TTT 	 eGe ATe AU GGA GGG CTC TTC GCC GAC ATe Gec Tee CAC cee 
,90 300 
TAP GLN ALA ALA ILE pHE ALA LYS HIS ARG ARG SER PRO GLY GLU 
TGG eAG GeT Gee ATe TTT Gec UG CAC AGG AGG TeG eee GGA GAG 
310 
ARG 	 PIiE LEu en GL Y GL Y IL E LEU lLE S[It SER CYS TR PILE LEU 
eGG 	 TTC eTG TGC GGG GGC ATA CT eAT e AGe Tce TGe TGG ATT eTC 
3<0 330 
SEA ALA ALA HIS OS PHE GLII GLU ARG PHE PRO PRO HIS HIS LEU 
TeT Gec Gec CAC TGC fTC CAG GAG AGG TTT eeG cee eAC CAC eTG 
340 
TIli! VAL 1 L E LEU GL Y ARG THR nA AAG VAL VAL PRO GLY GLU GtU 
ACG GTG Afe TTG GGe AGA ACA TAC CGG GTG GTC CCT GGe GAG GAG 
350 	 360 
GLU 	 GLH LYS PHE GLU YAL GLU LYS nR IlE VAL HIS LVS GLU PHE 
GAG eAG AAA TTT GAA GTe 	 GAA AAA TAC ATT GTe CA r AAG GAA TTC 
370 
AS:' ASP ASP r Hi! TVR ASP ASH ASP ILE ALA LEU LEU GLH LEU LYS 
GAT GAT GAC ACT TAC GAC AAT GAC ATT GCG CTG CTG CAG CTG AAA 
380 	 390 
SER ASP SER SER ARG CYS ALA GLH GLU SEi! SER YAL VAL ARG THR 
TeG GAT TCG rec CGC TGT Gee CAG GAG AGe AGe GTG GTC CGC ACT 
400 
VAL 	 CYS LEU PRO PRO ALA ASP LEU GLH LEU PRO ASP UP THR GLU 
GrG 	 TGC cn eec ceG GCG GAC eTG CAG CTG CCG GAC TGG ACG GAG 
410 420 
OS GlU LEu SER GLY TYR GlY LYS HIS GLU ALA LEU HR PRO PHE 
TGT GAG CTC TCC GGC TAC GGC AAG CAT GAG GCC TTG TeT eCT iTC 
Fig. 58. 
Iqq 
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430 
TYR SER GLU ARG LEU LYS GLU ALA HIS VAL ARG LEU TYR PRO SER 
TAT 	 TeG GAG eGG eTG AAG GAG GeT CAT GTe AGA eTG TAe eeA Tec 
440 450 
SER ARG eys TNR SER GLH HIS LEU LEU ASH ARG TNR YAL THR ASP 
AGC 	 CGe TGe ACA TeA CAA CAT TTA eTT AAe AGA AeA GTe Ace GAe 
4~ 
ASH 	 MET LEU eys ALA GLY ASP THR ARG SER GLY GLY PRO GLH ALA 
AAe 	 ATG eTG TGT GeT GGA GAe ACT eGG AGe GGe GSG eec eAG GeA 
470 480 
ASH LEU HIS ASP ALA eys GLH GLY ASP SER GLY GLY PRO LEU VAL 
AAC 	 TrG CAe GAe Gee TGe CAG GGe GAT TeG GGA GGe eee eTG GTG 
4~ 
eys 	 LEU A5H ASP GLY ARG MET TNR LEU VAL GLY ILE Ilr. SER TRP
raT 	 eTG AAC GAT GGe CGe ATG ACT TTG GTG GGe ATC ATe AGC TGG 
510 
GlY lEU GlY CYS GLY GLH LYS ASP VAL PAO GLY VAL TYR THR LYS~O 
GGe eTG GGe raT GGA CAG 	 AAG GAT GTe eeG GGT GTG TAC ACC AAG 
520 527 
VAL 	 TNA ASH TTR LEU ASP TRP Ilt ARG ASP ASH MET ARG PRO OP 
GTT Ace AAC TAe eTA GAC TGG ATT eGT GAe AAe ATG eGA etG TGA 
CCAGGAACACCCGACTCCTCAAAAGCAAATGAGATCCCGCCTCTTCTTCTTCAGAAGACA 
CTGCAAAGOOGCAGTGCTTCTCTACAGAcrTCTCCAGACCCACCACACCGCAGAAGCGGG 
ACGAGACCCTACAGGAGAGGGAAGAGTGCATTTTCCCAGATAcrTCCCATTTTOGAACT 
TTTCAGGAcrTGGTCTGATTTCAGGATACTCTGTCAGATGGGAACACATCAATGCACACT 
AGCCTCTCCAGGAATGCCTCCTCCCTGGGCAGAAAGTGGCCATGCCACCCTGTTTTCAGCTA 
AAGCCCAACCTCCTGACCTGTCACCGTGAGCAGCTTTGGAAACAGGACCACAAAAATGAA 
AGCATGTCTCAATAGTAAAAGATAACAAGATCTTTCAGGAAAGACGGATTGCATTACAA 
ATA~ACAGTATATTTATAGTCACAAGAGCCCAGCAGGGCCTCAAAGTTGGGGCACGCTCCC 
TGGCCCGTCATGTTCCTCAAAAGCACCCTTGACGTCAAGTCTCCTTCCCCTTTCCCCACT 
CCCTGGCTCTCAGAAGGTATTCCTTTTGTGTACAGTGTGTAAAGTGTAAATCCTTTTTCT 
TTATAAACTTTAGAGTAGCATGAGAGAATTGTATCATTTGAACAACTAGGcrTCAGCATA 
TTTATAGCAATCCATGTTAGTTTTTACTTTCTGTTGCCACAACCCTGTTTTATACTGTA 
CTTAATAAATTCAGATATATTTTTCACAGTTTTTCa "'1~UAA.U»U..A 
Fig. 5[,' 
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1 	 2 
factor proteins. for eumple. librino,en, Factor V and 
HUMAN TISSUE PLASMINOGEN ACIlVATOR Factor VIII. causina a bemorrbaaic potential. In addi­
tion. streptokinase is Itron,ly anti,enic and patients 
This is a continWition-in-pan or IPPlica.tiollS Set. No. with hI,b antibody dtm respond inefficiently to treal­
393.003 rtJed July 14, 1982 and Ser. No. 314,160, raJed S 	 ment and cannot remain on continuous treatment. Uro­
MAY 	S, 1982- kinase therapy is expensive, owin, to ill involved isola­
tion from buman urine or tissue culture, and it. there­
FIELD OP THE INVENTlON fore. is not perally accepted in 'clinical practice. U ro-
The present invention relates to human pJumino,en tinue bat been the subject of nllmerous invesligation­
nctivator. correspondin, to that rOllDd In buman tIcrWll 	 a-See. ror uampJe. references 1-6. 
and/or tiulIe&, and to novel rorms and compolliticml So-called pJumino,en activators have been isolated 
thereof and particularly to the me&lll and mt"thoda ror 	 from variouI.human tissue, e.,.,.lIterine tissue, blood. 
its prodllction to homo,endty in therapeudcally lianifl-	 tIcrWll-Me perally references 7-11 and from cdl 
cant quantities. 	 culture (reference 94). CompositiOlll thereof have also 
The present iDvention ariIeI in pan from the disco\'> IS been dacribcd-aee references 12, 13. See allO refer­
ery or the DNA seqllence and dedl&Ced IlDino add encG 14-11. The plumino,en activaton derived from 
sequence or human pluminoaen acdvator. Thil diIeov> . these 1OW'CeS have been claulfied Into two major 
ery enabled the production or human plumino,en !lCd· JfOupI: urokinase-type plumino,en actlvaton (u·PA) 
vator via the application or recombinant DNA tecbnol· and tissue-type plumlno,en actiVatOR (t-PA) based on 
ogy, in tum, enablin, the production oflllff1cient qual- differacet in tbeir immunolo,ica' properties. (The 
ity and quantity or material to Inlliate and conduct ani- abbreviations t-PA and u-PA are those proposed at the 
mlll and cliDlcaI testin, u prerequisites to market apo XXVIII Meetin, of the Inlemational Committee on 
proval, unimpeded by the restrictions necessarily Inher· Thromboii. and Hemoltasi., Ber,amo, Italy. July 27. 
ent In the isolation methods hitherto employed involv. 1982.) 
ina production and extraction from exlltinl cell culture. 2' Recently. a human melanoma line has been idenlified 
This invenlion iI directed to theM IIIIOClated embodi- which secretes t-PA. Characterization ofthis melanoma 
ments in all respectl. plumino,en activator has Ihown II to be indistinguish-
The publications and other materiaJa hereor uaed to able both Immunolo,lcali:, and in amino acid composi­
illuminate the bacqround or the invention. and in par- don from the plumino,en ,<:(ivalor isolated rrom nOf­
ticular cases, to provide additionaldetalbi concemin, itl mal human tissue (Rererence 19, 88). 
prc.clice are incorporated herein by reference. and (or The product was isolated In l·-.Ialively pure rorm. 
convenience, are numerically referenced in the follow- characterized and round to be a hi,,':l,.. active fibrino­
ins lext and respectively ,TOliped In the appended blbli· lytic a,ent (20). 
ography. Several atudies (e.l. Rererences 9~ to 98) whl.;Ji used 3' t·PA purified rrom the melanoma cell line have dem ....;'\·BACKGROUND OP THE INVENTION mated It1 hiJher amnily for librin, compared wilh uro-
A. Human Tiuue P1.umIno,en Activator idntle type plasmino,en activaton. More inlensive 
The fibrinolytic sYltem iI in a dynamic equilibrium Invesu,ation or human t·PA as a potential thrombolytic 
with Ihe cOlilllation ')'Item. maintalnln, an Intact. a,ent bat. huwever, been hampered by Its extremely 
p:ltent vascular bcd. The COIIulation l)'Item depoaitl low concentration iD blood, tillue utractl. 'Vessel perru­
libnn IS a matm lervln, to restore a hemOitatic coRdi· lit" and cell cultures. 
tion_ The fibrinolytic l)'Item removes the fibrin net- It wu perceived that the application of recombinanl 
work after the hemottatic condition iI achieved. The DNA and IIIIOClated technolo,les would be a most 
fibrinolytic prOCell iI brou,ht about by the proteolytic etrective way of providin, the requilite larae quantilics 
en:::yme plumln that iI,enerated from a pluma protein ., orhi,h quality human dillie-type pluminoaen activator 
precunor plumino,en. Plumino,en II converted to (earlier referred to IS human plumino,en activator). 
plll.'lmin throuah activation by an activator. essentially free of other human protein. Such material~ 
Currently, two activatOR are commerc1ally available. would probably exhibit bioactivity admlulng of their 
streptokinase and urok.lnue. Both are Indicated ror the UIe clinically in the treatment ofvarious cardiovascular 
trClltmenl of acute vucular dbeuea such u myocardial conditions or diaeases. 
infarcl, lIroke. pulmonary embolism, deep vein throm- B. Recombinant DNA TechnololY 
b03is, peripheral arterial occlualon and other venolll Recombinant DNA technolo,y hu reacbed the age 
thromboses. Collectively. these diaeua account ror or lOme IOphiltication. Molecular bloloaisu are nble 10 
mnjor health ha.u.tdl and rIab. recombine various DNA sequences with some fllcility. 
The underlyln, etiololical bull ror these dtseaaa " creatln, new DNA entities capable of producing copi· 
point. to either a panial. or in MVere cues, total ocelu- ous amountl or elIopnous protein product in trans­
.ion of a blood vessel by a blood clot-thrombus or formed microbes and cell cultures. The ,enera] means 
Ihromboembolus. Traditional antlcoa,ulant therapy, IS and methocIa are In hand ror the In vitro lilllliion of 
with heparin and coumarin, does nothin, to directly VulOIil blunt ended or "ltlcky" ended fragments of 
enhAnce dillOll.1tlon of thrombi or thromboemboll. The DNA. prodllCin, potent expreuion vehicles lIIeful in 
thrombolytic a,entl referred to earller. ftreptoidnue tranlrormln, particular or,anilml, thul directing their 
nnd urokinase. have enjoyed practical and effective \lie. emcient .ynthesil of desired exolenous product_ How-
However, each has levere limitations. Neither has a ever. on an individual product buls, the palhwlIY re-
high IIffinity ror Rbrin; conaequently. both actlvlte clr- mains IOmewhat tonuoUI and the science has not IId­
culating and Rbrin-bound plumino,en relatively Indl .. 6$ vanced to a Ilaae where reaular predictions of succes~ 
criminlltely. The plumIn ronned In c:ltc:ulallnl blood II can be made. Indeed. thOle who portend successful 
neutrnlized rather quickly and Io.t ror Ulerul thrombol· relults without the underlylna experimental bub, do so 
y~in, Residual plumln will de,rade leveral clonln, with conllderable rilk of Inoperability. 
z.o~ 
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DNA m:ombiaation of the essential elemenlS, Le., lID directed to methods of treatina vascular dborders in 
origin o( replicadon, olle or more phenolypic selection human subjects tWll, I-P A and to suitable phannac:euti. 
characleristic:s, an expression promoter, heteroloaous cal compositions thereor. 
sene insen and remainin, vector, pnerally is per- The present iDvention funher comprises essentililly 
formed outside the host cell. The raullin. recombiDant 5 pun: human tissue pllsmillolen activator. The product 
replicable expression vehicle. or plasmid, is introduced produced by IC1ICtically enlineered microorganisms or 
inlo celb by transformation and Iar.e quantities of the cell cultun: S)'Items provides an opponunity to produce 
recombinant vehide obtained by lrowinl the transfer- human tislue pluminolen activator in a much more 
manto Where the lene is properly iDsened with refer· etI1cIent lDUlDer than has been possible, enabling hith· 
c:nce to ponions whk:i'I ,overn the tnnICription ud 10 eno elualve commercial exploitation. In addition, de· 
transladon ohhe eacoded DNA D1CSIIIICt the resultiaa peadiq UpoD the hOlt cell, the human tissue plasmino­
expression vehicle is IIICft&I to actually produre the teD activator berllOf may contain usociated ,Iycosyla' 
polypeptide sequence (or whicb the inserted aeae tioo to a arater or laser extent compared with native 
codes, a procell referred to u e.lpreuioll. The resuiliD. material. In any event. the taPA will be free of Ihe con· 
product may be obIained by Iysiq. If nClCellU')'. the 15 tamiDanta normally UIOCialed with it in its non-recom­
bost cell. in microbial syatema, and recoverinl the prod- binlat cellular environment. 
uct by appropriate puriftcation (rom other proteins. The praent Invention Is also dim:led 10 replicable 
In practice. throu.h the laIC of recombinlal DNA DNA e.lpreuion vehicles harborinl lene sequences 
technolo,y. one can ClIpress eatircly heteroloaous poly- encodln, human duue plasminolen activator in ell' 
v-:ptides-so-called direct expression-or alternatively 10 preuible form, 10 microorlanism strain. or cell cultures 
mllY express a heterololOUS polypeptide f'bsed to a por- tranaformed with them and to microbial or cell cultures 
tion of the amino acid aequence of a homololous poly- of such transformed .train. or cultures, capable of pro· 
v-:ptide. In the latter cues, the Intended bioactive prod- duc:i.al human duue plasminolen activator. In still fur· 
uct is sometimes readered bioinactive within the I'wed. Iher upeelS, the praentlnvention is directed to various 
homoloB0us!heterololous polypeptide UIltU it is u processes laIC(ul for preparinl said Bene sequences. 
cleaved in an extracellular environment. See referenca DNA expression vehicles, microorganism strains and 
(21) and (22). cell cultures, and speeirlc embodiments thereof. Still 
Similarly, the art of cell or tluue cultures ror .tudyin, funher, this iDvention is dim:ted to the preparation of 
genetics and cell phyaiolol)' i. well established, MCIDI (ermentation cultures of said microoraanisms and cell 
and methods are in hand for mainca.in1n1 permanent cell 30 cultures. 
Un~, prepared by sUCCCS!ive aerial uansfen from iao- BRIEF DESCRIPTION OF THE ORAWINGS 
lote normal celli. For laIC In reaearch. luch cell lines are 
maintained on a eoUd .uppar: In UqlOld medium. or by P10. 1 Ihowa a I~ lOdium dodecylsuJ(ate poly· 
srow,1I iii s\l.~ulion contalilml IUPpon nutrimentL acrylamlde ,eI eJoctriphoresls (SDS PAGE) of 3S5­
S<:cle-up tor larlc preparations aeemlto pOle only me- JS methionine labelled proteinl precipitable with anti t·PA 
ch4nical problems. For (unher bKkaround. attention is laO ICCreted from melanoma cells with and without 
directed to references (23) and (24). proteue inhibitOr. 
Litewile, protein biochemi.try is a usefUl. Indftd P10. 1 lhoWl electrophoresis of the immuno­
necess.llry, adjunct in biotechnolo,y. Celli producinl precipitated translation products of mRNA (ractions 
the dClired protein a1IO produce hundredl or other 40 derived from melanoma celli. 
proteins, endoBenous products of the cell'. metabolism. P10. 3lhowa the hybridization pall ern 0(96 bacterial 
Thoe contaminatinl proteiN, as well as other com- colonies tranaformed with cDNA uslnl the pool of 32p 
pounds. if not removed (rom the daired protein, could labeled l4-met as probe prepared baaed on a 5 amino 
prove tOltic if administered to an animal or human in the acid sequence o( human t·PA. 
coune of therapeutic treatment with desired protein." FlO. 4 I. a restriction endonuclease map of the full 
Hence. the techniques of protein biochemlltry come to lenath human taPA eDNA. 
be::r.lllowin, the dailn oheparation procedures .uit- FIOS. Scr. Jb and Ie .how the nucleotide sequcnce 
!lble for the panlcular .y.tem under coulderaLion and and deduced amino acid aequence of the fuli length 
providin, a homo,encous product l&Ie ror Intcnded laIC. human t·PA cDNA. 
Protein biochemi.try aleo prova the Identity of lhe 50 FlO. , lIa .chernalic of the CODltruclion o( the e~· 
doired product. characlerizinl it and CIIIurlnl that the preuion plumid pARIPA', 
cells have produced It faitbtully with no alteratlona or FlO. 7 shoWl the results of a fibrin plate assay for 
rnntation•. This branch ohcleace Is aleo involved In the fibrinolytic activity of E. coil cellJ cransformed with 
delign or biouaays. llabilily studies and other proce- pARIPA'. 
dures neceuary to apply before IUCCCIIIfili cHnicalltlld-" FIO. , II an HPLC trace or peplida from humnn 
iC$ lind marketinl can take place. t·PA tryplln di.at. 
SUMMARY OF THE INVENTION FIO. t IhoWl the ~n.truction of a plasmid c~ding
ror the direct apres&lon of mature human I·PA In £. 
The present Invention II based upon the discovery coiL 
that recombinant DNA technololY CUI be uaed .uee.... 60 FlO, 10 .haWlthe resulll of a librin plate assay for 
fully 10 produce human liu\Ie plasmlnolen activator fibrinolytic activity of Ihe human taPA produced by £. 
(t·PA). preferably in direct (orm, and in amoUllts .um· coiL 
cient to Initiate and conduec animal aad clinical tatlnl FIO. 11 .hoWl the con.uuction of DHFR (mutant or 
l1S prerequi.ltes to markC\ :lpproval. The product human wild lype)/t·PA CReodln, plasmid ••uitable for trims· 
[·PA i. lullable ror use, in an or It. rorm•• 1n the prophy. " farmln, into mammalian duuc culture cells. 
Illctlc or Iherapeutic trealment or human belnl' ror P10, 12 I. a .chematic dia,ram or human tissue pins­
varioul cardiovascular eonditioDl or disc..... Accord- minolen activalor II prepared by the mechod exempli. 
ingly. the preaenllnven!lon. In one Imponant Upeel, i. ned In ILl herein. 
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also been shown to be active. The 2-cbain prolein can 
DETAILED DESCRlmON be prepared by in vitro proteolytic conveniion afler the 
A. Definitions l-chain material is produced. A so-called "kringle" area 
As used herein, "human tiaue plasmino,ea lCuva· is positioned upstreaftl Crom the serine protease portion 
tor" or "human I·PA" or '''.PA'' denotes human estrin· , and is believed to play an important function in binding 
sic (tissUe-lype) plasminopn activator, produced by the tisaue plaurlinoaen activator hereof to a fibrin ma· 
microbial or ceD cwture 1yst.emS, in bloac1ive forms em; hence. the observed specific activily ohhe present 
comprisina a protease portion and corrapondin, to lislue plumlnopn activalor loward tanaible. extant 
those:: tissue plasmino,en ICtivalora otherwiae _tive to IhrombL The tisaue plumino,en activator hereof is 
human tissue. The human lisaue plumlno,eD activalor produced containln, the enzymatically aclive portion 
protein produced herein baa beea deaned by _ of corrapcmdiq to Dlllive malerial aad the term human 
delermined DNA ICM and dedlolCtive amino ICId .. tisaue plumiDopn ICtivator defina producll compris. 
quenclna. II will be underatood tbat DIIcllllllllebc van· ina I\ICh poniun alone or loaether wilh additional 
ations exist aad occur rrom IIIdlvklual to IIIdlvidual.. amino ICId Mq'IIeIlCa up to the Mllen,ch molecule. 
These variatiolll may be dClDOllltrated by (Ill) amiDo" To aummarize ID the presenlinvenlion, human I·PA 
acid cUf!'erence(l) in the oYVlll IIqUCftCt or by dele- diu baa a fwIcdona1 deftnidon; it II capable of catalyz· 
tiona, Il&bstilut!oaa, illlertionlo IDveraioDa or Iddltionl or ID, the coaveraioa orpluminoaen 10 plumin. binds to 
(an) amino lCid(s) In aid Mq1IIDCL.ln addldoa. the ftbrin, and II cIaulned u a I·PA baaed on Immunologi. 
location or and de,.... of aIycoIylation will depend on cal propertia u leI forth hereinabove. 
the nalure or the hole cellular environment. "Eucntlally pure form" when·1IICd 10 dese::ribe the 
The potential ulab, in the \1M of recombinlllt DNA llate or hUIIIlD I-PA produced by the Invention means 
technolo,y. for Ihe preparation or vanoUl human IIUIMI rree or protein or olher materials normally associated 
pllUmino,en acdvalor derivatives, vanoUlI)' modified with human t·PA when produced by non-recombinant 
by resu1tanl sin,le or multiple amino lCid lubalhutlonlo celb, I.e. in Its "native" environmenl. 
deleliom. additions or replacemenb, for cumple. by 25 "DHFR protein" refen 10 a protein which is capBble 
means· or Ihe directed mutaaenesll or the UDderlyin, of the activity uaociated wilh dihydrorolale reductllSe 
DNA. Included would be the preparation o(derivatives (DHFR) and which. therefore. II required to be pro­
retainin, the esaentlal krin,le realon and IeriM proteaIC d1lCed by cells which are capable of survival on medium 
region characleriadc ,enerally of Ihe human tiuue plu- def1cien1 in hypounthine. ,Iycine. and thymidine 
minosen ICllvator described .pecUlcally herein, but (·HOT medium). In ,eneral. cells lackina DHFR pro· 
otherwise modlned u described above. All such allelic teln are incapable of ,rowin, on this medium. cells 
variatiol1l and modil1catioDl mwtiq in derivatiyes of which contain DHFR protein are luccessful in doing 
human tissue plumino,en activalor are Included within 10. 
the scope of lhlI Invention. u well u other related "Ce1l1lClUitive 10 MTX" rerera 10 cells which ore 
human extrilUic (tissue-type) plumlno,en ICtlyalOra, U Incapable of &fOwin, on media which contain the 
similar physically and biololically. 10 lon, u the euen- DHFR InhibilDr melhotreule (MTX). Thus. "cells 
lial. characlerildc human tiuue plasmino,en ICtivator lCI1Iitiye to MTX" are cells which. unless ,enolically 
activity remaiDl unaffected in Idnd. Human tiuue plu- altered or olhcrwllC supplemented. will fail to grow 
mino,en ICllvator is prepared (I) havin, methionine as under amblenl and medium conditions suitable for lhe 
it! finl amino lCid (prelCtlt by virtue of the ATO start cell type when the MTX concenlration IJ 0.2 Jj.g/ml or 
signal codon Il1ICrtion In rronl of lhe atructural ,cne) or more. Some celb, luch u bacteria. fail to exhibil MTX 
(2) where the methionine II Intra-or elllracellularly ICnsitivity due ID Iheir failure to permit MTX Inside 
cleaved. havln, Its normally flnt amino 1Cid. or (3) lheir cell boundaries. even Iho\llh they conlain DHfR 
logether with either Its lipal polypepdde or a COI\Ju- which would otherwise be lenlitive 10 thi. drug. In 
Silled protein otber than tlle conventional Ilpal poly· .. , ,enera1. cells which contain. as their DHFR protein. 
peptide. the .lpaI polypeptide or cordu,ate bein, spe- wild Iype DHFR will be lenlillve to methotrexate if 
ciflcDlIy cleavable In an Intra· or extracellular environ· they are permeable or capable or uptake with respect to 
ment (See reference 21). or (4) by direct expreulon in MTX. 
mature form without the neceuity orcleavin, away any "Wild type DHFR" refen to dihydrofolate reductAse 
exlraneoua, SUperflUOUl polypepdde. The laUer II par- U II ordinarily found Inlhe particular or,anism in ques­
ticularly Important where a ,liven hott may not, or nat tioa. Wild type DHFR is ,eneraJly aenaitive in vitro to 
efficiently. remove a ai,naI peptide where the Cllpres- low concenIratioDl of methotrelWe. 
sion vehicle II deailned to expreu tbe tilaue plumlna- "DHR pro&cin with low bindlnl amnily for MTX" 
sen activator 10lether with Its Ilpal pepdde. tn any hu • f\anctional definition. Thit i. a DHFR prolein 
event. the Ihlll prodgced human t·PA. in Its variolll " which, when ,enera,ed within cella, will permit the 
forms. Is recovered and purined 10 a Icvel ftuln. It ror lI'OW1h or MTX IClUitive cella In a medium containing 
use in the Ireatmenl of VarioUl vascular condldoDl or 0.1 "'Jlml or more or MTX. II it reco,nized that such II 
dise.ues. f\anc:lional deflDidon dependl on the facility with which 
furthermore. tePA hu fOl1l1l which Include both the Ihe oraanilm produces the "DHFR proleln with low 
single chain (I-chain) protein and the 2-chain protein. blndln, aIIlnity ror MTX" u well u upon the protein 
The latter i. proteolytically derived rrom thc l-chain IlIClf. Howcver. u IIICd in the context of thi. invention. 
compound. It II Iheorized thaI Ihe 2-eha1n proleln it .gch a balance belween Ihese two mechanisms should 
JUsocialed with produced fibrin and that proteolytic: nol be troublesome. The Invenlion operates with reo 
conversion from I· to 2· chain material occan at the specl to confemn, the capability of surviving Ihese: 
locus of the convenion or plumino,en to plaamin. The " levels or MTX. and h is nol conlequential whelher the 
pretent invenlion provides for Ihe adminlstratioll of tbe ability to do 10 II impacled by increased exprenion in 
I-chain protein ror in vivo converalon II JllIt described addidon 10 Ihe inRlte nalure of the DHFR produced. A 
or (or the administration or 2-chaln protein. which hu convenient DHFR protein which fiu Ihis definition is 
2:..10 
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disclosed in U.s. Appl. Ser. No. 459,151, med Jan. 19, itsowa proteins. Those promolen most commonly used 
1983. now abandoned. inc;orporated herein by refer- in recombinant DNA c;onstNclion include the ,,·Iacla· 
en~. mae (peni.cllUnase) and lactose promoter systems 
"Eapression vector" includes veclon which are ca· (Chana et al, NalllN. 275: 617 (1978); hakura. ct III. 
p~ble or elpmsin, DNA seqw:nc:es c;ontaiAed therein, 5 SdlIICf. 191: 1056 (1977); (Goeddel. et al NlIl",n 281: 
wh=re such sequences are operably llsWd to other leo 544 (1979» and a tryptophan (trp) promoter system 
quences capable of efl'ccUq their apreuioL It is 1m. (Ooedclel. ct ai, Nile/fie Acids Ru. I: 04057 (1980); EPO 
plied. althou,h DOt always uplicitly Slated. that these Appl hbI No. 0036776). While these are the most com­
elpression vecton must be replicable in the holt OrpD- mol'lly ..... other microbial promoten have been dis-
isms tither u cpiIomes or u III Jntep part or.lhe 10 covered IIIId \d:ilized. and details c;oncemin, their nucle· 
chromOlOmal DNA. Clearly a lack 01 rep1IcabilIty odde tequeoca bave bca pllbllsbed. enablln, a s'killed 
would render them effectively Iaoperable. In lum, "a· worker to Daate them f\mctiollally with plumid vcc:tors 
pression vector" II pven a ftmcdonal deftDidoto. and (StdIeI'IIIat. et al, Q/120: 269 (1980». 
lUIy DNA sequence whk:h II capable 01 efl'ectIn, u· . hi Iddldoft to prokaryotes, e.lwyotic microbes. such 
presaion or a specified DNA code dilpoeed dIereiD iI IS u yeIId ClIItva may abo be used. SlI«hllromycu ctmi· 
included In this Icrm u it iI applied to die specIfted .. or 00IDDl0Il baker's yeat is the moat commonly 
sequence. In pmcral. ellpnaioa YeCton or .tUlty III IIIId 1IDOa, nkaryodc mic:roor,aniams. altbollsh a 
recombinant DNA technlqllllil are onen in the rona 01 l18mber or other ItraIna are commonly available. For 
"plasmlcb" whk:h rerer to circular· double stranded upr.ioa III SlI«.wI'Wlt~ the plumid YRp7, for 
DNA loopt whleh. in their vectOr rorm are DOl bolllld 20 uample. (Sdnc:hcomb. It al. NlIt",,.. 282: 39 (1979); 
to the chromosome. In Ihe present lpeclf1cation, "plu- Ki.npman et al. Ofll" .7: 141 (1979): Tsehemper. et Ill. 
mid" and "vector" are v.sed Interchaqeably u the Ofll'. 10: 151 (1980» is commonly uled. This plasmid 
plasmid is the moll commonly v.sed form or vector. already containlthe Irpl,ene whlcb provides a Idec::· 
However. the Invention Is intended to IAclude luch lion marker ror a mutant atrain or yeast tacking the 
other forml of expression vecton which IeNe cqulva. 15 ability to ,row in tryptophan. for example ATCC No. 
lent functions and which become known In the art 1Ilb- 44016 ar PEP4-1 (Jones. Gtlltlia. 8S: 12 (1977». The 
sequently hereto. presence of tbe ttpl lClion u a cbaracteristic of Ihe 
"Recombinant bOlt cells" refen to ceUI which have yeut hOlt cell ,enome then provides an effective en'lj· 
been transrormed with vecton conatl'l.lCted uain, re- ronmcnt for detectin, tranlrormation by srowtb in the 
combinant DNA techniques. AI deli.ned llerlin. I·PA II 30 ablence or Iryptophan. 
produced In tbe amoun" achieved by winuc or this Suitable promotin, llequcnces In yeast vcc:ton in· 
transformation. rather than III au.ch I...... IIDOWltl, or. clude the promoten for 3-pboaphollyc::erale kinase 
more commonly. in IlM:h IClithan detectable IIDOWltl, (HItzeman. ct al.. J. BloL Chtm.. 255: 12073 (1980» or 
as misht be prodllCCd by the Wllrud'ormed hOlt. I·PA other .Iycolytic enzymes (H.... el al. J. Ad.,. E1Izyme 
produced by IlM:h celli can be referred to u "recombl· :t, R".• 7: 149 (1961); Holland. et aI. Bi,dtmulry. 17: 4900 
nant t·PA", (1971»' au.ch u enolue. ,lyceraldehyde.J·phosphate 
B. HOlt Cell Cultures and Vecton dehydrolenue. hellokinase. pYNnte decarbolylase. 
The vectOR and methods d\lcloeed herein are luit- pholphofl'l.lCtokinase. ,lucQIC.6-pbosphale isomerllse. 
LIb Ie for uae In hoIl ceUI over a wide I'IIlJC or prokary· 3·pholpho,lycerate mutuc. pYNvate kinase. triose­
otic and eulwy911c orpnilma. 40 pbolphate isomerase. phOlpho,lucole IIomerase. and 
In leneral. 01 coune, prolwyotes are preferred for .luoo1dnuc. In conatn&etinl luitable expression pins­
cioninl of DNA seqllencct In conatl'l.lClin. the vecton mida, the tennination llequences uaociated with these 
wscful in the Invention. For e.umple. E. coli K 12 Itrain .enes are allO Il.ated inlo the expression vector 3' of the 
294 (ATCC No. 31446) Is particularly uaeM. Other IcqIlCftCe dairtd to be npresled to provide polyadeny­
microbial Itfaina which may be v.sed include E. coil 45 ladon or the mRNA and termination. Other promoters. 
5Ir;!in. luch u E. roll D, and E. coil Xl176 (ATCC No. which have tile additional advantale of transcription 
) 1537). Thac eumpla arc, of counc. intended to be controlled by ,rowth conditionl are the promoter re-
illustrative ratber than IImltln,. Ilona ror alc;ohol dehydrollnue 2. Isocytochrome C. 
Prokaryota may also be v.sed ror eapreuion. The acid pbolphatuc. de,radatlve enlymlll uaociated with 
aforementioned Itraln&, u well as B. coil W3110 50 nitroan metaboillm. and the aforementioned Ilyce­
(F - ,A -. protOtrophic. ATCC No. 21325), "-cUll IlM:h ,raldehyde-J.phOlphate dehydro,CIWe. and enzymes 
:IS BtlcllllU l",btillU. and other enterobt.cterllceae au.ch u reaponalble ror maltOle and plactOIC utlllution (HoI­
Sa/mo"tlill typ/tilflllrl"'IfI or S,,.,.,,tfll lrutn:lftlfNl. and laneS. ibid.). An)' plumld vcctor c;ontainin, ycut·com· 
various ptClldomonas tpCCiea may be v.sed. patlble promoter. oripn of replication and termination 
In leneral. plasmid vecton containin, repllcon and 55 teqllCftCll 110 Iultable. 
conlrol aequcncct which are derived rrom .pccla com· In Iddition to microorpnilma. cultures or cellI de­
pillible with the hOlt cell are v.sed In connection with rived 'rom muillcellular orpniaml may allO be uaed as 
these hOlII. The vector ordinarily carries a repllcatlon boa", In principle. any IlM:h cell cullure is workable. 
site. u well as maridn'lIeqllenclII which are capable of whether from vertebrate or Invenebrate culture. How· 
providin& phenotypic Mlectlon in tranafol"lMd celli. 60 ever IIlterlllt hu been ,reatest In venebrale cells, Ilnd 
For example. E. coil II typk:ally tranalormed lllina propoptlon or venebrale cell. In culture (tissue cui· 
pBR322. a plumid derived from an E. rolllpccics (Boll· lure) hu become a routine proccdllre in recenl years 
var. et al.. Gt"t 2: 95 (1977». pDR311 contalna ,enes (or [TWII' C"'/tllN. Academic Prcsa. KNIe and Patterson. 
nmpicillin and tetracycline resistance and thua provides editon (1973»). Eumples of Illch uaet\al host cell lines 
ellS), mlllni rOr identifyin, transformed cells. The 65 are VERO and HeLa cella. Chinese hamster ovary 
pBR312 plumld. or other microbial plumld must also (CHO) cell lines. and W131. DHK. COS-7 and MOCK 
conlilio. or be modificd to contain. promoten which cell lin ... Elprcsaion vecton for .uch cellI ordinarily 
CAn be uled by the microbill arlanilm ror ClprCllion of IAclude (if necessary) an ori,in of replication. a pro-
z. j J 
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moter located in rront of the aene 10 be expressed, alona methoU'UAte. thus permiuina control of expr~ion by 
with any necessary ribosome bindin, sites., RNA splice control of the methotreute (MTX) conceniratlon. 
sites. polyldenylation site, mel trInICriptioDal termina- C. Methods Employed 
lor sequences. If cells withovt rormidable .ceU membrane barriers 
For use ill mammalian cells, the controll\mctiolll on , are \lied as holt cells, tnnsf'cctIoD Is carried out by the 
the expression vectors are onea provided bl vinJ mate- calcium pbOlpMte precipitation method as described by 
rial. For eu.mple, comm.oaJy used pl'OlllOla'l are de- GrIham. aad Vu der Eb, YlI'Vioo. ~2: 456 (1913). How-
rived from polyoma, AdCllOviM 2, mel !DOlt frequently ever, other m.edlods for iDtroducma .DNA into cells 
Simian Vinas <to (SV<to). The ..,ly and late procnotctl IUCh as by aucl.., .oonor by protoplast (usion Imly 
o( SV40 vinas are pudcvlatly uef\Il becallle bolh are 10 abo be \&Md. ••• 
obtained easily (rom the viM II • !tqmaat wlUcb allO tr prokaryodc cells or cella which conwn .ubnanual 
contalnl the SV40 viral orIaia of repllcatioD (Fieri, et cell wall COM~tiOl\l are \lied, the ~rererred melhod 
ai, Nfl"'" 273: 113 (1971) lDcorponted beteID by rerer- of traMfcctl~lI II c:alclvm tratment VIUla calcium chlo­
encc. Smaller or Jaracr SV<to ft'aamenca IDlY abo be ride as dacnbed by Cohen. P. N. et aI Prcc. Natl. Acad. 
used, provided there Is Included the appromaately 250 IS Sd. (USA), ~9: 2110 (1912). .• 
bp sequence extendlnal'rom the HInd III alte toward the ConatnlC:ltiOn of Iwtable vectors containln, the de-
BSII alle located In the viral orIain ofrepUcadon. Pur. alred codIq and .conlrol seqllences employ standard 
• • .A. _1_ I r.l1'_. lipdon techrdques. IlOlated plasmldl or DNA fmB' 
ther. It b also pouable, and ...u:n d ....... b e. to u. -- ments are cleaved, tailored, and relillted In the form 

promoter or control sequ.cnces IIOf'Il\aIly ISIOCllted 20 d-....... t r th I ...t_ .......

. h h d-'....... Yided uch t I .......... 0 lorm e p ami.... reqWI""'. 
Wit t e """' .... acDC.seqUence. pro I con ro Cleavaae II perf'ormed by treatina with restriction 
sequenc:a are compatible with the host cell I~teml. enzyme (or enyunes) In suitable buffer. In general. 
An orl~ln of replication may .be provided ather by about I "I plasmid or DNA fralments is used with 
co.n~u·\lCtion or the vector to IDctLide an exolenous about I unit orenzyme in aboul 20 "I of buffer solution. 
Qnlln. such as may be derived rrom SV40 or other viral 2' (Appropriate buffers and su.bstrate amountt for particu. 
(e·l· Pol,Yom.. Adeno. VSV, BPV. etc.) 1OIU'Ce, or may lar reatriction enzymes are .pccified by the manufnc· 
be provided by the host cell cbromOIOmal replk:atlon turer.) Incubation times or about 1 hour al 37' C. orc 
mechanllm. If !he veclor Is Intearated Into the hOlt cell workable. After Incubations. protein is removed by 
c;hromOlOn,w. !he latter II often ",mclent. extraction with phenol and chlorororm. and the nuclcic 
In selccllnl a preferred bOlt cell (or tranalection by 30 acid II recovered from the aqueous rrac;tion by precipi. 
the vectors or !he Invention which compriM DNA tation with ethanol. 
lICquences enccdlna both ,·PA ad DHPR. protcin.1t Is If blunt endl are required. the preparation is treAted 
appropriate to aelect the bott aecordina to the type or for .., minutes at 15' C. with 10 u.nits of Polymerase I 
DHFR. prolein employed.lfwUd type DHFR. protein II (Xlcnow), phenol-ehlorororm extracted, and elhanol 
employed, It II prefcnble to Mlecl a host cell which II J' precipitated. 
deficient In DHPR, thus permitina !he use or the Size aeparatlon or the cleaved rraaments il perrormed 
DHFR. codlna sequence u a marker ror .ucceul\ll lllina 6 percent polyacrylamide ael described by Goed· 
transrection In selective medium which lacu hypoun- del. D., et ai, Nllc/tic Acids Ru.. 8: 4051 (1980) iru::orpo' 
Ihine. aJyclne, and thymidine. An appropriate host cell rated herein by reference. 
in this cue II !he Chinese Iwnatcr ovary (CHO) cell line 40 Por Uaatlon approllil'l'Ulteiy equimolar amounU of Ihe: 
deficient in DHFR activity, prepared and propeaated as desired component&, Iwtably end tailored to provide 
described by Urlaub and Chuin, hocl. N~tl. Aca:L St, correct matchina are trealed wilh about 10 units T4 
(USA) 11: 4216 (1980), Incorporated hereill by refer· DNA lIa- per 0.' "a DNA. (When cleaved 'veClOn 
cnce. are used u component&, It may be useful 10 prevent 
On the other hand, If DHFR. protein with low blnd- ., rellptlon or the cleaved veclor by pretreatment with 
in, amnily for MTX II used u the controllin, JCquencc. bacterial alkaline phOlphat_.) 
it Is not tICCCIII&f)' to 11M DHPR. de&lent cells.. a.eallM For analysll to confirm correct sequencel in plasmids 
Ihe mutant DHFR. Is ra.latant to methotreuce, MTX COIIICl'1ICted. the lIaatlon mbtvrea are used to transform 
contalnlna media can be \lied u a means or MIec:t1on B. to/I X12 Itrain 294 (ATCC 310446), and .ucceuful 
provided that the host cells are themaclvea melhotrell· 50 tranaformants selected by ampicillin or letracycline 
ale ICIIIitive. MOlt eulr.aryotic cells which are capable of reslltance where appropriate. Plasmid. rrom the Irans· 
absorblna MTX appear to be mcIhotreute ICIIIitlve. (ormanll are prepared. analyzed by rest ric lion and/or 
OnCluch usef'lli cell line lIa CHO line. CH()'XJ ATCC sequenced by !he method or Meulna. et al. Nucleic 
No. CCL 61. Acids Ra. 9:309 (1911) or by the method or Maxam. el 
Eumplct which are sel rorth her:einbelow describe " al, Mtlltods i" ElUJ'mDloo. 65:499 (1980). 
use of E.. coil uslnl the lac and up promoter I)'Item and Ampl11lcatlon or DHFR. protein cod ina sequences is 
usc or CHO celli II hOlt cells, and eJlpraaion vecton effected by arowina hOlt cell culturea in the presence or 
which include the SV40 ortaln of replication u a pro- approdmacely 20-500,000 11M concentrations of melho­
moter. However. It would be well withln the 1k.i11 ofthe treUle, a competitive inhibitor or DHFR. activity. The: 
an to use anaJoJOus techniques to conatnac:t eaprealon 60 effective ranle orconcentration II hlahly dependent. or 
vec;lon for ,Jlpreulon or desired protein JCquences In eou.... upon the nature or the DHFR. lene. protein and 
ahemadve prouryotlc or .ulr.aryotlc holt cell culturea. the charactetlstica of the hOlIt. Clearly. aenerally de· 
Salillactory amounts 01 human t-PA are produced by lined upper and lower limits cannot be asc:ertaincd. 
cell cultures. bowever.laterreflnemenll usln,alCCOnd· Suitable concentratlonl of other rollc acid analogs or 
ary codlna JCquence Nrve 10 enhance production I.vell U ocher eompoundl which Inhibit DHFR. eould_ also be 
even funher. The 1IC0ndary codlnl seqvcnc:e com· used. MTX itsellil. however, convenient. readily avail­
prises dihydrorolate reductase (DHFR.) which II ar· able and effective. 
feeted by an ealemally controlled parameter, luch ... D. Oeneral Deacriptlon or Preferred Embodiments 
LJ'Z.. 
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Human tiuue plasmino,Cft activator was obtained prescn!;e or controlled leyels or MTX by amplification 
acc:ordin, to the roUowin, protocol: or the sene COtlin, for tbe DHFR coding sequence 
I. 	HWIlan melanoma !;ells actively producin, tissue (Schimke. Raben T. et ai, Sei",«, 202: 10,. (l978); 
plasmino,en activator were cultlUld 10 COIIIIucncy. Biedler, J. L. el aI. 0,11«1'Ru. 31: 1'3 (1972): Chang, S. 
2. Cell pellets from luch ceO cu1tW'tl were utracted in , E, et aI. e.l, 7: 391 (1976». .. 
the presence or ribonuclease Inhibiton to iIolaae all Ofimponance to tbil aspect or the Invention is the 
cytoplasmic RNA. showiq that ampHftcttion orlbe ,ene ror DHFR may 
3. 	 An oll,o-dT c:olwnn iIolaaed lhe lotal '!Ieaenaer caue ampliftcttion orauociated .quences which code 
RNA ~mR.NA).1n polYat.H:nylaaed torm. ThiI mRNA ror other proteins. ThiI appeara to be the case when the 
was me ~ed taIUII add·u.rea Ipmsc lei 10 auoclaled protein la hepatitll B surtace antigen
electrophore:uL 	 • J4. The ,el trlCCioa cOIIllinin, tiuue plasmiaoJCft acd- (HBaAa) (Cbriatman. • II aI. ~ NatL ACQQ. s.ci.. 79: 
vllor apeciflc RNA was identified bI the rol:owina 1115 (1912». Ihe /l. coil prolem XOPRT (RIngold. 
manner: The RNA fromachortbead tr.cdon.l was 00nI0n. II aI. J. M_ Gild AppL Gtlt.. I: 16$ (1981)); 
translated in I rabbil reliculocyte lysate in vitro aya. _lUI endo,lIIous.quence t'rom a DHFlVSV40 pillS' 
tem lupplemcllted with doa pancreas 1Ilfc:rC*)ma. 15 mid combiutloll (JCau~ R. F. et al, J. Mol«. 8iol. 
The rauJtIna translation products were thea 1m. 1$9: flO! (1911». 
munoprecipltatcd with bwnaa tluue pluminopa Other mecbutillilt ror contertin, methotrexate resist 
activator apedfIc laO lUIti'body. taace bldude diminution or the bindin, amnity of the 
.5. 	The appropriate RNA (21 to 24S) was convened to ::0 DHR protein. 10 that It 1,leu luxepdble to methow 
~orrapondlna 1in,IIIll'aDdcd c:ornplementary DNA treutl (Flintofl', W. F. It aI. ,somill. c.ll G~n'L. 2: 245 
(eDNA) trom wllich was produced double Itra.ndcd (1916» but III this instanCI. amplification appean to 
(;DNA. Arter poly-dC tailia•• It WII inMncd Into a occur II well. 
vector, luch III pwmld barin, one or more pheno- It would appeal' that the ,enes both for wild type 
typic marken. 2' DHR a.nd tor DHR which is resillant to MTX by 
6. 	The thus prepared vectol'l were \tied to trallltorm virtue of its own decreased bindln, capacity are ampli· 
bacterial cells providln, I cloned cDNA library. A fted by tbe pmcnce of MTX. Hence. in principle, this 
pool otnldlolabeled Iyntbetlc cleolY oli,ollocleodda upeel or lha iIlv_1Ion herein concern, using the impact 
complementary to codona for knowa amino acid or DHFJl.quence amplification on wociated protein 
sequenca In I·PA. such II, ror example the pool o( I 30 codln, MqueDCII to provide a control mechanism 
l4-mers. which pennits enhanced expression levels of t·PA sew 
quenca iA the pmcncc or MTX. or by vinue of prior 
treatmenl or tnnsCormed !;ells with MTX. 
E. Ewnpla 
. l5 The rollowln, eumpla are Intended to illustrate but 
(complementary 10 seq~CII cedln, for the know- nol to limit the invention. In the eumpln here an E. Coli 
n-see. Infra-:-amlno acid MqllCnee: trypIOP~- hOlt cuJtlll'l and a CHO cell line luitable for the type or 
glutannc acid-t)'1"Oline-cyateine -aspanlc lCid DHFR protein codin,.quence to be Introduced were: 
(W-E-Y:C-D) was prepared and \tied to probe the employed II bolt cell cultures. However, other eukary. 
colony library. Ie .M.I 100__' II . bl ~ h h d r1. From the positive cDNA clona plumid DNA wu 40 ot ...... P~"'.I'otlC ce I are IUlta e .or t e met 0 0 
i!lOll.led a.nd .q e ced the InventlOD u well. 
8. The sequenced uDNA ·encodln. t.PA was then tal. E.I Exp~lon otthe Human ,-PA Oene in E. coli 
lored in vitro for InIenlon Into an appropriate up..... EI.A fl.url Leaendl 
lion vehicle whlch WII UICd 10 lransrorm lUI appro- FlO. 1 is an autoradlo,rll!' ~"a 10 r,rcent S~S ~lIge 
priate host !;ell. which WII, In tum. pennilted to .., dllplayb!, the lmmunopreclpltaled ( S).methlonlone: 
,row In a culture and to produce the desired human labeled prot.cln<l) ICCreted rrom human melanomll cells 
tilluc plasmlno,en activator. durin,I1 hour pulle III vivo. In Ihe presence (lane b) or 
9. 	 Human tlilue plaamino,en activator thus produced ablencc (lane I.) or the proteaac inhibitor aprotinin. 
baa CL 251 amino acidl blltslUyrnatlc ICriac prote. After illUllunoprecipitation with tluue piliminogen 
aac ponion and a "krinaJe" contalnin, ICqIlCDCl up- 50 activator lpeelftc laO. three bands were observed (lline 
atream Ihere(rom which II praently believed to be a) havln, moJecuIar Wei,hts or approximately 65,000. 
responaible ror ftbrin blndln,. The mature protein 61.000 _3'.000. III the pmcnce or Ihe proleaac Inhib­
plUl Itlsl,na! PfCleqUCftCC. totall '62 amino addI. lcor, however. no 35,000 molecular welSh! species is 
The (oreaoin, proccdlll'l. in ItlClf. la lucceuruJ In obierved. No products are lmtnunoprecipitlted when 
producin, pure t.PA. Methods or the Inventloft em. " prcImmWIC ICrWIIII UICd (lane c). The migrations lind 
ployin, an Iddiliona! codin, tequence ICnIidve to molecular wci,hts or 14(:. labelled protein standards arc 
melhotreute permit the prodoctlon In holt cell cultura shown to the left or lane L 
of anti,enically aclive t.PA prolein In amounts peater FlO. 2 cleplctl the ,el electrophoresi. of the immuno­
than 0.1 PI per cell per day. With suitable application of precipitated tnInIlatlon products of RNA fractiona iso· 
lImplifyin, conditions, amountsarca1er than 20 p, per 60 lated rram an ICId u.rea &JIrOIC ,el. A major band was 
cell per day can be obtained. Stated In alternate lemu. oblerved In rrlCtion aumbenl 7 and 8 aner translation in 
gene clI.pretlion level. raultln, In production or more the presenr.c or do, pancreas microlOma followed by 
than 9x 10-6 Plou,h unlu. per cell per day or, wlrh Immune precipitation with tillue plasmino.en Ictivator 
suitable amplification. morc than II X 10-4 Plou,h units apeelrlc J,a. Tbil ba.nd hAl I. moleeular weight of ap· 
per cell per day of I-PA 1C1Ivlt)' are IChleved. U prolimately 63.000 dalton" The liu of the mRNA 
Advanta,e is taken In this llpeet or lbe Invent loa of mi,rl.tia, I.a rractions 7 and I II approll.lmately :z I 10 
melholreute as a drv, wblch. wblle normally fatal to 245. The posilions or ribosomal RNA markers which 
celli capabl, or III uplIke. permlll cells to ,row in the were determined after electrophornil on the RNA urea 
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ael and visualized by etbidiwn bromide stalnln, are FIG. 15 is • schematic diapun of the construction of 
labeled above the appropriate pI lanes. a tissue ptasmiDopn activator ellpression plasmid 
FIG. 3 displays the hybridiution pattern or 96 colo- pARIPA·. The SlII'tin, plumid pPA25EI0 was lirst 
nies with . di&ated with P,d to bolate a 376 lip. (raiment Ihat was 
, then cIlaated as shoW1'l in the fllUfe. 
FIG. 7 shows the reswt or a fibrin plate assay for »P-dTCtaJCA~)TA(f)TCCCA(W-E-Y-C:-D) ftllriaolytic activity o( the tllpression product obtained 
• • . via pAlUPA' In traurormed cells. 
Pt?be.. 96 indIvidual U'IaII'OI"llWlU were ,roW1'l III a FIG. • is III HPLC trace or peptides (rom tissllc 
lNCrotlter plate, replica plated UId powa OD a nitrocel· plumlnopD lICtivator (hereof) trypsin diaest (Absor' 
1~lose membrano. The colonia were then lyaed, bacte- bance at 210 IUD). The arrow identifies the peak corre· 
nal DNA Ihed and the fIIten were hybridized with the spondirI. to the peptide used. to deslan the nucleotide 
llP·I4-mer (W·E-Y-C·D) probes. The tUterl were probe \lied with the colony library. The peptide repre· 
washed to remove 1I0nhybridized probllllld expDIIed to _ted by this peak was found to have the entire se· 
X·ray film. ~ autoradlopam It representative o( the " queace: LoT.W.E Y-C o.V.P-S-C-S·T.CG·L. The 
pattema obtained wl&h 4Ilndtvldual fIIten (4«10 Inde- other auYor peaks Ilkewile were sequenced and found 
pendent colonia). All example ora poIltive tIsIue plu- to confirm the correct amino sequence of human tissue 
mlno,en activator cDNA clone on fUcer number U Ia plumbtopn activator. The peptide one leiter code 
labened u EIO (arrow). referrlnl to amino acid deslanations II II rollows: 
FIG.• Is a restricdon endonucleue map or the Full 
lenlth human tblue plumlno,en activator cDNA. The 
number and Iize o( frqmenll produced by restriction AJp D A....nit: ",,14 lie t bol",,~ln. 
endonucleue cleava,e WII atlmated by cIectrophore. 'tlor T Tlu:_1M u~ L u ... inc 
I. P . io r' Set S Striae T)'I' Y TytDIincI h h 6 1 IdII t roul percent acry am I p... cliln ns 0 uta Ol~ I Ol .. _it: Kid PIle F Phenylalanin. 
were conftrmed by nucleic acid sequeace (preaented In 2S ""' P Prall.. HII H Hillidine 
FlG. .I). The codlD, reFon or the Iar...t open radin, (1), 0 OIJCIM L)'I It Lylinc 
(rame Is boled and the hatched reJion repraenll the Ala A AIMIM Ara" Arlinine 
putative "anal peptide sequence while the Idpled rea C)'I C C)'IIIiM Trp W Trypto~h.n 
. • VII V VIlIM 0111 Q Olullm,n.
lion repraenll the putative matlln! tblue plumlno,en Net to( MtlhionlM Am N Alp....in. 
activator sequence ('27 amino IClda). The " end or the 
mRNA II to the left while the 3' end II to the ript. . ' 
FIGS. SA, 58. and 5C UIliltrate the nucleotide.. FIG. 9 depicu the constructIOn of & plasn:ld coding 
quence and dedllCed amino acid sequence o( the fun ror the direct expreuioo or mature human lI~sue pIns· 
leolth human tluue pluminopn acdvator cDNA The mlnolen activator in E. coIL 50 1" or pillmid pPAl7 
3' amino acid. (-35 to _I) precedin, the rnatu;' .. 3S wu dl,ated with 5&u3AI. HinclJ and Hhat and elcc· 
quence is depicted as an uninterrupted sequence. It II trop~oreud on a 6 percent polyacrylamide gel. Ap· 
believed thai this .l5.amIno acid acquence Ia comprised prolUmately 0.5", orthe " bp Sau3At·Hhal fragmcn! 
of a hydrophilic "pro" acquence, precedin, IIoerine (+ 1) wu recovered. Similarly. approx~lIelY l f.Li of the 263 
or the mature protein or about 12 to I' amino acids, In bp Hhal·Narl (raament wu punned from 80 f.LB or 
turn preceded by. "~nventional" hydrophobic alpal clone pPA25BI0 by .nnt.lsolat~nl a 300 lip ~sd.Nnr! 
(e:uendin, ,'to - 3'). ThIs type or pre-pro .It'UCture on rrqment and then dl,Htlna thl. rra,ment with HhaI. 
ICCreted proteiftl hal been dacribcd prevloUlly, e.,. All dl,all were performed at 37' C. for I hour and the 
with preproalbumin. AIIumlo, this theory, all or the reaction prod'UClI resolved and electr~l~ted from 6 
ICCreted l\uue plumino,en activator molccwa will percent polYlCrylamlde ,els. The two lndu:ated dco~· 
SW1 with the IIoerine (+ 1) as the amino-tarmina A ., yoll,on'UCleotida " dAATTCATOTCTTAT· 
ICCOnd theory II that the hydrophIlic sequence could be CAAGT (I) and " GATCACTTGATAAGACATO 
involved with the rllnction ortluue pluminolen ICtlva. (II) were Iynthalzed by the lOUd phue phosphotric:sler 
tor In a manner anaIo,OIll to that obIerved with pJu. method (51). 100 pmole oroli,onllCleotide II WILS phos­
minolen where a peptide or 10.000 daltons can'" phorylated In a 30 ,,1 reaction mixture containing 60 
cleaved (rom the amino termlnaJ ponlon ofnativ. pJu. mM Tria (pH 1),10 mM M,Ch. 15 mM p·mercaptoe· 
mino,en (Olu·pJuminopn. named for the amino tennl- thanel and 50 "CI [yllP)ATP (Amenham 5,000 Ci 
nat ralduc). resultln,in alllUlller molecule, with alteW mmol- I) 12 unlll of T4 polynucleotide kinase were 
amino lerminUl, desi,nated Lys-pJumIno,en. Lys-pJu. lidded and the reaction allowed to proceed at 37' C. for 
minoaen II more cuily activated to plumin, and alto " min. One '" or 10 mM A TP and 11 units ofn kiM.e 
}w a ,realer amnlty ror nbrin than Glu plumiDolen. 55 were then Idded and the reaction allOwed 10 proceed 
Plasmin hal been thown to catatyu the convenion of for an Iddltional 30 min. Alter phenol/CHCb elt(rac· 
OIu· to LYI.plumlno,en. Thil type or control mecha. tlon, the photphoryllted oll,omer II and the 5' hy· 
nl.m mulll in a "poeilive feedback" meclwdam. The drollyl oll,omer I were combined wilh 0.' f.Li of the 
lint amounll of plumln rormed. beside de,radin, ft· eluted" bp Sau3AI-Hhal rralment and 2 Jl.1 of the 263 
brin. allO result In the ,enention of plumlnoaen mole- bp Hhal·Nul rr.ament and ethanol precipitated. These 
cules which are more cully ICtivated. and abo bind rrapen" were Ii,lted at room temperature for 4 hour; 
tilhter to their tubltr.te, than native pJumIno,en. The In 60 '" or 20 mM Tri..HCI (pH 7.'), 10 mM MiCh. 10 
result is. futer de,radation of fibrin. The hydrophilic mM dlthlotbreltol. 0.' mM ATP and 1000 units of To! 
peptide or tlMue plumino,en ICllv.tor could.,. In· DNA lipse. The multure wu dl,ested ror I hour wi!h 
volved In a .lmUar mechanism. III clcava,e raultin, in " 41 unlll of Nul. 20 unlll or EcoRI and 40 unit. of BEll i 
modilled bindIn. Or thl Inayml to nbrln. In any evml (10 IlImlnace polymlrlution throu,h lI,atlon of c:ohc· 
the 3' amino ICld sequence II coftlidered. presequence live Sau3AI terminI) and electrophoresed on a 6 per-
of the maCure protein. cent pI. The 331 bp product (approximately 0.1 ,.,.B) 
2.14­
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was recovered by e1ectroe1ution. The remainder of the precipitated pfodUC1S were displayed by electrophoresis 
I-PA codin, seqUCDCCS (ammo Kids 111-511) were Oft a 10 pen:eat SDs.ac:rylamide leI. The slab ael was 
isolaled on a 1645 bp fra,ment by di,estiq plasmid rued, dried aDd subjected to OllOro.raphy. 
pPA2jEIO with Narl and BalIl. The· plasmid pLeI· E.1.e Meueuaer RNA IsolatioD IDd Size Fractionation 
FAtrpl03 is a derivacive of the plasmid pLelFAl5 (52) STotal RNA from mellDOm& cell cultures was ex-
in which the EcolU site distal to the LeIF A aeoe bas tracted eucndally IS reported by Ward et aI. (55). Cells 
l:1:cn removed (53). Three VI or pLeIFAtrplOl were were peJletcd by CCDtrifUptioo and then resuspended in 
digested with 20 Wliu or£coRI and 201IftksorBlillfor 10 mM NaCI, 10 mM Tris-HCl pH 7.!I. 1., mM MaCh. 
90 min. at 37" C.• e1eccrophorelCd on a 6 perc:CD1 poly- Cells were lyad by the addition o( NP-40 (I percenl 
:lcrylamide le1ud tile larp ( -4.200 bp) vector fraa- 10 final cooc;atratiaD), and ftuclei were pelleted by cen· 
ment was recovered by e1ectroehadoD. For the IInaI trifUpdoD. '1'he supem&Wlt contained the total RNA 
construction. 80 na of EcolU.BIIII pLeIFAtrp103 was wJdcb WIll ftutber purified by-mwtiple phenol and chic­
li!l:lted with 100 al or the 164!1 bp Narl B,UI rr..-t roform.trIICtioIu. The aqueolll phue was made 0.2 M 
ar.d 20 nl or the 331 bp £coRI·Narl I'rapIoeDt for 10 ill NaCllDd tJ:aea total RNA was precipitated by the 
hOUD at room tcmpcmure. This Uption IIIixIare was I' addition of two volumes ofelhanoL Olilo-dT cellulose 
used to lI"IIIII'orm B. coil K-12 StraiD 2M. PIatmid DNA cbrolllollOlfIPIa:y WllllIdlized to puriry mIlNA from the 
WIIS prepared rrom 31 or theM tranatOl'lD&DtI IDd di- total RNA prepe.radoftI (54). Tfl)ical yields from 10 
gelted with EcolU. Tea ofthae plumic:lacontalned the Jr&IDI of cultured melanoma cells were' to 10 milli­
de:lired 600 bp and 471 bp EcolU fraammts. DNA Jr&IDI ortotalRNA and 50-200 mieroaraml of Poly(A) 
sequence analysia verified tbat ODC or thCM ptumida :10 plUl dNA. 
(pl-PAtrpI2) had the desired nudeotlde Mquence at the FractionatioD or PolyA+ dNA (200 Ill> ('6) was 
junclions between the trp promoter, Iynthetic DNA performed by electrophoresis throulh urea-a,arose 
.lnd eDNA. -lela. The Ilab aptOlC lel(.57, ,a) was composed or 1.1, 
flO. 10 &hOWl the result or a fibrin plate .....y ror pen;:ent aJ&l'OlC, 0.02.5 M lOdium citrate, pH 3.a and 6 
fli;';nolytic activit)' or a liuue plasminolen activator ~ M urea. Eleccrophorail was performed for 7 hours al 
cltpre.. .ion product hereof. An ovemi,ht culture of E. 25 milliampl and •• C. The ,el was then fraelionaled 
coli W~ i 10 (ATCC 2732') conwninl a t.PA .prCllion with a razor blade. The Individualilices were melted al 
'lector in L.;~~ !-roth containinl' lit mI-1tetracycline 70' and eJltracted twice with phenol and once wilh 
Wl!.S diluted 1:100 ill M9 medium conialruna 0.2 percent chloroform. FractioDi were then ethanol precipilated 
glucose, 0.5 perce:at cuamiDo 1CId. IDd , '" mI- 1 30 and .ublequcndy .....yed by ill vitro translation in a 
ICll1lcycline. The celli were grown at 37" C. to an A"o rabbit redcu.loc;rte l)'Iate l)'Stem. Bethesda Rescarch 
of 0.2 and indole acrylic acid WII added to a ftJW con- Lab. (59.60), aupplemented with dOl pancreas micro­
ccnlnation or 20 "JlmI. Samples Were conected by IOIIleI as (01l0W'l: TranaiatioDi were performed using 25 
ccntrifuption at ..4,»-0.514-0.6 (-2X 101 celli mI- l ) ,,0 of [l'S] methionine and !lOG nanolrams or each gel 
4I1d immediately froZCft. The eell pellell were 1111- 3S alice RNA ill a ftJW volume of JO pJ containin, 25 mM 
p:/ided in 6M ,uanidine hydrochloride at 5x 101 HEPES. 41.3 mM polaUium chloride. 10 mM crealine 
cclb/ml. IOnicated ror 10 ICC. Incubated at I.· (or 30 phOlpbate. 19 amiGo acids It 50 mM each, 1.1 mM 
min and then dialyzed lor 4 hnq&inlt 2' mMTril-HCI mapesi'llDl chloride 16.6 mM EDTA. 0.16 mM dithio­
pH 8.0. 2$0 mM NaCI. 0.2' mM EDTA and 0.01 per· lhreitoll.3 mM hcmI.n. 16.6 "Jlml creatine kinase. 0.33 
cenl Tween 80. After dialysis tile aampla were ccatri· 40 mM c:aJci'llDl chloride. 0.66 mM EOTA. 23.3 mM so-
fused It IJ.OOOX, ror 2 mJn aDd 10 f'I of the Illperna- dlum chloride. 
1~1lt.s analyzed (or tillue plumiDo,en activator .clivity. Incubidoal were carried out at 30" C. ror 90 minules. 
Followin, the proccdureorOrauelll·Pipemoand Reich Do, puc..... microIomal membranes prepared from 
(31). tbe pllte was incubated ror 3.' boun It 37· C. and roup IDic:roIonIa UIinJ EDTA for removal of the 
1)'3is ;tones measured. Plumin produca a clear lysis .. , r1b01oma (61) were treated with nucleue as described 
lone in the fibrin plate and the area o( this zone CID be (62) and were praent III the translation mixture at a final 
correlated to the amount titaue pluminolen activator In concentration or 7 Auo uniU/mi. Tranllatlon producls 
lhe slImple. or lmmW'lO'precipitaced traDIlatlon productl were ana-
E.I.B Source ofTlaaue Plumlnolen Activator mRNA Jyled by elecuophorall on 10 percent polyacrylamide 
Human melanoma celli (Bown Melanoma Ceo line. ~ ,el. In 1Odi'llDl dodec:yllulrate II previoully described 
ATCC acceuion number CIlL9607) were ued. The (63). The \lDIItalned slab pll were fixed. dried and 5ub· 
melMoma celli were cultured to collflucnt moaolayen jeeted to fluoropaphy (64). 
in 100 ml Earles Minimal Euential Media .upplemented The rtlultiD, lraDIIatlon prOducti (rom cach ,cl frac­
wilh sodium biealbonate (0.12 percent Rnal coacentra· tion were lmmWlOPreclpitated with rabbit anti-human 
lion), 2 mM Ilutamiae and 10 percent hat·lnact1vated 55 tlullC pluminoJca actlvltor specific: 1,0. One major 
(ellli cal( sefllm. To confirm that the melanoma eelll lmmlUlOpl'Cdpitated polypeptide band was observed in 
were actively productnl human tluue pJaamlno,en the trIIIIIadoa 01 RNA fraction Dumben 7 and I (mi,ra· 
activator. human melanoma celli Were cultured to con· tIon or 21 to 24 S) havill, a molecular wel,ht or approx­
flllency in a 24 well mlcrotlter dla.h. Either Itl the pr... \mately 63,000 daJtOIll. This band WII not observed 
cnee or ablence of 0.33 "M the prol.elLle inhibitor 60 wben prdmm\IM laO was \lied for immunoprecipil.­
nprotinin. che cell. were wllhed once with pholpbate don which .ugated thete polypeptides were tissue 
buriered saline and 0.3 ml of Mrum free methloDine free plumlnolen activltor 'pecific. 
medium WII added. " "CI of [lsS].methlonlne was E.1.D Prepl.:atioD o( a Colony Library Conlaining 
added and Ihe cella were labeled It 37· (or 3 houn. At Twue PWminolen Activator Sequences 
lhe end o( the 3 hour tabellln, period the media was 65 Five '" of ,el fractionated mRNA (lei slice 7 
removed rrom the cell. and treated with either twue mRNA) w~ \lied (or the preparation or double 
plll~minOlen acllvator .peciRe laO or pre-Immune .tranded eDNA by .tandard procedureJ ('2.6'.66). The 
~crum for immunoprecipllatlon ('.). The Immune- eDNA was liz« iractionaled on a 6 percent polyacryl. 
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amide lei. The eDNA IlUtu than 3~ base pairs in each colony rllled to the filter by che Grunslein Hogness 
lenlth (12S Ill> was ekctroeillted. JO III of eDNA was proc:cdure (69). 
extended with deoxy(C) residua usinl terminal deox­ The 
)'nucleotidyl transferase (67) II'Id Il'lne&1ed with 300 nl 
of the plasmid pBRJ22 (61) which had been similarly , J2p-IabcIltd.TC~)cA(~)TA(~ITCCCA
tailed with deoxy(O) residues at the Pst I site (67). The 

annealed mixtllre was then transformed into E. coU Kl1 . . 

strain 294 (ATCC No. 31446), Approximately 4.600 probe was prepami (from the I~thetlc oligomer) 
t (, ts obtained (W.E-y..c.D) l4-mer pool as descnbed above. Fillers ~o;.;ere f DNA Probe 10 COlitainlnl 4.600 tnnsformants. were prehyb~idized ror 
. on 0 • • . 2 hoW"l at room temperature 1ft 50 mm sodium ph05. ~rified h~ uaue pluaunolen ~uvator was phate pH 6.8. 'x SSC (80). I~ J'vml sonicated 
obwnedaccon:bnltodMproc:cdureofdIllCIOIcdrefer- ulman .I'm DNA, 5X Denbatdt's solution (8.5) 10 
enea (19.20). • . pm:eDt To~de II'Id then hybridized with !lOx 10. 
The molec\lle ~ ICIIUIed 1ft order to locate re~ns U counts per minute of the libelled probe in the same 
best suited for ~ syntbetic probes. as ~OUOWl. solullol1. Af\er 11'1 ovemllbt incubation It room temper. 
To mate dM protems lUlCeptible to dlaCition by tryp- ature. dM ftlters were washed 3 timea at rcom tempera. 
sin II was redu:ed IUId carboxymethylated. A 2 m. ture Ia 6X SSC.O.I percent SDS for JO minutes. once 
sample or tiuue plumiDolen activator was flnt dia- ill lX sse II'Id then exposed to K.odak n.' x-rllY film 
Iyzcd aillast 0.01 pctCCIlt.TWlllln 10 over lllaht at room 10 with Dllpont Lilbtninl PillS intensifyin, screens for 16 
temperature. The l)'Opbllizcd protein was then dis- hours . 

solved in Il mI of 0.56 M TN-HCI bllffer (PH 1.6), 8 P~d DNA was Isolated by a rapid method (71) 

molar In urea II'Id , ~ ~DTA. The dlsllifide bonds from all colonies showinl a positive hybridiution relic. 

were reduced by Ihe additIon oro. I ml ora·mercaptoe· lion. The eDNA Inserts rrom these clones were then 

thll'lol. Thil reaction wu carried Ollt under nitrolen ror 2' MqllCnced after 'lIbelonin, (raiments into the M I J 

2 hours at 45' C. The reduced diauifidCl were a1kylatcd vector mp 7 (73) II'Id by the Maxam Gilbert chemicnl 

to tbe carbo~ymethyl ~vatiye by Ihe addition of 1:0 proc:cdure (74). FlO. 3 dl.plays filter number 2!1 show. 

ml Of .... M lodOllCetic aad in IN NaOH. After 20 DIln Inl the hybridi.ution pattern of a positive !issue plas. 

at room temperature Ihe reaction was stopped by dlaly- minopn avator clone. The cDNA insert in clonc 

,is apinst 0.01 percent Tween 80 for II hours at room 30 25EIO was demonltrated to be the DNA coding for 

temperature ~ lYOP~izcd. . tissue plasmlnolen activator by comparing ilS amino 

The n:sulttnllyophilized carbolIymclhylated protllUl acid MqIlllnCe with peptide sequcnce (See Supra) ob· 
was rediuolved in 3 mJ of 0.1 M sodium phosphate tsined from pllrifled tissue plasminogen activator and 
buffer (PH 7.'). TryptiD (TI'CK) was added (l to ~ by Its expression product produced in E. coli as de· 
ratio) II'Id dileated at 37' C. Allquots (0.1 ml) were l~ ICribcd in more detail infrL The cDNA lnser! of clone 
taken at J hollrs, 6 hours, and 12 hr. A teeond addition 25£10 (Plasmid pPAl5£10) was 2304 base pairs in 
of tryplln wu made .II 12 hr. The ~Ion was ItOpped !enlth with the lonlesl open readin, frlme encodinE 3 
after 24 hI' by frllllzini the sample until It could be in- protein of 508 amino acids (MW of !l6.7S6) and contnin· 
jeeted on tbe HPLC. The proJrell of the dllCition was Inl a 772 bp 3' untrll'lilated re,ion. This cDNA clone 
delCrmincd by SDS lela on the a1iqllOts. All leI, were ..0 lICked tbe N-termi.na1 codinl sequence •. 
blank except (or a raint bind on the J hour aliquot. Thls BlCteriai clone E. coIl (pPA2'EI0). as well as II sam· 
indicated that the 24 hour dllCitlon was complete and pie of plasmid pPAl5£IO, have been deposited with Ihe 
no larle peptides remained. American Type CUltllre Collection II'Id accorded acces· 
A sample (CL 0.' ml) was Injected into a hllh resolll- lion numbers 67587 and 40401. respectively. 
lion Altex C·8 IIltrasphere 51' column with two run•. A ..~ £,1.0 Direct Eltpreuion of I Hllman Tissue Plasmino· 
Iradient or IICCtonitriJe was made Irldual (I pel:QCnt to .en Activator Clone In E. coli ' 
.5 pen:cnl in , min, , percent to 3' pereent in 100 min, With reference to FlO." 50 1" of pPA2!1EIO (supra) 
l5-~ pen:cnt in JO min). In OM of the two preparative were dilCited witb Pst I and tbe 376 bp fraamcnl i~o· 
runs. the el\lll'll was monitored atlwo wavelenJlM (210 laled by electrophoresis on a 6 percent polyacryillmide 
nm and 210 nm). The ratio of the two wavelenath ab- ~ pl. Approximately 3 J" of this (ra,ment was i.soltllcd 
SOtptiOM was \lied 10 indicate the tryptophan contain- from the lei by eleclroelutlnl. di,ested with 30 units or 
inl pepcides. Ode I for I hr at 37' phenolll'ld chloroform elllrnctcd. 
The peptide peW moet likely to conllin tryllloPhan. and ethanol precipitated. The reaultinl Dde I slicky 
or that were believed 1IIII!'u1 for other :..aIOIII, were ends were ClItended to blunt ends by adding S units of 
Mqucnced nrst. This enabled the det,. ....ul'l.Idon or the " DNA polymerase I (Klenow fra.ment) and 0.\ mM 
sequence around most of the tryptopllana. After III- each of dATP. dCTP. dOTP, dTTP to the reaclion 
qllencinllbout 25 or the best poIIible peptide peab, all mixture II'Id Inc\lbltinl at 4' C. (or 8 hours. After ~~. 
Ihe sequence data thaI could be a1lped was pooled to trlCtion wilh phenol and chloroform. the DNA W~.~ 
obtain a preliminary model or the primary structure o( d1lestcd with U IInits or Nar I ror 2 hours and the 
tiss1.lC! plasmlnolen activator. Prom this data and model, 60 reaction mixture electrophoresed on a 6 percent poly. 
several pouible probes were located. ICrylamide leI. Approximately 0.5 111 of the desired 
E.l.F Identification of Bacterial Clones Containinl 125 bp blllnt end Nar I fralment was recovered. This 
Ti.,lIe P1asminolen Activator cDNA SeqllllllCCl (raiment codes for amino acids number 69 through t lO 
The colonies were Individually Inoculated into weill of tbe mature full lerilth li.,ue plasminoien activator 
of microliter piates contalnlnl LB (93)+ 5 J'vml tttra· " protein. 
cycllne and stored at - 20· C. aner addition of DMSO For isolation of the 1600 bp Nar I • 8al·ll fragmenl. 
10 7 percent. Two copies of the colony library were JO J'I of pPA25El0 were dl.ested with 30 units of I'Inr 
,rown lip on nilrocelllllose nllers and the DNA (rom I and 35 unitl of BII 11 (or 2 hours at 37' and the re;,,;. 
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tion mixture electrophoresed 011. a 6 perceIIt pol)'Cl')'l- dODeS contaiainl N-terminaltissuc plasminogen ICliva· 
anUde ad. Approltimatdy 6 '" or tbe desired 164' bp tor codiq tequences. 
Nar I • 811 11 £raplent were recovered. TIle ftnt step in lhis precess involved establishing the 
The plasmid pdel1llUSRC is a derivative ortbe pia- r.:t that only a sin,le boll'lOlolOUS tissue plasminogen 
mid pSRCul6 (79) in which the Eco RI.tes proDmll S IIC1i.vacor ,me is present in huma.a IComic DNA. To 
to the trp promoter and distal to the SRC ,Iae have dctermiDe this, a Southern hybridizatiou. was per· 
been removed by repair with DNA polyme..... I (21), Formed. Ira thia procedure (77), 5 1'1 or high molecular 
and the sctr-complemenwy oli,odeoltynucJeocidc weiPt huma.a lymphocyte DNA (prepared as in 80) 
AATTATOAATTCAT (synthesized by the pbolpho- was di.-ted to completion with various restriction 
triester method (75) wu inIened mto the remaiainl 10 eadoauc:leues. eIectropboreied on 1.0 percent asaros,~ 
Eco Itllile immediately acUacent to the Xba I lite. 20 n1a (11) ad blotted to a nitrocellulose mter (77). A 
1'1 or pdeitaRlSRC were di,ested to colDpledoD with J1P_1aheIled DNA probe wu prepared (16) rrom the S' 
Eco Itl, phenol and chlorororm utnctcd, Il.ci ethaaoI ad or the eDNA Wert or pPAl5EIO (a 230 bp Hpa iI 
preeipitated. Tbe plumid wu thea dilated witb 100 - ilia I hpent) &nd hybridized (12) witb tbe: nitrocel· 
units or nuel.... SI at 16· C. tor .10 mlDuta m 25 mY 15 IaIoM IIlter. 3.sx lOll counts per minute or the: probe 
sodium accute (pH 4.6)., I mYZaCb and 0.3M N.cJ to were bybdcUzed for 40 houra &ad then wuhed lIS de· 
ctUlII a blunt cud witb the IIeQ1ICDCC ATO. Attar p.... IC:ri'becI (11). Two adonuclease d1le.tion patterns pro­
nol and chlorororm utnlc:don and ethanol pn:cipill. viele only a liqIe bybridl.z.lnl DNA rralment: Ogl 11 
lion, the DNA wu dl,ated with Bam HL electro- ('.1 Jtbp) and Pw II (4.2 Kbp). Two hybridizinS DNA 
phoresed on a 6 percent polyscrylamidc pI, &nd the 20 rnpents were obIerved with Hlnc II (S,l Kbp lind 4.3 
larle (4,j()() bp) vector rnpmlt recovered by dectroe- Jebp). Tlkcu to,ether, thae data IUlleat the presence 
lution. or only a.nlle tisaue plasminolc:n activator aene: in the 
The: expreaaion plumid wu uaembled by lI,atlnl buma.a ,cuome, &ad that this lene contains It least one 
toaether 0.2 1'1 of vector, 0.06 '" or the 125 bp blunt mtervenift'teq\llJlCc. 
end· Nil I rrapent and 0.6", or the 164' bp Nat I - 2' c. Sc:reeninl or the Human ). Phale Library ror Tissue 
Balli rrapnent witb 10 unllI orT. DNA Ilple ror 7 PlumInoICft Activator Oenes. 
houn at room temperature and UIed to traaaCom B. coil The atratelY UIed to ldentiCy ). phale recombinants 
slrain 294 (ATCC No. 31446) to amplcUUn resiatuce. c:anyia, tIIIuc plumiftolcu activalor aenes consisted in 
Plumid DNA was prepared 'rolD 26 orthe colonia and dctectm. nvcJcotide homololY with a radioactive 
diicsted with Xba I and Eco RI. Twelve or tblle pi... 30 probe prepared rrom the tiasuc pluminoaen .ctivalor 
midi conWned the dalred 415 bp Xba I-Eco JU and CDNA 1 pPA2'EI0. One million reeombinant). phage 
412 bp Eco JU·rlqllllllta. DNA teqUCllee aaaJfIlI veri. were plated out Oft DP 50 Sup F II a den.sity o( 10.000 
lied that several of these plum1dl hid an A TO iDidation plull' em platc, and nitrocellulose filter replica.. were 
codon correctly pllCed at the start or amino ICId Dum· prepared tor each plate by the method or Benlon lind 
ber 69 (serine). One or thae pl.umidt, pAJUPA· wu 3S Daw (71). A UP-libelled DNA probe wu prepared by 
teated and produced the desired tiasue plaaminoaen llaDdard procedures (13) (rom a 230 base pair Hp4 II ­
activator (FlO. 7). Itt I Crapent located 34 bue pain rrom the S' end or 
BacterialcloneE.t:Oll(pARIPA·),uweUu...mple the plumid pPA2'EIO. Each nitrocellulose filler was 
o( plasmid pARIPA·. have been dcpoIited witb tbe prchybridlzed at 42' ror 1 boun in SO mM sodium 
American Type Cullure ConecUon and ac:c:orded ar::c:a- 40 pbolphate (PH 6.'). 'X SSC (11), 0.0' mllmlsonieated 
5ion numben 675., and 40400, respectively. IIImotl sperm DNA, 5X DenJwdt'l solution (84). SO 
E.I.H Full Lcnllh Tiasuc Pluminopn Activator percent tomwnlde and then hybridized with 'Ox 10<' 
eDNA counll per minute ot the labelled probe in the same 
a. Preparation of a Colony Library Conl&lnlnl N.termi- IOll.ltioft COftI&lnIn, 10 percenl sodium dutran sulfate 
nal Tillue Pluminolen Activator Sequenca ., (IS). After an ovemilhl Incubation at 42· C .. the filters 
0.4 1'1 or the Iynthetic: oIpucleotlde" were w..hed 4 tima al SO' In 0.2X SSC. 0.1 percent 
TTCTOAOCACAQQOCO J' wu UIed ror priminl SDS ror .10 minutes, once In 2 x sse It room temper.:!­
7.' 1" or ,el frICtion number amRNA (supra) to pre- lure and then expoted to Kodak XR·' X-ray IiIm with 
pare double llranded cDNA by .tandard procedures Dupont Cronex Intenlifyinl ICreena ovemiahl. A lota1 
(65,66). ThecDNA was aiu fractionatedoD 16petCCftt 50 or 19 clones were obtained which hybridized with Ihe 
polyacrylamide ,el. A size fraction ,realer lhan 300 probe. Phqe DNA w.. prepared u previously de-
b:uc: pain (36 n,) wu electroeluted. , III cDNA wu ICn'bed (16) from 6 recombin&ats. ). Clone C WAS 5e· 
extended with deoxy(C) residua uain, tmninal dCOlt· lected ror prepltltlon or a Pvu II (raiment ror colony 
ycytidyltranarerue (61) and annealed with 50 nl or the tcreaIn,. 30 1" or DNA w.. dllCiled with Pvu n ror 
plasmid pBRJ22 (61) which hid been alnillarly tailed " I how at 37·, and electrophoresed on 1.0 percent 1I8a­
with deoxy(O) residues .t the Pat I lite (67). TIle an- roll lela. A 4.2 JeDobale pair fr'lment previously 
ncaled miltture wu then transformed IAto B. coI/Je12 Ihowu to COftI&ln tisaue pluminolen activator sequen. 
strain 294. Approximalllly 1,5(}() t.ra.nalormants were c:&I wu tlecltolluted &ad purif1eci. A up labelled probe 
oblJlined. WII prepared by .tandard procedura (U) for colony 
b. Southem Hybrldlutlon ot Human Oenomlc DNA 60 hybrtdiUtJona u dac:ribed InCra. 
Since the cDNA primln, rac:tloft hid been done d. kreenln, or Colony Library for " Tillue Plumino­
usina a synthetic: (r.,ment that bybridlzed Il bale pairI ,en Activator Sequcncet. 
from Ibe N·terminal orclone pPAl'El0, no COftvenlent The coIOftiea were tranarerred from plates and grown 
restriction (raiment wu available In this 29 bale pair OIl nitrocellulOll ruters and the DNA from e:ach colony 
reJio" (whkh Includa the 160mer &eqll4l1lCe) rOr ICrnn- " ftud CO the IUter by the Orunateln • HOineaa procedure 
In, the cDNA clona. Therefore, It wu neceuary to (69). A UP-labelled probe wu made by c:alf.lhymu~ 
isolate a human tiNue plumlno,en acllvator ,enomlc primin, ('3) a 4.2 Idlobue pair Pvu II (raimenl from an 
cione In order to Identify any primer eltcnded cDNA isolated tissue plumlno,cu ICtivator ). lenomie clone. 
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Fillen containin, the 1.m 1RDSf0rmanlS were hybrid· thylenehexamethylene diammonium diacetate) was 
ized with 112 x 10' cpm or llP.pnomic Pw II rrq· used as a carrier in the cup. (6JC) The sequencer WllS 
ment. Hybridization was ror 16 boun usia, CODditiODS modified with a cold trap and some pro,ram changes to 
described by FrilJeh et. al (12). F'llteR were exte:nsively reduce backJl'OUDd peaks. The ret,ents were Beck· 
washed and then exposed to Kodak XIl·' X·ray film , maD·s. sequenc:e arade 0.1 molar Quadrol buffer. 
with Dupont Uahtnin,·P!us iIltensilYina screeas ror pbenylisothiocyanate, and heptal]uorabutyric acid. 
16-41 houn. Eiptccn colonies clearly hybridized with The collected Edman cyclcswere manually con-
the ,enomic probe. Plasmid DNA wasilolated rrom vened to 2-Milino-5-thiuolinone derivatives. The l­
each or these colonies and waa bound to nitroccllulOie cblorobutane wu dried imder nitro,en. Then 1.0N Hel 
filteR and hybridized with the llP·labeUed syDthctic 10 ill water wu added to the 2-anilino-'·thiazolinone lind 
oli,oDucleotide (l6-mer) used ror the onpw priminJ heated to 70' C ror 10 min to conven it into the )-phc· 
~ction. or the II cloDCl, IeYCD hybr;ldUcd with the nyJ.2.thiohydantoin (PTH derivative). The PTH­
kinased l6-mer. Upon ICqIaence analym after sabcloa· &IIIinI:Hcid residue wu then dissolved In '0 percent 
in, rraamenta Into the mU ~r DIP' (73~ ODe cl?De ecetoDitrile and water and injected into a reverse-phase 
(pP.A 17) w~ shown to conWD ~ correct '. N terminal " hiP-pressure liquid cruomato,raph. Each PTH.amino 
re,lon or tiSsue plumln~aca Kavator, a. aipallader acid wu then ideDtined by comparison to the retention 
sequence and an 14 bp' UDtraDIlated rel1OD. From the times or a standard mixture or PTH.amino acids thllt 
two clona pPAl'EIO and pPAI7 the complete nuc~ waa Introduced iIlto the conversion vial and treated the 
tide sequence FlO. S and restriction pattern (FlO. 4) or same way u a cycle rrom the lCquencer. 
a rull I~n'th tissue plumino,CD activator clODe were 20 E.I.K. Assays ror Detection or Expression or Tissue 
determln~. _ Plumino,en Activator 
Bac.terial clone E. coli (pPAI7), ~ wel~ u a umple ~r I. Direct Assay or Plasmin Formation 
plasmid pPAI7. have been deposited WIth the Amen· L Theory 
can Type· Culture Collection and ICCOrded accession . . ... .
"16 and MYN'I t' I ." A aenllUve as.ay ror tissue plasmmo,en actlvlltor cnn 
numbeR 67oJ -60 respec tve y. 6" be ob . ed b .. h' I' .The native t\saue pl ..m1l101en activator molecule hat taln y mODlton~, t e tluue. p asmlnogen DC.tI. 
lhe potentlal to be ltabllized by 17 dilulflde brid,es vator ca~yzed convenlon ~r plasminogen to plasml~. 
based on homolo,y with other terine proceua. There Plumln .. an enzyme for which there are chromogenic 
Olrc rour potential N.,IYCClylation aitCl, three located in lubltrate as.ays. These. as.a~ are based on the proteo:>. 
the "Ir.rin,le" reliona at aN1I17, unll40 aN1111 and one JO lytic cleava,e or a tripeptide ~rom a chromophonc 
potential aite in the Upt chain reJlon. at &ID44I- Varia. JI'Oup. The .rate or cleavage b dJr~lly related to both 
lionl in the Itructure or the oliaouccharide llganda may the speclftclty and the concentration or the proten.· ~ 
be retponalble for the different molecular rOrml (6'.000 bcIn,lcIted. The balil ~r thc ....y is the.det~rminllti In 
and 63 000 mol WI lpecies). or the amount or plasmm rormed follOWing mcubnon 
E.!.l Direct Exp~on or Full Lcn,th Tillue Plumln. 35 or the tiuue plumino,cn activator containing sohtion 
ogen Acti".'alor cDNA CloDe in B. coil with alOlution orplumlno,en. The ,reater l~e ar.JOunr 
A reconatruction or the entire codln, lCquence w.. or activator. the ,reater the amo~nt of plasmin fOI rncd. 
pouible cmployin, the common HhaI reatriction cndo- Plasmin II ~easured by monitonn, lis cleavage 01 .th~ 
nucl_lite shared by both partial cloncl pPAI7 and chromo,enJc lubltra~e 522'1 (purchased rrom t.llbl 
pPA25EI0. A "bp Sau3A1.Hh&I reatriction rnament .a Oroup, Inc .• Oreenwlch. Conn.). 
correspondln, to amino acids S-23 w .. iIolated rrom b. Procedurc ... 
the plasmid pPAI7. The SaJa3AI reatrlcdoD lite was An aliquot or the sample II mixed with 0.10 ml orO.7 
located at codon rour or the preaumed mature codin, mplml pl..mino,en (In 0.05M Tris.HCI. pH 7.4, con· 
sequencc and w .. used to remove the llpal peptldc tainln,. 0.~12M ~aCI) and the vol~me adjusted ~o 0.1 S 
codin, re,ion. A 26J bp Hhal.Nul rralJDCllt (codln, ., mi. The mixture .. incubated at .37 .C. ror 10 mmutc~. 
ror amino acids 24-110) w .. allO iIOlated rrom plumld 0.3' ml or 522'1 (1.0 mM IOlullon In above buffer) IS 
pPA25E10. Two Iynthetlc deoxyoll,onucleoddes wcre added. and the reaction continued ror 30 minut.es at 37' 
designed which restore the codona ror amino acldt I..... C. Olacial acetic acid (2' ~L) II ~ded to termmate the 
Incorporatc an ATO truwlatlonal initiation codon and reaction. The umples arc ccntnruged and the IIbsor­
crealc an EcoRI coheslvc termlnu&. These three rra,•. 50 bance at 40' nm II measured. Quantitation or the 
menta were then lI,ated to,cther to rorm a 331 bp rra,. amount or activity II obtained by comparison with n 
menl codIn, ror amino acids 1-110. ThIa rrapent and ltandard urokinue IOlution. Activity was recorded in 
Ol 164' bp Nul.B,1II rraament rrom pPAl'EIO were Plou,h unit&, wherein 90,000 Plou,h unitl il equal 10 
lhen lI,ated between the EcoRl and B,JJI litel or the the activity exhibited by I m, or purined tiuue plamino­
plasmid pLelFAtrPI03 ('3) to Jive tbe expresaion plu- " am activator. 
mid pt PAtrp12. The cloned t·PA ,etlC II traDlCribed 2. Indirect Assay or Plasmin Formation 
undcr the control or a 300 bp rraament or the E. coil trp L Theory 
operon which contalna thc trp promoter. operator, and A aenaltive ....y ror tiuue plasmino,en activlltor 
lhe 5hine·Dalgarno aequence or the trp leader peptide activity baa been dcveloped (87). The assay is based on 
bUI lacuthe leader peptide ATO Initiation codon ('2). 60 determination or pl..min rormation by measuring lhe 
A sample of pl..mid pt.PAtrpl2 baa been deposited extent or plasmin digestion or fibrin in an agar plate 
Wilh the American Type Culture Collection and ac· contalnin, fibrin and plasminogen. Plasmin produces II 
corded accCllion number 40404. clear IYIII zone In the fibrin plale. The area of this lysis 
E.l.1 Sequence AnalYlis zone can be correllted 10 the amount of tissue plasmino· 
Sequencc analYlil was bued on the Edman de,rada· 65 ,en activator In the sample. 
lion. (l3b) Thc sample was introduced into the cup of b. Procedure 
lhe Beckman 1908 or 190<: Ipinnln, cup lCquencer. Followln, the procedure of Oranelli·Piperno lind 
Polybrene TM (poly N.N.NINI·tetramethyl.N.trlme· Reich (87). the plales were incubaled 3.5 hours 11137' C. 
2.1<6 
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and lysis zones measwed. QuIIlulation was obtained by 
 TABLE l-continued. 

comparison 10 a stIJIdard III"Okiftase solution. I'IuIIIiIIopll Ac:tivaIioII by E. t.vIl EXlIKIS o( 

E.1.L. Decection of Tissue Plumiooaen Activacor At:- Cullures Containill. pUIPA 

tivity l'erceftl Calc1ll,ucd 

1. Bacterial Growth and Sample Preparation. , s.m,Ic A.IOS Actlvlt)'1 Plou.h Unitslml 
A colony or E. t:oil conWninJ the plasmid (p4JU- ::1ftIi=?=I'P;A~IIIII-=bad-::-ln--;':;"'-";';;;;';';;'---~:;;"';;""';;""';~ 
PA.) was inoculated into a rat tube CODtainiq 5 alL of 
,_lIC'IMIy ............ II, _-.. ,!Ie .....1< IO.om fNM '0 ..I.... ,010­
LB If'Owtb media CODtaIniq 20 p.JlmI ampiciUln. The 
................. 1If ...... _ .... - r""" , ....... ,.. •. 
cells were .roWD ovemi,ht at 3r c. An aliquot or this 
cuh~ was dihatcd I: 100 inlO 300 ral o( M9 media CCIIto PIG. 10 repments the resulb or a fibrin platc assay 
wnin, 20 p.Jlm! ampicUIia. The celli were powIllD a performed wll.h eltnlCb (rom 10 L fermcntation cui· 
shaker nuk at 31' C. for fOW' boan, with a raultlD, tures o(E. t:oil containin,a tlaue pluminolcn activ.tor 
nbsorbance at 550 nm 0(0.419. The tryptophan analo. . ap..... plumid. The ftbrinolytic ac:dvity or thc tis· 
indole acrylic IICid was lidded to a concentration or 30 1110 pl&lmino.en acllvetor containin. eltract is reprc:­
"simi. The c:clb were Incubated 90 aniDula., with a IS 1CIl1ed ill PIG. 10 by Wen A. Tbia fibrinolytic aClivity 
rcsultin. abIorb&Dce at 550 lUll 0(0.621. The celli wen Ii IDhlbkecl by IftlI t-PA laO (Well C) but not by preim· 
hMvcsted. by ceotrill.l,atioa ud ralllpeftded In o.a m! raVoU laO (Well B) or anll uroldnuc I,G (Wcll D) and 
of O.OIM Tria, pH 1.0, CODtIIInJna O.OIM EDTA. The DO ICdvity II Melt frora an atract prepared. rrom cells 
resultin,llIIpenaioD was.tIned rapidly at room temper- CODtaiDiD. u a control the leukocyte interfcron plasmid 
l'IIure for 18 hOW'L Thc sample was CCfttdfu,ed and the pulPAtrp103 (Well H). 
supernatant lSIayed ror tislue plumino,en activator E.1 ProdllCtion or tPA Usin, DHPR Protein with a 
!'Jctivity. Low Bindla, Amnity for MTX 
2. Activity Detection. E.1.A Vector Construction 
Table I shoWi the raulta of the a.ctivalion of plumin- The tequence encoc1ln. human tissue plasminogen 
ogen by E. t:oil alra.cta wbeD asaayed. An activity II 2' a.ctlvator (t-PA) II insened. into an clpression plasmid 
gcnerated. which II dependent on the presence of pJu. contain1n,a mutant DHPR with low binding affmity 
minolcn. Tbia ICtivity II not affected by pre-Immune for MTX. d.eacdbed In the now abandoned copending 
. ~erumohrabbitbutllmarkedlyinhibitcdbyutilerum appl.lcation U.s. Set. No. 459.151. filed. Jan. 19. 1983. 
which wu railed apinat puri1Ied melanoma cell de- c:om:apoadin, to European Paleftt Application Publ. 
rived twue pluminoaen ICtivalor (88,. Tbia demon- No. 111.0&) Incorporated. herein by reference::, by the 
Mrales tbal the E. coil extracts are prod.lICln,a plumin- followia. procedure (ace FIG. II): 
ogen activatia, a.ctivity which II inhibited. by antibodiea Three (rapenta from overlappinl I·PA plasmids, 
"SlUnst the tlaue plaam.ino.en acovacor. pPAl5EI0, and pPAI1. and pt.PATrp11 (supra) were 
FIG. 7 allows the rault or a fibrin plate lSIay for 3' prepared u follows: Plumid pPAI7 was di,csled with 
fibrinolytic: activity. A standard amollDt of urokiDaIe . Ode I, rdled In usin. Klenow DNA polymerase 1. and 
was added to the center row in concentratiolll, from left IUbelIt with Pst Ii the approximately 200 bp rragment 
to right. of 0.24, 0.14. 0.10. 0.05 and 0.01 PlouJh Unlta. contalniD' 5' terminal t.PA sequcnce thlll generaled 
The bonom row II aampla or natlH'll tl..ue plumi.sloo- wu IIolated. The KCOnd t.PA fra.ment was obtained 
8cn activator. witb the aame UDOIIDt ofeuyme lD eacb by d.I,atla, pt.PATrp12 with Pst [ and Nar I and iso· 
wcll. The wei.. contalft, (rom left 10 d,ht, tislue pJu. lilJA, the approximately 310 bp fra,menl. The third 
mino,CII activator. anti·plumlDo.en ICtivator pllll pre- t-PA frapent was obtained by di.atin, pPA23EIO 
immune aerum. and IiIaue pluminoaen ICtivelOr pllll with Nat I and B.I II and IIolatin, the approlimalcly 
tiMuc plumloo,eft ICtivalOr antibodies. Tlse weDa In 1645 bp fn.ment which contalna., in addition to much 
the lOp row each contaln I pJ ohhe recombinant tiIIuc "5 of the l-PA codln. repn. lOme 3' non-translated se· 
piasmioolen ICtivator E. t:oil atracta. The nnt well II quenca 
the extra.ct alone. the aecond well hal preimmune ICfUID Plamld pEl42 which expreues HBV surface antigen 
added. and the third well baa the tislue pluraino.eft (abo ,..fctted 10 u pHBa34a.E) hal been described by 
activalor antibodia added. It II obviolll that the preim- I.evIraIOa It al. patent application Ser. No. 326,980. filed 
mune ICrllm doea not affect natural or recombinant Dec. 3, 1911. now abandoned in ravor of continuing 
ti!!Sue p\aamlno.enlCtivalOt, and thai tiKve pJumlno. application Ser. No. 603.519. ftIed. Apr. 14. 1984. now 
Bcn a.c!ivator antibodialnhibit the activity O(lIItlH'llu U.S. Pat. No. 4,741,9011av.ed May 31. 1988, and corre­
well u the E. coil extract&. Baaed OIl the urolr.inue 1Ian- lpondln. to European Patent Application Publ. No. 
dnrds. the eJ.tracta contain Illahtly leal thM 1.5 Ploup 13,656, which II incorporated. herein by reference. 
unitt per mi. Tbia c:omparea favorably with the value 5J (Briefly. the oriJin or the Simian virul SV40 wu i$O­
obtained in Table I of 1.3 P10up unlta per mI. latcd by dl,atln, SV40 DNA with HindIlI, and con-
Table I ICU forth the multa or 1SIa)'l performed u wrtia. the Hlndlll ends to &oRl ends by the addition 
d~ribed above in E.I.K.I.b.: or a COIlverter (AOCTOAATTC). Thll DNA wu CUI 
TABLE I with Pwll. and Rlllnken lidded. Pollowlng digestion ---~PI~_-lfIO-""-A.c1-::-=I;';YaI-=:_~..,~£:-..tI~E:"s-II"IIC""'Il-fIIO:--- with EeoIU, the 341 bue-palt (rqmcnt spanning Ihc 
CY'IY'" Con"",,,, p4 R I PA 0.wu iIolated by polyacrylamide ,cl electrophore· 
I'm:ftl CaIc"'ltd iii and elect.".lution. and cloned in pB1l322. Expre •• 
SAmple A«I' Mti..IIJ' PkMIlh U,,'lsIInL alon plaamld pHBa348.E _ constructed by cloning 
E.rllel 101 the 1916 bue-pair (n,IDCnt rnultinl from EcoRI and 
(with itO "lumlllO....l 
., B,III dilation or HBV (,4111",,,/ VI,,", O'lI,t/cs. (Ch. 3)
fioUlC1 (1(1)) u0.." Acad. PteII, N.Y. (1910» (which .pana the icne encod·E'''ICI ply, 0.411 106 in, HBIAJ) Into the plamld pML (LUlky et al .• Natul't, 
E1"1C1 plua 0.01. 9 293: 79 (1911)at the Ecolll and BamHI.itea. (pML is II rrnmrnUM "rum 
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denvllive of pSR3ll which has a deletion ellmiaatin, 

sequences which are inhibitory to plasmid repUcation in 

monkey cells). The resultin, plasmid (PRI-B,I) was 

then linearized with Ec:oRI, lAd llIe 348 bile pair h.­
ment representinl the SV40 oriain ,.Jion was Intro­
duced into the Ec:oR.I site of pR.l.B,I. The oriain trl,' 

ment CIA in&en in ellher orienlatioa. Since tlUl rraament 

cncodes both the early lAd late SV40 promoten In 

l!ddition to the oriJin of ,.pllcation. HBV paea c:ould 

26 
pcnded in 1 ml (per UO mm plate) 10 mM Tris·HCI pH 
I, I mM EDTA (TE), RNase added to 0.1 ma/ml. and 
the solution incubated 30 minutes at 37" SDS is then 
added 10 0.1 pcrcelltlAd pronase (SI.ml) iSldded to O.j 
5 mJ/ml. After 3-16 houn 1nc:ubation at 37" the solution 
is qain phenol extracted, chloroform extracted. and 
ethuol precipitated. The DNA pellet Is I'ftuspended in 
0.5 1111 WIler aDd dileated with restriction enzymes. 
ApproxJmate1y S-IO 1" or dlaated DNA is electro­
be e~preued ".nder the eontrol or either proIDOter de- 10 phoreaed In 1Il.,&rOIe pi [I perc:eDt Ilarose in Tris ­
~ndln, on this orielltatioll (pHBS34I-E n:preICDdDl acetate bv.fI'er (40 mM TriI. I mM EDTA, made to pH 
HDs expreued under ClODtrol or the carly promoter). 1.2 with acetic Kid)]. Crouse, et ILl, J. BioL Chlm.. 2j7: 
pE.342.is modtned by panlllly dileatlna willi Ece RI, 7117 (1912». Af'tc:- bromphenol blue dye had mi,rlled 
filling In the cleaved aite uainl Klenow DNA ployme- f or the way down the &el, the ,el is removed Ind 
fa.5C I, and nptln, the plumld bIck toptber, 1lI1Il,.. 15 atalned willi cthJdlum bromide. After visullizing the 
:novina !he Ec:o RI lite Pm:edJn1 the SV40 orip In 
pEl.l. The reau1t1na p1umld, daifl1&ted pE341ARI, 11 
digC'Sted with Ec:o R.I, ruled In ur.In. Klenow DNA 
polymerase I, and aubeut with Bam HI. Arter electro­
phoresin, on acrylamide ,ei, the Ipproxlmately 3500 bp 20 
fragment is electroeluted, phenol-chloroform extracted, 
and ethanol prec:lpllaled u above. 
The thus prepared p.l42E 3500 b.p. vector. an~ lbove 
d<:scribed t-PA .fraamenu compOlln. Ipprol1m&tely 
2160 bp were Jipted lO.ether UIIn. ltandard tech· :.U 
niqllCS. A plumld c:ontaininltbe IlIr .. t~PA enc::odlna 
fragmenu In Ihe proper orientation wu 1JOI~ted, chat­
~cterized, and desipted pEJ.42.t-PA. 11ul plasmid 
W1I! di,ated with SIC II IDd treated with bliCterial 
alk~lne pbOlphataM (BRL). To provide lhe DHFIl 3D 
sequence (alon. with controllCQIICIICCI lor lu «aprea­
,ion) In approximately 1700 bp rnpent wu ,enerated 
by S&cll dl,estlon or pEHEIl. (PEHER II I plumld 
e~preuinl mUllAt DHB dacribed In U.S. Set. No. 
DNA with ultraviolet Uaht the DNA is trln.fened 
from the pi to nltrocellul~ nllen accordin. 10 the 
proced\lte or Soulhem (J. Mol. BloL 91: jOl. (1975)). 
The mten are then hybridized with I niclt trlnsllted 
probe made from the 1700bp Sacll frllment of 
pEHER (prepared and hybridized u described lbove). 
or rrom the Ipproximately 1970 bp Sll II frlgment of 
pETPER. 
E.3 Production oft-PA in Conjunction with Wild Type 
OHB Pr tain 
E.3.A. V::tor Con.&truction 
In a manner ana!o.oua to thlt used In the construe­
. 
tlon of pETPER, plasmid PETPFR w~ eon.llructed 
containln. the DNA lequence enco~:hnl. Wild type 
OHFIl. The cONtruc:tion was as dac~bed In Example 
E.1.A. eleept thaI In plliCC or plumld pEHER IS • 
IOUn:e tor the DHB protein .ene.lCQuence, the P~IS-
mid pE342.HBV.E400.D22 descnbed In copendmg 
459.ljl (.&IIP'I). TbiI fraament wu Ilpted Into the J' U.S. Ser. No. 459,152, filed Ian. 19, 1913. now U.S. Pit. 
pE342-t PA plumid 10 create pETPAER400, • plumid No. 4,713,339 illued Dec: U, 19.7. conapond~ng to 
whicb i.a anaIa,OIll to pEHER elCCpt that the HBaA, European Pltent Application Publ. No. I I 7.0j 8, lDcor· 
codln, reaion baa been replac:cd by the cDNA lequen- ponied herein by refe,.nce, wu aubsdtutc:d. The pll.· 
CC3 from t-PA. mid pB341.HBV.E400.D21 ill the ame u pEHER ex-
E.2.S Elpreillon IDd Amplification 01 the t.PA Se- 40 eepl for a .&Inale base pal: difference between wild type 
qucnee IDd mallAt DRPR.. Thill the raultlni plasmid 
pETPAER400 (pETPER) wu tranII'ected Into both pBTPFIl II ana!o,oua in every way to pETPER except 
dhfr- CHo..DUX BII cella and DHPR.+ CHo..KI that the DNA lequence encodin. for wild type DHFR 
(ATCC CCL61) cella by the method or Oraham and II lubltltuled ror lhat of Ihe mUllAt. 
VAn der Eb (IUPI1l). Tranaformed dhrr- celli were.' .A ample of.plumld pETPPR. has bce~ depolited 
~d<:eled by irowlh in ,lyelne, hypounlhine and thymi- WIth the Am~n Type Culture Collecllon and ac· 
dine deficient medium. Tr&I1Iformed DHFIl+ celli corded &ccClllon number 40403. 
wcre telected by ,rowth In • 100 nM MTX. Colonies £.3.B ExprcMion or t-PA lequence 
which IrOle on tlte Ippropn.te selection medium were pETPPR wu ur.ed 10 tr~lfect DHF~ defidenl 
isol3tc:d u.inl elonin, rinp and propqated In the ame 50 CHO eell. (lJrlaub and Chuln (Iuprl» u.lnl the cal­
medium to several .encrallon,a. 
For amplification celli from the colonies are Ipllt Into 
medii contain!n,'x 1()4. lOS, 2.'X IOS,'X lOS, ~lId IO' 
II M MTX and .,.....ed severiLI tima. Cell, are plaCed II 
vcry low (1()l-10l cella/pllte) cell denllties in 10 em 
dishes and tbe resullin, colonies are iIolated. 
E.2' C. AKay Methoda 
Eltpreuion of t.PA In the tranlfected amplified colo­
nio mly cpnvC'llicntly be UIIyed by the methods aim!­
1M 10 thOle sel ronh in E.1. K.I.b (.uprl). 
COilmplillcalion of DHFIl and I-PA IeqUC1lCCl Is 
a531\yed by iJolalin, DNA (rom connuenl lIIOftollyen 
of :'Impliraed colonies u rollows: Connuent monollyen 
in 1'0 mm pilles Ire wuhed wilh 50 millerile PBS and 
1Y' cd by the addition or, ml of0.1 percent SDS, 0.4M 
ColC!:, O.IM EDTA. pH I. Arter '-10 minules, the 
mixture II ,.moved. phenol eltracted. chlorororm el-
Ir:lclcd. Ind ethanol preclpil.lted. The DNA Is resus­
" 
clum pholphale precipitation method or Orlblm Ind 
VIIl der Eb. Twenty-one colonia whicb arose ~n the 
selectivlI medium (-HOT) were UIIyed by detection of 
plumln fonnatlon u UICIIed by the dilation of fibrin 
In III Ipr plate c:ontainln. fibrin and pluminoien, dc-
ICribed by OraneUl.Plpemo, et ai, J. ~p. MId.. 148: 223 
(1971). 
Four or the IIIOIt Itron,ly positive clones were then 
UIIyed qUlAtll.ltlvely ror plasmin formllion on I per 
60 cell bulll.ccordin. 10 lhe method set fonh in E. UU .b. 
" 
Upon luch qUIAtitative determination it was found 
that the rour clonea tested uhlblled the lime or comp.· 
flble I-PA _redon Into tbe medium. determined IS 
unlu/cclVday. Subc:lones were prepared by trlnsfer· 
rin,lnocula (rom two of the clones into separlte plates 
contalnin, -HOT medium. Two or the resulting sub­
clona. liB lAd I were ur.ed for runher Inllysis. 
E.3.C. Amplificltion lAd I-PA Production Levels 
2. 2. 0 
• 
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The above subc:lOD.eS were plated at 2x I()$ cells per hereby mcorponted by reference. Such compositions 
100 mm plates ia 30 nM MTX to promote amplification. will contaiD an effecdve amount of the protein hereof 
Those cells which survived, when assayed as described to.ether with a suitable amount of vehicle in order to 
above, .ave, ill aU cues, about 10 times the WW1Iplified prepare plwmaceudcally acceptable compositions suit-
amount of tissue plasmino,en.activatOf activity. Two of S able for effective IIdmiAistratioo to the host. 
these clones were chosen for funher study and were For eumple. the human tissue plumino,en activator 
named 1-15 and 1&8-9. hereof' ma)' be pItCIlterall)' administered to subjects 
Subclooe .1-15 was funher lID~iftecI by Media, suft'erina from canliovuculat diseases or conditions. 
2 X 1()$ cells m 100 mm plates .con~ 500 aM MTX. Douae and de. late may parallel that cllrrently in use 
Assay of the cells thus ~fIccI YlClded a fUrther la- 10 illc:IinbI iIlvestiptionaofother cardiovascular, throm. 
crease (or ~t 3 fold) 1ft ~-PA prodllCdon; what Do bolydc qeD'" e.,.. about 440 [U/ka. body wei,ht as an 
sayed quanutadveJy bl the method of C.I-c.. levela iDtraVCftOUl primiD, dOrIC rollowed bya continuous 
were in the J'1:ftP of1x 10-4UDiralce1llday. A pordoD IatraVCftOUl iaI\aaion at abollt 440 lU/kalhr for 12 
of tbete amplilled cells wa dIetl tranarerrecl anJ maiD- .' • • 
tained in the pnscnce or fo,OOO nM MTX. Subclona or boI&n. III palienll suft'efUl, rrom p.ulmonary embolism. 
1-15, and 118-9 were f\u1her tested aft.ct bela, main- IS As OM eumple or an appropnat~ desale f'o:m ror 
taincd for approalmatcJy 1-2 moaths at the COIIdidonl CllCfttiaU), IIomopllCOus human. ClSIue pl~mlnog~n 
lpec:ilied in Table 3 activator III pereIlteraJ form applicable herem. a VIal 
• contaiain,l5OOO W tissue plasmino,en activator activo 
TABLE 3 kyo 25 m,. manaitol and 45 m,. NaCI. may be reconsti· 
Cell U... O~ CCNMIil10u IIII.PAlctlVday· 20 lUted with 5 mL lterile water ror bijection and milled 
I.Ul!.ll :100 11M MTX 2U X 10·) with a lultable volume o( 0.9 percent Sodium Chloride 
I· Ul!.ll :100 11M MTX 16.0 X 10·J bVection or 5 percent Dextrose Injection for intrave· 
1.15,.., (-HOT IMdlum. flO MTX) U x 10-) nous admiDistration. 
I,U:Ql (-HOTlMdiIlllloIlOMTXI 11.0 x 10. 1 
l·U,o.tm 10 I'M MT)( 29.l x 10.,.J 2' O. Detailed Description of Recombinant Human 
1.Il'MlQ 10 I'M MTX ',.0 x 10-J t-PA ::~: :::~ :~! : :~:! The Itructure of the particular embodiment or human 
119-9 (-HOT IMdI-. 110 MTX) 14.1 x 10·J t-PA prepared In the examples herein has been studied I.... (-HOT 1IIItd1...... 110 MTX) 1404 )( 10·J Ia lOme detail, both by elucidation or the ,ene coding 
1 (-HOT IMCII-.IIO WTX) \.0 x 10-; )0 aequence lAd by protein biochemistry techniques. The 
I (-HOT IIItdIIllll, 110 MTX) 0.' x \0- CWTent undentandln, of the protein structure is iIIus­
·I~'A la IN NUN"..........,.. ............, ..........unu .,. ._......... J_ FlO 12

,.,,-., ","1IooI'.'A"" po... iod__ '.'A _ ........_ ....... &II 

cdJo..."'... d__' .. __........11J1.a"lll.....-. It has alIo previously been demonstrated by Collcn 

_.II.................___ 
•• 
is
I'HUQ.'....-......_.-...UI and coworbra (II) that two chain human t·PA 
poron. T_ III. .... Q.QJ _ NoHJ. A"....,..- .......... _ • • . 

....!'In .. be _,... ............... _;..I,~_ ........n. 15 formed by proteolytic cleavale or the Imlle cham mol· 

...._ ...... .tIbaooooIIO __..... _ ................. ,......... ecule lato two polypeptides connected by disullidc: 

• I;lo.tm dUo'_ ... II.. 1,0 froo'_ .... _ ........'A ....we- A._,. • 

•n..... .-pIio.... _...- ~ ...,.... 10 ..... __ 1,0 ___ boadill,. The present work permillthe conclUSIon that 
.....nIIllo....trOfIWO ......... ___.n.__........ ~I... the heavy chain (lOIB2 mol. wt.) is derived rrom the 
~::==!:':"'..:..--:.":"'=:;:::....:.!: NH1 terminal pe.rt and the li,ht chain (lBI16.mol. WI.) 
_ ....... c_..._ ..... _ ..... ~___ 'M ,.,.,..,. - 40 CQmprila the COOH·terminal re,ion. N-terminal se:­
~.nI. qucnc:in, of the two chain molecule SUliests that the 
The c:ellllnes an u rollowa: Ccllllne "." is an 1UWft- two chain rorm ia ,enerated by cleava,e of a singk 
pillied clone from the orilinallet of'rour. "I.UXlO" ia u ariinyl-lioleucine bond (FlO. 12: arrow depicted).The primary ,tructure of a portion of the heavy chain 
amplined lubc:lone ofc:eUline "I" whIch wu amplined reAlon of human f-PA (FlO. 12) reveals a hi"h degree 
initially in SO nM MTX to live 1-15 and then U'anI- 4' .' •(erred (or further ampMc:atlon lato ~M MTX or aequence homolo,y with the "krinlle" regions of 
1.1'10.000 ia lubc:lone of H5XlO whk:h hal beea further plumlDO,en (19) and prOt~romb~n (~, 41). "K.ringlc" 
amplified the pracnce of 10.000 aM MTX. Cell 11M reaion refen to a chanctenatlc tnple dIsulfide .tructure 
I8B.9 ia I lubc:lone or one ohlle orilinal rO\lf detected oriJinally dllcovercd in the "pron·rralment of pro-
which had been ampUfIed on 30 nM MTX. SO thrombin, nnt dClCribed In detail by Maanuuon et al. 
A urnple ofCHO c:eI1I1M 1-15:100hal beea depolited (91.91l: From,!he ~rimary aequ~e of ~.PA, two 50­
with the American Type CWture ColJecdoa and ac- called kriDaJe reJlOnl, or 12 imino acIds each. thllt 
corded acccuioa number eRL 9606. share a hi,h dear- or bomoloJ)' with the 5 "kringle" 
All or the amplified celli show increued levels or reJlonl of plumiao,en an apparenL The remainins 
I.FA production over thatelhlbtted by the unampllned ~" N-termlnal 91 amino lCida ,hare little homololY to the 
cell culture. Even the WW1Iplifled culture produces conventional "krlll,le" relion. One cln speculate how­
amounll or t·PA ,rcater than 0.' pa/c:eIVday; ampllfl- ever that thia reaten may allO Ulume a structure con· 
cation resulll in Ievell approchin, 30 pJ/ccIVday. tainina multiple diaulftde bonda u 11 additlonll cysteine: 
F. Phannac:eutic.al Compolitions ralduea an round here. 
The compounds of the pretentlaventlon C&II be ror- 60 The catalytic aite of the Il,ht chain or human t·PA, 
mulated accordln, to k.nown methoda to prepue phar- the ao-called serine proteue re,lon. u in other serine 
maeeutlcally _ful compolitiolU, whereby the human enzymes, ia moat 1Iltely formed by the histidinem. as· 
tillue plumino,en activator product hereof II com· partlcm and 1letla14.,. residues. Furthermore. the amino 
bined In admixture wlih a pharmaceutically acceptable acid teq\lenCCl 'Ul'Toundin, these residues are very 
carrier vehicle. Suitable vehlcl. and their rormulatlon, " bomoloJOUI to corrapolldln, parts of other acrlne pro­
inclUllve of other hllman proteiDl. It.,. human ..rum &I.... luch u trypIln. prothrombin and plasminogen. 
:llbumln. are described for eumple In llemln,ton', Notwlthltandln, that reference baa been made to 
PhOfm{lClutlctll &IInClI by E. W. Manln, which II pll1i1:u1ar prererrld embodlmen.II,1t will be understood 
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lhal the present invention Is DOt to be consU'\led IS Hm­
iced to slIch. rather to the lawfw IC:Ope of tbe appended 
claims. 
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I. A DNA !Iolate conlislln, _ntially of a DNA 
lCquence encodln, human lillue pillminolcn aClivalor. 
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1. The DNA isolae or claim 1 wherein Slid buman 6. AA Ii. coil mic:roorpnism accordinl to claim 5. 
tissue piasminoaen ldivator bas the amino ICicI Ie- 7. The mic:rootpDism orclaim 5 wherein said human 
quencc I.S:n set rorth in FIGS. Sa. 5b and 5c. tiuue pJuminoaea activator has the amino acid se· 
3. 	 A recombinant ....pmIioa vector containiDl a qwmce 1·'27 lit rorth in FIGS. k 5b and 5C". 
DNA 	lICQueuc::. ellCOdin, hUllWl tissue plasminoaen' .. A. ceU culture capable or expra.siq human tissue 
. r _~ plumino,eIl aetivator. obtained by transforming a 
:lctlvator. wherein ~ vector ~ c:apable 0 ell..,._ft, mamlNliaa cell line with a vector accordina to claim 3. 
h~ tIss~ pluminoaen lCuvaIOr in • transformed f. A. ceU culture accordin. to claim. wherein the cell 
mlcroorpnlSltl or.cell cultW'C. • . line Is a Chinele Hamster Ovary cell line. 
4. The recombinant uprauoa vector or claim 3 10 10. The ceU culture or claim • wherein said human 
wherein Slid hWI"IUI tiuue plumiaopn acdvator baa tissue p1uanir1opm acdvaor has the amino acid se· 
the amino acid 'lIqueDce I·S27 act t'onh In FlGS. k 5b qllCl'lCe 1.'27 let ranh in FIGS. k 5b IIId 5C". 
~nd 5c. 11. The cell cultun or claim , wherein said human 
5. It. microor.1IIiam uanatonaed with the vector or t1uue plumiaopn acdvator hal the amino acid Je­
cJllim 3. Slid microorprdam beIn. capable or....praalna IS queac:e 1.'21 or FlOS. k 5b and 5c. 
human duue plumlnopn activalOl'. • • • • • 
2' 
30 
3' 

45 
65 
.. 
2..2..3 

----------------------------
c 
........ --~ 

BIOFLO@ 5000 
Mobile Pilot Plant Fermentor 
• For Process 
Development 
and Small-Scale 
Production 
• 40, 80 or 120 l 
Capacities 
• Automatic 
In-Place 
Sterilization 
• Space Efficient 
• Equipped with 
Resterilizable 
Valves for 
Addition, Sample 
and Harvest 
• Thermal Mass 
Flow Meter or 
Controller 
r{n\ii NEW BRUNSWICK SCIENTIFIC 
~) Where Quality and Innovation Have Bewme Tradition 
BIOFLO® 5000 PILOT PLANT FEI 

New Brunswick Scientific offers the most compact and complete pilot plant fermentor in the industry. Designed for culturing both aerobic and anaero~ic 
organisms, the versatile BioFlo 5000 fermentor is capable of 
process development and small-scale production of 
bacterial, insect, yeast, plant, fungal and algal cells. This 
sterilizable-in-place system is available in 40, 80 and 120 
liter (total volume) capacities, yet occupies just 7.3 square 
feet (0.70 m2) of floor space. It comes equipped with all 
accessories needed for out*of-the-box start up, as well 
as for convenient and contamination-free operation. 
Automated data logging, process control and optimization 
are made possible with an optional software package. 
With its outstanding array of standard features, this proven 
system provides an exceptional value. 
UNIQUE ADVANTAGES 
• Guaranteed high oxygen transfer rates (OTR) of 350 mM 
0!UHr or higher enable high-density microbial culture*. 
Up to 1,500 mM O/L/Hr attainable via O 2 supplementa­
tion utilizing an optional NBS 2-gas mixer 
• Capable of rapid temperature shifts in growth phase, to allow 
for heat induction (1 °C/minute in range of 23°C to 45°C*) 
• Capable of remote control, data logging and process 
programming using optional AFS-BioCommand® software 
• Smallest footprint of any pilot plant fermentor 
• Most complete, fully accessorized, pilot plant fermentor 
• Set-up and start-up assistance provided, with optional 
validation and training packages available. Process develop­
ment and scale-up assistance can also be provided 
• Most comprehensive warranty in the industry. One year 
on parts and labor 
• 	Only NBS has an in-house ASME-accredited vessel shop, 
microbiology and cell culture labs, software and instru­
mentation development group, and integrated cGMP 
bioprocess area to provide added customer support 
• Optional on 120 L systems 
TWO-POSITION 
ADDITION VALVE 
SHOWN CLOSED 
d~l.o 
W;;..:!i·;~;:~1;if:k~W·~~~~'~~frrif~c,£j:I.q.'[(.~ ~."~-t'jj i~ttil. '-'.,'
.:<t .. :',\;."i',-,~. ,~;l",7:' ''', •., ~A.L -..-I'.\-~~ t-_~A',.t':~~.J';rfr~~; J~"~ot.4).'",,~t,:,d(~" '. '. -~' """'.,,' ., 
~ II 	Easy-To-Read, 8" (20.3 cm) Vacuum Fluorescent Display 

is clearly visible under all light conditions. Simultaneously 

displays current value, setpoint and control mode for 

(4) parameters 
er Membrane Keypad facilitates activation of setpoint 
entry, calibration and sterilization cycles. vVatertight 
and easily cleanable 
Swing-Away Headplate provides easy access to vessel interior1m 
EI Resterilizable Addition/Inoculation, Harvest and 
Sampling Valves for aseptic operation are readily 
removable and cleanable. Straight-through flow path 
attains complete sterilization of the valve and transfer 
lines. (See diagram.) All valves utilize quick connect 
fittings. Sample valve provides variable flow 
Large Window allows viewing the culture above andII 
below maximum working level 
Sterilizable-In-Place vessel, ASME coded, available inII 
40, 80 and 120 L capacities. Type 316L jacketed 
stainless steel provides rapid sterilization and precise 
temperature; Internal finish of 15 - 20 Ra facilitates 
cleaning and prevents residue build-up 
DO, pH, Foam, Level, Temperature RTD SensorsII 
Choice of Ingold or Broadley-James pH and DO 
Probes. In-Line Amplifiers for pH and DO sensors, 
compatible with polarographic and galvaniC DO probes. 
(pH probe and pressurizable housing shown) 
[I 	Mobile System with Lockable Casters facilitates prepara­

tion/ clean-up, maintenance and servicing 

Addition Bottles and Support Stand for acid, baseII: 
and antifoam provided for added convenience 
Three Peristaltic Pumps provided for acid, base andlm 
antiioam addition 
Two Switched Outlets for optional remote pumps toIII 
control nutrient and level 
In-line Sterilizable Air and Exhaust Filters designed forII 
100% removal of viable organisms 
Lamp illuminates vessei contentsIII 
Resterilizable Valve is coupled to a welded 
fitting (Al by a retaining ring (B). A steam 
inlet line (C) delivers pressurized steam to 
the interior and exterior of the valve before 
and after each use. Liquid is transferred via 
quick-connect fitting (0) maintained sterile 
by steam cap (E). Outlet steam IF) is fed to a 
condensate trap (not shown). This design 
eliminates "blind" pockets and crevices to 
ensure sterile operation. The two-position 
Addition Valve (shown closed) is spring­
loaded so that Entrance Port (G) opens a 
steam 	 path through the hollow tube (as ./ 
shown). When in the forward position, the 
tube is extended into the vessel for addition 
of sterile liquid. An optional Quick Connect 
(inset) can be readily coupled to the valve 
for sterile and adjustable flow of additives. 
MENTOR 

D Extra-Large Powder/Fill Port with septum 
:m Exhaust line with heat exchanger and view 
glass. Heaters keep moisture-laden gases above 

the dew-point and prevent condensation and 

clogging of the exhaust filter 

Features 16 - 28 are not visible in the photo 
Choice of Thermal Mass Flow Controller or11 
Thermal Mass Flow Meter 

Automatic In-Place Steam Sterilization of vessel, 
 I]D 
process piping, valves and filters 12l1 	Safety override permits manual operation of the 
pneumatic control valves in the sterilization!cool­
ing system to protect pe~sonnel and culture 
jj 	Automatic Cool Down from sterilization tempera­ 11 
ture to growth temperature 

Steam Traps, multiple traps guarantee the steriliza­ill 
tion temperature is maintained in all process lines 10 
n Powerful Bottom-Drive Motor, 1.5 hPJ allows 
easy access to headplate ports and vessel interior r ...... 
Double Mechanical Agitator Seal, carbon-to­ l~~ 
tungsten carbide, mounted in a pressurized 

steam/steam-condensate environment maintains 

constant pressure and protects contents of both the 

vessel and the environment from contamination 

Rupture Disk Safety Device, side mounted, ofD 
316L steel. prevents over-pressurization of 

vessel; includes discharge tube to convey liquid to 

bottom of reactor 

I) 	Three Additional Ports, 19 & 25 mm Ingold-type, 
allow for insertion of extra sensors 
High-Level Foam Control for the exhaust line shuts offH 
air and reduces agitation while signaling alarm 

Rear Connection for All Utilities. Open frame
1i 
piping facilitates cleaning, maintenance and servicing 
l] Pre-Filter Regulator Kits for air, water and steam 
fo~ removal of particulates or impurities 
Serial Port for data logging and computer controlB 
il:l 
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HEADPlATE PENETRATIONS 
• 	 Foam Probe Port * 
• 	 Level Probe Port * 
• 	 Diaphragm-Type Pressure Gauge 
• 	 High Foam-Sensing Probe * in Exhaust Gas Line 
or in Optional Exhaust Gas Condenser 
• 	 Combination Filling and Inoculation Port 
BOTTOM PENETRATIONS 
• 	 Bottom Agitator Double Mechanical Seal Housing 
• 	 Resterilizable Bottom Drain Valve with Quick Connect 
SIDE WAll PENETRATIONS 
• 	 Ring Sparger and Gas Overlay 
• 	 Three Septum Addition Ports 
• 	 Resterilizable Addition/Inoculation Port with Quick Connect 
• 	 Rupture Disc 
• 	 Five Ingold-Type Probe Ports for pH*, DO*and other sensors 
• 	 Resterilizable Sample Port with Quick Connect 
• 	 Jacket Pressure-Relief Valve 
* Sensors supplied 
15 
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Total Capacity 40 Liters 80 Liters 120 Liters 
Working Volume 1 0 - 30 Liters 20 - 60 Liters 25 ­ 1 00 Liters 
Aspect Ratio (H:D) 2:1 2:1 3:1 
Geometry Cylindrical with dished bottom 
VESSEL 
Pressure Rating Vessel is ASME-coded, rated for 40 psig (2.8 kg/cm2) Jacket rated for 50 psig (3.5 kglcm2) /149' C 
• Viewing Window Rectangular, sidewall mounted above and below the maximum working level. 
! 40 L: 8.5" x 1.25" (21.6 x 3.2 cm); 80 & 120 L: 11.25" x 2.5" (29.2 x 6.4 cm) 
Baffles (4) 316 L stainless steel removable baffles 
Dlm&nslons Inches 11.625" 10 x 23.25" H 15.625" 10 x 28.625" H 
'cm 29.53 x 59.06 cm 39.69 x 72.72 cm 
MATERIALS Vessel 316 L stainless steel, orbitally welded and electropolished 
& FINISH Process Piping All piping fabricated of 316 L stainless steel including valves and fittings 
Gaskets/O-Rlngs Gaskets of Silicone; O-Rings of EPDM 
IMPELLERS 
Diameter 4.87" (12.38 cm) 6.44" (16.35 cm) 
Type (2) Six-bladed 316 L stainless steel, Rushton blade, standard 
Marine blade and pitched blade optional 
Headplate (1) Powder/Liquid Fill Port with Septum; (1) Pressure Gauge; (1) Exhaust/High 
Foam; (1) Level; (1) Foam 
Upper Side Wall (3) 19 mm septum ports; (1) 25 mm port and resterilizable valve; 
PENETRATIONS (1 j 19 mm spare port, plugged 
Lower Side Wan (1) 19 mm port and resterilizable septum valve; 25 mm ports, plugged: (4) in 40 L vessels and (5) in 80 & 120 L vessels 
. Bottom Bottom drive; Steam-sterilizable ball drain valve 
Drive 1.5 HP, AC motor, bottom-entry drive 
Sensor Magnetic speed pick-up sensor 
AGITATION Range 80 - 800 rpm ± 2 rpm 55 - 550 rpm ± 2 rpm 
Control Plo regulation of speed VIa microprocessor feedback circuit 
Bearing Housing Double mechanical seal 
Sensor Platinum ATD in thermowell 
Control Microprocessor-based via Plo control of tempered water, employing a pulse-width 
TEMPERATURE modulation of steam and coolino control vaive 
Range 5°C above coolant supply temperature to 85'C, ± 0.2·C. (See also sterilization, below) 
Shift 1 ·C/minute in growth phase in a range from 23· C to 45·C(l) 
Inlet Filter Sterilizable-in-place absolute 0.2 IJ filter with 316 L stainless steel housing 
AIRFLOW Outlet Filter Depth filter Control 
Range 
PRESSURE 
STERILIZATION 
I 
COMMUNICATIONS PORT 
WEIGHT Net Gross 
DIMENSIONS, Inches 
OVERALL cm 
Choice of Thermal Mass Controller or Thermal Mass Flow Meter 
0- 60 SLPM 0-90 SLPM 
Manual back oressure control standard. Automatic back pressure control optional 
Automatic sterilization and cool down 
Selectable temperature from 105°C - 130·C with duration of 1 ·120 minutes 
RS 422 BioCommand port for automatic data logging and control 
630 Ibs. (286 Kg) 670 Ibs. (304 Kg) 880 Ibs. (400 Kg) 
680 Ibs. (309 Kg) I 700 Ibs. (318 Kg) 920 Ibs. (418 Kg) 
34" Wide x 32" Deep x 70" High 
86A Wide x 81.3 Deeo x 178 Hiah 
Recorder Output 0- 1 V AC lor logging pH, DO, temperature and agitation on optional recorder 
ELECTRICAL Connections 
Receptacle for optional nutrient pump, 120 V AC (2 Amps) or 220/230 V AC (1 Amp) 
Receptacle for optional harvest pump, 120 V AC (2 Amps) or 2201230 V AC (1 Amp) 
Power 200 V / 208 V 50/60 Hz or 230 V 60 Hz AC, 1 Phase, 20 Amps Meets UL CSA VDE and British Standards 
UTIUTIES Requires appropriate utilities for steam, air, water, exhaust, water return and drain 
-
• Specifications subject to change without notice. Q) In the 120 L system, this is an optional feature. 
OPTIONAL 
ACCESSORIES 
( 
• Gas Overlay 
• Exhaust Condenser, 
water-cooled installed in 
headplate to minimize 
evaporation of culture 
medium 
• Resterilizable Ouick 
Connect for inoculation! 
addition, sampling and 
harvest valves 
• Adaptable to Recirculation 
of Tempered Water with 
optional chiller to con­
serve water 
• Aerosol Containment 
System to prevent aerosol 
formation when sampling 
• Steam Generator for 
utility and clean steam 
• 2-Gas Controller for 
oxygen supplementation 
and gas mixing ( 
• Low-Shear Impellers, 
marine blade or pitched 
blade for insect cell culture 
• Auxiliary Pump, aSSignable 
peristaltic pump 
• Validation Documentation, 
10 & 00 packages 
• cGMP ValidatIon, 
hardware upgrades 
• Chart Recorder, 4 channel 
for data logging 
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" The entire process is regulated 
by the Ml-6100 controller. 
This controller is capable of 
operating up to sixteen 
process loops. Setpoints are 
easily specified along with 
high and low-limit alarms that 
warn of any deviation. 
Intuitive Control 
The menu-driven system is 
designed for simplified control 
using on-screen programming 
of Loop Configuration, Pump 
and Sensor Calibration, 
Display Configuration, x-Y 
Trend Graphs, Cascade 
Control, Sterilization, and 
Alarms. Change setpoints by 
touching the appropriate 
gauge to bring up a numerical 
display for that parameter. 
Then, simply key in the new 
setpoint. 
The touch-screen controller 
ML-6100 
TEMP 
~~..­ ..~.-----l 
I lOC!.O I 36.9 
I DegC
iip..j.l) 
I Soft 32.0 o.n Oft: JO.O 
pH 
, ...0 ! 7.111 
1 :'7~ 0.0 Oft: 56.J 
, ADVANCED FEATURES OF 
THE TOUCH-SCREEN 
CONTROLLER 
Add ancillary equip- , 
ment, from simple 
pumps to complex ana· 
Iyzers, right on screen 
without factory instal. 
lation or added cost 
, • Control and display up 
to 16 parameters on a 
large' color VGA display 
• Graphic user-interface 
repfaces alpha-numeric. 
based controllers 
• Select high and low 
process hmits and 
alarms 
From the main scrSB(1 'can easily aCcess programs for 
sterilization, cascadecon.trol, lo()pconfiguration:calibration,. trend 
graphs, and alarms:.:~ ", ',' . ' , ,:',: 
has the built-in intelligence to·" 
fnu~~~e~~:~:~ NBS TOUCH-SCR1E~f.'~b'NTROl(ER'" "~:~~~r;1f 
. operator 	 . ' " ,'" ., ' , control 0.0:: 
'-- ' :;~u~ht~:ery WORKS SMART~~;::~t~;I.l."~ IM~~~R" ,'., '}~~~~~i~~ion, 
~~~~S~dding THAN ANY OJH~~~,;:~ ,.' ~~8,~~~:~,,;:,~;-I,,~;;1 ~L~~~~~~~~i:'; 
such instrumentation as glu­
cose, optica' density or C02 
analyzers, the loop Config­
uration Screen will help link 
each facet of the control loop. 
The controller can be adapted 
to the signaI requirements of 
all instrumentation right at the 
touch-screen. just choose the 
appropriate loop from a menu 
of options and set the input, 
the control algorithm and the 
output. The display screen 
shows you exactly where each 
connection is made, obviating 
the need for a service repre­
sentative to install an optional 
circuit board. 
There is no longer a need to 
order special factory-installed 
control loops at extra cost 
Now, you can immediately 
create and name your own 
specialized loops electronical­
ly from a menu of options. 
The controller accommodates L. a wide range of input/output 
signals from different sensors 
and actuators, and may be 
connected without requiring 
additional interfa i , T~o~-' ':,;ren'~:"d:~'G'"ra"nh',' 'D','splay 
ics. These ·inclUd~J~~Tris,,"Jte'm~· "',J r peraturesensors};ro~rri andi3y"gr~~hslare,dispiayed 
level (conductance) probesi through the TrEmd Graph " " 
tachometers, p~andP70. . .,:rT.!.~nlJ,~which are programmed 
transmitters; as~w~ll'aspumps ;'.: • Jo,plot data against time: Up, 
and other devices thah.isei~ , 
voltage or current-outputs. 
(See loop Configwation 
Screen tl5)'$ 
Cascade Control," ' 
Create cascadesfg;'uptQ fi~~ 
parameters from a,;single;;:' 
to fou(graph~ maybe dis~:'l; . 
,playedsimul!arieously ,in .real,". 
' ~ime,whichcan help to deter~,' 
" mine the influence orone vari­
able uroriaflother: With this 
information 'available right at , 
'" ,Jbelermeritor, the data may~~ 
,,:, used tp make rapid process:" 
screen. Control any parameter " ",'Cidju,stmEmtS during the~.:·-{"" 
using serial, parallell"or'over-", .':',fefftl,:nt~tion. ' " 
. ,I. ";;"~"'<':: ; 
SPECIFICATIONS, TOUCH-SCREEN CONTROLLER 
I 
Controller interiace available in various console 
configurations: 1) In a floor-mounted water-tight 
Console mobile console; 2) As a benchtop console; or 
Types 3) As a Hat-screen monitor mounted directly on 
the piping console. 
Signal conditioning included for DO, pH, RTD, Signal Tachometer, and conductance probes, Controller 
Inputs accepts 4 - 20 mA, 0 - 5 and 0 -10 VDC, 

conductance, resistance, 0 - 30 kHz, fiber optic signals. 

Supports 0 • 5 V, 0 - 10 V (analog and digital), 4 - 20 rnA. 
Signal Available modes include PID, ON"()FF, PWM, Dead 
Outputs Band, Gas Mix, mutti-channel outputs, and cascades. 
Alarm output. 
' 
" 
, 
.. 	Simplified, menu-driven 
calibration of D.O., pH 
and other parameters 
• Automatic sterilization 
. screen enhances scale­
, up by duplicating 
tfiermal conditions of 
industrial reactors 
• Valve se~uences and 
, . sterilization time easily 
programmed directly
from the touch screen 
• 	All control operations
easily performed from 
the main screen for 
simplified control 
• 	 Multiple controller 
configurations can be 
easily recalled to 
accommodate different 
processes 
• 	 Password feature ensures 
process security 
• 	 Battery back-up prevents
loss of setpoints In event 
of power failure 
• 	Serial port for data 

lo~ing and control 

usmg optional AFS 

BioCommand® ­
software package. 
)5 CONTROL RIGHT·AT YOUR FINGERTIPS 

- ,..,. .. - ~ ,.::,. ~:.-<!" >~'. ,.::.• '-";, 
hI!.fM§t.J§¥ 
[i i 
I I ITEMP i i AGIT i 1 AIRFLOW 
100.0 I 36.9 I! 500 i 300 l 200.0 1 80 
I Deg C ! I I RPM' SLPM 
II NO ~ i l '1 P-I-D f· I' Manual """" 32.0 i, 50 Sed'1: 30.0 r Soft 6.00 0.0 Out%, 30.0 LI Clut'lOc no I 10 Clut'lOc 5.' 
U I 
";='1========'1 .f~1====== 
pH I I D.O. I ~ 
8.0 I 7.01 I 100.0 20.0 I 100.0 I 0.0 
I np:.~o!1 P:~! I ~ ~I::::.;: f ~.. ::::.::" II J::::.:: 
l 
FOAM 
PRES 
5o.oJ 10.0PSIG 
P·I-D 
Soft 203 
QuB.. 2040.0 
NUTR 
100.0 I 60.0 
I Manual SetPt S.O 0.0 (')un!.: 61.5 
2 
,; - '": ;,~~ I"':;;"~" ,,:­ '" I 4 
-a3b 
:Pracess Status Screen: Uses bar graph gauges to display up 
to:16 process loops'on 2 screens, presenting an on-line 
pano'?lTlaot the process. 
The StertIiZatlo., Menu: To enhance scale-up capability you 
. can program a laboratory or pilot fermentor to perform the 
same as an-industrial fermentor. This menu permits the selec­
-1ion'of heat-up, sterilization and jacket drain time, as well as 
. valve operating sequences, etc. to duplicate the thermal condi­
-tions of larger fermentors. 
Alarm Shutdown Selection Menu: With this menu a selection 
of pamrrleters can be programmed to shut down in the event an 
. alarmcondition is reached, and continued operation would have 
"anaav8rSe effect on the process. 
,-",. _. 'J' ,0"_'" < 
Trend Graphs: Up to four on-line graphs may be displayed at 
011~ ti!'1e. 
Loop Configuration Screen: Displays precise configuration of 
each loop, showing exactly where the appropriate connections 
are to be made, and allowing the user to create optional loops 
electronically without extra cost. 
Custom Fermentation and Cell Culture Equipment :-::: 
"J.~ 
New Bnmswk.k Sde.ndfk Is sUuc:tured to 
pnMde specialized equipment desIsn and 
construction seMces for a full range of 
custom-built c:.GMP compliant fermentors 
and bloreactors (10 to 10.000 L range) 
which sdsI'y reguIamry vaIIdadon requh­
ment by fDA. EMEA and national authoJi.. 
des. 
Destsn PhIlosophy 
A design philosophy similar to the computer 
industry's ·open systemsft approach Is 
practiced by New Brunswick Scientific. 
Cu.staneIs can purchase fermentors. bloreac­
tor.; or otherskId-m.ounted systems designed 
and fabricated utilizing proven off-the-shelf 
componenfs. This approach ensures that 
technical and service support, induding 
replacement components. are readily 
available from mUltiple sources. The 
selection of proven components increases 
reliability and accelerates validation. 
f.D&Ineedng CapabDity 
A dedicated engineering group, spedaIlzlng 
in custom system design. Is staffed with 
mechanical. electrical, automation and 
process engineering experts. A complete 
support staff consisting of AutoCAD 
designers and derlcal per.;onneI back up the 
group's engineers. 
AutcC.AD R14 Is used as the primary design 
tool. with all of the engineering drawings 
supplied In hard copy and on magnetic 
media. Software tools are used in the design 
of pressure vessels and process piping. 
DetaIled protocols have been developed for 
executing validatable cGMP compliant 
projects to ensure that the systems meet 
regulatory validation criteria. 
An experienced project manager is assigned 
to each project. ServIng as the dlent's pri­
mary contact during the project's execution 
cycle and ReId start-up of the equipmart, the 
project manager provides continuity through 
completion ofthe entire scope ofWOlk.. 
Process InsCrumentadon 
Our fully-staffed automation group utilizes 
Industry-proven PLC (programmable logic 
controller) based systems to solve a broad 
range of control applications. NBS has 
standardized on such Industry leaders as 
Allen Bradley and Siemens to offer our OJS­
tomers added Oexlbllity in system configura­
tion. processing pa.NeI' and I/O capadiy. 
NBS \nteglates process control. data logging. 
recipe management and Internet appIk:ations 
with Microsoft Windows-based, 32-bit 
object-oriented graphical hurnan-rnachine 
Interfaces (HMI) such as Wonderware's 
In Touch and Intellutlon's Fix software 
programs. These industry-sta.ndard applica­
tions offer our' customers the latest in 
technology Indudlng VBA. Active X, OPC 
and DOE. 
ManufadudngCapabDity 
NBS utilizes the manufacturing capabilities 01' 
its 250,000 square foot manufacturing 
plant, iocated in Edison, New Jersey. for the 
• 
execution of Its projects. The plant Includes the 
most advanced manufacturing machinery In the 
rermentation business, Indudlng automated 
CNC milling madlines, orbital welding devices 
and an ASME certified vessel shop which 
enables NBS to directly control quality and 
delivery Of its projects. 
The manufacturing facility routinely executes 
wstom-engineere projects lndudlng: 
• 	d:MP Compliant Fennentors and 

BIoreactors 

• 	ASME Code Compliant Process Vessels 
• 	Clean-in-Place Systems 
• 	Validatable Process Control Systems 
• 	Addition. Mixing. Hold and KIll Tanks 
• 	Sterile FdtratIon Systems 
v..Idadon SeMc:es 
New Brunswick has consIdeIabIe experience in 
providing valldatable bioprocess systems. which 
are in full compliance with cCMP regulations. 
To more fully support the diem's IQ and OQ. 
efforts. NBS can supply the following 
documentation: 
• 	 Boroscope Weld MappIng with Videotape 
• 	 As-Bullt EngineeQng DrawIng 
• 	 Material Certificates 
• 	 Instrumentation Calibration Log 
• 	ASME Pressure Vessel Calculations 
• 	Temperature Maps 
• 	BIll ofMaterlaIs/OFM Part Numbers 
• 	 CIP Coverage Test Reports 
• BIoI0gIcaI ChallengeTest Report 
The material used In the manufacturing of any 
d:MP compliant system Is carefully controlled. 
incoming raw materials are carefully inspected, 
tagged, segregated and secured in a locked 
area within our fadlity. !lllateial certificates are 
carefully controlled to assure full traceability. 
In addition. NBS performs control loop tuning 
using actual cultures or biological solutions. 

Process corrections can therefore be made 

before shipment. speeding InstAlJlation, start-up. 

and validation. 

fleJdSeMce 
For decades. NBS has sold and installed fer­

mentation and bioreactor suites allover the 

world. These installations are serviced by 

New Brunswick Scientific's ten U.s.-based 

field service offices and worid-wlde service 

offices located in the UK, the Netherlands. ' 

Belgium, France. Germany and China. 

Due to the customized nature of most of our 
projects. service engineers from our field 
service organizations are typically trained on 
each individual piece of equipment at the 
factory prior to shipment. After delivery., 
service engineers partldpate In the commis­
sioning of the equipment at the customer's 
site. 
Spare parts are stocked in our Edison, NJ 
quarters, as well as at our domestic " ..nlln"'t.. 
centers and worldwide offices ready 
ment to the customer at short 
Complete spare parts lists, with rArlvnMrlPnl 
on-hand quantities, are prepared during 
. detailed engineering phase ofeach project. 
Support ServIces 

New Brunswick Scientific can ofrer a , " 

range of consulting engineering services, trOll'! 

preliminary conceptual design studies to 

complete bioprocess facility design and pro-, 

ject management. '."'~""""'",' 

To help support our customer's PQs and . ' 
dients with biological processes that are not'·.., 
fully characterized, we otrer process develoP­
ment and optimization services that are unl~~"~,,l 
In our Industry. We are the only fermentof,,'l 
manufacturer with biochemical engineers, moI-". " "Iecular biologists, cell biologists and mlcroblOk>- (, 
g ists on staff who operate a mode~n, " 
obIoI....;,.,,1 rer~fully-equlpped pilot plant, a micr V.5~30 L£>,,1j,;' 
mentation lab and a cell culture lab up to t I, ",~;; ~ 
Generic tPA Appendix C 
***Correspondence with New Brunswick Scientific Co. All other correspondence 

occurred over the phone with Ted Sheilds.*** 

X-Sender: tshields@207.162.131.33 (Unverified) 

Date: Wed, 29 Mar 2000 08:19:15 -0500 

To: maudette@seas.upenn.edu 

From: Ted Shields <tshields@blast.net> 

Subject: Fermentor Pricing you requested 

X-Status: 

X-Keywords: 

X-UID: 84 

Dear Melissa, 

Here are the "ballpark" prices you requested, ifyou need any additional 

information please don't hesitate to ask. 

BF-5000 (30 liter max working volume) $ 85,000 

400 Liter Industrial Fermentor $ 125,000 

5000 Liter Industrial Fermentor $ 250,000 

These are strictly estimates, actual prices can vary substantially 

depending on options and configuration. 

Sincerely. 

New Brunswick Scientific. Co. 

Ted Shields 

------------------------ ---~--~~-
(Jeneric tPA Appendix C 
; • 
\I: Sool"lL \J ­ "t'f r z. h 
: 
-: -rr (1\\2 ~ 
, 
-
14 .;:> 
, l\:~c:? 5 (){')l") l ';( \ N'\ 3 ,..,.. { tJ')2 ~b
-
;;;;;.,t." 
" i irv-£)L 
1 
t:)N'\!> 1'-4'\ \\3 
- {~ JIf' 
b = \ Yl co 
AQ a rt.rtr:'L 
C::: O)Tt r 

-: 183 38 &ro 

.;) 914 co X 39 3] tL"p liS :JY J. JnC b 
\ co 
______.___ ____ _____.______,_______ _______________ ____..__ ____ .. .____"______ 
'W 
.~ ~ ~ ~_7 ~ ~~~_
h£E 
Wlh'\ ------. -----.J----.----. 
-------------------------------. 
-----------------z~UJ~.t~n~z=,~·~O)~5~n~. ~ ~~Td~~~o~o~q~-----4-------
z: ur,t' 5;' C'b SIC' = 
tt""""""gr-r,..-)\:y C 'C J 1L e ::. q J :UZ :. ~t; 
-·-----~'1J7~fVU 
, I l -dj:J):t1 -; -),---"r-1CXy.-.S"""?;: ...... ·T"'1' iI"'er J rf-"lTO":)O....-rC'T'h"".:'"'\...-Ii ,.r."""'r
I -
--------------------------------------------+-~--------~-+------~' 
:J XJ.puaddy Ydl ;J!.IaUa 
I 
Generic tPA AppendixC 
c2:rt r b:. ;::;;:rr (2 25\ (Eo" Jli>Vo \ . 
arB 0 p' flO - 1185 8 6.l.o 2. 

':J39,5® 
~ 2rr f 2 25"'1 {139. 5) 
., H,I 2L1.I)1., 
2TT(2 25) (111.2) 
2 
j 
1 ( e o..db f23 p-P .La 2CXJ Un 7. .Q..w.D 1m a.1l 00....) 
:±o±a9 GA\>O ben br:d±tr'O::: i185 8+ 98lo +=r8t" \ + 58(p , '25 If 3Blo 4 
d3S 

,~+--------
\70'0 ! 
.-~.----.-­
. ... 
.:J LL-i3') '8b ---=-., '0 
..-~ 
sz €V 

-
~----
~ 
.:! ' ,+.::r
-' Yb
-, 
n.L~ [['gL :. II 
-
:J. '-t-j \J:( .::I-Z+:T'.JU n..L9hLL I 
\~z: I ~ +:t \ZO'Q -t­
--
..:I b5-cl 'g5 -11 Xb 
").,S I eJ 
.-~ 
y. -Z+j" 
,I 
n.LB b'OOJ 
.: '\ 'D 
-
J ..VZ--g.I 
.::I'oz+l'JY I 
..:; . 'Z.-tj"'-! , HL9 h L L 
t::f\Z<J Q -+ \" ..., at· -~ 
:J XJpuaddy 
GenerictPA Appendix C 
• 
18."]3 BTu ( 24lo 3£'-Z.,)
-W.h 
J 
J 
0) - 2 \) "='j JAru 
I 
;A,,6 e 

m - \ \ 503 9 tbro ,J he 
..--------. --.---.' -_.. 
-----------------------------~~·~~~T~~-·-~-T~~--~-----------
----.------_.._---------­
.-------zid"' q ­
-------r-«-r<;~b.--.b--h -00' 1 "? [ ~-'1'''~ Z" 8L.1\;]:' Czt'f': \ &!l h~-;-'h.----I------­ -------------.-. 
,\"Z.o~O? 
,gO).:C'rj"S b) ~ ;*'b-.-r-------­
j.OZ @ d~~ 
~\;:i 
--------------------------------------------J-6-o~·f~ ~1·0~:~~~-----~~.-~~ 
----_.-----------------------­
c<; :b-FCN;7b:;:~~ i '4r:/Ji~;;;:lh}:~.TJC Ib!) -'~~g rl----­ +-1' 
----------------------------------------4h~L~·L~~~~nz~Q~·c~,~~-------_+------ --+ -. zl, L\ZQ"Q} , 1."t.lf1:1· 
:J X1puaddV VdPlJaua1 
I 
Generic tP A Appendix C 
!Temp @ 

3, iq BTU I .f.p.. be 
I 
0.02i 
O.OZL:>(.p 't ,if 
.. 
m :. {o]q )bm J be J 
m -: Dc 085lp !l,5 ,1M, . 
- -
Generic tPA Appendix C 
, flu. yr.b JJJ;;U; aM.., fICI1Lv Ct!J !3a1t:l.A1..U . ~@C!Tf/J 
6cn Jv~ j~crn 5<X)OL f-'~ 
; We ~ llO"w /1 o.J..o (fYl a)(.') 
D" I U> .Jt.:J IAJU:.. 
a\IV'lQ.? .. O. IZ I Jt:..y / A,,9.c. 
./.).:UO(Y1 ~ .;(0 Jua.:L.~arrt. :i.e .'38"c fum ~DaL. 
. (~)~;(0 ~ok -fM ~a1uAoj<Y.l4- fYI>#.A 
. Cp: 4.1:18 k:3 ... .. .. ._ 
kj"<" 
pyUAj Y ~ fu JLoocJ.. IJiru ~ c6 wctW... 
(O.I2.t \<"9 ') (4 .rl'e) k"J ( 38-30) 
~ kj~~ 
"':' 4.(:)4'4 k 3'J.Mc.. 
Hea\- <t vo...p b01 ~~: 2173 kJ")Jl.~ 
'4 .c>4 4 k -:I).4R.C.. :: O. DD\ 8lo ~. 

Z' 7 3 k::sJ ~~ AU.. 

6o.:L:..k-~ 6(j\ 240 h.ft.i). 
D.DO' BCl> '.:::1 x (PO Au. lC. C9Dm..vvi., X 240M. 

AU . I mJA'L. . I Iv\.. 

~ I (oCf) k-j/ bo.;lck i /:J;.Ia.YYl~. r h~ 
... 
~40 
Qeneric tPA Appendix C 
, 

,i 

~ Tota \ AiJl On d Co2.. , R<:.'O lJ....U\ c:::. men-tD 
5 C>DO L F€I') T"i\c=.n+ 6"t : 

"\ -12. 1\
N<::ec::l: l ().Cl...D - O.::t) X \D (YloJ vz 
hr·tpJl 
ma)<.. 02. LoYV:l ~Cm.., 
3. S X. \OlP 0 \\ )I,. \ooornL)(. 4coc L = L 4 x.. \C\ '!. 0\\s ,n ~1"Y\.QJn4d': 
mL IL 
lD l3.OJ S'X..lC\~ ro.o1..0, x.- L4 X 0115 : 

hr' ull 

. ') 
_=2. lme\0,- . (+~±Q..P_. - .. 

hr"' . 

. ~-N e;l.cl.D..tfi -Aln.LJ.._~. -i--5~D_CiJ2.-- ..Lln.av.fjM_¥ ..b.crtYL.O ..C3?lo.uO OJ 
. Oz: 2\~0 ~ 
...2.. -: 0.03 + x 

~ 100 100 +- X 500+ 5~ " 3 + JOO~ 

I 
1-.. -:. 5.23 
N..ew % ~~Cr,v:,: 
O 2 ·0. 2.C>.-""IZ.lmoLDz I hr 

N2. .. 0." l{ ., -, .17 rr-o\ N2../ h '('" 

CDl. 'c.05 't o. S25m~1 C02./h'l"'" 

+oteJ) ~ rrCJo..r.j 10.5 fY\ol/h't" 
;.~ AAll-·. 
2.'rnc\ {)z. <::L9l5 mo\ ~ 
C."2 hr. 
.-." .' ! 
Generic tPA 
AppendixC 
tt %hou.J\.D A-slo..dcn M GflA.J"~d ':"" 24 h ...... x.. lC do'iS " 
. -:= 24c hns _" 
240 hrS )(. 2SQ. 3 ~.-L " LIl Q.42.(P k:q au. 
t'\f"'. ba-kk.. 
:1::ti+~ 
: I +-~ -= B.10("('\'3 ~ , .".3 !' 10.441::) 
D.e33m/l<~ 
lo q .'-\~ x. ' ~runlt.. ': -I (P. c.o 5 ~aJ'f\k.o / btxidt..7 
baJch /0.44 ~ 
6>. f.J> 5 +o..tr\k..D X 50 1.xucJu,.D 
~135() +a~ (~lUA.\ 1 
~~ \ 
COl. 
D.52'5 mo\ -(O.DCOZ81(ID.S) '- 0.522 (\'"'\0\ CO~ ~ 
.heel. b~ 
0.522 mDI c.o z )(. ~ 22. 'HoB ~ / h COl ­
h . mDI" 
240 hcu..LJ.) ~ 2.2 .q~ . -:. 5. 512. k~/ .. 
boJ-d'L 
h COl. 

CUm 0\..VY\::l NY\. ~ ~.' 

LDD \\:, x ~ .. 2"1 .2.\ ~5 

2.2.04 ib 
. 5. SI2.~ ')( \+Ovv\k. D.202 +onk.
-We}..., 2,.2.1 K J bo.:lc.k. J 
-= ;) 5 -ttlln..Dr..D 
\j eo../L ..:) ~ 7 
Generic tPA AppendixC 
-
;- 3.5 )I.\DtD . ~ )(. \OOOI"'nL ~ 300L ":' l. oS X \ (;)\ <t <..0\\ S +o-l-o...O 
. I'Y'\L \ L 
fI .oS X \el Z o\\:s x D. \S ~\C>-''Z. m()\ o:? ., D.; 575 mol Oz/hr 
hy' oil 
~ [ 0 .l515 N'\ol bz ... D . .,815 me:> \ +e~ o..1A. ')(. 29 3 
niO\0.20 
~ 22.. 83.5 o..U., 
~22. 83 3 o..u:.. x \GZhrS :~~.~::;uu<:~- :/D.38~ :~J 
h ..... 
l­
; 
O. 3Btl +o.xJt. x 5D bcddul.l ~ 

b~ 
!l.Oz. 
~ D., 815 mol x D. oS ! O. 03'13 mol C.Oz 
hr. 
~O.C3G3 (Y\O\ eel, - (O.'81S)(c.CCOz'81 " 6.C3Q' tnt;), co, x 4~ 
h Y". (VlO I 
)( Iqz. hr x ~ ~ ~ 
2.1. lo\ \'-j lOCO) 
-~qQ5 -X 
"yro 6'"'0 +0...1­
"~PC( 
" " ':1 UD+" 100 '9 
L-YV~~~EJ' 
 boool b':>{ hh '01 ~q " ....-'y 
[;;fl)( "--r ')( 'J.Y hhl)¢. ~G' G")"z 
--'y 
:n-o \ouJ s-zlg hLO'O ~ <ib£oo"Q-S L9 LO'O 
y-:J~vq ..A.y 

.. ,.,n.{hh7 X bLf'O.: 

."It( 

'ZOJIQW fb£QO'O: -SQ'Q')lSl)~LQ'O 

'JI..( o'Z '0" 
\:n'J (OW tfPfCYJC SLSLO'O" "2Q \QUJ SL"S\o'O" 
--"-ZO -"tou.JSL~/Q-·Q" = rlll?"IIQ(x"~-O'l ')( zOlQUJ z,_Qf'x ~"Q-. 
:Q-pr'TNzO' 
., , ,LU r,fOfo+ S"1IfT') \lOt x >"0 '/ : "o~'){ ,wOOQ\)(. Sno> ~Q\x c;.'~ 
" , 
JX!puaddV 
• 

Generic tPA Appendix C 
Design Calculations for the Heat Exchanger used to Heat up the Media for the 3 Fermentors 
1) Overall Energy Balance: 
Q = total Energy needed to heat up media (BTU/hr) 
m'=2. 1 , 1 .'60: 

. 164TI 1.00.10- 3 ',T I Volumetric Flow of 2gallmin converted into kg/hr 

m =454.253 kg/hr 

H out := 159.1 Enthalpy of water at 38 C in KJ/kg 

Hin:= 16.8 Enthalpy of water at 4 C in KJ/kg 

Q .- 'H H \. - m· i out - in) 
Q = 6.464.104 KJ/hr 

4
1.- Q . 1000 [i.9 .486.1O- ] Conversion of KJ/hr into BTU/hrtota ,-' . I 
total = 6,132.104 BTU/hr 
Calculate the flow rate of the warm water 
H outw := 200.9 Enthalpy of water at 48 C in KJ/kg 
H inw :=230.2 Enthalpy of water at 55 C in KJ/kg 
m w := --...---Q--.-.-­

H outw- H inw' 

kg 
mw 2.206.103 Flow rate of the water on the shell side 
"Fir 
2) Estimate overall heat transfer coefficient for a water-water heat exchanger 
Ui =BTUlF*ft/'2*hr 
U i :=70 
3) Assume 1-1 heat exchanger 
4) Calulate Ai from equation 8.7 
Calculation of the correction factor 
,_ (55 - 48) S:_(38-4)R =0.206 S =0.667R. (38-4) (55 - 4) 

F T := 0.95 From graph on page 323 of Seider and Seader 

1 
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Calculation of the log mean temperature 
T ,«48-38)-(55-4» CaT LM = 25.165a LM'- [(48-38)] 
In (55 _ 4) 
ilT LMF :=25.165·1.8+ 32 Convert temp to F 
.1T LMF = 77.297 Ftotal 
Ai:= Uj,ilTLMF.FT 
Ai =11.929 ftA2 
1 
A' '=A" --...,.. Conversion to mA2 from ftA21m . 1 3,28082 
5) Choose ui to be between 1 and 10 ftlsec 
U i := 0.6 fUsec 
1 
U im := U i'J:L'8i}'8 Conversion of u into m/sec from fUsec 
U im = 0.183 m/sec 
6} Calculate Ad for the shell side 
mw = the flow rate of the water that is being cooled (kg/hr) 

p = the average density of the water stream 

. I + 1 'J 

._ 
[ 1.01l·1O-3; 1.021.10-3 , kg/mll3 

Pavg . 2 

mw 
A .'- 36Oi)CI .­
P a vg ·u·1m 
A ci = 3.404.10- 3 mll2 
Assuming 3/4in Steel Pipe tubing 
0.0. = 0.75 in 
1.0. = 0.62 in 
1 
ID :=0.62'39.37 
\4·A Ci ID ::: 0.016 meters 

N t := n;.(1D)2 

1 
00 :=0.75'39.37 
Nt: 17.478 00 = 0.019 meters 
2 
cd4l.o 
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7) Assume Tube Length L= 3 ft 
At'" 0.06 m"2 
AimN '­
P .- A eN t 
8) Determine the diameter of the shell 
Using table in the Process Design Book found on page 333, the diameter of the shell 
was found from extrapolating the given data to apply to smaller number of tubes. The following 
equation was found by graphing the points in excel and drawing a trend line. 
Guess Value 
x :=5 
Given 
IS=0.757S·x2 - 2.7436·x + 3.701 	 Equation of the line from Excel using the number of tubes 
found above (NT) 
Find(x) = 6.516 Shell 10 in inches 
9) Calculate hi, ho, Ui 
Oshell :=6.6 Diameter of shell in inches clearance := 0.25 inches 
b 4 length of tubes in ft. P t := 1 inch 
12 
D sheWclearance·b· T 
Acfu:--------np~t-------
2A cfo =79.2 in
kg 
m w = 2.206.103 Flow rate of the water on the shell side m 
mw 
G o :=-­ Gj :=p avg' u imAcfo 
kg 
G i = IS0.007 kg
Go = 27.S55 hr.in2 2 
m ·s 
39.3i 	 kg
G om :=G o'T'3()OQ G om = 11.993 	 ----..­
s·m" 
3 
d41 
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Properties of the fluids: 
',567.2.10-6 + 504.6.10-6 6 6 
! 1560.10- + 695.10- ) Viscosity of FluidsJ1 h :- 2 )1 c := '\ 

kg
J1 h :: 5.359·1 (} ,J<g )1 C :: 1.127.10-3 
m·s m·s 
Thermal1.648,10- 3 + 641.10- 3 (577.2.10- 3 + 629.10-3 ,k .- / Conductivityk h:= " c'- 2 

w w 

k h :: 0.645 k c 0.603rn:-K rn:-K 
Heat Capacity 
._ (4200+ 41 78)
C ph:= (4183+4180) C pc'- 2 

2 

3 J 4.189.103 
JC pcC ph=4.181·10 kg·K kg·K 
The Nusault numbers are calculated for the shell and tube side of the exchanger 

I 

OD·G ]0.55 [[C J]JNu :=0.36. ~m. ph' J1h: !Nu o·k h 
o ho:=~[ J1h kh 
Nu 0 ::: 15.243 
!D.G ']0.8 [[C J]O.4Nu i :=0.023. I. pc' J1 c Nu j·k c 

h·
[ Ilc kc I 
Nu i = 27.516 

The calculation of the overall heat transfer coeffiCient 

Uie 
w 
U · = 391.849 --r,;'KIe m. 
U i := U ie·0.17612 Conversion of the units back into BTUlh*ftI'l2*F 
U i :: 69.012 BTU 
-;-;::r;:h·ft ·F 
4 

~L\8 
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STAINLESS STEEL 
COMPONENTS 
Storage Tanks 
Agitation Systems -
_And More 
STATIONARY 
PRODUCTS 

Walker Stationary Products Group 
specializes in engineering, design, fabrication 
I 
Iand service of storage and processing tanks 

and equipment for the food, dairy, beverage, 

pharmaceutical and chemical industries. 
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Appendix CGeneric tPA 
Design Calculations and Utility Requirements for the Fermentor Section 
of the tPA Process 
All Pumps used in the Fermentor Section of the tPA process are identical. The 
flow rates, pressure drops, and size of each of the pumps is within a close 
enough range that the same type of pump can be used for each application. 
The pumps are Randolph Austin Series 610-362 peristalic pumps. 
Pump Characteristics for P-1, P-2, P-3, P-4, P-5, and P-6: 
Ib Assume an average pressure drop F:= 1001.4· Flow through Pump nr AP:= I5'psi 
Ib 
p :=63.72'ft! Oenisity of Water 
l] :=0.80 Pump efficiency 
Using the specifications provided by Randolph Austin Co. for the Series 610-362 Vari-flow 
speed control peristolic pump: 
Motor power :=O.2S·hp 
Total power! := Motor power·7920·hr 
'-2-S galFIow max'- :> 'nr 

Total powerl 1.476·103okW·hr 

._ gal

Flow min .-12·nr 
UtilityCost :=Total powerl·0.04·k~.hr 
Costing the pump UtilityCost "" 59.0S9 
The Cost of the pump as quoted by Randolph Austin Company is $1595.00 
Pump P-7, Heat Exchanger water Pump 
lb 
F :=4862.02· Flow through Pump Assume an average pressure drop nr 
dP := IS ,psi lb 
p ::;:; 63.72'-;3 Oenisity of Water 

ft 

l] :=0.80 Pump efficiency 
Using the specifications provided by the Corcoran Company for the Model 30000-H01 (AA05): 
Motor power :=2·hp 
Total power? := Motor pO\\/er·?920·hr 
Appendix CGeneric tPA 
I 
Total power7 = I.IS1·104 okW·hr 
UtilityCost := Total powerTO.04.KW1iT 
UtilityCost = 472.475 
Costing the pump 
The Cost of the pump as quoted by Corcoran Company to be $3250.00. 
Total Energy needs for all the pumps per year: (50 Batches) 
totalUtility := \Total powerl·6 + Total power7, ·2 Cost perpump := 1595.00 
totalUtility = 4.134·104okW·hr (there are 14 pumps total in the plant, 7 in each 
I fermentor train) 
UtilityCost := totaIUtility.0.04.l<W1iT 
TotalPC := Cost perpump·12 + 2 ·3250 UtilityCost:; 1.654.103 
TotalPC :; 2.564.104 
Utility Requirement for the Fermentors, Blending Tank, and Harvest Pumps. 
40L Fermentor 400L Fermentor 
Agitationmotor 40 := 1.5·hp Agitationmotor 400 := 5 ·hp 
Power I := Agitationmotor 40' 7920·hr Power 2 :=Agitationmotor 400·7920·hr 
Power 1= S.S59·103okW·hr Power 2 =2.953·104okW·hr 
I I 
UtCost I := Power 1 ·0.04· KWlif UtCost 2 ;= Power 2 ·0.04· l<W1iT 
UtCost 1 =354.357 UtCost 2 = I.\SI· 103 
5000L Fermentor 5000 L Harvest Pump 
Agitationmotor 5000 := lO·hp Harvestmotor 5000 := 5 . hp 
Power 3 := Agitationmotor 5000·7920·hr Power 4 := Harvestmotor 5000' 7920·hr 
Power 3 = 5.906· 10.tokW·hr Power 4 = 2.953·104okW·hr 
1 ; I 
UtCost 3 := Power 3 ·0.04· KWlif' UtCost 4 := Power 4 .0.04.·l<W1iT 
3 J 
25L\ 
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UtCost 3 = 2.362,103 UtCost 4 = 1.181· 103 

The power for the media blending tank is equilvalent to the largest fermentor. 

Blending Tank 
Agitationmotor tank := 10·hp 
Power 5 := Agitationmotor tank' 7920· hr 
4Power 5 = 5.906·10 okW·hr 
, 1 \ 
UtCost 5 := Power 5 ·0.04·: 'T:Ti"f"'I:" • 
\KVV 'nf/ 
UtCost 5 = 2.362.103 
Blending Tank Refrigerator 
refrig := 8 ·ton 
,I kW. 
energytocool :=refrig· 1·-' ·7920·hr\ ton l 
energytocool 6.336.104 okW ·hr 
, 1 
energy cost :=energytocool.0.04·: kWliT 
energy cost = 2.534·103 
Total Utility Requirements for the Fermentors, Pumps, and Blending Tanks: 
Total := total Utility + Power I + Power 2 + Power 3 + Power 4 + Power 5 + energytocool ·2 
Total =5.401·105okW·hr 
The total Energy Requirement (with a large over 
TotalCost := Total·0.04 estimation) is 5.4*10"5. kW"hr per year and the cost of 
'KWlif the electricity is $21610Iyear. 
TotalCost =2.161,104 
25S 
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Cat. No. 

500-200, 

610-200, 

750-200 

Explosion Proof Model­
Fixed Speed 
Cat. No. 500-200 shown 
Cat. Nos. -200 are complete with pulley - belt - 114 hp - 115/volt - 60 hz - single phase - sleeve bearing­
explosion proof motor and switch with 10 feet of flexible three wire electrical conduit and explosion 
proof plug. All class I group D electrical equipment. Units are mounted on a durable metal base. Series 
750 model is equipped with 113 hp motor. Refer to page 8 for flow rates, specifications and shipping 
weight. 
Dimensions: 	 500-200 - L 18-3/4" x W 12-1/2" H 8" 
610-200 - L 18-3/4" x W 12-1/2" H 8-1/2" 
750-200 - L 24-1/2" x W 14" x H 11-1/4" 
Technical data 
Cat. No. 
500-201, 
610-201, 
750-201 
Explosion Proof Model 
and Speed Control 
Cat. No. 750-201 shown 
Cat. Nos. -201 are complete with a zero max speed control, 114 hp ­
115/volt - 60 hz single phase - sleeve bearing - explosion proof 
motor and explosion proof switch with 10 feet of flexible three wire electrical conduit and explosion 
proofplug. All class I group D electrical equipment. Units are mounted on a durable metal base. Series 
750 model is equipped with 112 hp motor. Refer to page 8 for flow rates, specifications and shipping 
weight. 
Dimensions: 	 500-201 - L 25-1/2" x W 12" x H 8-3/4" 
610-201 - L 24-1/2" x W 12" x H 8-3/4" 
750-201 - L 32" x W 14" x H 12-1/2" 
Technical data 
Cat. No. 
500-332, 500-342, 500-352, 500-362 
610-332,610-342,610-352,610-362 
750-332, 750-342, 750-352, 750-362 
Vari-flow DC Speed control Model 
Cat. No. 610-362 shown 
The Vari-Flow models meet IPC-44 specifications and are available with a 
L....----.....;;;.-----I'variety ofDC motors, each spanning a specific rpm range. Units are complete 
20f4 	 25LD 41710012:09 PM 
~ 
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with a 114 hp - 115N - 60 hzmulti-speed motor (112 hp on 750-362), an integrated controller capable of 
accepting a 4-20 Ma signal, and a reversing switch, all mounted on a durable metal base. The IPC-44 
protection rating allows for intermittent contact with water without damaging the motor. Refer to page 8 
for flow rates, specifications and shipping weight. 
Dimensions: 	 500 Model - L 17-1/4" x W 13-3/8" x H 6-1/2" 

610 Model - L 17-1/4" x W 13-3/8" x H 7-3/4" 

750 Model - L 21" x W 17" x H 11-1/4" 

Technical data 
Cat. No. 
500-400,610-400,610-425,610-450 
750-400, 750-450, 880-400 
Air Drive Model 
Cat. No. 500-400 shown 
Cat. Nos. -400 are equipped with an ARO air motor, regulator, and 
pressure gauge. Cat. Nos. -425, 450, are equipped with a GAST air 
motor. The 610-425 is belt driven while the -450's are equipped with 
air motor and gearhead. Both models also are supplied with pressure 
gauge, regulator, and muffler. Operation of 500 and 610 series (all models) require compressed air to 90 
psi and 15 cfm, while on the 750 and 880 series 90 psi and 30 cfm, are required. Pumps are suitable for 
use in hazardous areas and are variable speed by adjusting the air regulator. All units are mounted on a 
durable metal base. Refer to pages 8 and 9 (model 880) for flow rates, specifications and shipping 
weight. 
Dimensions: 	 500-400 - L 16" x W 9-1/2" x H 8-1/4" 
610-400 - L 16-1/2" x W 9-1/2" x H 9" 
610-425 - L 15-1/4" x W 10-1/4" x H 9-1/2" 
610-450 - L 16-1/2" x W 9-1/2" x H 9" 
750-400 - L 21" x W 11" x H 11-1/4" 
750-450 - L 16-1/2" x W 9-1/2" x H 11-1/2" 
880-400 - L 28" x W 14-1/2" x H 20-1/2" 
Technical data 
RANDOLPH AUSTIN 

COMPANY 

Made In U. S~ A. By 
Randolph Austin Company 
P.O. Box 988, Manchaca, Texas 78652 
(512) 282-1590· Fax (512) 280-0678 
email mikem@randolphaustin.com 
800-462-1590 
Pumps Flexible Tubing 
30f4 	 ZSl 417100 12:09 PM 
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model 
500-400 	Air drive 10-90psi 7 .13- 8.3- 17 lb. 

model 31.1 56.5 

Back to Intermediate Volume Page 
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Series 610 - Models 
Output gph 
Pump Flow Rate 
Speed Motor 3/8" ID 1/2" ID Ship. 
Cat.#. Model rpm. hp. Tubing Tubing wt. 
610-PHO Pumphead only 8 lb. 
610-000 	Pumphead and pulley 8 lb. 
610-100 	Std. model­ 430 1/4 125 200 29 lb. 
single phase 
motor 
610-101 	Zero-max 0-400 1/4 0-116 0-186 40 lb. 
speed control 
model 
610-200 	Explosion 430 1/4 125 200 69 lb. 
proof model 
610-201 	Expl. proof 0-400 1/4 0-116 0-186 75 lb. 
model/speed 
control 
610-332 	Vari-flow 3-125 1/4 2.4-41 3.2-65 38 lb. 
speed control 
model 
---------_._-----------------------------------------------­
610-342 	Vari-flow 4-165 1/4 3-56 4.7-86 38 lb. 
speed control 
model 
610-352 	Vari-flow 6-250 1/4 4.4-81 7-123 38 lb. 
speed control 
model 
~610-362 Vari-flow 12-500 1/4 8-174 12-255 38 lb. 
speed control 
model 
610-400 	Air drive 10-90psi 28.4-150 35-225 19 lb. 
model - ARO 
610-425 Air drive 10-90psi 30-155 40-230 35 lb. 
model - Gast 
(Belt Drive) 
610-450 Air drive 10-90 psi 27-144 34-224 20 lb. 
model - Gast 
(Direct Drive) 
:1>\ SG? .(:CI 
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Series 750 - Models 

Cat.#. Model 
Pump 
Speed 
rpm. 
Motor 
hp. 
750-PHO Pumphead only 
750-000 ?umphead and pulley 
750-100 Std. model­
single phase 
motor 
430 1/3 
750-101 Zero-max 0-400 
speed control 
model 
1/2 
750-200 Explosion 
proof model 
430 1/3 
750-201 Expl. proof 0-400 
model/speed 
control 
1/2 
750-332 Vari-flow 3-125 
speed control 
model 
1/4 
750-342 Vari-flow 4-165 
speed control 
model 
1/4 
750-352 Vari-f1ow 6-250 
speed control 
model 
1/4 
~750-362 Vari-flow 12-500 
speed control 
1/4 
model 
750-400 	Air drive 10-90 psi 
model - ARO 
750-450 	Air drive 10-90 psi 
model - Gast 
Back to Intermediate Volume Page 
Output gph 
Flow Rate 
5/8" IO 3/4" IO 
Tubing Tubing 
390 570 
360 470 
390 570 
360 470 
8.2-113 12-<166 
10-150 14.6-219 
14-227 20-332 
24-454 36-662 
102-390 126-570 
92-288 111-544 
Ship. 
wt. 
20 lb. 
20 lb. 
65 lb. 
120 lb. 
120 lb. 
140 lb. 
66 lb. 
661b. 
66 lb. 
66 lb. 
42 lb. 
38 lb. 
$ Z19 S\.$I·OO 
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Close Coupled Centritugal Pumps Problem Solver http://www! .thomasreglster.cOInJSs/.LU04"'O<:>~U 110H';lcorcorallpUIllp~1 10.:) .HHll 
BCORCORAN
t::i COMPANY 
I iS5llio,· uti,ioin:-lShipboard "Plastics waste 
processor" required fresh water 

recirculation Cup to 3SO"FI at 200 PSI 
 >I Model: 3OOOD·HD1 !AA051inlet pressure at rates of 12 GPM @ Material of Construction:125 FT TH and 21 GPM @ '17 FT TM. 316 Stainless Steel 
'-.. Size: 1/t" x 1" RF FL (301)#) 
,~ 
........,......----....... 

........~-~~....­
..... 
Features: 
1. 	 Lightweight (65 Ibs.) heavy-duty design: 350 PSI hydrostatic test 
2. 	 LOW FLOWIHIGH HEAD design: enclosed impeller (5.50" dia.) with 1/4" wide vanes (5) 
3. 	 Single internal mechanical seal: Carpenter 20 Cb-3 metal bellows, chemical grade carbon vs 
. silicon carbide mating faces, EPDM elastomers. No stuffing box or chamber bore restrictions; no 
flush required 
4. 	 Deep-drawn and fabricated casing with self-venting top horizontal discharge and drain 
5. 	 Marine-duty chemical Processina hostile environment motor: 2 HP 3450 RPM, 230/460 V AC, 
TEFC, 1.15 SF, 145 TC frame with base, cast iron frame. 
Click here to return to the Close Coupled Centrifugal Pumps page. 
For Centrifugal Pumps, see: 
Z1.90 
10[2 4/13/003:43 PM 
Close Coupled Centrifugal Pumps Problem Solver http://www I .tnomasreglSter.coIlliSSI . .lVu-r:700:7V 11 UII"I I"V, I"VHmp,",u1l"'''' 'U~.h'''' • 
1. Close Coupled Centrifugal Pumps 
2. Pedestal Mount Centrifugal Pumps 
3. Self Priming Centrifugal Pumps 
4. Vertical Sump Pumps 
5. Vertical Options 
Table ofContents 
• Return to Corcoran Home Page 
• General Catalog of Corrosion-Resistant Pumps: Size and Styles 
• Centrifugal Pumps 
• Mag Drive Pumps 
• Pump Questionnaire 
9CDRCORAN
f::.:;:i eOMPANY 
P.O. BOX 429 
500 N. VINE STREET 
NEW LENOX, IL 60451-0429 
Phone: 815-485-2156 
Fax: 815-485-5840 
TOLL FREE: 800-637-1067 
2l.P\ 
20f2 4/13/003:42 PM 
w .. ~_& ... __ ~ ""(. ___ "' .. ~~~ ~ .... _ ..""""_ .... , _____ ..,-.... ..... 
Subject: Technical Question - Your E-mail, 28 Feb 00 

Date: Wed, 1 Mar 200009:01:35 -0600 

From: "Lewis, James" <JLewis@osmonics.com> 
(' 
To: "'kasidit@seas.upenn.edu'" <kasidit@seas.upenn.edu> 
Dear Mr. Nootong, 
Thank you for inquiry regarding Osmonics' Pleated Filter Cartridges. For 
any of our cartridges, we recommend a maximum flow rate of 5 gpm/Ten Inch 
Equivalent (TIE) length. Thus, a 20" long cartridge would have a maximum 
flow rate of 10 gpm. The maximum can be reduced by other factors such as 
the micron rating of the cartridge, the solution viscosity and available 
pressure drop. 
'7_ IJ. 'N\ 
When we size a ousing for a given filtration, typically we would include 
enough TIEs to eep the initial differential pressure at 2 psid or less. 
For the F t e -AP021 cartridge this rate would be 5 gpm. For the 
M~mtrex-~~21, this rate would be about 3.5 gpm. In each case, a fluid with 
a ViSCOSit~fwater was assumed. The data necessary for these calculations 
is availabl op ou website, osmonics.com. 
Please let us know if you have further questions. Good luck on your 
project. 
O~~~ 
Best regards, 
Jim Lewis 

Application Engineer 
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<nobr>Flotrex™-AP Filters<inobr><br><srnall>Polypropylene Microfiber<ismall> http://www.osmonics.coIlllproductsiPagel03.htm f 
FlotrexTM..AP Filters e OSMONICS 
Polypropylene Microfiber 
Product Infonnation 
(0.65, 1,2,3,5, 10,20, and 40 J.lm Absolute Ratings) 
Constructed of thermally-bonded polypropylene fiber media, absolute-rated Flotrex -AP (FAP) 
filters combine exceptional solids holding capacities with precise micron retention ratings. 
The F AP filters are constructed ofhigh-purity polypropylene and are made with all 
FDA-acceptable materials. 
F AP filters are absolute-rated for air, gas and liquid filtration with low pressure drop across 
the wide range of 0.65 to 40 micron. The graded sheets ofmelt-blown media are layered to 
provide absolute particle retention, high solids loading and long service life. 
The F AP filter is just one example of our strong commitment to liquid, gas and air treatment. 
Our complete portfolio includes filters for every stage ofprocessing, and we offer custom 
solutions for your unique applications. Osmonics is your complete source for filters, housings 
and other filtration equipment. 
Whether you require an integrated solution or a single component for a specific application, 
look to Osmonics first. From one end of the filtration spectrum to the other, Osmonics has a 
total commitment to fluid purity. 
F AP Advantages 
lof5 04/02120008:05 PM 
<nobr>Flotrex™-AP Filters<lnobr><br><small>Polypropylene Microfiber<lsmall> 	 http://www.osmonics.comiproducts/Page 1 03 .htrn 
• 	 Broad chemical compatibility 
• 	 Dependable protection for final 
filters 
• 	 Efficient removal of 
Cryptosporidium and Giardia 
cysts 
• 	 High throughput 
• 	 High efficiency 
• 	 Long service life 
• 	 Absolute rating (99.9%) 
• 	 Fast rinse up to 18 megohm 
• 	 Thermally-bonded 
polypropylene fiber media 
• 	 All FDA-acceptable materials 
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ACFM = Actual Cubic Feet per Min. 
ACFM = SCFM at 70°F and 14.7 psia 
Note: For pressures and temperatures other than 14.7 psia (0 psig) and 70° F, ACFM can be 
approximated with the following formula: 
l\ -( = 3<\.2° ~ 
ACFM = SCFM E 11.7 pSi" :1 [ 6f .... "160 :1. (pSig + i4.1) :.J t: 536 :.J 
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<nobr>Flotrex™-AP Filters</nobr><br><small>Polypropylene Microfiber</small> http://www.osmonics.comJproductsiPagelU3.htm 
Specifications 
Polypropylene Microfibers 
Effective Filtration Area for lO-inch Equivalent Cartridge Dimensions (Nominal) 
0.65J.1m - 5.0 ft2 (0.45 m2) Outside diameter ­
2.75 inches (70 mm) 1J.1m - 5.0 ft2 (0.45 m2) 
Inside diameter ­
2J.1m - 5.2 ft2 (0.48 m2) 1.25 inch (31 mm) 

3J.1m - 5.2 ft2 (0.48 m2) 

5J.1m - 6.1 ft2 (0.57 m2) 

10J.1m - 6.7 ft2 (0.62 m2) 

20J.1m - 6.9 ft2 (0.64 m2) 

40J.1m - 7.2 ft2 (0.67 m2) 

Operational Data 
Maximum Rated Differential Pressure ­
Forward flow - 60 psi (4.14 bar) 
Reverse flow - 30 psi (2.07 bar) 
Maximum Rated Operating Temperature­
1800 F (820 C) at 10 psid 
(0.69 bar) in water 
Integrity test and particle retention data available on request. 
Applications 
Flotrex-AP filters are specifically designed for pharmaceutical prefiltration. Typical 
04/0212000 8:05 PM3 of; 
<nobr>Flotrex™·AP Filters<lnobr><br><small>Polypropylene Microfiber<lsmal1> http://www.osmonics.comlproductslPageI03.htm 
applications include: 
Prefiltration and Final Chemical Bottled Water Final Filtration 
Filtration • Efficient removal of Giardia and 
• Broad chemical compatibility Cryptosporidium cysts 
Prefiltration of Pharmaceuticals High Throughput for Beer 
and Biological Fluids Filtration 
• Dependable protection for final filters 
Ordering Information 
Type Absolute 
Micron 
Rating 
Cartridge 
Length 
I End #1 
Adapter 
End #2 
Adapter 
Elastomer 
Material 
FAP 96 =0.65J.1m 
01 1.0J.1m 
02 2.0J.1m 
03 =3.0J.1m 
05 = 5.0J.1m 
10 = 10.0J.1m 
20 20.0J.1m 
40 =40.0J.1m 
1 = 10 Inch 
2 = 20 Inch 
3 =30 Inch 
4 =40 Inch 
IA Open End IGasket 
i B = 120 O-RingIC = 213 O-Ring 
i E = 222 O-RingIF = 226 O-Ring 
J 020 O-Ring 
I Q 222 O-Ring 
II Stainless Steel Support Ring 
i A = Open End 1 B = Buna-N 
Gasket E = EPDM 
B = 120 O-Ring S = Silicone 
C =213 O-Ring T =Teflon* Encapsulated « 
G = Closed End 2 and 226 Sizes) 
H Fin Adapter V = Viton* 
Z =226 O-RingIStainless 
SteelSupport Ring 
* Viton and Teflon are registered trademarks ofE.1. DuPont de Nemours and Company, Inc. 
Downloads 
Flotrex-AP Filters Polvpropylene Microfiber 
2..l91.o 
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Memtrex™-FE Filters e. OSMONICS 
PTFE Membrane 
Product Information 
(0.1, 0.2, 0.45, and 1J-lID Absolute Ratings) 
Memtrex-FE (MFE) filters consistently achieve absolute filtration with low extractables. 
Constructed using a 100% PTFE membrane, they are especially designed for reliable general 
chemical and air filtration. 
The PTFE membranes achieve absolute filtration and are ideal for aggressive chemicals. They 
are designed with all FDA-acceptable materials. MFE filters are ideal for air and process gas 
filtration and vent uses. These highly hydrophobic membranes from 0.1 to 1.0 micron provide 
critical control over your processes. MFE filters are integrity testable. 
The MFE filter is just one example of our strong commitment to liquid, gas and air. Our 
complete portfolio includes filters for every stage ofprocessing, and we offer custom solutions 
for your unique applications. Osmonics is your complete source for filters, housings and other 
filtration equipment. 
Whether you require an integrated solution or a single component for a specific application, 
look to Osmonics first. From one end of the filtration spectrum to the other, Osmonics has a 
total commitment to fluid purity. 
:MFE Advantages 
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<nobr>MemtrexTM_FE Filters<lnobr><br><small> PTFE Membrane</small> http://www.osmonics.comlproductsIPage91.htm 
Electronics Grade Chemical Filtration Bulk Chemical Filtration 
• High purity • Broad chemical compatibility 
Acids, Base, and Oxidant Filtration Process Air and Gas Filtration 
• Highly hydrophobic membrane • Excellent vent filter 
• High air flow 
Ordering Information 
F' End #1Type iAbsolute Cartridge End #2 Elastomer 
1Micron Length 
 Adapter Adapter Material 1, Rating 
A Open EndMFE 91 = O.lllm 1 = 10 Inch A=Open End B Buna-N 
Gasket92 0.2 11m E =EPDM2 20 Inch Gasket 

94 = 0,451lm 
 B 120 O-Ring S = SiliconeB = 120 O-Ring 3 = 30 Inch 
T = Teflon* Encapsulated 01 1.01lm C ;::: 2.13 O-Ring C = 213 O-Ring 4 = 40 Inch G = Closed End (Only in 222 and 226 E =222 O-Ring Sizes)CapF ;::: 226 O-Ring 
H = Fin Adapter V =Viton* J = 020 O-Ring 
Q= 222 O-Ring 
Stainless Steel 
Support Ring 
Z = 226 O-Ring 
Stainless Stee I 
Support Ring 
.. VUon and Teflon are registered trademarks ofE.!. DuPont de Nemours and Company. Inc. 
Downloads 
Memtrex™- FE Filters PTFE Membrane 
Associated 
2LP8 
40fS 04/0212000 8:01PM 
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<nobr>Memtrex™-FE Filters</nobr><br><small>PTFE Membrane</small> http://www.osmonics.com/productsiPage91.hIQ 
Specifications 
PTFE Membrane 
Effective Filtration Area for 10-inch Sterilization 
Equivalent Autoclave at 250°F (121°C) -Maximum 
10 hours0.1, 0.2,0.45, and 1.0J,1m - 6.6 ft2 (0.52 
Steam-in-Place at 257°F (125°C) ­m2) 
Maximum 10 hours 
Operational Data 
Integrity Test: Diffusional Flow (60% IPA) Maximum Rated Differential Pressure ­
0.1 J,1m - <15 cc/min at 20 psi (1.38 bar) Forward flow - 60 psi (4.14 bar) 
0.2!lm - <15 cc/min at 13 psi (0.90 bar) Reverse flow - 30 psi (2.07 bar) 
0.45!lm - <10 cc/min at 9 psi (0.62 bar) Maximum Rated Operating Temperature 
1.0!lm - <8 cclmin at 5 psi (0.34 bar) 
I800P (82°C) at 10 psid 
(0.69 bar) in water 
Cartridge Dimensions (Nominal) 
Outside diameter - 2.75 inches (70 
mm) 
Inside diameter - 1.25 inch (31 mm) 
Retention data available on request. 
Applications 
Memtrex-FE filters are specifically designed for chemical and vent filtration. Typical 
applications include: 
30f5 04/0212000 8:01 PM 
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, 
201'5 
http://www.osmonltS:CtJ''~Y__ 
• PTFE membrane from Gore * 
• Low extractables 
• Ideal for aggressive chemicals 
• Ideal for vent filtration 
• All FDA -acceptable materials 
• Highly hydrophobic membrane 
*Gore is a registered trademark ofWI. Gore & Associates, Inc. 
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ACFM = Actual Cubic Feet per Min. 
ACFM = SCFM at 70° and 14.7 psia 
Note: For pressures and temperatures other than 14.7 psia (0 psig) and 70°, ACFM can be 
approximated with the following formula: 
4°C.= sQ.2F 
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***Correspondence with Hyc10ne Media Company. All other correspondence occurred 
over the phone with Neil Collins.*** 
From: mark.wight@perbio.com 
X-Lotus-FromDomain: PPUS22@PPUS35@PIERCE 
To: maudette@seas.upenn.edu 
Date: Mon, 6 Mar 200009: 12:30 -0700 
Subject: Request for information 
Content-Disposition: inline 
X-Status: 
X-Keywords: 
X-UID: 33 
Melissa, 
Thanks for visiting the HyClone website and for your request for information. 
Neil Collins would best address your questions about the mixing tank and I will 
give you his email and contact information below. Another option for you to 
consider would be to allow HyClone to produce the media for you and deliver it 
in BioProcess Containers up to 900L in volume. Either way we would be happy to 
work with you. 
Here is Neil's contact information: 
Here is Neil's contact information: 
Neil Collins 
neil.collins@perbio.com 
800-492-5663 ext. 7182 
Please feel free to contact me as well: 
Mark Wight 
Technical Services 
HyClone Labs 
mark.wight@perbio.com 
800-492-5663 ext. 7223 
Thanks 
Mark 
271 
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HyQ PF-CHO is a protein-free medium designed for growing 
suspension cultures of Chinese Hamster Ovary (CHO-Kl) cells as well as 
many derivatives of this parent line. HyQ PF-CHO has been specifically 
engineered for minimal adaptation, making it an excellent choice for 
producing and purifying recombinant proteins. Cell densities obtained 
using HyQ PF-CHO compare favorably to those of serum-free and 
serum-containing media. This product has been designed to decrease the 
cost of manufacturing and purifying recombinant proteins. 
HyQ PF-CHO MPSTM 
HyQ PF-CHO Multi-Powder System is a two-powder protein-free 
medium designed for the suspension growth of Chinese Hamster Ovary 
(CHO) cells. the medium is designed to maintain high cell densities and 
high protein output. 
HyQ PF-CHO MPS is ideal for large scale recombinant protein 
production because it contains only minimal animal-derived material 
and plant hydrolysates with no peptides > 10,000 Daltons MW. 
HyQ PF-CHO MPS gives you the convenience and stability ofa 
dry powder medium. The two-powder system is economical for 
large volume users. Powders are packaged in matching aliquots so 
no measuring is required and hydration is easy. 
HyQ PF-CHO MPS can be used with Dihydro Folate Reductase 
selection systems because HyQ PF-CHO MPS contains no 
glutamine and is deficient in hypoxanthine and thymidine. 
HyQ PF-CHO Multi-Powder System performs as well as 
HyClone's liquid medium (SH30220) and supports greater cell 
growth and sustained viability compared to competitive products. 
Cells maintained in HyQ PF-CHO MPS show consistent 
performance over the long term. Population doubling times wer 
constant over more than 10 weeks with cell viability over 90%. 
:!pF-CHO MPS : Proteiii=free medium for CHO cells ­~. iproduct 
. Multi-powder system 
ICataloiN~b~r-rSH303i3 -- .. - - ...- ._..... H~' -- •••••__••••• . 
IPackaging . .... IsftoioooL 
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ICell Density 1>3.0 x 106/ml in 5 days; viability >95% 
ISelectionsystem IDihydro Folate Reductase,Glutamme Synthetase 
lNutri~ion .. .. . .. !thYmiaine,'hypo~anthine, deficient, futamme ttee:J 
(Protem ExpressIon 1>5 mg/L . . 
Icumulati~epopulation doubling >90 days 
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HyQ PF-CHO MPS supports higher cell density and longer sustained viability than the 

competitive product. 

Media Development CHO 
Cell Line: CHO 519 Ma 3-18 
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Cells maintained in HyQ PF-CHO show consistent performance over the long term. Popu 
doubling times were constant over more than 10 weeks with cells viability over 90% 
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The multi-powder system is composed of two parts .. main powder and base powder. The 
powders are packaged in matching aliquots so no measuring is required. ' bicarbon 
(2g/L) is added when the medium is hydrated to achieve a pH of7.2-7.8. No 0 er supple 
are required, but some cell clones may show improved growth with addition ofglutamine 
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Comparison of cell growth and protein (hm-CSF) production in HyQ PF-CHO MPS and HyQ PF­
liquid medium (Catalog No. SH30220) 
Features and Benefits ofHyQ PF-CHO Multi-Powder System 
Dry powder system 
Multi-powder system 
Propri~tary lipid blend 
HyClone powdered medium 
No glutamine 
Deficient in hypoxanthine and 
thymidine 
No Pluronic F-68 
Metabolically designed 
Simplified medium composition 
Protein-free 
Stability, economy, and convenience of a powd 
Two powder components combined without the 
need to measure makes hydration easy. 
Powder is stable and the requirement to add 
supplements is limited. 
Lots ofup to 400,000 L-eq. can be produced. 
Medium can be used with glutamine synthetase 
(GS) selection. Glutamine levels can be adjuste 
for individual cell line requirements. 
Medium may be used with dihydrofolate reduct 
(DHFR) selection. 
Pluronic may be added for suspension cultures 
require extra surfactant. 
All components of the medium are identified fo 
simplified protein purification. 
Supplements may be added to meet requiremen 
ofparticular cell lines. 
Medium components will not interfere with 
recombinant protein purification. 
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BOC: Special Gases: Product Catalog http://WWW.bOc.convgaseslproUUl.:t:'I ... lHClll,,af )JiUUU"l~' O"".. ~, 1'''<''' ~:~ 
To Order Call: 
·SOO-BOC·GASES 
Carbon Dioxide A colorless, odorless, liquefied gas. Also available in bulk 2 quantities and tube trailers. 
I !Cylinder Contents @ Pressure . Equipment . 
I 
· ISize* N.TP .. . . (P.Sig).. vaiV. e Recommendations 
,-----.--- Purity IU.S.ICan.IIb ~1@70 of Outlet .. 
''''S-p-ec-;-tr-a--C~le-an--'®''''R \99 999<Y< (15.. 2 hS..2 ~.O. 118 14 rs;s--..I.C.. GA ,iRegulatorIGrade 5™ '. 0 .-1 [V . f"'v. 33~ b~~~o~rass, Model 
Research 199.999<Y< ['152 rt52~'118.14 rs;s--jCGA 'I Stage High Flow 
Grade5TM 0 'L ........ ,".., lVoJU 320 ModelBSR310 
\~~~~;!~~n \99.995% [200 ,12001.~0 ....... \27.22 F.[~~A Purge 
.. Brass Deep Purge 
r--. ~9% kS . ld G' Model 481 0 ILasershleld 199.995%ree Lasershle ases Section 
fg:~~M [99.99%[200 f [60••'[27.22 [838lfgA !~:~:~5~cron, 
~:~~O:l~ 199.99% 1200IKI60***127.22'FI~~A . iFlowmeter 
i poo'""r-'"P'"FT".F'W' IModelB7920 chooseiBone Dry . 200 K 60*.** 2.7.22 838 . CA. owtu e or reqUIre 
j 
'Grade 2.8TM 199.8%. I • 320 !flowrate) 
I I fLB.iFFFW
r------~ 
ILiquid 
I 
anollS SIzes an 
request. 
* Other sizes available upon request. 
21S 
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BOC: Special Gases: Product Catalog http://www.boc.comJgases/proaucls/ ...menl:i:IJplUUU~L'>1 gd'>C'>1 PUlC, "Vk.HLll1 
Purity MaximumSpecifications MinimumGrade Impurities(ppm unless Purity (ppm)
otherwise noted) FFFFF 
ISpectra-Clean® [99.999% 10 IrflFf1 
IResearch 199.999% 
Ipure-clean 199.995% 
!Coleman** 
1 
99
.
99% 
.IAnaerobic 199.99% 
12.8** 199.8% 
Technical Data: 

Mol. Wt. 44.01 

Boiling Point -109.3 of (-78.4 DC) 

Sp. Volume 8.74 cfllb (0.547 m3/kg) 

Critical Temp. 87.8 OF (31 DC) 

Critical Press 1071 psia (7381.5 kPa) 

Flammable Limits Nonflammable 

Toxicity TLV 5000 ppm 

Compatibility Moisture promotes corrosion 

* Available with a dip tube upon request. 

** Liquid phase. 

*** In Canada volume is 50 lbs (22.68 kg). 

10 5 rrf8!2lo.1 
150 Iliff
. . . . . 
I IFFfIOfW 

I Ilrll 
IIIIII 
Shipping Information: 
DOT/TDG Name Carbon Dioxide 
HazardITDG Class 2.2 
IDNo. UN 1013 
DOT/TDG Label Nonflammable Gas 
WHMIS Class A, D2B 
CAS No. 124-38-9 
MSDSNo. G-8 
20f2 4/20/00 12:44 PM 21l.D 
BOC: Special Gases: Product Catalog 
Order Call: 
-soo·aOC·GASES 
Air Also available in bulk quantities, tube trailers and aluminum cylinders. 
, ..... 	 , .. .. .. ~----r=-c~,.-- ~--;-----;---r;;;:----"-" .." 
Equipment
· IC'yIi:der Iconten.ts. IPr.~ssure 
I jSlZe ,j@ NTP l(pSIg) . Valve Recommendations 
r--------U.S.Can.Jcf~I@700F OutIet*** 
1300 ~131018.7012640 
230 6Zero O.ITM [200r.1 1...3.. 8..... '122.00.... 'II ~fSb1238 12200 
[TOC Grade' I:: 	~ i;!~ :~. :~.~ li~ 
\ [<r186[23812200 
\Zero Ambient ISee Environmental Section 
ICGA 590 

ICGA 590 

ICGA.590 

.·ICGA590 

[eGA 590 

A 	 0ICG
. ..' 59 
. 1300 r pro 18.70 12640ICGA 590 ~~~~~~n**zero '200 EI230I6.3~12200 ICGA590
,-------1 ~186 , \2.3 8.• =-12.2-;-;;0~0_______."""IC"""G-,-A.,.,.59"",0;-- _752_o 
I 1300 rplO 18.70 -12640 [CGA 590 Flowmeter 
zero 1.0TM C-::-~ f230 [638[2200. ICGA 590 Model B7920 (choose 
OOlI 12UU ~18612.3812200 [CGA 590 iH6::~erorregUlred 
~----POO~1310poI2640 jCGA590 
IC02 Free 
, 
Zero 2.0TM 
I 
.,------
IDry 
I 
I 
1	 rr-[230 16.38 12200 [CGA590200[<rfSbfD8[2200ICGA 590 
1300 ~pmI8.70 12640 
1200 EI23o[O.38. 12.20~ [<r18612.38 '12200 
[L.B. 	 r~II775 
rr-1310 18.70 12640 
c-::-rr-f230[638[2200 
[200 [<r186[D812200 
IL.B·r--!2~11775 
It=H;:-;-ig-:-h-;;P=--re-s-su-r'e-f500r--1502j13.92 16000 
*** Other sizes available upon request. 
10f2 
=Ro--e-gu-'l-at"--o-r -­
2 Sta!:te Brass Model 
BHT300 
1 Stage Brass Model 
BHS500 
High Pressure 
1 Stage Brass, Model 
. BHS 4 Lecture Bottle, 
Model 325 
Filter 
10micron,Model 
jCGA590 

.. JCGA 590 

jCGA590 

ICGA 170 
ICGA 590 
ICGA 590 
[CGA 590 

ICGA 170 

ICGA 702 
 ..... 
... 
He 
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BOC: Special Gases: Product Catalog n«p://www.ooc.conllgasl:slprUUU-':lbl ... lHell\..:1; ill u",,,,,,,,, 0"""'" p ...... , .......HU. 

Shipping Information: 
DOT/TDG Name Air, Compressed 
HazardlTDG Class 2.2 
ID No. UN 1002 
* TOC Grade is used on a Total Organic Carbon analyzer which measures carbon 

compounds in water. 

** Prepared and certified to meet Federal Register Specifications, Title 40 CFR 86. 

114-78. 

*** The Valve Outlet for Canada is CGA 346. 

Technical Data: 

Mol. Wt. 28.97 

Sp. Volume 13.3 cf/lb (0.833 m3/kg) 

Critical Temp -221.1 of (140.6 0c) 

Critical Press 546.8 psia (3774 kPa) 

Flammable Limits Supports Combustion 

Toxicity Nontoxic 

Compatibility Noncorrosive 

DOT/TDG Label Nonflammable Gas 
WHMIS Class A 
CAS No. (02) 7782-44-7 
(N2) 7727-37-9 
MSDSNo. 0-113 
20f2 218 4/20/0012:44 PM 
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Appendix CGeneric cPA 
BOILER.lCS (Project Summary) 
ITEM 
PROJECT INFORMATION 
Project Name 

Project Description 

Analysis Date and Time 

Simulator Type 

Simulator Version 

Simulator Report File 

Simulator Report Date 

Economic Analysis Type 

IPE Version 

Project Directory 

Scenario Name 

Scenario Description 

CAPITAL COST EVALUATION BASIS 
Date 

Country 

Units of Measure 

Currency (Cost} Symbol 

Currency Conversion Rate 

System Cost Base Date 

Project Type 

. Design code 
Prepared By 
Plant Location 
Capacity 
Time Difference Between System Cost Base Date and Start Date for Engineering 
User Currency Name 
User Currency Description 
User Currency Symbol 
PROJECT RESULTS SUMMARY 
Total Project Capital Cost 

Total Raw Materials Cost 

Total Products Sales 

Total Operating Labor and Maintenance Cost 

Total Utilities Cost 

Total Operating Cost 

Operating Labor Cost 

Maintenance Cost 

Operating Charges 

Plant Overhead 

Subtotal Operating Cost 

G and A Cost 

UNITS 
USD/U.S. DOLLAR 
Days 
Cost 
CosUperiod 
CosUperiod 
CosVperiod 
CosVperiod 
Cost/period 
Cost/period 
Cost/period 
Cost/period 
Cost/period 
Cost/period 
VALUE 
TPA-2 
Thu APr 2014:08:392000 
AspenTech 
10.1-0 Build 25­
C:\boiler.rep 
Sunday, April 09, 2000 
IPE 
5 
C;\PROJECTS.lPE\Projects\TPA-2 
20-Apr..Q0 
US 
I-P 
U.S. DOLLAR 
1Q 98 
Grass roots/Clear field 
ASME 
IPE 5.0 User 
North America 
1.#INF 
276 
USD 
US Dollar 
USD 
0 12E O+
o 
o 
440000 
10682.3 
843137 
440000 
o 
110000 
220000 
780682 
62454.6 
Generic tPA Appendix C 
-AP3F. tmp 
Aspen stream report for the design of the plant steam boiler: 
1 2 
STREAM ID 
FROM 
TO 
SUBSTREAM: MIXED 
PHASE: 
COMPONENTS: LBMOL/HR 
WATER 
TOTAL FLOW: 
LBMOL/HR 
LB/HR 
CUFT/HR 
STATE VARIABLES: 
TEMP F 
PRES PSI 
VFRAC 
LFRAC 
SFRAC 
ENTHALPY: 
BTU/LBMOL 
BTU/LB 
BTU/HR 
ENTROPY: 
BTU/LBMOL-R 
BTU/LB-R 
DENSITY: 
LBMOL/CUFT 
LB/CUFT 
AVG MW 
1 
B1 
LIQUID 
61.0849 
61.0849 
1100.4617 
17.6573 
68.0000 
14.7000 
0.0 
1. 0000 
0.0 
-1.2297+05 
-6825.8988 
-7.5116+06 
-39.1336 
-2.1722 
3.4594 
62.3232 
18.0152 
2 
B1 
VAPOR 
61.0849 
61.0849 
1100.4617 
1. 2148+04 
266.0000 
39.1600 
1. 0000 
0.0 
0.0 
-1.0243+05 
-5685.8179 
-6.2570+06 
-10.0992 
-0.5605 
5.0286-03 
9.0592-02 
18.0152 
Page 1 
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-AP3D.tmp 
Aspen Block Report for the plant wide steam boiler: 
BLOCK: B1 MODEL: HEATER 
INLET STREAM: 1 
OUTLET STREAM: 2 
PROPERTY OPTION SET: IDEAL IDEAL LIQUID / IDEAL GAS 
*** MASS AND ENERGY BALANCE *** 
IN OUT RELATIV 
E DIFF. 
TOTAL BALANCE 
MOLE (LBMOL/HR) 61.0849 61.0849 0.0000 
OOE+OO 
MASS (LB/HR 1100.46 1100.46 0.0000 
OOE+OO 
ENTHALPY (BTU/HR -0.751164E+07 -0.625703E+07 -0.1670 
*** INPUT DATA *** 
ONE PHASE TP FLASH SPECIFIED PHASE IS VAPOR 
SPECIFIED TEMPERATURE F 266.00 
o 
SPECIFIED PRESSURE PSI 39.16 
00 
MAXIMUM NO. ITERATIONS 30 
CONVERGENCE TOLERANCE 0.00 
010000 
*** RESULTS *** 

OUTLET TEMPERATURE F 266.00 

OUTLET PRESSURE PSI 39.160 

HEAT DUTY BTU/HR 0.12546E+ 

Page 1 
2.8\ 
07 

GenerictPA AppendixD 
THE FOLLOWING IS A PRINTOUT OF THE SUPERPRO DESIGNER STREAM REPORT. 

IT PROVIDES COMPONENT FLOWS FOR STREAMS THROUGHOUT THE SEPARATION SECTION. 

BULK RAW MATERIAL REQUIREMENTS PER SECTION 
==============================================================~=========== 
SECTIONS IN: Main Branch 
Separation Section 
Raw Material kg/Year kg/Batch kg/kg MP 
Arginine 72491.27 1066.048 N/A 

WFI 20811.12 306.046 N/A 

Glycine 540.29 7.945 N/A 

NaOH {I Ml 13106.55 192.743 N/A 

Media 242386.00 3564.500 N/A 

Biomass 31094.70 457.275 N/A 

tPA 146.88 2.160 N/A 

Sodium Chloride 4500.97 66.191 N/A 

PBS 116234.76 1709.335 N/A 

Sucrose 1. 75 0.026 N/A 

Section Total 501314.31 7372.269 N/A 
SUMMARY (Entire Flowsheetl 
Raw Material kg/Year kg/Batch kg/kg MP 
A!:ginine 72491. 27 1066.048 N/A 

WFI 20811.12 306.046 N/A 

Glycine 540.29 7.945 N/A 

NaOH (I M) 13106.55 192.743 N/A 

Media 242386.00 3564.500 N/A 

Biomass 31094.70 457.275 N/A 

t ?l\ 146.88 2.160 N/A 

Sodium Chloride 4500.97 66.191 N/A 

PBS 116234.76 1709.335 N/A 

Sucrose 1. 75 0.026 N/A 

F10wsheet Total 501314.31 7372.269 N/A 
======================~===============~=================================== 
.2.83 

Generic tPA Appendix D 
BREAKDOWN PER RAW MATERIAL AND SECTION {kg/batch} 
=====================================~================ 
Raw Material Separation Section Subtotal 
Arginine 1066.048 1066.048 

WFI 306.046 306.046 

Glycine 7.945 7.945 

NaOH {1 M} 192.743 192.743 

Media 3564.500 3564.500 

Biomass 457.275 457.275 

tPA 2.160 2.160 

Sodium Chloride 66.191 66.191 

PBS 1709.335 1709.335 

Sucrose 0.026 0.026 

TOTAL 7372.269 7372.269 
====================================================== 
BREAKDOWN PER RAW MATERIAL AND SECTION (kg/year) 
====================================================== 
Raw Material Separation Section Subtotal 
Arginine 72491.3 72491. 3 

WFI 20811.1 20811.1 

Glycine 540.3 540.3 

NaOH (1 M) 13106.6 13106.6 

Media 242386.0 242386.0 

Biomass 31094.7 31094.7 

tPA 146.9 14 6.9 

Sodium Chloride 4501.0 4501.0 

PBS 116234.8 116234.8 

Sucrose 1.8 1.8 

TOTAL 501314.3 501314.3 
264 

GenerictPA Appendix D 
COMPONENT BALANCE AND STREAM REPORT 
========================~==~=============================================~===== 
STREAM NAME P-2 P-11 P-16 P-19 P-20 
SOURCE Centrifuge UF2 Pump INPUT Affinity Co INPUT 
DESTINATION OUTPUT UF2 Affinity Co ER Tank ER Tank 
==========~===========================================================~======== 
STREAM PROPERTIES 
ACTIVITY U/ml 0.0 0.0 0.0 0.0 0.0 
TEMP °c 4.0 5.7 4.0 4.0 25.0 
PRES bar 1.0 3.0 1.0 1.0 1.0 
DENSITY gil 1050.0 1150.5 1187.7 1186.8 1043.0 
COMPONENT FLOWRATES (kg/Batch) 
Arginine 0.0000 115.1645 148.6561 114.3509 0.0000 
Biomass 457.2750 0.0000 0.0000 0.0000 0.0000 
Glycine 0.0000 0.0000 7.9455 6.1119 0.0000 
Media 0.3565 200.3153 0.0000 0.0000 0.0000 
Sodium Hydroxid 0.0000 0.0000 0.0000 0.0000 0.0126 
tPA 0.1080 1.9375 0.0000 1.6068 0.0000 
Water 0.0000 0.0000 0.0000 0.0000 0.3154 
WFI 0.0000 0.0000 199.9221 153.7862 0.0000 
========~====================================================================== 
TOTAL (kg/batch) 457.7394 317.4173 356.5237 275.8558 0.3280 

TOTAL (m3/batch) 0.4360 0.2759 0.3002 0.2324 0.0003 

=============================================================================== 
=============================================================================== 
STRElo.M NAME P-4 P-27 P-25 P-7 P-5 
SOURCE INPUT INPUT ER Column UFl un Tank 
DESTINATION un Tank MF Tank MF Tank OUTPUT un Pump 
=============================================================================== 
STREfu\1 PROPERTIES 
ACTIVI7Y U/m1 0.0 0.0 0.0 0.0 0.0 
TEMP °c 4.0 25.0 25.0 4.0 30.6 
PRES bar 1.0 1.0 1.0 3.0 1.0 
DENSITY gil 1562.0 1000.0 1186.6 1074.4 1074.4 
COt-1PONENT FLOWRATES (kg/Batch) 
Arginine 850.0000 0.0000 114.3509 802.2275 850.0000 
Glycine 0.0000 0.0000 6.1119 0.0000 0.0000 
Media 0.0000 0.0000 0.0000 3363.8282 3564.1436 
SodiL:.m Hydroxid 0.0000 0.0000 0.0126 0.0000 0.0000 
Sucrose 0.0000 0.0000 0.0258 0.0000 0.0000 
tPA 0.0000 0.0000 1.6028 0.1145 2.0520 
Water 0.0000 0.0000 0.3154 0.0000 0.0000 
1'1FI 0.0000 59.0000 153.7862 0.0000 0.0000 
Generic tPA Appendix D 
======~===:==================================================================== 
TOTAL (kg/batch) 850.0000 59.0000 276.2056 4166.1702 4416.1956 

TOTAL (m3/batch) 0.5442 0.0590 0.2328 3.8775 4.ll03 

=====~========================================================================= 
=========~===================================================================== 
STREAi.'1 NAME P-8 P-10 P-13 P-14 P-22 

SOURCE UFl UF2 Tank UF2 Affinity Ta INPUT 

DESTINATION UF2 Tank UF2 Pump Affinity Ta Affinity Co ER Column 

================================================~=========================~==== 
STREAM PROPERTIES 
ACTIVITY U/ml 0.0 0.0 0.0 0.0 0.0 
TEMP °c 4.0 4.0 4.0 4.0 4.0 
PRES bar 3.0 1.0 3.0 1.0 1.0 
-DENSITY gil 1074.2 ll50.5 1150.5 ll50.5 1043.0 
COMPONENT FLOWRATES (kg/Batch) 
Arginine 47.7725 115.1645 112.8646 112.8646 0.0000 
Media 200.3153 200.3153 196.3148 196.3148 0.0000 
Sodium Hydroxid 0.0000 0.0000 0.0000 0.0000 7.3888 
tPA 1.9375 1.9375 1.8904 1.8904 0.0000 
Water 0.0000 0.0000 0.0000 0.0000 185.0267 
=============================================================================== 
TOTAL (kg/batch) 250.0253 317.4173 311.0698 311.0698 192.4154 
TOTAL (m3/batch) 0.2327 0.2759 0.2704 0.2704 0.1845 
==========~==================================================================== 
=============================~================================================= 
STREAM NAl-'lE P-23 P-32 P-31 P-l P-18 
SOURCE INPUT Microfilter Microfilter INPUT Affinity Co 
DESTINATION ER Column FD Tank OUTPUT Centrifuge OUTPUT 
======================~====================~==============~=======~============ 
STREAM PROPERTIES 
ACTIVITY U/ml 0.0 0.0 0.0 0.0 0.0 
TEMP °c 4.0 4.0 4.0 37.0 4.0 
PRES bar 1.0 2.3 2.3 1.0 1.0 
DENSITY g/1 1000.0 ll48.9 ll48.8 1005.5 1047.0 
COMPONENT FLOWRATES (kg/Batch) 
Arginine 0.0000 114.3497 O. 0011 0.0000 147.1698 
Biomass 0.0000 0.0000 0.0000 457.2750 0.0000 
Glycine o.odoo 6.1119 0.0001 0.0000 1. 8336 
KCl 0.0000 0.0000 0.0000 0.0000 0.0034 
KH2P04 0.0000 0.0000 0.0000 0.0000 0.0034 
Media 0.0000 0.0000 0.0000 3564.5000 196.3148 
Na2HP04 0.0000 0.0000 0.0000 0.0000 1.8803 
Sodium Chloride 0.0000 0.0000 0.0000 0.0000 79.8655 
Sodium Hydroxid 0.0000 0.0126 0.0000 0.0000 0.0000 
Sucrose 0.0000 0.0258 0.0000 0.0000 0.0000 
tPA 0.0000 1. 6028 0.0000 2.1600 0.2836 
Water 0.0000 0.3154 0.0000 0.0000 0.0000 
WFI 47.1239 212.7841 0.0021 0.0000 1739.9087 
=============================================================================== 
281.o 

--------.-~-------------"4-
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TOTAL (kg/batch) 47.1239 335.2022 0.0034 4023.9350 2167.2631 

TOTAL (m3/batch) O. 0471 0.2918 0.0000 4.0021 2.0699 

=================~============================================================= 
=============================================================================== 
STREAM NAME P-24 P-15 P-17 P-12 P-3 

SOURCE ER Column INPUT INPUT UF2 Centrifuge 

DESTINATION OUTPUT Affinity Co Affinity Co OUTPUT UFl Tank 

=============================================================================== 
STREAM PROPERTIES 
ACTIVITY U/ml 0.0 0.0 0.0 0.0 0.0 

TEMP °c 4.0 4.0 4.0 4.0 37.0 

PRES bar 1.0 1.0 1.0 3.0 1.0 

DENSIT'f gil 1016.6 1020.5 1020.5 1150.4 1000.0 

COMPONENT FLOWRATES (kg/Batch) 
Arginine 0.0000 0.0000 0.0000 2.2999 0.0000 
KCl 0.0000 O. 0011 0.0023 0.0000 0.0000 
KH2P04 0.0000 O. 0011 0.0023 0.0000 0.0000 
Media 0.0000 0.0000 0.0000 4.0005 3564.1436 
Na2HP04 0.0000 0.6268 1.2535 0.0000 0.0000 
Sodium Chloride 0.0000 26.6218 53.2436 0.0000 0.0000 
Sodium Hydroxid 7.3888 0.0000 0.0000 0.0000 0.0000 
tPA 0.0040 0.0000 0.0000 O. 0471 2.0520 
Water 185.0267 0.0000 0.0000 0.0000 0.0000 
WFI 47.1239 564.5910 1129.1819 0.0000 0.0000 
=============================================================================== 
TOTAL (kg/batch) 239.5433 59"-.8418 1183.6836 6.3475 3566.1956 
TOTAL (m3/batch) 0.2356 0.5800 1. 1599 0.0055 3.5661 
=============================================================================== 
============================~============~===================================== 
STREAM NAME P-6 P-2l P-30 P-33 P-35 
SOURCE UFI Pump E~ Tank MF Pump FD Tank Freeze Drye 
DESTINATION on ER Column Microfilter Freeze Drye OUTPUT 
============~================================================================== 
STREA~l PROPERTIES 
ACTIVITY U/ml 0.0 0.0 0.0 0.0 0.0 
TEMP °c 32.2 4.0 5.1 4.0 12.0 
PRES bar 3.0 1.0 2.3 1.0 1.0 
DENSITY gil 1074.4 1186.6 1148.9 1148.9 1000.0 
COMPONENT FLOWRATES (kg/Batch) 
Arginine 850.0000 IH.3509 114.3509 114.3497 0.0000 
Glycine 0.0000 6.1119 6.1119 6.1119 0.0000 
Media 3564.1436 C.OOOO 0.0000 0.0000 0.0000 
Sodium Hydroxid 0.0000 0.0126 0.0126 0.0126 0.0000 
Sucrose 0.0000 0.0258 0.0258 0.0258 0.0000 
tPA 2.0520 1.6068 1. 6028 1. 6028 0.0000 
Water 0.0000 C.3154 0.3154 0.3154 0.3154 
loJFI 0.0000 153.7862 212.7862 212.7841 212.7841 
=========~===================================================================== 
2.81 
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TOTAL (kg/batch) 4416.1956 276.2096 335.2056 335.2022 213.0995 

TOTAL (m3/batch) 4.1103 0.2328 0.2918 0.2918 0.2131 

=============================================================================== 
=================================================================== 
STREAM NAME P-29 P-36 P-9 P-26 
SOURCE MF Tank Freeze Drye INPUT INPUT 
DESTINATION MF Pump OUTPUT UF2 Tank ER Tank 
=================================================================== 
STREAM PROPERTIES 
ACTIVITY U/ml 0.0 0.0 0.0 0.0 
TEMP °c 4.0 12.0 4.0 4.0 
PRES bar 1.0 1.0 1.0 1.0 
DENSITY gil 1148.9 1552.1 1562.0 1581.0 
COMPONENT FLOWRATES (kg/Batch) 
Arginine 114.3509 114.3497 67.3920 0.0000 
Glycine 6.1119 6.1119 0.0000 0.0000 
Sodium Hydroxid 0.0126 0.0126 0.0000 0.0000 
Sucrose 0.0258 0.0258 0.0000 0.0258 
tPA 1. 6028 1. 6028 0.0000 0.0000 
Water 0.3154 0.0000 0.0000 0.0000 
WFI 212.7862 0.0000 0.0000 0.0000 
TOTAL (kg/batch) 335.2056 122.1027 67.3920 0.0258 
TOTAL (m3/batch) 0.2918 0.0787 0.0431 0.0000 
=================================================================== 
OVERALL CO~PONEN~ BALANCE (kg/Batch) 
============================================================================== 
COMPONENT IN OUT (OUT-IN) 
Arginine 1066.048129 1066.048129 0.000000 

Biomass 457.275000 457.275000 0.000000 

Glycine 7.945491 7.945491 0.000000 

KCl 0.003419 0.003419 0.000000 

KH2P04 0.003419 0.003419 0.000000 

Media 3564.500000 3564.500000 0.000000 

Na2HP04 1.880268 1.880268 0.000000 

Sodium Chloride 79.865456 79.865456 0.000000 

Sodium Hydroxid 7.401347 7.401347 0.000000 

SClcrose 0.025800 0.025800 -0.000000 

:PA 2.160000 2.160000 0.000000 

Water 185.342066 185.342066 0.000000 

t-JFI 1999.818810 1999.818810 0.000000 

TOTAL 7372.269205 7372.269205 0.000000 
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Re: Senior Design Project 
Generic tPA AppendixD 
Subject: Re: Senior Design Project 

Date: Thu, 02 Mar 2000 13:55:03 +0000 

From: Scott Diamond <sld@seas.upenn.edu> 

To: Christian M Metallo <cmetallo@seas.upenn.edu> 

tpa is shipped at lOO-retPA per bottle. When the tPA is dissolved in 100 
of 
sterile water, the result is 2 M arginine, I think. I do not know the 
sucrose level but 
I suspect that it is between 10 uM and 200 uM sucrose. 
As long as the final salt concentration after dissolving the tPA in 100 m 
of sterile W~' 
is .less than,lSO u it will look like a balanced saline solution suitable 
for inj ection" ­
Ccri"('E"ctEd ~ \51)1'V\ H 1'1'1. ~O"t)cJ 
Dr. Diamond c..erm~\Jl'hC.o..+t ~ ~I ?ro~. 0\.Q 1K'IO"(tJ. 
Christian M Metallo wrote: 
> Prof. Diamond, 
> Do you know where I can find info on the exact packing "recipe" for tPA 
> I need to know how much tPA per dose. I'm assuming the rest would be 
> sucrose and arginine. There would also be some salts left from adjusti 
> the pH after the anion exchange. Will that be a problem? 
> 
> Please get back to me when you get a chance. 
> Thanks 
> 
> Chris 
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Update Profile Tech Library Product Search MSDS Surch Or~ Centw Contact Us Home Help 

Product Number: A6969 

Product Name: L-Arginine Hydrochloride 

Product Infomation 
• Description 

.. Certificate of Analysis 

• MSDS 
~~>W_"___' 
.. Add To Shelf 
• Print Preview 	 Molecular Weight: 210.6 

CAS: 1119-34-2 
• Bulk Quote 
Purity Grade: Biotechnology Performance Certified, EP, JP, USP, >=98.5% 
• Ask A Scientist Quality/Application: Cell culture tested 

Form/Aspect: Powder
Go To Assay: >=98.5% 
.. Previous Page Comments: Source: Non-animal source 
.. §lama-Aldrich Home 	 Soluble in water (100 mg/ml) . 
Endotoxin tested 
~qO 
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Product Number: G8790 
Product Name: Glycine 
~ Description 
~ Certificate of Analysis 
~MSDS 
Glycocoll 
Molecular Formula: C2H5N02 
Molecular Weight: 75.07 
CAS: 56-40-6 
Purity Grade: Biotechnology Performance Certified, >=98.5% 
Quality/Application: Cell culture tested 
• Previous Page 	 Form/Aspect: Powder 
Assay: >=98.5%
• Sigma-Aldrich Home Comments: Source: Non-animal source 
Soluble in water (100 mg/ml). 
Endotoxin tested 
415/00 4: 13 P~l1 of 1 
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• ~ma-A1drich Home 
Product Number: 84105 

Product Name: D(+)-Sucrose

- Productlnfomatian 
.. Description .~ ~s.w. 2:z.
• Certificate of Analysis 
• MSDS 
• Structure Image Synonyms: Beet sugar; Cane sugar; J 
-Options ~-D-Fructofuranosyl-a-D-glucopyranoside; 0(+)-Saccharose; Sugar 
Molecular Formula: C12H22011 "'1$!{'/~_
Molecular Weight: 342.30 
CAS: 57-50-1 
Purity Grade: BioChemika for biotechnological purposes; ~ 98.0% (HPLC) 
Comments: 
a20546 +78.0± 10 (c= 26 in H20) 
a20D +66.5± 10 (c= 26 in H20) 
Solubility (0.1 glml H20) soluble 
mp ~185°C (dec.) (Lit.) 
•ELINCS/EINECS Number: 2003349 
BRN: 90825 
Merck Index: 12,9051 
Beilstein Index: 17, 8, V, 399 
R&S: F: 3 
Compliance: RTECS WN6500000 • WGK 0 
Miscellaneous: Mono- and oligosaccharides; Culture media, additives for 
10fl dQ2' 4/5/004:09 P\1 
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Product Number: 07030 
Product Name: Oulbecco's Phosphate Buffered Saline Hybri-Max® 
~Product InfollatiGD 
~ Description 
• Certificate of Analysis 
.,MSDS 
~.,,,,----~-~
Options 
Synonyms: 

Quality/Application: Hybridoma tested. 

Form/Aspect: Powder 

Comments: Without calcium chloride and magnesium chloride. 

Endotoxin tested. 

Formulated to contain 9.6 grams of powder per liter of medium. 

Storage Temp: Store at 2-8°C 

R&S: R: 36/37/38, S: 26,36 

• Add To Shelf 
4/5/004: 16 PM1 of 1 
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Product Number: 55881 

Product Name: Sodium hydroxide 

Product Infomation 
.. Description 
• Certificate of Analysis 
tMSDS 
• Structure Image 
~
• Add To Shelf Molecular Weight: 40 
• Print Preview CAS: 1310-73-2 
tBulk Quote Purity Grade: Minimum 98% 
t Ask A Scientist Form/Aspect: Pellets j fT. 5L-t'i/~
Assay: Minimum 98% 
Gola Comments: Bulk packages 
• Previous Page Storage Temp: Store at RT. 

t §lgma-Aldrich Home R&S: R: 35, S: 26,37/39,45 
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Product Number: 71376 
Product Name: Sodium chloride
- Product Into.alion 
~ Description 

~ Certificate of Analysis 

~MSDS 

~ Structure Image 

~ Add To Shelf 
Molecular Weight: 58.44 
CAS: 7647-14-5 
Purity Grade: BioChemika MicroSelect for molecular biology; ~ 99.5% (AT) 
Comments: Sales restrictions 
Total nitrogen (N) ~ 0.001% 
Iodide (I) ~ 0.001% K ~0.005% 
Mg ~0.0005% 
As Mo~ 0.00001% ~0.0005% 
Bi ~0.0005% Ph ~ 0.0005% 
Cd Zn~0.0005% ~0.0005% 
Cr ~0.0005% A(run): 260 Amax: 0.01 
ELINCS/EINECS Number: 2315983 
Merck Index: 12, 8742 
Literature References: Component of lysis buffer and extraction buffer in 
the large-scale phenol extraction of RNA: D.M. Wallace, Meths. Enzymol. 
152, 39 (1987); Simple salting out procedure for extracting DNA from human 
nucleated cells: SA Miller, et al., Nucleic Acids Res. 16,1215 (1988) 
Compliance: RTECS VZ4725000 ·CH-Giftkl. free· WGK 0 
Miscellaneous: Density gradient centrifugation; Crystallization of 
biopolymers; Sodium salts (MicroSelect); Molecular biology, common 
reagents 
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Westfalia Separator, 
Fax: 

To: Christian Metallo From: Derek Ettie :20 \-7 f.Ll-6 g1 J 
falc 215-573-7601 pages=i 
Phone: Date~ 03129/00 
Re: CHOcelis cc: 
::: 
Cl Urgent 0 For Review bPIe;tSe Comment Cl Please Reply Cl Please Reqcle 
• Comments: ,; 
PRICE FOR esc 4 IS $355,OOO:~SKlD MOUNTED • MOTOR AND CONTROLS. CAPACITY OF 
THIS UNIT IS 40()..500 LlHR. :i 
., 
ANY QUESTIONS PLEASE CALL~E 
DEE1@WSUS.COM 
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Data Sheet 

CSC 4 Clarifier 
< 
In steam-sterilizable design 
CSC 4-06-476 
Complete plant systems 
with automatic or manual SIP 
for down-stream processing 
of fermentation broths under 
sterile conditions 
Fields of application 
Biotechnology, pharmaceutical 
and food industry 
;Jq 
Operating principles and constructional features 

esc 4-06-476 Bowl with turbidity measurements 
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1 Feed 
2 Discharge 
3 Disc stack 
4 Hydrohermetic feed system 
5 Cooling, hood 
6 Sediment ejection ports 
7 Annular valve 
8 Discharge nozzle 
9 Cooling, solids collector 
10 Storage chamber 
11 Operating water discharge 
12 Sealing liquid discharge 
13 Slide-ring packing 
14 Operating-water feed 
15 Valve (dosing and pre-filling) 
16 Valve (Opening) 
17 Leakage outlet 
18 Sealing liquid feed 
19 Sliding piston 
20 Closing chamber 
21 Feed, solids collector cooling 
22 Discharge, solids collector cooling 
23 Feed, hood cooling 
24 Control unit 
25 Centripetal pump 
26 Discharge, hood cooling 
27 Turbidity meter 
Typical product applications 
• 	 Starter cultures for the food and pharmaceutical sectors 
<e.g. lactic acid bacteria). 
• 	 Recovery of biomass for pharmaceutical products (e.g. 
E-Coli). 
• 	 Treatment of genetically engineered micro-organisms 
and vaccines, made possible by the dosed machine and 
installation concept (biocontainment). 
• 	 Gentle discharge of biomass with product-damaging 
cell constituents. 
This clarifier incorporates the very latest developments in 
centrifuge constructio~. 
The basic features of this new development are: 
• 	 Clarifier bowl in sanitary design. 
• 	 Cleaning-in-place - capacity of the clarifier. 
• 	 Steam-sterilizable (SIP) up to 1.5 bar steam pressure 
(127°C). 
• 	 Double-acting slide-ring packing as interface to the drive 
chamber. 
• 	 Closed product feed and gentle treatment of shear-sensi­
tive micro-organisms due to the hydrohermetic feed 
system. 
• 	 No product contamination due to wear of lip seals and 
mechanical seals as is the case with hermetically sealed 
machines. 
• 	 Low noise pollution due to double-walled coolable hood 
and solids collector suitable for connection to a closed 
sealing system up to 1 bar overpressure. 
• 	 "Hydrostop" system for controlled partial solids ejec­
tions. 
Bowl 
The product enters the bowl via the inlet (1) and is clarified 
in this disc stack (3). Centripetal pump (25) then conveys 
the clarified liquid under pressure to outlet (2), where it is 
discharged without foam .. 
The separated solids collect in sediment holding space and 
are ejected periodically via ports (6). 
Operating water is used only during the actual process of 
ejection. , 
Automatic solids ejection 
Bowl ejections are controlled automatically by control unit 
(24) 
The following operations are possible: 
• 	 partial ejections 
• 	 a combination of short and long partial ejections 
• 	 Displacement of the liquid phase from the bowl before a 
total ejection 
• 	 Flush ejection after every total ejection 
Control systems 
The following systems are available for controlling the au­
tomatic bowl ejections: 
• 	 Time-dependent control to suit the particular operation. 
Recommended for use with products in which the solids 
content remains constant. 
30C 
• 	 Photoe!ectnc control usmg a turbIdlty measurement ~.:./ ) 
to monitor the clarified liquid. If a pre-set turbidity level 
is exceeded, a signal is passed to the control unit (24) 
which then initiates the solids ejection process. Recom­
mended for use with translucent liquids in which the 
solids content is not constant or if the throughput capaci­
ty varies. This monitoring system can be installed on 
every standard centrifuge. 
The "hydrostop" system for 
controlled partial solids ejections 
When product is processed, only partial solids ejections are 
performed. 
The solids ejections is initiated by the control unit. 
In the case of partial solids ejection, the hydraulically oper­
ated sliding piston (19) must be opened within as short a 
time as possible so as to ensure that the ejection ports are 
opend wide enough to allow unimpeded solids ejection. 
The sliding piston (19) is in closed position (left side of fig­
ure) when the closing chamber (20) is full. The annular 
valve (7) is hydraulically opened via valve (16) (right side 
og fig.). The operating-water flows from the closing cham­
ber (20) into the storage chamber (10). When the storage 
chamber (10) is full, the flow of liquid from the closing 
chamber (20) will automatically stop, although the annular 
piston (7) is still open ("hydrostop" system). The bowl then 
opens and the solids are discharged rapidly through the 
ejection ports (6). 
The amount of solids ejected depends on the liquid level in 
the storage chamber (10) (controlled partial solids ejection). 
The amount of solids to be ejected can be pre-selected by 
partially filling the storage chamber (10) before the solids 
ejection is initiated. This is done by opening valve (15). 
After the ejection process, the closing chamber (20) is 
topped up via valve (15). The annular valve (7) then closes. 
The storage chamber empties through discharge nozzle (8). 
This new "hydrostop" system reduces the actual solids ejec­
tion time to less than 1/10 second. In the case of solids 
which are difficult to eject, a longer solids ejection cycle is 
initiated after several partial solids ejections, which has the 
effect of flushing out remaining solids while the product 
feed is still open. 
Total solids ejection sequence 
For total solids ejection, the closing chamber (20) is emptied 
via the annular valve (7) and the nozzle (8) by the addition 
of operating-water via valve (15). The sliding piston (19) 
remains open until the whole bowl contents have been 
ejected. The sliding piston (19) is then closed by supplying 
closing water via valve (15). 
Feed and discharge 
The product is fed into the centrifuge by means of a closed 
system of pipes. The clarified liquid is discharged foam-free 
and under pressure via a centripetal pump. 
Hydrohermetic product feed 
In this design the centrifuge is equipped with a hydroher­
metic product feed (4). This new inlet system prevents 
shearing forces from acting on the product when entering 
the bowl. Similar as with the fully hermetic design, the 
product stream is accelerated by the product itself in the 
filled bowl. This makes for gentle treatment and optimum 
clarifying efficiency, especially in the case of sensitive prod­
ucts and low throughput capacities. 
Cooling 
The solids collector and the hood are of double-wall design 
for cooling the discharged solids (5, 9). 
Cleaning~in-place (CIP) 
Once the centrifugation process has been completed, the 
machine can be cleaned-in-place. The cleaning solution is 
circulated round the centrifuge and the connected system. 
Total ejections are initiated during CIP manually or auto­
matically on the control unit via an external CIP control. 
Sterilization 
The stationary installation is sterilized with hot steam 
(127°C) under an excess pressure of 1.5 bar. The duration 
of sterilization is dependent on the nature of the bacteria 
and the number of germs. Experience suggests a time 
between 60 minutes. 
The condensate is conveyed from the lowest point of the 
system to the killing line. 
Following sterilization, the whole system is blanketed with 
sterile air until the next product run. 
Frame and drive 
The cast-iron frame is equipped with brakes, a rev indicator 
and an oil level sight glass. 
•The machine is driven by a three-phase AC motor with fre­
quency converter for smooth starting. Power is transferred 
to the bowl spindle via a flexible coupling and worm wheel 
gear. All bearings and the gear are splashlubricated from a 
central oil bath. 
Monitoring 
• 	 Lube oil sight glass 
• 	 Temperature feeler and overcurrent release for motor 
protection in case of overload .. 
• 	 Speed measuring device 
• 	 Vibration monitoring system .. 
• 	 Turbidity meter for monitoring the discharge .. 
• 	 Level probes in the solids tank in case of enclosed solids 
discharge 
•Additional parts available at extra charge 
Materials 
All parts coming into contact with the product are made of 

austenitic Cr-Ni-Mo stainless steel or, in the case of highly 

stressed bowl parts, of soft martensitic Cr-Ni-Mo steel or 

duplex alloys. 

The gaskets are made of ethylene-propylene-diene­

caoutchouc (EPDM) and Polyamid. 

Assembly and dismantling 
Special tools for installing and removing the bowl are 
included in the supply schedule. 
Additional equipment 
(available at extra charge) 
Complete plant systems with automatic or manual SIP 
3D\ 

I 
I Technical data 
I 
Technical data 
Bowl 
Speed up to 12000 min-! 
Total bowl volume 1.8 I 
Volumen of sediment holding space 0.7 I 
Max. pressure produced 
by centripetal pump approx. 5 bar 
Three-phase AC motor 
Motor power up to 7.5 kW 
Speed at 87 Hz 3000 min-1 
Type IM:B5 
Type of protection IP55 
Weights 
Separator complete approx. 230 kg 
Bowl approx. 50 kg 
Capacity 
Rated capacity 
with one channel centripetal pump approx. 100 l/h 
with three channel centripetal pump approx .. 300 l/h 
The rated capacity indicates the maximum throughput rate of the bowl. The actual Height 900mm 
I operating capacity .is usually lower. It depends on the particular product and on theWidth 1000mm required level of clarification. Depth 750mm 
I Subject to modification 
@ 
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KOCH PRODUCT SPECIFICATIONS 

PRODUCT TYPE: HF .14-43-PMSO PART NUMBER: 0720082 
DATE; 7/18/95 
REVISION: 
CONFIGURATION: 3" X 25" HOLLOW FIBER CARTRIDGE 
COMPONENTS; 
MEMBRANE: POLYSULFONE 
HOUSING SHELLJEND CAPS: POL YSULFONE 
CONWED: YELLOW 
FDA STATUS~ APPROVED MATERiAlS OF CONSTRUCTION 
DIMENSIONS/PROPERTIES: 
MODULE DIAMETER: 3.011 . (7.6 em) 
25nMODULE LENGTH: (63.5 em) 

MEMBRANE AREA (NOMINAL): (1.3 m2)
~ 
FIBER-COUNT MAXIMUM 660
b[;Qt-jhr MINIMUM 625 

MEAN WATER FLUX@25/15 ps',4S"C: ~ G<!I/-r+Idi 
TYPICAL RANGE: 
-­(Based on New Membrane USing RO Water) 
 ~ 

FEED FLOW VS. PRESSURE DROP: Q =12.1261 x In(L\p) - 5.1685 ~ 

RECOMMENDED OPERATING LIMITS (PROCESS TECHNOLOGY MUST APPROVE/DEFINE OPERATING AND 
CLEANING CONDITIONS FOR AlL NEW PLANTS AS WELL AS ANY CHANGES TO EXISTING PLANTS): 
MAXIMUM INLET PRESSURE @ 25"C: 40 psi ') ...... 'SjJ..t-,. 

MAXIMUM TRANSMEMBRANE PRESSURE @ 2S"C: 35 psi 

MAXIMUM BACKFLUSH PRESSURE @ 2S"C: 20 psi 

MAXIMUM TEMPERATURE AT pH 6: 140°F (60DC) 

MAXIMUM pH RANGE AT 130"F (54°C): 1.5-13.0 

MAXIMUM CHLORINE (CLEANING): 200 ppm @ pH 10·10.5, 130G F (54°C) 

oppm @ pH less than 9.5 
* 
J~",)SD A~~ 
('11111'.
,I~ {--t~ '.,.­
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KOCH PRODUCT SPECIFICATfONS 
PRODUCT TYPE: HF 14-43-PM500 
CONFIGURATION: 3" X 25" HOLLOW FIBER CARTRIDGE 
COMPONENTS: 
MEMBRANE: 
HOUSING SHELUEND CAPS: 

CONWED: 

FDA STATUS: 

DIMENSIONS/PROPERTIES: 
MODULE DIAMETER: 
MODULE LENGTH: 
MEMBRANE AREA (NOMINAL): 
FIBER COUNT 
MEAN WATER FLUX@ 25115 psi, 45°C: 
TYPICAL RANGE: 

(Based on New Membrane Using RO Water) 

FEED FLOW VS. PRESSURE DROP: 

PART NUMBER: 
DATE: 
REVISION: 
POL YSULFONE 
POL.YSULFONE 
YELLOW 
0720083 
7/18/95 
1 
APPROVED MATERIALS OF CONSTRUCTION 
3.0" (7.6 em) 
25" (63.5 em) 
14 ft2 (1.3 m2) 
MAXIMUM 690 
MINIMUM 650 
>400GFO 
a::: 12.6419 x In(Ap). 5.3779 
RECOMMENDED OPERATING LIMITS (PROCESS TECHNOLOGY MUST APPROVE/DEFINE OPERATING AND 
CLEANING CONDITIONS FOR ALL. NEW PlANTS AS WEL.L AS ANY CHANGES TO EXISTING PLANTS): 
MAXIMUM INLET PRESSURE @ 25"C: 

MAXIMUM TRANSMEMBRANE PRESSURE @ 25°C: 

MAXIMUM BACKFLUSH PRESSURE @ 25DC: 

MAXIMUM TEMPERATURE AT pH 6: 

MAXIMUM pH RANGE AT 130°F (54'C): 

MAXIMUM CHLORINE (CL.EANING): 

40 psi 

35 psi 

20 psi 

140°F (SO°C) 

1.5-13.0 

200 ppm @ pH 10-10.5. 130"F (54°C) 

op~m @ pH less than 9.5 
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Synergies Between Ultrafiltration and lon exchange nnp:IIwww.Kocmnt!nlOl.aIlt!.4..;UJll!lt:l.jillil.ai_Hi! VI ::.t:jJaHtllVll.HLlH 
SYNERGIES BETWEEN ULTRAFILTRATION AND ION 

EXCHANGE, or 

WHY UF SHOULD BE USED AS IX PRE- AND POST-TREATMENT 
by Dr. Jamie P. Monat 
Ion Exchange (IX) is a unit operation widely used for water softening, boiler feed water conditioning, ultrapure 
water generation for electronics manufacture, pharmaceutical-grade water, and other applications. Ultrafiltration 
(UF) is another unit operation often used to remove suspended solids, colloids, and macromolecules from liquid 
streams. There is a natural synergy between these two unit operations, which has largely been unexploited. As 
pre-treatment to IX, UF can significantly increase resin life and time between cleanings, thereby reducing 
operating expense. As post-treatment to IX, UF can eliminate resin fines, bacteria, organics, and colloids, thus 
improving product water quality. 
Overview of Ultrafiltration 
Ultrafiltration (UF) is a pressure-driven unit operation in which particulates, colloids, emulsified oils, and 
macromolecules are separated from a liquid feed stream upon passage through a porous semi-permeable 
membrane (Figures 1 and 2). 
Cross Flow Membrane Filtration 
Bacterium 
'Virus Fibertf rP Starch 
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Protein• ~~ 
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Figure 1 
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Basic Membrane Concepts 
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Suspended Solids 
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~ 
Water BOD 
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DissollPed SI1liIII Polysaccharides 
Solids 
Figure 2 
The separation is based primarily on the size of the species in the liquid relative to the size of the membrane 
pores (Le. a simple sieving process) although geometry of the pores, geometry of the species to be separated, 
electric charge, and membrane surface chemistry may also playa part. On the separation size spectrum, UF falls 
between Nanofiltration or NF ( membrane pore sizes below approximately 0.01 micrometer) and Microfiltration or 
MF (pore sizes greater than 1.0 micrometer; see Figure 3). 
Tangential Flow Filtration 
Reverse Osmosis Ultra1iltralion 
MicrojltrationNanoliltration 
I I I I I I 
0.0001 0.001 0.01 0.1 1.0 10.0 
Microns 
Fi ne Particulate Remo\l3l: Coarse 
Dewatering Oesahing Macromolecule:!! Clarilicati on 
Solute [I. -.a lent Ion:!! OilS. Grease Suspended Solids Co noentr.m on Suspended Solids RemovalProteins 
Remove Colloids 
Trace Os.G BaC1l!ria 
BODiCOD \Aruses 
Operating Pressures (psi) 
400·1.000 200·600 20·11)0 20·100 
Figure 3 
In ultrafiltration, small molecules such as water, monosaccharides, simple alcohols, and all ionic species pass 
through the membrane while larger molecules, particulates, bacteria, and emulsified oils and fats are retained. 
The UF membrane is usually a polymer such as polyethersulfone, polysulfone, polvinylidene fluoride, or 
polyamide and is typically cast on either a flat sheet or on the inside diameter of a tube. It may also be extruded as 
a hollow fiber. Tubular membrane products are excellent for high solids loadings as may be found in wastewater 
streams. but their low surface area-to- volume ratio makes them too expensive for pure water applications (Figure 
4). 
4/10/004:03 PM20f8 
Synergies Between Ultrafiltration and Ion Exchange http://Www.Kocnrnemorane.COIll!lel:nIlll:i:U_ill!VIl>Cpa.taUUU.ULlU 
Membrane Configurations 

Open, Wide Channel Height> Narrow, Thin 
©J 
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UlTRA-COR UII (112") 20,43,60,15 & 106 mil 4",6"& 8" 
SUPER-COR (112'" 3"& 5" sizes 
Figure 4 
Spirals, on the other hand, have a high surface area-to- volume ratio, but their narrow flow channel renders them 
susceptible to plugging. Hollow Fibers strike an excellent balance between high surface area-to- volume (and 
hence reasonable cost) and resistance to plugging, and are typically the configuration of choice for IX pre- and 
post-treatment. In addition, because hollow fibers are not cast on a backing they are not subject to delamination; 
this allows hollow fibers to be back-pulsed which is crucial in cleaning foulants from the membrane surface. 
Ultrafiltration is a well-known, proven unit operation that has historically been widely used in the food, dairy, juice, 
pharmaceutical, biotech, automotive paint, environmental control, textile, and potable water industries. Typical 
applications include the concentration of whey protein during cheese-making, clarification of fruit juices, removal 
of emulsified oils and particulates from wastewaters, separation of water from pigment in electrocoat paint, and 
removal of microorganisms from potable water. There are dozens of other applications as well. Removal and 
concentration capabilities of UF vs reverse osmosis (RO), nanofiltration (NF), and microfiltration (MF) are shown 
in Figure 3. 
Either batch or continuous process designs are available with UFo Batch processing is preferred when the feed 
stream is available intermittently in batches (as opposed to continuously) as may be the case when a small 
volume of pharmaceutical liquid needs to be clarified or concentrated, or when larger volumes of wastewater are 
processed once per week. Continuous designs are preferred when the feed stream is continuous as in a potable 
water filtration application or in the continual filtration of an automotive electrocoat paint bath; or when a 
biologically active feed must be processed quickly as in food and dairy streams. 
Hollow fiber systems are constructed with from 1 to 80 hollow-fiber cartridges on a single "stage" which is 
comprised of the membrane cartridges, a pump, feed and permeate manifolds, and appropriate valves, pipe, and 
fittings. Up to 6 stages may be ganged together for increased capacity. Hollow fiber UF membranes come with 
membrane pore sizes from 10,000 to over 2,000,000 daltons and with fiber inside diameters between 10 mils and 
106 mils, while hollow fiber cartridges come in diameters of 1,2,3,5. and 8 inches and in lengths ranging from 6 
to 72 inches. Several hundred to many thousand hollow fibers are potted together in a single hollow fiber 
cartridge. Typical cartridge membrane areas are between 10 and 132 square feet per cartridge. 
Hollow fiber water ultrafiltration systems typically operate at feed pressures of about 25 pSig and with capacities 
between 50 and 2 million gallons per day. On each hollow fiber system stage. for a typical 5" diameter x 43" long 
cartridge, the pump must have the capacity to output approximately 20 gpm per hollow fiber cartridge at 25 psig. 
Thus, a 50-cartridge skid would require a 1000 gpm pump at 25-30 psig. 
As an adjunct to IX, UF is commonly used in three places: Before the IX system as pre-treatment, after the IX 
system as post-treatment, and between the cation exchange column and the anion exchange column in 
multiple-bed systems (Figure 5). 
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Enhancing Water Purification 

with Ultrafiltration Technology 

RO Pretreatment Pre Ion Exchange Post Ion Exchange 
Improved RO Performance Imploved Resin Performance Removal of Resin Fines 
Longer RO Membrane Life Longer Resin Life Microorganism Removal 
Lower RO Operating Pressure Rdduced Particulate Fouling Low Particulates 
Figure 5 
UF As Pre-Treatment to IX 
Resin beds are often fouled by particulates deriving from upstream processes, bacteria, RO membrane particle 
shedding, or suspended matter in the feed stream such as colloidal or "non-reactive" silica. Colloidal silica is often 
naturally present in well waters and river waters. Polymerization (the linking together of silica molecules in long 
chains) of silica may occur if the pH is maintained below 7.0. This polymerized silica is extremely difficult to 
remove from the resin. The typical result is long bed rinses and ineffective resin regeneration. A UF system 
upstream of the IX column typically removes more than 95% of the colloidal silica (and often more than 98%) 
before it reaches the IX resin, preventing irreversible silica fouling. 
In addition, in those instances where an IX column follows a reverse osmosis systems, bacteria growth in the 
upstream RO system can result in resin bed fouling. Many RO systems and RO membrane cartridges for 
industrial use are not designed to high sanitary standards and contain "dead zones" or spaces that are not 
adequately flushed by cleaning solutions, as well as non-sanitary valves and seals and unpolished wetted 
surfaces. If conditions of temperature and pH favor their growth, bacteria may build up in these regions. A 
well-designed sanitary-standard ultrafiltration system, however, will reduce the bacterial concentration in the RO 
effluent by 4-6 orders of magnitude. Note that in this scenario, the UF system would be located between the RO 
system and the IX system. Of course, in those instances where there is no upstream RO system, bacteria may 
still be present and present a fouling problem for the IX column. A UF system also obviates this problem. 
Many liquid streams contain particulates that are too small to be removed by bag filters, strainers, or conventional 
dead-end filters, or even by microfiltration upstream of the IX system. Particulates in the size range 0.01-0.1 
micrometers would fit into this category. Unfortunately, IX resin beds tend to remove these particulates quite 
effectively, but the resin becomes fouled in the process. Reducing the turbidity of the influent to less than 3 
Nephelometric Turbidity Units (NTU's) is usually suffiCient to avoid particulate fouling; UF typically addresses this 
problem fully and can often achieve NTU's less than 1. 
For some water types such as those found in chemical processes, petrochemical recycle, or wastewater recycle, 
oil contamination is another problem affecting resin performance. Oil is often present naturally or it may be present 
as a result of lubricating or cooling fluids having made their way into the feed stream. While free oil is easily 
removed via settling, coalescence, and skimming, this is not true for naturally, chemically, or mechanically 
emulsified oil. In severe cases, resin fouling by emulsified oil has been so serious and difficult to correct that it has 
proven more economical to replace the resin bed than to attempt to clean it of oil! Fortunately. UF is extremely 
effective (>99% removal) at removing emulsified oil prior to the resin bed. 
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UF is also very good at removing large molecular weight dissolved organics from process streams. These 
organics may be present in the feed water or may be leached from wetted surfaces upstream of the IX column. 
Organics can seriously foul resin beds, significantly increasing operating expense due to cleaning chemicals, 
downtime, and ineffective regeneration. The organics can foul both the surface of the resin beads and the pores. 
Although activated carbon is often used to address this problem, it is typically not effective at removing high 
molecular weight organics, and it is often selective in the organics it removes. Activated carbon also tends to grow 
microorganisms, which are removed by UFo UF, on the other hand, is selective only based on molecular weight 
and can remove organics with molecular weights as low as 10,000 daltons, provided that the correct UF 
membrane is selected. The optimum UF membrane will be one whose pore size is sufficiently small to remove the 
organics, whose surface charge is the same as that of the organics (typically negative, but not always) so that 
membrane fouling is minimized, and whose chemistry will resist the temperature, pH, and chemicals that may be 
present in the feed and during cleaning so that an adequate membrane life is achieved. 
UF As Post-Treatment to IX 
A common problem with IX effluent is the presence of resin fines due to bead breakage and oxidation. A certain 
amount of resin attrition is inescapable due to attack by chlorine and other oxidizers, and without post-treatment, 
the fines contaminate the effluent. The oxidizing agents attack the bonds of the plastic from which the IX resin 
beads are made. Over time, a sufficient number of these bonds break, yielding fracturing of the resin bead. 
Thermal shock due to cleaning and regeneration chemicals also contributes to resin bead breakage, as do friction 
and abrasion as the beads scrape against each other and against the IX vessel walls. Finally, shrinking and 
swelling of resin beads due to drying and re-wetting causes mechanical stresses which can fracture the beads. 
Resin attrition rates of 3-5% per year due to bead breakage are not uncommon; these fractured beads 
contaminate the effluent. UF is very effective at removing these fragments. 
Another problem is the growth of bacteria within the resin bed or within the RO system upstream of the resin bed. 
As for RO systems, many industrial-grade IX systems are not designed to high sanitary standards and contain 
"dead zones" or spaces, unpolished wetted surfaces, and non-sanitary valves and seals that are not adequately 
flushed by cleaning solutions. If conditions of temperature and pH are favorable, bacteria may build up in these 
regions. A well-designed sanitary-standard ultrafiltration system, however, will reduce the bacterial concentration 
in the IX effluent by 4-6 orders of magnitude, eliminating this as an effluent quality problem. 
Still another problem with IX effluent is the leaching of high molecular weight organics from the resin itself. UF 
effectively removes these contaminants, as well as any other high molecular weight organics that were not 
removed by pre-treatment or by the IX process itself. 
To quantify the improvements in post-IX water that can be afforded by ultrafiltration, Kunin (3) has developed the 
following data: 
Water Property Mixed-Bed De-Ionized Water Mixed-Bed De-Ionized Water 
After Ultrafiltration 
rurbidity 10.50 JTU* FTU* 
[Non--reaCti·ve··Si6;·m.. _ .........  
 01 
I ro·
'Sacterl"aTCou';;T"------"--' 17mL 
IElectrical reSistivity i12,000,000 ohm-cm 18,000,000 ohm-cm 
* JTU= Jackson Turbidity Units 
These data show that in this example, ultrafiltration reduced the water turbidity by a factor of 2.5; removed 95% of 
the non-reactive silica, reduced the bacteria count by four orders of magnitude, and increased the electrical 
reSistivity of the water to near its theoretical limit. 
Economics 
Ultrafiltration as pre-treatment to IX reduces down-time, cleaning frequency, and regeneration frequency, and 
increases resin life. There are clear direct economic benefits of this. UF as post-treatment to IX yields higher 
quality de-ionized water that is free of particulates, which also has direct economic and performance benefits. 
The data below from Owens (4) show that for a 500 gpm demineralization system, ion exchange annual operating 
costs can be reduced by $361,000 if the influent water is upgraded from "poor" to ·'excellent". 
Ion Exchange Annual Operating Costs as a Function of Feedwater Quality 
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(500 gpm system) 
Influent Water Quality Excellent Poor 
Resin Cleaning 
Frequency: 2 years 1 month 
Annual Cost: $2,000 $24,000 
Cation Replacement 
Frequency: 8-10 years 3 years 
Annual Cost: $2,200 $6,700 
Anion Replacement 
Frequency: 5-6 years 1.5 years 
Annual Cost: $4,600 $18,400 
Cation Regenerations 
Frequency: 1 per day 2 per day 
Annual Acid: $35,000 $70,000 
Annual Water $63,000 $126,000 
Anion Regenerations 
Frequency: 1 per day 2 per day 
Annual Acid: $173,000 $346,000 
Annual Water: $60,000 $120,000 
Annual Totals $340,000 $701,000 
Upgrading the influent water to this degree should be achieved by a well-designed hollow fiber ultrafilter 
positioned upstream of the IX system. 
The operating costs of the UF system must be subtracted from the IX system cost savings. Annual operating costs 
for the UF system are estimated to be $104,000, broken down as follows: 
:Membrane Replacement 1$50,000 
""iE'T:le:--=c7":tr"'=ic'7:ity-:-----------[$33,000 
'CTe"i3nmgCfiemicals 1$10,000 
Ir:;O::-p-e-ra-;t7"'in-g--:L-a-:-'b-o-r--------[$11,000 
,---"-----..------------------r-----~~-"---
=,=--0:-:--·----------;$104,000 

Thus the NET ANNUAL BENEFIT of the UF system is $361,000-$104,000, or $257,000 per year. 

To determine return on investment or simple payback, the capital cost of the UF system must next be considered. 

A hollow-fiber ultrafiltration system to accommodate 500 gpm of water would cost approximately $650,000 

installed, broken down as follows: 
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[Hollow Fiber UF System, complete with (100) 5"-diameter hollow fiber -'$500,000 
icartridges 
fConcrefePad,EqulpmenfSeHing;-mil1ty"ConnecUons~prplng~ana------ [$1"00,006 
,Transportation to site 	 ; 
!Start-Up and Operator Training ,-- [$"25,000 
IMiscelianeous and contingency 
I 
1$25,000
I 
iTOTAL =1$=65=0'-;;,0=0=0 
The investment of $650,000 in this UF system would result in an annual net savings in IX operating costs of 
$257,000, resulting in a simple payback for the operation of the IX system of ($650,000)/($257,000/year) = 2.5 
years, Or, looked at another way, the Return on Investment for this project would be ($257,000)/($650,000)= 40% 
, which is an excellent investment. (Please note that these simple calculations account for neither depreciation nor 
taxes, both of which must be considered for an accurate analysis, They have not been included here because 
they are highly variable and dependent upon the location and business practices of each individual firm.) And 
these values take -0- credit for improved IX effluent quality or for the economic and process benefits associated 
with no suspended solids, low NTU's. and no bacteria in the effluent Installation of a UF system in this case would 
be a clear money-saver. 
Pre-treatment options other than UF should also be considered, Nanofiltration and Reverse Osmosis would clarify 
the feedwater as effectively as UFo However. the lower flux rates inherent in these unit operations together with 
much higher-pressure pumping energy requirements would yield a larger system with substantially more 
membrane area and pump horsepower and hence substantially higher first costs and operating costs, 
Microfiltration. on the other hand. (as well as sand filtration, cartridge filtration, and diatomaceous earth filtration) 
would not be effective in removing colloidal silica, some bacteria, smaller particulates, and large molecular-weight 
organics, 
Sources of UF Equipment 
The thirteen largest North American vendors of Ultrafiltration membranes and equipment are: 
VENDOR 	 MEMBRANE CONFIGURATIONS 
h Membrane Systems, Inc. S, T, HF* 

ington, MA 

OsmonicslDeSal S 

Minnetonka, MN 

!AMT 
ISan Diego, CA 
'IrUOP/F-IUid Syste'ms S 
,San Diego, CA I 
rp'cT'-'--'~"---"--"----'-'-"-'--~-'---'-------'---'---------- ,-----------~---='----'------''''''''---'---','---'--''-
IEden Prairie. MN 
lsynder
Vacaville, CS 
[Ffoec1i"st-Celanese------- --~- r S 
,Charlotte, NC 
r""----"'-- ,-­j2enon 
Burlington, Ontario, Canada 
""", -AF~~e~~~,6~~y"" 
fMillipore 
IBedford, MA 
'pafl/Asahi:kaseT"'---'-'------------------­!East Hills, NY 
[Rydranautics 
,San Diego, CA 
I	Membrex 
Fairfield, NJ 
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*S=Spirals, T=Tubes, HF=Holiow Fibers 
Conclusion 
Ultrafiltration is an under-utilized unit operation that can significantly enhance both the economics and product 
water quality deriving from IX systems for water purification. As both pre-treatment and post-treatment, UF can 
reduce chemical consumption, increase resin life, reduce down time, eliminate microorganisms, and scavenge 
resin fines from product water resulting in higher produced water quality at lower net operating cost. 
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Generic tPA Appendix D 
Pumps for chromatography columns 
Affinity Column Pump 
cm 
v 0 := 100'hr 1:= 15'cm J.I :=.015·poise 
E := 0.35 p:= 1000.~ 
m 
L\P = 1.216"Psi 
Assume pressure drop across column is 10 psi L\P := lO'psi 
ka Size :=F.L\PF:= I 34.6'-ii Flow through Pump p 
Size 
Ib Power:=­
P :=63.72'3 l]
Density of Waterft 
L\P 

l] :=0.80 Head :=­
Pump efficiency p.g 
Hours per batch: t := 7920·hr 
Size = 3.457·10- 3ohp 
Power = 3.222 W 
Electricity := Power·t 
Head =22.599oft Electricity =25.521 okW·hr 
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DATE: Monday, February 21,2000 
Dear Chris, 
TAKE A LOOK Ai OUR NEW PRODUCTS 

Purify GST fusion proteins in one step 

High binding capacity 

• GSTrapTM 
1 ml and 5 ml prelJacked HiTrapTt.I columns 
• Glutathione Sepharose™ 4 Fast Flow 25 ml 
For more information and to place your order, call 
Amersham Pharmacia Biotech today. 
Here is the information that you requested on CNBr Sepharose & Superdex 200 pg. 
CNBr4 FF 
250g $3514 lA (Jt.;; ~ <k;k.on,NL/ "\17:)\ u~ ~ MCS'::l 1. 
11 -- 5""rf\ \.. ..J2Kg $2~96 
Superdex 200 pg 
1L $1703 \~'500· )(f.b ~ '35'93 
5L $8499 
Regards, G -ie-c~ ~u~~ 
Andy Mitchell CD ~~<:>i-<X)J ~u.lc') ()r ~t~ ~ 
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Pi&<:ataway, NJ 08855-1327 
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CNBr"activated Sepharose® 4 Fast Flow 
INSTRUCTIONS 
Important user infonnation 
Please read these instrUctions carefully before using 
CNBr-activated SeEharose 4 Fast Flow media. Should you have 
any comments on tbls insuuction m.anual, we will be pleased to 
receive them ar: 
Pharmacia Biotech AB 

5-751 82. Uppsala 

Sweden 

Warranty and liability 
Pharmada Biotech warrants mat the Product(s} has been tested 
according to the established test procedures of Pharmacia Biotech 
and that it conforms with the specifications published by 
Pharmacia Biotech. This warranty shall be void if the Product(s} 
has not been used in accordance with the operating instructions 
supplied by Pharmacia Biotech. or if the Praduct(s) has been 
altered, misused. or damaged. 
Pharmac:ia Biotech disclaims any warranty for merchantability 
and any responsibilicy for me suitability of the Producr(s) for any 
particular pW:pose. Nor shall Pharmacja Biotech be held liable fot 
any incidental or consequential damages t including without 
limitation, lost profits or loss of use caused by any defect or 
malfunction of the Product{s}. 
I 
Pharmacia
171-5000-15 1 Biotech 
Edition AA 
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dr:lwal. or other obscacleJ in obr.o.ining $uch li~es or 
aurhoriz.uions. 
Trademarks 
BioProo:ss"", I!!PG...... INdEX'" and So:pharose(!l ate tmdcmar1c5 or 
Pharm~ Biotech Alt Tris{f) is a rradem;1rk owned bv Rohm IX 
Haas Inl;. In viII.... of .he risk of trademark delcneration. it is 
re'pecrfully sugg~(ed chat audlon wishing to UIII ehese desisna­
rions refer to their rradem<lck starus at least once in each arm:le. 
Copyrighto 1996 Phannacia Biotech AB 
.~II riRhrs rcscrvecL No pan- ofthis publianio/! ma~ be 
reproduced. scored in a retrieval sysrem. or tf:ansmirr,d in any 
form or by .1I1Y mean! wirb.ouf permission in wriring. • 
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2. Media characteristics 
CNBt"activared Sepharose 4 Fast Flow is a bead-Eonned. highly 
craM-linked pre-:1CbYli1!ed. maW produced by reacring Sepnarose 
4 fa.~[ Flow wi-cb qanogcn brornii:ie (CN'rl_ This collpliDg makt& 
me medium more rigid ,¥bich ill turn impfO'Ve.S the preuW'C:IHow 
c:hara.c;~ristk.s, sec FiS' 2. !>rotc:'ins and other molecules containing 
primary amino groups £!::In be coupled direcdy to the prc:-activaU:Q 
medium. Multi-point attacbmen~ ot profeins provides the immo­
bili\ted product "'lith good chemical stability_ Tile rc.su1rini .affinity 
medium can i.'lol&(.I; a specifk substance aom ;I complvc m.L"tture, 
ohem achieving very high yield :add purity in a single step, 'Many 
references dc:monsrr;lte that binding affinity is frequendy weU 
maintained after CNBr coupling. 
A typic:1l application of pre-acr:iv:l.I:ed affinity media lik.", CNBr­
activated Seph:uO!Oe 4 Fasr Flow is bas,d on antigen-antibody 
reactions wuh immobil.ized mOlloclonal antibodic:.s as ligands. In 
such cases. purification f:lcton; of 2 000-20 000 can be obtained. 
Table 1 summarizes the main characeeriscics of CN'Br·activaced 
Sc:pharosc 4 Fasr Flow. 
hP/IB'_ 4 FNt !'law Malrf" 
!!olean particle a~" 90 ~MI 
Particle i= '&n<;Ie 45-11:5 fill! 
Sad 911Ucwre HIgI'tIy C7'0SS-4In'1\90 4"" "9IIf01il, $phetical 
CNIiINlcll ....... d Se,1'I::IraoI.e 4 fIast Flow 

S-mng 11lCIQ1" 4-5 (I'll rhifIed m8<llum/9 
C;QUplin9 IlGPI'dty YJ-26 mg Cl'cnym"!l\Ip&lnl;lglltlltn[ 
pH $l1:Ibi&IY­
long Iem'I 3-11 
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1. Introduction 
The p"parlltion lind use <If .lffinity .:hr<Jrnllto~r;lph<· medi:1 h, 
coupling biospeclfic lillonds C(J CNBr-;J<:tivlIteJ m:un.:!!> I~ ;1 
widely used. ~uccessiul :md ",dl·docum.:nretl r..-.:hnu.lu". 
CNBr-aaivlIred Scpharosc" FOlit Flow is :l new Ilrc·.J..:ti\-:\u;J 
::Iffilliey matrix rhar '::Qmbinl:S che :1dvanf:1~eli <Ii C:"Br ":l)tJl'lfI1~ 
IWirh rhO! high flow and ;mbiliry chl'l(l'I<."Temtics of Seph<HI)~< .. 
F:lSr Flo.." In our experience. me CNBr ':ol.lplins tc:'~hni4ue h:I' .1 
well-proven trnc:1t record for rhe purifkuion r>f thcr:lpcuci.: 
prOtelllll, This. plus the perform:1nce of the rt1l1rril<: ,it l;lr~e .,.:.\1.,;, 
makes rhc use of C~Bl'-actlVllred Sephll(Ose 4 Fan FJ"W 
parficulacll' atfracri'"e for manl.1f:u:tIJ.rin" :1"plic3ril1r1~ in the 
biopharmac:e:utical industry. Ful'thermure, me medium i.. a 
mllmber of the BioProccSJ media familv and ~frit:S 
comprehensive technical and regul:atory- support for produ..:rillll 
applu:.atlQns. 
To ellS11te best performa.n~ and trOuble-fre" oper3tiofl. plt::l)e 
rc:ad ekese in$tructions bc:fore using CNlh··acti.... 3ttd Sepharu~<: .j
Fast Flow. 
Sepharose 4 Fasr Flow matrix 
Sepharose 4 Fase Plow is a highly I.TOss-linked agamSe llIarris. In 
irs prc-activared CNBr form. it otfers much imprnved 
performance Wheil compared with ,he well escablish~d CS-lk­
activated Sephilt()llC 4B. The Seph;l(oR 4 1':15t F1uw marri.'t h,u 
higher rigidity and clln thus be run at high flow tatcl! 
(s.:e "able 1). 1\5 the ;lvailable cal'aeirie.~ for proreins liN '1imil.Jr 
in barh 1.<1.5115, th", ra$[ Flo'" lnllrri.-": offeri gte<lrt:r prod ucri,·i~. 
The higher mechanical nren~h of the cross-linked m:!trix n\~kc~ 
ir well-5ui~d fnt use in largt! columns. Scaling up a purifictlrion 
de....eloped nn CNBMlctlvared Sephatoll! 4 fOIst Flow is rheretute 
simple o.nd more predictable. The coupled product is sr:1blt .It low 
pH. which is often required for elution from some 
immunoadsorbt:nts. 
(!-=nr app\i.:::l[iuos ,hat rllC)uire operation at hiSh pH. nott: tllJ[ [he: 
:imide bond formed ..,hen !.Ising [he l;omp:1I1100 pmdu<:t ;-\H$­
a<:nv:m:d SlIph:1ros(' 4 fast Flow il stable up to pH. 13 i.)r n<lrm~1 
use). 
3. Coupling 
CNBr-a.ctiv;lted Seph:uos", 4 F:I.~[ Flow is suPl'licd ~~-drie<.1 ill 
[he pre~~.lee of additiveS. Insrructions for swclUng. the medium 
and pr-cpararion k)r coupling the Iipilld .Jor", I&i"t:n below. In ord~r 
[0 r"rain ma:timum binding ~-::Iplltity of CNBr-lIcti"<I{cd s.:pharo.c 
-4 Flisr Flo.... prior to cnup1ins [he li",,-od, Ule cold (U-4 'CI .olu­
rinns. The cim~ interval hctWc:'Cn washin~ i1lld coupling mu.! Ill.: 
minimiseul d,£rcfore prcpararions of all rcquin:d ~QluritJl'Is prior 
fQ coupli"S is n:comme:nded. 
1. 	 Prepare rhe coupli,1S foluri..,n. Le. diS$olvl: th~ IiganJ II) be 
l."Ou"led in 11 suitable coupling bufll=r. Fur good clluplin~ 
oI:ffk:ienc), ~void IInnt::ce55<lrilr dilufe .'!t'llurion$ I Rc.:omnl.:ndc:d 
ratio af volumes, couplil\g solucionimedium is 0.5; I I. 
The couplinG pH depends on [he ligand. Normallv pH ill the 
ranl:le 7-9 is u5ecL . 
2. CNBI'-Ilaiv;lted S"pbaro~e " FaSt Row is supplied freeze·,lrieJ 
wi,h sugar additj"(:$ :lod i;:l wMhed initially with' lJ-15 
4 5 
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A.Mt!J/tf6d- A$1 p:lmDns 01 .:a. 
C:OlLlmn "".""Ie CQkI , m.. HCI. 
JOO srlr ""d ',","_lsi\' _. t/Ioit 
101\011· 
IH'M"':A<llI_ 01 ! 
",,111_ ""kI",. Cold 1 ""'" HCI.
.........­ 511' lor BPI''''''' S nm <l1'l<I 11\""100 .-
-'''''lIqUId.
.' L· « 
FI;. 1. Th" cantll"t 01 "'-'qaIln :lie "'InII" 311e1 "'&oiling ",UI1 llIlfarlilnl medillln 
vrolrpn~ '" cold 1 I'IIM Hel, 
medium volumel of cold 1 m.."l HCL See Fig 1. Usc: small wash 
portiol\l (e.g. 1 medium volume) and Ict me nUlCt\.InI 
tquilibmte II. few minutes durin, ench washing step. A.ftc:r 
washing, detern1im: rhe c::aCt mlldium "Olumt.: obt:lLncd using 
e.g. centrifugation or PD-I0 column (the medium volume 
may vlIry berwl!en rexpc;.rimenrs). 
3. ~li.x me washed medium ll!ld coupling solurion. AdjuSt pH to 
rhe desired vlllue. To obrain good repradw:ibillp:y it is wise to 
adjun toral reacrion volWlle ro a fixed value with coupling 
buffef. 
... CoupLing is normally vary rut. At room ~ra~fllturc: t:be 
reaeriort is U5ua.lI~ I:ompletc:d after 2-4 hQurs..1E coupling is 
performed ;1.[ 4 ·C. it can be performed overnIght. It may be 
praerical tl'l follu.., rhe tellerion uiing lJV·ab$orbance 
measurements. 
5. After .::ouplinS. non·reac~ groups on rhe m<!clium 5hol.lld be 
blocked 0'1 keeping rhe coupLl!d medium in Tns bulEc:'C or ~th3,nol amine tor ~ few huurs. 
6. 	Wa$h rhe coupled medium ",sing al.temarc 10"'" and higb pH. 
Recommended buffers are Ilcc:t:1cc: pH 3-4 and Tm Hel pH 
8-9. A suit'ilble procedure could be Jxl medium volume Tns 
HCL buffe, followed by 3..:1 VoIWlle5 acemte: buffllr. R.epear 
thi$ evcle .3-6 rimes. 
7. The c~l.lpled mc:dillm is no",," reltdl' for use. To pn:v~nf 

micrl)bial grou.·ch. srore in 2.0% ethanol for c:xample. 

4.2 Packing laboratory scale columJ\$ 
L 	Equilibrate :Ill mi'lfcn:JI to the rc:mpel":1tu'Ce at which rhe 
chromarographY will be performed. 
2. Deg.il5 [he slurry. 
J. 	Elimin.He ait from th~ column ch:.ad spac;c$ hy f~lIlihjns [he .md­
pieces with binding buffer. Make sure thar no air hu been 
trap~)ed under rhe column neC. Close rhe colUlnn nuder Ic;aving 
a few centimctre:s of binding buffer tellllJining in the: column. 
4. 	Pnur rhl!! durC}' inEo tilt: column in one conrill:uous morion. 
Pouring the slurry down a "Iau rod held as::unsr rhe .....all of 
the column will minimize: th( intrueJur::tion uf air bubbles. 
5. 	[mmediatd. fill [he te",aind~r of Eno:: calumn wirh bindini 
buffer, motint the I:olumn rup-I'ic:c:e ontQ rhe column and 
connccr the colum., [0 a pur1lp. 
6. 	Open the outlet of the column and .~t th~ pump (0 run at rhe: 
de:sired Ro..... r';ltc. Ideally, Fast flow me:d(.(l l1re packed at 
CUIl~t:1nr pre~~u~ nor c.xc""ding I bar crl.l lwlra" in XK 
column5. If [hc: p'l.::king t'qllirmenc dncs nuf includ<! a rteSJUl1\! 
gl1lJ1l.e. ulle a packing flo"" rat!: uf at lo:ast 400 emlh ,1. em b4d 
height. l.S 'C, low vil;co~ity buffer). If tht recornmcnd~d 
pres.<ure or flow rafe cannot br:lllhtllim:d, use tlte mUlmum 
flow ..te: the J:lump ~"tln deliver. This .~hould nlso IPv" a 
n:allnnably wdl-plle!r:ed bed. 
Nute: 	Do no[ cxc~d 75% of rhe p;:IckinS flow mre in 

!>uluequcnr chmmarographit.: proce:dul'<:s. 

7. 	~Iaintajn [he p:ll:kin;l flow rate. fnr 3 bEd volumcs aftt:r a 
connaOr bed height IS ubcnineli. 
Using an adaptor 
Adapto/'S sfJl:ilJld be fltrs<lll5 tolklW$: 
I. 	Afrer the mediunl hOI! b.:t:n pnr::ktd :IS described above, dose 
d'llt column nutlet and n:mullt the rop:-pi<:e:e from the t;nlwnn. 
Cal"l!:fully fill the relit (If the ,..,Iumn with bindinK b~,ffer to 
form all upward meni,cl'$ :1t the tnp. 
8 
4. Colum" packing guidelines 
Gener:!1 ..:ollJmn packing guiddinr:s for Se:p";]m,,, 4 F:lH H"" 
bas~d media. 
4..1 Recommended columns 
ubQfllrory scale 
• HRIOftO (10 mm i.d.1 for bed vol"mc.~ up co ~ ml.lc h.'J 
height up to 10 em. 
• 	 XI( 16110 116 nlm i.d.1 for bed "oilima up w.i() ml O{ h"J 
height' up tu IS em. 
• 	 XK :!.6Il0 126 mm i.d.) for bed volumd "p co SO 1"l..lr "~d 
heighr up ro 15 em. 
Large st:.I~ 
• BPe 100/500 (lOa mm i.d.) for bed volWlles "'? (0 2.4 L.n J 
maximum bc:d height of 30 ~m. 
• BPG 200/500 (laO mm i.d.) for bed volumes up 10 9 .... L .l( ,\ 
maJ(inlum bed height of .30 em. 
• 	 BPG 30015'00 (300 mm i.d.) for bed voilima up to 11 L.le.l 
maximul"l bed heilht of 30 em. 
• 	BPe 4501500 (450 ram Ld.l for bed volumes up co 43 L ,If .\ 
ma.'Cimum bed. heighr of 17 era. 
• 	PS 370 1170 mm i.d.l with a Ih:ed bed volume!li L6 L olr.l 
fixed bed height of 15 cm. 
roceu Stainless Src:c1400l150, 600/150. 8001150.10 
. 
1000/150. 1200/150 and 140011.50 (400-1400 mm i.d.l. \\:ith 
illCe:c1 bed volumes ranging from U ro 231) L 11[ .1 Ii ;(r:d bed 
he t.lt IS em. 
• INdEX 1001500 1100 mm i.d.) for bed volumes up ru 2.-1 L .lr.l 
maximum bed height at .30 em. 
• 	1;:'Il.j£X lO0l500 1200 mm i.d.l for bed volurn". up co 9.-1 L .It J 
maximum bed height of 3Q em. 
2. Insert the adaprot a[ :In angle into the column. ertSlIring rhat 
nu air ill tra.pped under !:he ner. 
3. Make all tubing eonnecdons at tbis Stage. The!€' mUit be i\ 
bubble-free liquid I.:onncai..,n bet.....een [he I:olumn ami rhe 
pump "'lid the sample application IIYste:m {l.V-.~ or LV4 1':1IVe:51. 
4. Slide the pillnger slowl" down the column so thllr the air .. hm.'c 
rhe net a.nd in the: cllpiOl1ry tubing is displaced by [he eluent. 
Valve:; 00 rhe inlet slQe of the column should be: rurned in all 
din:ccions during rhis proa!Sl to ensure thar air is remlwed. 
5. 	Lo.. k rhe !lliapror in pOlirion. open the \:I'llumn mlrie[ and H;ln 
che eluen~ flow. Pass eluent throul/;b [hc column :at the packing 
flow rate: until ~"e bed i~ 5tabl~. Rc-position the adapror on tn<: 
med.ium :surface :1.5 Ilc:l..-r:ssa roy. 
11.3 Packing large scale columns 
Genet'S1 packing prOcedure!; 
Columns can be packed in diffe:rent ways depending on tho I}'rr: 
nf column and equiJ"'I'1enr used. Always read and milo..... the 
rde:\llInr column instruction mnnual carefully. 
S<!ph:lrase 4 Fast Flow bncd media III'1lCllliY tu pa.;k sinc~ [htl"ir 
rigidir:v allows rhe use of high flo.... I'ilt.-:$, sec Fig. 1. Four ~Uir:lhk ~c:s uf p~clcing llle~hod5 ate given: 
• 	 Pressure pnd:in; fro~ column, with :Ilupron.l 
• 	 Combined Pl'c.r;suw$uctlon p'aeking (for medium Ai7.ed 
culUll1n, wlrh S~d bed heiilusl 
• Suc:tion p;J.cking (fot large columfL1 wirh fixed b..-d heigrlCs) 
• 	 Hydraulic pl'CS5Ute" p.~king 
How well the ..;ulumn is packed will ha.ve a m3jor e:ff~r nn tht' 
re:suJE of the scparacio>n. Ir is; tberefore very import.lnt Co p,l.::k l1nd 
tc:sc the column at."C()rding 1:0 the following re.:ommcmlar;(lO!1. 
Besin me: packing proct:dLlte by determini~ th", optimal plleking 
flow rate. Guideunes are given for dctenninll', rhe uptimal
p:l.cking flow r:lfe8 mr corumn$ with ad<lpeon; and ~"jxllld bed 
hl!:ighu. 
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media (BPG 1 CO: 1 ba'; !!.1 C/T1 ~ he'llhl). 

4.4 Determining optimal packing flow rates 

The opc:imal packing flow I'lm: is deperul.enr on column size ;md 

~~, medi\l~ volume. packing solurion and temp.enltuR. Th", 

oj:mmal p'acklng Ao"" r:1tc must r"('rcEon be dctl:nnincd 

empiricall}' for cach individual system. 

To decennU;e the optimal packing flow rarl:, procecd as folloW3! 

I. Calcu1are rhe amOr,l/lr of mcdil,llIl nc:c:d~ for the slurry (this is 

especially impo!'t.:Lnt lor columns 'l"'ifh fixed bed heights). 1ft,: 

quantity of medium raquired per litre packed volume is 

approximately L 15 lirrc.s sedimented medium. 

l. Prepare the column cxac:t\y liS for <;olurrtn pa<;King. 
3. Begin packing the medium :u a 10,,", flow Brill (30 anlh). 
.... Incre:ue dll: presaure in inc:rcmel\l:!l and record tht: flow rare 
when fhe pressure has st:1biliud. Do nor exceed rhe maximum 
pn:ssure or rhe column, or (he mL'l:im<lm flo"" rare for the 

medium. 

.. - .._-._-_.__.,----­
5. When the medium has serried, dose the butTOm val"1l lind stuI' 
the pump. Thc bc:cl sram rising in the: column. L005~n the: 
O-ring Bod IOW<:'f rhe adapror {n abol.lr 0.5-1.0 cm from the 
bed surfQ:ce. 
6.S<lal the O-ring, sam the ,Pump lind contin ...e packins- Repeat
Step... 5 and.6 uncil there IS II mnICimum or I em be~cen 
bed 5UrfaC~ <lna adaptor when rhe:: bed has mlbilize,j. Mark rhe:: 
bed ht!ight em the column tube. 
7. Close rhe: butcom V1l v e, s{np thc pump, disl:o,\necr the column 
inlet and push rhe: adaptor auw,\ rn apPt'o;<:imatdy ,) mm bduw 
the mark on the column tub<l. withuut kum:ning [h.: adaptot 
O·rillg. The p.u:kjng -tolulion will flush rh~ adilptor inlet. 
RIf:1.Tlnve any tr:lppe(J air by pumpinG liquid frnm the botrnm 
(afrcr the inlet tubing (lnd [he bortnm v<lllIlj. have btcn 
properly filledl. 
4.6 Combined pressure/suction packing 
Procl!I5$ Stac:k (PS 370) Column 
Tnt: ProcCIIS Stack Column is supplied with fi;P;eQ cnd-pieces ;md :l 
fixcd bed heighr of 15 em. It is packed by a comhined 
pressure/suction technique. 
1. Fit:m ex{1'll column !;Caion on !:Op of the column mhe, for use 
as /I p:J.<:k.ing: devicc. 
2.P<.iur some warer (or paclc;"lg buffi:rl into rhe ,;o1 .. lI\n. MaJ<", 
$urc rhat there is no {rllpped air under the borrom nero l.c:3ve 
:lbout :z. em of liq\1id in che column. 
J.PnuT the: ~Iur ...y inru rh.. column. Add bufft::~ m wiehin 1-2 em 
of the rim of the upper 5c.:rion. Stir genrly [0 give Il. 
hnmogenel)t.I.~ slurry. Add buffer I,Inrillevd wirh rhO' UPFer rim 
and 1i:ccun: tho! lid in pla.:.;-. 
4. Connect :l pump lind a ilrEl$$urc meret' ilnd St:let packin~ ae tile 
pn:de{cnnined p;!cking How ratt:: (or pro;:ssure). Keep th~ flow 
rate lor pressure) conseant during par;:king and che.:k the 
pressure at the cnlumtl inlcr. Nt!"er exceed [ile pro!>llre limit for 
column ur lucdium. 
1 
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.;. Th~ mJ:lximum E1o,", rate j, rt:;lched when !h~ pre~lUrclfll)\V 
curvc levds off or the lruI:<imum ptusure I)f (h..: CIllumn " 
re:u::hcd. Stop cheJllldldns: and do nt)t e~o::d chiS fin", r.He. Th,­
optimOiI packing flo ... r;lI:dpr~ur~ is 70-IOO~, 'lf rh.: 
maximum flow I1m:fpTcssure. 
6. 	Plt)[ the prcssurc:lflow rate curve ;\S in fig. .1 JOlI .1 ..rcrI"'u,' rIll' 
optimal pllcking flow rOltc:. 
The operOitiunal now ratc:/prrssure dlOUkl b.;- <7'0''1" lit the 
p'lI:kinl,'; flaw titre/pressure. 
Not;: 	For 8PSS columns, first pOlck the culumn by ,,,ctinn 
pllcking :It ~ low flow r~rc chcn determine ehe nowl 
pressure ch;.lfllcterlnio::s U .lb.).... e Ill' pumping Wlth 
downward flow through rne column . 
4.5 Pres.sLrre paek.in; 

BPGcohlmna 

BPC; Columns are supplied ...ith a mOllOlblc adOlpror. The~ ;tr~ 
packed by eonvflntinnal prlfssun: packing b~ p~lmping che p:lo.:bnf,: 
sohni!)" throllgh me chromllrolJl'OIpnic bed at COlIsranr tll>w r.lt'l: (or bade pres$u~cl. 
1. Pour some Wlltll't for packing buffer) into the colunll''l. _"l.lk~ 
sure rh:st then: is no air rrapped under the bottom lIet. Lc;! "0 
.about 1 em of liquid in rhe column. 
2. Mix thc pac;king bulkr with the medium ro form a 50_70"" 
slurry. (Sed.lmentcd bed yolume/slucl'V volume :; 0.5-0.7.) 
Pour the slurry inca the column. rnsm the ;daptor and lowcr 
it to the surface of the slimy. making 'Sure no OIir is tr:lpped 
under the ad:lptolO Secure the adaptor In plar:-e:. 
3.Seal [he :ldapt:or O-ring and lower the adapcar .1 lictlil into the 
slUJ;J;f, enoup co fill rlie ad1ipcar inlet with paclr:ing soluriun. 
4. Connect a pump and a PCl!'f5ure meter ;md SUrt packing <It eh.: 
pcedea:nnincd packing flow rare (or l'ressurel. t..::~ep the flow 
rat:e: (or pressure) constant during paclcing ~Rd cht:ek the 
pressure at the c:olumn inlet. N~r eXceed the !?t'U$ur" limit 
tor <;olumn or medium. 
----------- ." --- . 
5. When tho! bed has stabilizcd, the t'Op of tl'te bed sh<)uld be 
txac:tlv I~vd with rhe top of .he column cube. Ar ehis point, 
exclude the buffer rank from the system by;;iOluir::mt:ousiv 
s'lAlicchinG che 1Ia.lve at che column outlet and the val"~ an 'the 
SlIccinn :lIde of the pump, :u ~hown in Fig. 3. PackillG buffer i ~ 
flOW ret:itculll:a:d tbrough the S}'!Item. If. when ~C'.Ihili~ed, th" 
packed bcd is oor el(:Ictly level wiJ:h the rop pf rhe c(llunlll, add 
or remove slurry. A.lwa!'S seit ihe slurry rhoroughly bef ... rc: 
packing. 
6. Keeping the pump rUllninl,l. disconnect the CQlumn hIler from 
the lid and dlrec[ it to \valilil. The packing solurion in the 
p.1cking secci011 e:tn be remnved by s...aion thr"ush rhe bed. 
7. Whilc rht:: packing set:tion is beizl$ emptied, loosen th..: boll:; 
holding the column :lnd th ... pnckmg secrinn togefher ~o that th.: 
packing scc:cion C<ln be removed. Durill@: thil oper:tcion. 
manu.llly press down on the packing .o;ccciOIl to prevent leakage 
between th. [WI) sections. 
"I 
FIg. 1 Eqr,dpmem ''''' up lor P""=J"l'lliVctlol1 packing. 
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s. Wh,uI the pll.:king so~u[ion is ""irhin 5-8 mm of rile bed 5urf:1­
ce, dose {he v:llve lit ch~ column nuder, sroll rhe pump, quickly 

remo"l: rl'le packing se<:dQn and replace it with the lid. 

':\<[an\,l;l.II" preS'> down on the tid ",hile ic.is secureJ in plOlce. 

This final oper:nion should bill .:omll'lercd ;as ql.ll;lcly ll.S possible 

heclluse the hed wil[ ,,~plll'ld when tit, f1nw StOps. 

9. St:m pumping buftl:r with I.lpw::Ird flow through the column to 

remo"e :111)' ,ur bwbblc:.~ tr:lpped under thl: lid. 

4.7 Suction packing 

BioP(oc::c:u StalnJe!l!l Steel (BPSS) Columns 

BioProce:ss Sl:lIinle.iS Steel Columns :Ire supplied with fixed ~d­

pieces. Thev lue p:lI::kcd by suction, i.lII. by sucking packll'lJl 

solution through the cntomacogtillphic bed lit :I consrllnr flow 

fl'lte. 

I. Fir l'l packing device on tOP of rhe c:olumn rube. 

l.Pour some warer (or packing solutionl into ~he .:olumn. Make 

S\l(¢, rhl'lt there is no air tr.apr;n:d under the bon-om nero L~::Ive 

:lbouc 1-3 o:n of liquid in rne c:alumn. 

.LMi..'C rlK- packing b",ffet with rhe medium to form 3 50% slurry 
(scd.imenred bed volumclslurry = 0.51. PoW" rhl': slurrY inro the 
column. Srir gently to give ii. nomogeneous slurry. 
4. Connect the column oud«t wive to the sUcOon sid!: of a £lumP 
and starr p,:u;:ldng rhe bet!. by suction through thl\' bed at the 
predetermined tlow rat:c:., .ic:c: Fig. 3. Keep the flow rate constant 
during packinJ. 
5. Wben the bed hu stabilized., the top of the b.d should be jU$r 
below the junction of the COlumn and the paclcing device.. If, 
when stabilized. fM level of the bed is im::orrCdf a.dd or 
remolle siurr'l". Always stir the slurry r:horaughij' before packin!l. 
6.Ju.sr beforl\' the Lut of the solution has el'ltered me packed bed 
(before thl\' surface scatts to drY). dose the valve Ill: the column 
outlet, stOp rhll pump, quicklv'remove me :padc:ing dltvil:e and 
~pl;!,ce ir with the lid. This nn31 operation $bould he completed 
...------~­
..---..... 
::15 <I.\lickly :IS pnssible l1eO:lIl.15e: the hed will cxp:mJ whl·n rh\· 
flt)w;;cops. 
1.SCltt pumpln~ buffer with upw:!rd fI""" rhr!luf?/! ehe ,;oIUIl'" '" 
rem'}-'e any :llr bubbles trl1pped unr.J,:r che: Illi. 
4.8 Hydraulic packing 
INdEX CalulTlrttl 

INJEX Columns are supplied wirk n hydr.lu1ic functil1l1 :,·tll.h 

:tl!ow!i:m ntremely simple, n:lpid ;tnd repmJu':lhl~ p~lcktll1-' 

procedure. The rnllclium is packed :1t the same tIm!: ,I:> rhe ,IU.IP:I" 

15 lowered into position acene correct pttl$$"r~, 

Thll ad::lpcor is pushed down bY:l J:on$r:Int h~'('r:lu!i<: pr,,""I\J'I:. 

furc:ing waccr through che slurry and cl)mpresmg It ;'11 th'lt :L 

Pil..:kec bed i$ Sn:ldual1y huilt up. The h:"drauli': pres~ure ':.1n l'c 

gener:1to:<i using ::I pllmp ::IDd I pressure reli.tf V':1h-e. 

When the 3dii.p~a( r=hllll the surface of the serrIed medi~I"'. lr 
condnues downward" III'1dc:r hyd.raulic pressure compr~s$lnj:! tn" 
medium. The c::xtmt to which cb. medium i$ cnmpr~o;eJ J~p~nJ, 
upon the pressure from the adllptor and ~he d::lsricit;' (?t th~ 
medium. The qllllnti.:y of medium required when packm!;. 
Sephl'l(oSC >4 Fa,( Flo", m.di:l by hydrnullc pressure is 
approxilnlltely 1.2 litre s<:dimentc:d medium per litre p,\ckcd r.cJ. 
1. Pour some warIJr (or f:l8clcing solution) into the CQlumn. :\,I;\l.~ 
sure: rhat there i$ no air trapped under rhe bottom ncr. l':;HC 
about 2 ern of liquid in the column. 
2. Pour the slurry inco the column. Fill the ..:oh.l~nwitl'l p:lckln!; 
solutiOl1 up to the tOP of che glass Nbc :lnd mil< the siurr:;-. 
Allow rhe: medium to sediment to jusr kKllow the bevd at tn~ 
glass Nbe (G). Ht Fig. 4. 
3. Put the adapror in II rucl~ position :lj?insr the hc:v.:1 of rhe 
glass rube ..Avoid uappinr; air .bubbles ~ndr::r the :lrJaptor b~ 
i1ighdy tIlt:u!.& me adaptor while mounting. 
~. Lower the lid and seCure it in place. 
lQ. Close (AI and (D) and Stop the pump. 
1 L Run rht: column with upward fl",w fot a fC'\" minutes (II 
remove residual air t:nIpp~d ii, the :tdaptor. Th~ Cl\(,,Jn1n is 
nnw rc:ady .fur use. 
12. To unpack die column. col'lne.::r the: outler from tho': plln,p co 
Ill) and npcn IC) while kt'l'ing (D) do.sc:d, This will cause the 
adllpcor to rist: from (he bed. siirf.ac:e. 
ng. 4. Sdlerlulllc tellteeentaUOl1 01 INdex call/mn wntl a 4-part (2.-.y) valvg 
_""""" ;n IIu: bc:IlklrII ouIJeL 
i.Connect a. pump fO rho inlet of me hydralilic c:h>tmber IAl. with 
a manometer and :1 prc5$ure rclief valvc in-line between rhe 
pump and the hyd.rllufic c:h.:1mhcr. The Inllnomerer should be 
pl:u::cd after me: val...&: in the din:c:cion of me fluw. 
6. Open the hydtll..,li.: inlet IA). and the hydt;lulic outler (e). Starr 
rhe punlp and flush the hydrl'lulic chamber (E) free of air :mtl 
any residual medium. 
7. Cioslil (Cland Opel! {ke elution inler/olJrler IB) m :1l1ow rrlilppcd 
air iI' the adlll'tor nct to e!W:apc. 
S.Close (B) and open the elution inlct'lolltlet (D) ro Staft the 
p.,,;king, Ilpplyi"8 ;) 1)tI::d.;ifined co.l!tunr hrdraulic packing
prc:.ssurc. When packing Sepharose 4 Fan Flu", media in lm 
INdEX column to a bed hei~ht of 15 em, rhe recommended 
hydraulic packing pressure is 1.5 bar for INdEX 100 :md 
0.9 bar for INdEX 200. 
9. When the 3dapror has tear:hed rh" sll~face nf the ~errled hed. (.vnrin",e (0 run the pump until rhe l'ldaptor ha5 been IO,",I\'n:d 
.) InOll inco the packed bed. 
1716 
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:So E,va1uation of packing 
. -To ~heck [h~ '1....a1iry of rhe pa~king and to moniror this durin.: 
th. working lite r)f the column. column cffidency shoull! be (i."Stc:d 
dir:=ctiy "frer p"c1dn~, ;It regular in~""ill$ afterw:mis, and when 
scpar;lcion p.lrformant:., is seen to dt[eriorQ~. 
The recommended method of II'lCpt"s5ing rhtl effkic:nc:y of a 
plI.::ked t:<)lumn i~ in terms of [htl height cqllival"nt ro a rheorctiOlI 
p!.:m:. HE"'. and the asymmetry factor. AS" These v.dues :I..." e:l$i­
Iy d"ctrmined by lIppl~ing II $;Imple such :15 1% 3c:erone soluci.m 
to ehe .::oluml\. Sodium ch\('>ridc an al~o be used lIS ;t telll 511h­
mmce. U$1r a .::oncc:nrracion of l.O ;"'1 NaCI in water wich 0 . .5 .M
"""el in Water as c:l<l~nr. 
It is or utmost imporrance to te"lIze 'that the calc:ulafed 'plant 
number will ":1r)' dll'pending on the test condicion$ ')lld It sholiid 
therefore be used as a rc:retence: value only. It is also importnne 
that conditions .uld e:quipmlrnt are kept constant $0 rhat results 
Me .:.omp'anble. Changes in solute, solvent.. .eluent. sample 
volume, flow r:lre. liquid path.,.,a!'. tcmperacure. etc. will influence 
rhe res141cs. 
For oprimal results, the sample volume should be it maximum 

2.5% of the ..:olumn volume and the flow cate berwecn 15 ~nd 

)0 cmlh. 

If an 3cceprancl: limir is dclfined in relation to column 
perfQtmanC:iI, the column plate numbo:t can be I.Ised 35 part of the: 
~CXC;pClnce crireria for column use. 
Method for measuring i"iETP arKS A's . 
To 3void dilution of thc: sample, <lPP{Y it as close to eke column 

inlet as possible. • 

CondIt/Qna 
Hl!lpI$ voI...,a: 2.5% 01 ~. b.a .on.ne 
ample"""".: 1.0-Ya vN aQ9l'OC"18 
/toow ",,,," 15 tlmIh 
IJV: 28Q nm. , em. 0.1 AU 
IJVCQlUrtm: BFG ~ 
M";'•• """_ & F»\ Flow 
1Iod"""",,:!rr.5"" -­• 
8_ VOJUj'n,,: od.Q.G 14.1'4£ 
_0101.... ...... 
5.......' 1.011 ,.,... 11% __, 

Fklw rahJ' 11 """"t 	 Wn ­
"".",t87 
W"oCl.9 
HfPT-O.OZ"Ii em !.. ~ 
a: 0 \K> 
I~:O.II$ 
~ -~ _....-­
....:0.,.. 
..., : .._ 	 .. ;:1::-=-"-::. ..- .. 
_______________~~~~ I 
RtJ. 5. I,N wee ~( f1,C8lcne in .....,.pit;aJ te91 chn>matogram ~" Ihe HErP and ..., 
val"~ c:alculatioru;. • 
6. Maintenance 
rnr beSt performance of coupled CNBI"l\cciva(cd Sclpharose 4 FMr 
Fin"" j)v"r a long w()rldng life, fullnw the geneml proc"dllrt::S 
described below. tn all cases, we: recommenu {C5till!! [he 
prucedures at ~Fru111 seal" first. 
Eqm'/ibraJiun 
After pacldng. ilnd before <1 chromatographic: nul, equilihrate 
wit!> working buff... by <V:lsbing with ;it least 5 hed !lolumes. 
CItIItJJ'1irrg-in.PltJ~t: 
CI"'lning-in-placc. (CIP). i$ a denning procedure: ....hich r"move>; 
<:nnClllninan~ such as lipids. pre.::ipir:ltes or denllcured proteins 
thaI may remai.1 ill the packed cnlumn after regen~ratiul\. Such 
cont:3rttinatiun is ..s@eciilily likely whJ;n ....orkin; with crucl_ 
!naterials. RCl'luh\r ell' p'rt:!ltlnts the build-up ..,t the~e 
conmminllncs ill tht: packed bc<.!, :md hdps rn mainmin the 
c:lpllcity, flo'" propl'rries and &e:neral perlurmancc ut the Itl<ldlum. 
A ,pcci fie ew protocol ~hould be oesig'lcd fur e::ICh prOl.'eltS 
llccording to th~ type of ~"OntaminiltlCl rm:sent and stability uf 
coupled ligand. The m:4uency nf CIP depends on the nature and 
CaJ.:ularc HET!' ::md A. from the UV .:urvc (or ~onlJu~"",: 
curYc) :1$ follows: 
HETl' '" UN 
..nd 

N '" S54IV,fWh,L 

where 	l. " Bc:<l height «m) 

N " Numhc:r of theorc:ci.:::d plates 

ViC " Peak d u tinn di st;!nce 

'IlIIh " P~:1k width :It half peak heigh! 

Vc an.:! Wit :Ire in th" S<1me units 
To facilic:ue comparisnn of column performance rhe con..:"pc .. f 
reduCt:d pl:lrc heiSht is oiten used. 
The rc:dlJccci plate height ;5 .:alc:ulated :1.S 

HETP 

-r 
""here d is the diamerer of the bead. As a guid,f/ine. a ":lluo:: I)f 
<l is normally ar:o:ptable. 
The peak skould be symmtltrir;.al. and Chd asymmerry t~etnr .1S 
.;\05e u possible co IlvaluC5 betwftn 0.8-1.5 :lre usII"llr 
ac:e-epmble). A chante in the $hape of the pe:!1c is usually t~c first 
indication of bed deterioration due l:I:I use. . 
Peak asymmetty faCtOr calculation: 
As" b/a 
where 

a =1st hal! p\!l'1k widch at 10% of peak lleiglH 

h .. 2nd hOllf penk "'idth ae 10% of peale height 

Figure 5 shows a LN traCt: for :leetone in :I t'!'Pica.1 teSt 
diromacogl'a.m in whidl the HETP lind A, values arc: cal..:ulaced: 
19 
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~tion of the ,racri.ng man:rialand other process 
II!(tuirl!l1'lcna. but one elF cn:1c is gencr.tUv recommended eve 
1-5 seplI.ration cycles. FoUowicg are gtlner:3.lly recomrru:nded 
,rocec.uRS, 	 ' 
, '·-Gf1'lffl:5sOCQ. 
Prec:ipiated or W';J.Sh ..,ith 2 column volumes ",f 
dellaiured 6 M j);ullnidirle hyd.rocltloridt. WiL$h 
substances substances immedi;ltc:ly with Ole lel1st 
5 column vollllPl!t5 of $cefile filtered binding 
buffet. 
Hydropbobic:aliy 	 't'Uash the column wich 2 column IfolumllS of 
bound substances 	 a non-Ionic dercrgent (cone. 0.1-0..5%), 
Wa.sh immediately with a. leut S column 
volumc:~ of sn:rile fil=ed binding buffer. 
or 
Wash the column with 3-4 column volumes 
of 70% ethanol. Wash immedill~!y wirh at 
leaSt 5 colnran volumes of sterile filrerc:d 
binding bulfer. 
Saniriz;p.tion 
Sanitization inactivates microbial conmmin:>.nts ilt rhe p~ckc:<.! 
column and re\;m,d equipment'. A ipl:l-ific sanitization protocol 
shol.lld bel dcsi,gncd for .acb p'roce5S llecocdins to the type of 
cotltaminaIlts present an" stabili;y of coupled ligand. 1'01/0\l1inl: 
are geRenlly recomme.\ded procedures. 
Equilibrate with i1 buHw~ e:onsisting of 2 % hibitane digluconar"
and 20% ethanoL Allnw to stand tor" hours, rhen ""~$h with 3.[ 
least S column volumes of srerilc binding butrer. 
or 
Equilibrate with 70% erhanol. Allo'" to mlOd for 12 hUllrs, then 
",uh with at \.eaSt 5 column volumes of sterile: bind in!!'. bufftlc. 
2~ 
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• 
Note: 	Specific regularioru mlly apply ",hen using 70% ethanol 
sincr: it can ro:quirc the use of explosion-proof arc.:1S and 
equipment. COl'l6ulr your local saftey regulations for mare 
informacion. 
Sroraglll 
CNBr-activlIted Sepharose 4 F3~t flow is Sl.Ipplied freeze dried. 
Additives ;ITC: included. ro preser". the bead FOrm of the Inedium. 
When stored below g .c, the shelf life is at least 18 munths. 
Packed o;Qlumns should preferebly be: equilibrated in binding 
buffet containing 20% ethanol (ligand dependent) to Pfevcnt 
mi"'"\'Qbiai growm. 
7. Trouble-shooting 
High baCk pnaS$ure 
1. Check that aU valves between the pump and me collection 
"elIsc! are fully open. 
2. Check that aU ";lIves are dean and fret: from blockase. 
3. Check if equiplncnt in usc: up to and alter the cahllDn is 
generating any back-pressure. (For exa.mplc valves ,md How 
cells of incorrecf dimenllians.) 
4. PlICform ClI' to rcmove..,tigbdy bound mawi;l.1 from me media. 
S. 	Check column .earn s11ch as filret:S, net> etc., according to the 
columfl instruction manual. 
Unupecrad chromatographic 1'8SUl1s 
L Check the recorder speed/siglla!. 
2. Check the tlaw rate. 
3. Check the bl,lffi:n;. 
4. 	Check that mete ar,,;: no ,&ap:; bc:tween the ad;1l:Jmr alII;!. the: 
medium bed. or back rru.-ung of me samplli beron: al'pliClIioll. 
5. Check the d£icienC)' of the column padcing, $ct: page 18. 
6. Check if'rlu::rc: have bet:n 3ny changes in the pretre::u:mcnt of 
me .~ample. 
22 
Ir"ections 
t. Check the cClnncctiull$ :1nd prdilters. 
2. 	Ch~ck the in-soing compunel1tS ~uch n$ huffo:,;, sampic 
componentS, erc. 
3. Check th:n the cuI limn has b~n prtJpcrly sanitized. 
TllIpped air 
1. 	Check that mo: buFfen are equitibrim:ci to (he 5..me 
rc:mper.uure ;as the packed column. 
2. Chel;k th.:1t there arl!' 110 loole: ,,"emnec!ioos or Illilkin~ ",lives. 
If air hll$ entered rh~ column, rhe column ~hodd be: t~~,;)ckeu. 
Ho...evc:t, if only a $m:1l1 amount of aie h:1s been trapped on r<lp 
of the b.,d, or between th~ adapt'" nct and heau, ie ClIon b<I remo­
ved by !lumping eluent in the opposite direction. J\ner this, ,'htck 
me efficiency of the p;1cked bcd, set' page 18 • .:lnd o.;omp:o.r. the 
result wim rho:: original effidency v"lues. 
8. Ordering Information 
109 17.0981·0;-­
2509 17.()9SH):) 
2kg 1N1951·00 
All product$ are supplied fre:ese d.ied In thl: prec~l1c. of 
;ldclltives. 

Fot adclitionlll lnfuclllliclon, including O:1ta File:, appJicadon 

fl:fl!:n:nOls ;lnd RCS\1lat:Or)' Supporr File:, picas<: conroCt your loc~1 

Pharmaciil Biote:ch representative. 
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Data FileBioProcess-rM Stainless 
Steel ColUIlUlS BioPracess Columns 
BioProcess Stainless Steel Columns are specially 
constructed fixed bed height columns intended for 
routine production. The range of columns has 
been constructed from component materials of the 
highest quality to meet the most stringent demands 
of production chromatography. and to resist 
sanitizing and cleaning agents such as sodium 
hydroxide and ethanol. Furthermore, the design of 
the columns wIth fixed end-pieces provides the 
highest standards of hygiene. 
• 	 Hygienic design and operation 
• 	 300 kPa (3 bar) operating pressure 
• 	 High throughput 
• 	 Materials include high grade elecrropoUshed 
stainless steel 
• 	 Standard bed heights of 150, 300. 600 and 
lOOOmm 
• 	 Supported with procedures for packing. 
sanitizing, cleaning and trouble-shooting 
BioProcess Stainless Steel Columns, BPSS, are 
derived from the range of Sephamatic Gel Filter 
columns with improvements made in both column 
construction and design of the accessories. 
Columns are available in standard heights and 
both 10 mm and 22 mm .internal diameter tubing 
can be obtained for the 400. 600 and 800 mm 
diameter dimensions. Sanitary tti-clamps facilitate 
quick and hygienic connection of all tubing. 
High pressure specification and low flow resistance 
make these columns suitable for use in ion 
exchange. gel filtration. aftlnity. and hydrophobic 
interaction chromatography. They are compatible 
with all Pharma.da Biotech gel media and permit 
flow rates of up to 150 ]/min. enabling kHograms 
of product to be processed. 
.FJg. 1. A sellllCtion ofBioProc:ess.... Stainle,.., Su ...el Columm. 
All gaskets are made of recognized EPDM rubber, 
and electropolished stainless steel to ASTM 316L 
is now a standard material. Each column is issued 
wjth a pressure test certificate and a materia] 
certificate for the steel. BPSS columns can also be 
made to specific dimensions and custom 
requirements. 
The range of columns is fully supported with an 
Instruction Manual which gives details of packing. 
sanitizing and cleaning procedures, trouble­
shooting and lists all spare parts and accessories. 
Pharmacia 
118-11 21-08\ Biotech 
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Column components 
The column components are the stainless steel 
column tube, lid. 2 filter nets which are ordered 
separately, and 2 support nets with jet stream 
stoppers. Lids and column tubes are constructed of 
electro polished stainless steel; tubes are avallable 
in diameters of 400,600.800. 1000 and 1200 
mm. Depending on diameter; different standard 
tube heights are avaUable. refer to Table 1. Other 
tube heights can be constructed to order, Contact 
your Pharmacia Biotech representative for details. 
Valve assemblies 
The inlet and outlet valve assembly configurations 
differ for the diameter of column in use. Two sizes 
of tubing are available for the 400. 600 and 
800 mm diameter columns. either 10 mm or 
ZZ mm internal diameter. The 22 mm Ld. tubing is 
standard for the 1000 and 1200 mm diameterFlg. 2. BPSS 8001150 colUlIm show.lng main assemblies. 
columns. All gaskets and tubing used in the inlet 
and outlet assemblies are made from EPDMColumn Description 
rubber. The columns are supplied for upward flow 
BioProcess Stainless Steel Co]umns comprise three with the flow-through pressure sensor and safety 
major assemblies: column components; inlet and va1ve fitted to the bottom of the column, Reversed 
outlet valve assemblies, safety valve and pressure flow kits are available as an accessory, 
sensor: end-piece and stand. These are illustrated 
in Figure 6. As an option a complete BloProcess 
Stainless Steel Column can be fluoroplastic coated, 
in which case 22 pm polyester nets are required. 
Table 1, Primary lo-pec.ificati.cns and characterIstics of the range of BPSS l;olumns . 
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End-piece and stand 
The combined end-piece and stand is supplied 
with adjustable feet and lifting bars as standard. 
The 400 and 600 mm diameter columns can be 
fitted with the optional wheel kit. The wheels 
incorporate foot operated brakes. 
Fig. 3. Some components and lJo;~rics for BPSS columns; 
flow-through pressure sensor with manomlttcr. safety V\'l!ve. 
filb:'r nets. support nets. valve. eye bolts. steering bolts. torque 
wrench. tQbjng connectors with damps and gaskets. 
Standard components 
BioProcess Stainless Steel Columns are supplied 
with a number of components. includlng a flow­
through pressure sensor with manometer, a safety 
valve. 3-way manually operated valves. support 
nets. steering bolts. eye bolts. a box wrench and a 
torque wrench. 
Fig. 4. The Air TF<lp is one of the so:e..'lSOJies 
Elvsilablc for BPSS colurnns. 
Accessories 
The accessories available for BioProcess StairJless 
Steel Columns include an Air Trap. Reversed Flow 
Kit, Packing Device, and connectors with damps 
and gaskets. 
The Packing Device facilitates the packing of 
media using the suction method. The packing 
device is supplied With a flat gasket and sufficient 
clamps (4.6 or 8) to secure it to the column tube. 
Haste1loy nets are an alternative to stainless steel 
nelS when using fiuoroplastic coated columns. 
They are available for all diameters. 
Column Perfonnance 
BioProcess Stainless Steel Columns are easy to 
pack. test, run and maintain. Their compatibility 
with BloProcess chromatography system and 
BioProcess Media (Sephadex G-25, Sepharose Fast 
Flow and Sephacryl High Resolution) greatly 
(.:ontribute.s to safe. effective and reliable 
bioprocessing, as the folloWing example 
demonstrates. 
Fig. 5. Rmclent desaldnB and remoV\'l! af low molecullJr 
weight impurities on a BPSS 4001600 packed with Sephadexllt 
G-25 Coarse. 
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Large scale desalting 
Figure 5 shows how a BPSS 400/600 packed with 
Sephadex G~25 Coarse to a bed height of 60 em 
effectively desalts Factor IX depleted plasma, 
leaving it free of low molecular weight impurities. 
After centIifugatlon and pH adjustment. the 
plasma is loaded onto an ion exchange column for 
further purification. The productivity of this step 
was 53,3 litres of plasma per hOlJr. 
Hygiene 
BioProcess Stalnless Steel Columns have been 
designed to give the highest level of hygiene. They 
contain the minimum of components to facilitate 
simple cleaning methods and reliable operation. 
All the steel surfaces are electropolished to hinder 
microbial attachment and the clamp fittings used 
permit the use of clearung-in-place (CIP) 
procedures. All column parts can be cleaned with 
the most commonly used agents. such as 
detergents. ethanol, weak adds, sodium hydroxide 
and high salt concentrations. Regular CIP of 
packed columns between production batches 
removes precipitated material, strongly bound 
substances and other contaminants from the 
column bed without dismantling the column. 
Challenge test procedure 
To test the effectiveness of the hygienic design a 
BioProce5s Stainless Steel. CO]lJmn was challenge 
tested with a combination of microbes (Table 2). 
The column, a BPSS 400/600. was packed with 
Sephac:ryl 5-200 High Resolution and connected to 
an RRA 7lB/l pump, The column was first 
infected, then sanitized, and then tested to 
determine the number of viable organisms. 
Table 2. Microbes used in th' challenge tests are from ATCC. 
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'"ATCC - American Type CuiLure CoDect.lon 
Contaminated Peptone Water was pumped into 
the column from the top at a flow rate of 36 IIh 
and a pressure of 80 kPa. The column was then 
left at room temperature for 18-20 hours with no 
pressure applied. 
0.5 M NaOH was introduced into the collJmn and 
circulated at a presslJre of 80 kPa for 60 minutes, 
After this time interval 5 lltres of sterile 
phySiological saline were pumped thrOlJgh the 
column. The outlet sample was taken before the 
saline wash was completed, 
The teSt sites were sampled following sanitization 
with NaOH and despite very high infection 
through the introdlJction of highly contaminated 
solutions no bacteria, yeast or fungi were detected. 
Challenge test results 
The results confirm that NaOH is an effective anti­
microbial agent, and that it. is appropriate for use 
wlth BPSS columns. Pharmacia Biotech 
recommends. however, that this method be applied 
in conjunction with other carefully controlled 
hygiene routines and rigorous control of buffers, 
water and other materials, 
Materials 
The materials used in the construction of BPSS 
columns have been carefully selected for their 
compatibility with the solvents rnost commonly 
used in liquid chromatography, column 
maintenance and cleaning procedlJres. 
The components of the column may be consIdered 
to contain wet and dry parts. Table 3 shows the 
major components of the columns and identifies 
the materials from which the wet and dry parts are 
manufactured. 
Table 4 is a guide to the resistance of the materials 
used in BPSS columns to chemicals used as 
solvents. and also to autoclaving. 
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Generic tPA AppendixD 
ER Column Pump 
cm 
'= lOO'-=- I :=26·cm J.I :=.0 15'poise D p := 1l0·1O-4·cmv 0' nr 
kg
E := 0.35 p:= 1000.~ 
,·.2 /1 ']'1-£ 2', -E)
1iP:= 150,J.I·V 0'\ 3 + 1.75·p'v 0 '----y ·1 liP '" l.92"si 
[ Dp2'E Dp'E 
Assume pressure drop across column is 10 psi 1iP:= 10'psi 
kgF:= 10,99' Flow through Pump hr Size := F. LiP 
p 
Ib Power := Sizep :=63,72'ft! Density of Water fJ 
1] :=0.80 Pump efficiency Head:= liP 
p.g 
Size = 2.823·\O-4 "hp 
Hours per batch: t := 7920·hr 
Power = 0.263 W 
Electricity := Power·t 
Head = 22.599ofi 
Electricity = 2.084 okW ·hr 
b := 1.5·hp 

b = 1.119okW 
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Master F e on the 
~ )'0 ~Teall earlier today. EDclosed please find lIIe prieiDg infonnati<m you 
reque on Aeti lean Etox. The pricing info is as follows: 
Cat# 
2705-01 
2705-02 
2705-05 
Vol. Priee 
20ml $420.00 
100m) 51575.00 
,-~
10~ $4320.0~ 
5 SO.OOJL 
SOL S3840.001L 
being used' for the manufacture ofthcrapcutics which are approved 
trials. In addition we ha\lc a ReguIatmy Support File and a Drug 
sin to assist you with regulatory issues 'With the resin. 
furthe questions or need additionaiassistance. please give me a call. I can 
be reaCh at 800. 35-0735 or througb email atbshoffm.an@eartblink.net. Thank. youfor your' terest - Sterogene Bioseparations, Inc. We look forward to working with you. 
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sterogene 
sterogene technical profile 
Acticlean Etox 

Easy, rapid endotoxin removal from biologics 
· High binding capacity 
· Dissociates endotoxin-protein complexes 
· Nontoxic, stable ligand 
· Stable linkage chemistry 
· Sanitize with 1 M NaOH 
· Reusable 
· Drug Master File 
Removing endotoxins from proteins and other biologics can be difficult and expensive. The most commonly used 
methods include ultrafiltration, size exclusion and ion exchange chromatography. Recently, SOlid-phase 
endotoxin-adsorbing reagents have become available, however, their binding affinities are often too low to 
dissociate endotoxin-protein complexes effectively. Nonspecific binding of proteins to these reagents is another 
common problem. 
To address these issues, Sterogene has developed Acticlean Etox, a solid-phase reagent with a high affinity for 
endotoxin. Acticlean Etox effectively removes endotoxin from all biological media of interest, including water, 
buffers, cell culture media, and purified proteins. Affinity of the immobilized ligand for proteins is very low, 
delivering a mass yield of proteins which typically exceeds 95%. 
High Binding Capacity 
The endotoxin binding capacity of Acticlean Etox has been measured in buffers and protein solutions. Capacities 
vary from 20,000 EUlmi in aqueous buffers to 200 EU/ml in a 25% serum albumin solution. Capacity is a function 
of sample composition, buffer condition, contact time and to a smaller degree pH. Binding capacity is typically 
inversely proportional to the protein concentration in the sample. The nature and concentration of the protein in 
the sample also have a major effect on the available capacities. 
In a comparative study, Acticlean Etox exhibited significantly higher endotoxin binding capacity than immobilized 
polymixin: 
Stable Linkage Chemistry 
Acticlean Etox utilizes Sterogene's proprietary ALD coupling chemistry. an immobilization technique that produces 
a highly stable secondary amine linkage. Leaching is negligible (less than 0.1 ppm). 
Column Chromatography 
lof6 332. 3/30/0012:44 AM 
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Acticlean Etox can be used in either a batch mode or a chromatography column. Columns are easily prepared by 
packing with the depyrogenated resin as a 50% slurry in sterile buffer. Contact time with the resin should be 
optimized for every application. To further increase endotoxin binding efficiency, the protein solution can be 
passed through more than one column. Column operation is generally more effective than batch processing. 
Batch Processing 
For batch depyrogenation, the settled gel is simply added directly to the protein solution. Several contact times 
ranging from 3 to 20 min should be tested to determine the most complete removal of endotoxin. 
Nontoxic Ligand 
The immobilized ligand is nontoxic, nonmutagenic and biodegradable. Both acute and chronic animal studies are 
completed. 
Specifications 
Sanitization 
Acticlean Etox is the only endotoxin-removing resin that can be regenerated with 1 M NaOH. This is made 
possible by the stability of the ligand and matrix, as well as the ALD linkage chemistry. Acticlean Etox can be 
sterilized by autoclaving at pH 7. 
Drug Master File 
Sterogene is a cGMP manufacturer of bioprocessing resins. A Drug Master File is on file with regulatory agencies 
in the US and Europe. 
Applications 
The following applications were developed to demonstrate endotoxin removal from plasma derivatives. The final 
endotoxin levels reflect application needs. Lower final endotoxin levels can be achieved by increasing residence 
times on the column or increasing resin-to-sample ratios. 
All solutions were prepared in endotoxin-free water (LAL Reagent Water, Bio-Whittaker Inc .• Walkersville, MD). 
Endotoxin was measured using the Pyrogent Plus and chromogenic QCL-1000 LAL test kits from Bio-Whittaker. 
Sterile, disposable plasticware and glassware were used at all times to reduce the chance of endotoxin 
contamination. Acticlean Etox resin was packed into 2 ml bed volume columns. The columns were cleaned by 
perfusion with 30 ml of 1 M NaOH. allowed to stand at 40C overnight. and washed with LAL water until neutrality. 
A sample of the final wash must test negative for endotoxin. 
1. Sterile, 25% human serum albumin solution (HSA, Alpha Therapeutic Corp., Los Angeles, CA) was spiked with 
standard E. coli endotoxin to 30 EU/ml and adjusted to pH 7.0. Ten ml of the HSA solution were perfused through 
two columns set in series at approximately 0.3 ml/min. Five fractions were collected at 2.0 ml increments, then 
diluted 1 to 10 and heat inactivated (70 OC for 10 min) to prevent any enhancement or inhibition of the endotoxin 
assay. The fraction with the highest protein concentration was selected, and further dilutions were made to the 
maximum of expected lysate sensitivity. 
A Significant reduction in endotoxin was achieved while more than 99% of HSA was recovered. 
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Endotoxin Remoyal from Human 
Serum Albumin Using Acticlean Etox 
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2. A pyrogenic lot of human Intravenous Immunoglobulin solution (5%) was treated with Acticlean Etox. Ten ml of 
the IgG sample were perfused through the column at approximately 0.3 ml/min. Five fractions were collected at 
2.0 ml increments, then diluted 1 to 3 and heat inactivated at 700C for 10 min. The fraction with the highest protein 
concentration was selected, and further dilutions made to the maximum of expected lysate sensitivity. 
A 10-fold reduction in endotoxin was achieved while more than 98% of IgG was recovered. 
Endotoxin Remoyal from 5X IgG Solution 

Using Acticlean Etox 
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3. A sterile, affinity-purified Factor VIII solution (Alpha Therapeutic Corp., Los Angeles, CA) containing 100 units 
Factor Vlll/mi was spiked with E. coli endotoxin to 20 EU/ml final concentration and adjusted to pH 7.0. Ten ml of 
the Factor VIII solution were perfused through the column at 0.3 ml/min. Five fractions were collected at 2.0 ml 
increments, then diluted 1 to 3 and heat inactivated as above. The fraction with the highest protein concentration 
-33l..\ 
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was selected, and further dilutions were made to the maximum of expected lysate sensitivity. 
Endotoxin was reduced below 0.1 EU/ml while Factor VIII recovery, determined by a chromogenic assay, was 
found to be greater than 95%. 
Endotoxin Removal from Purified 

Factor VIII Using Acticlean Etox 
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4. A sterile. affinity-purified Factor IX solution (Alpha Therapeutic Corp., Los Angeles, CA) containing 100 units 
Factor IXlml was spiked with E. coli endotoxin to 40 EU/ml and adjusted to pH 7.0. Ten ml of the Factor IX 
solution were perfused through the column at 0.3 ml/min. Five fractions were collected at 2.0 ml increments, then 
diluted 1 to 3 and heat inactivated. The fraction with the highest protein concentration was selected, and further 
dilutions were made to the maximum of expected lysate sensitivity. 
Endotoxin was reduced to 0.5 EU/ml while Factor IX recovery, determined by a chromogenic assay, was found to 
be greater than 98%. 
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5. Sterile fetal calf serum (Biocell Laboratories, Rancho Dominguez, CA) was spiked with E. coli endotoxin to 10 
EUlml final concentration and adjusted to pH 7.0. Ten ml of the serum were perfused through the Acticlean Etox 
column at 0.3mllmin. Five fractions were collected at 2.0 ml increments, and then diluted 1 to 3 and heat 
inactivated. The fraction with the highest protein concentration was selected, and further dilutions made to the 
maximum of expected lysate sensitivity. 
The treatment reduced the endotoxin level in the serum down to 0.12 EUlml. 
Endotoxin Removal from Serum (FBS) 

Using Acticlean Etox 
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500ml 
1 L 
i~iclean Etox :L 2705-PP II 9 ml (Prepacked column) 
L _ IL2705-04 
Acticlean Etox media is available in bulk pack sizes for industrial applications. Please inquire for pricing 
information. 
Sterogene Bioseparations provides a wide range of resins and services for industrial chromatography. For more 
information, please contact our Client Services Group at: 
1-800-535-0735 
Visit our website at www.sterogene.comfor new product information and applications as they become available. 
to place an order or for technical assistance call: 
1-800-535-2284 
Sterogene Bioseparations Inc. 5922 Farnsworth CI Carlsbad, CA 92008 USA Tel: 760·929·0455 Fax: 760-929-8720 email: 
info@sterogene.com.website:www.sterogene.com 
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oTELEFAX amersham pharmacia biotech 
TO: Chris Metallo 
COMPANY: University of Pennsylvania 
DEPT: 
PHONE: 

FAX: 215-573-7601 

FROM: Nancy Elser 
DEPT: Technical Support 
PHONE: 800-526-3593 
FAX: 415-695-1189 
DATE: February 22, 2000 
Dear Chris, 
TAKE A LOOK AT OUR NEW PRODUCTS 

Purify GST fusion proteins in one step 

High binding capacity 

• GSTrapn.t 
1 ml and 5 ml prepacked HiTrapn.t columns 
• Glutathione Sepharosen.t 4 Fast Flow 25 ml 
For more information and to place your order. call 
Amersham Pharmacia Biotech today. 
Please find enclosed the information you requested on BPG columns. I am still trying 
to find you more information on the BPSS columns. As soon as I find something 
appropriate, I will fax it to you. 
Regards, 
Nancy Elser 
Tech Support 
Amenlham Pharmacia Biotech USA tel 8Q0.526-3593 
800 Centannild Aw fax 415-695-1169 
P.O. Sol( 1327 www.apbiotClch.com 
PiI.c:ataway, NJ 06855-1327 
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BPG™ Columns 100, 140, 200, Data File 
and 300 series Columns 
BPGT" columns are glass chromatography columns 
designed for industrial applications which demand 
high standards of hygiene. The columns are 
constructed from component materials of the 
highest quality and withstand the harsh conditions 
used for cleaning in place of packed separation 
media. They are characterized by: 
• 	 Hygienic design and operation. Microbial 
attachment and growth is hindered through the 
use of calibrated precision glass, high grade 
electropolished stainless steel and an absence of 
dead pockets. 
• 	 Easy, efficient packing and running with the 
single-screw adaptor. 
• 	 Operating pressures matching most BioProcess 
Media. 
• 	 Materials that conform to the requirements 
described in the US Pharmacopoeia (USP XXII). 
• 	 Comprehensive documentarion. 
General description 
BPG columns are designed to meet [he needs of 
process development and biopharmaceutical 
manufacrure: 
- Inner diameters of 100, 140,200 and 300 mm. 

. Pressure specifications of 8, 6 and 4 bar. 

- Low flow resistance. 

- Single screw ada ptor. 

- Suitability for use in ion exchange, gel filtration, 

affinity and hydrophobic interaction chromato­
graphy and comparability with BioProcess 
Media. 
- Tubing connectjons made with hygienic sanitary 
clamp firtings. 
- All gaskets recognized as suitable for use in 
biopharmaceutical production. 
- Capacity to offer a wide range of bed heights 
and volumes. 
An instruction manual containing full details of 
componems, packing, resting, procedures for 
cleaning and sanitizing, trouble-shooting, and 
spare parts lists. 
i 18-1115-231 
Fig. 1. BPG .:alumn family, including BPG 450. 
Design features 
Column tube 
The coJumns are designed to very high standards 
and use high quality materials: 
• Manufactured from calibrated precision 
borosilicate glass. 
- Exact internal diameter tolerance of the glass 
tube. 
- Thin O-ring between the column rube and the 
adaptor/end-piece forms a very tight seaL 
- Minimum dead volume. 
- Liquid distribution over a great surface area. 
Pharmacia 
Biotech 
Liquid distribution 
Efficient liquid distribution is crucial for optimal 

column performance. In BPG columns this is 

assured through: 

- Adaprors and end-pieces based on the well 
proven design of a single channel inlet/outlet. 
- Support nets with a coarse, open structure to 
distribute liquid from the central inlet rapidly 
and uniformly over the entire surface area. 
- Thin ners to maintain even pressure distribution 
over the bed surface and permit liquid to pass 
through quickly and evenly Onto the bed, 
without creating extra back-pressure. 
- Polypropylene distribution plates in the adapror, 
and in the bottom plate in BPG 300 columns, 
which give uniform distriburion/collection of 
liquid at the interface between the net and the 
packed bed. These plates are not necessary in 
narrower diameter columns. 
/ 
.........,.., 

-

Fig. 2. Adapror end.piece and net. Flat surfaces 
give even spread of sample. 
Operation 
Hygiene 
BPG column are intended for use iil environments 
with some of the toughest regulatory controls: 
- Design and materials of construction ensure 

hygienic operation. 

- Little maintenance is required in routine use. 

The columns a re easy to keep clean and free 

from microbial contaminations. 

- Autoclavable when disassembled. 
- All tubing connections are made with sanitary 
clamp fittings. 
- Columns are easily sanitized. A packed BPG 
column was subjected to microbial challenge 
tesring using five micro-organisms recommended 
by the United States Pharmacopoeia (USP XXI). 
Sodium hydroxide (NaOH) was the anti­
microbial agent. The study showed that 0.5 M 
NaOH applied for 30-60 minutes is a good 
basis for developing an effective sanitization 
procedure. The study is presented in Technical 
Note 211. 
Easy to pack 
The design of adapror with a single-screw makes 
light work of all adaptor movement. It is easily 
adjQsted during packing and operation, even on the 
largest of columns. 
Scalable 
BPG columns are ideal for scaling up from smaller 
lab scale or method development columns. As the 
example shows here, Fig. 3, the chromatogram 
obtained with an XK 16/20 column, i.d. 16 mm, is 
consistent with the chromatogram obtained from 
the scaled up run on BPG 300/500 column, i.d. 
300 mm. The scale up factor is 350 and no 
evidence of dilution or loss of recovery was 
detectable. 
Materials 
All the materials selected for the manufacture of 
BPG columns are of high quality, often with 
special properties, or specially treated, Table 1 . 
All materials used in BPG columns meet the 
requirements described in the USP XXII; 
- Materials are compatible with the liquids 
commonly used in process scale chromarography 
(including sanitizarion and cleaning agenrs such 
as NaOH and ethanol), see Table 2. 
- Parrs in contact with sample and process liquids 
are made of marerials of very high quality and . 
chemical resistance. 
- All stainless steel r.omponents are e1ectro­
polished. This improves resistance to corrosion 
and reduces friction and contamination. 
- Polymeric materials have been tested for their 

biologica1 reactiyiry according to USP XXII. 

- Documentation of all material testing is 

compiled in the Validation Support File. 
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Table 1. Column component materials. Componenrs may be considered to contain "wet" pam, parts coming into contact with 
process liquids, and dry partS. The table identifies the materials from which the "wet" and dey parts are manufactured. 
..Borosilicate glass 

Ethylene Propylene rubber (EPDM} .. 

... .. 	 ... ..Stainless steel: 	ASTM 316L 

ASTM 3041 

.. 	 ...Polypropylene (PP) . 
..Polycetrafluocoethene (PTFE) (Teflon) 

Polyamide (PA) nylon (lO)lm net) 

Polyerheretherketone (PEEK) with 

30 % carbon fibre 

Acetal plastic (POM) 

FJ uoroethenepropene (FEP)l 

..Polyurethane 

Polyvinylchloride (PVC» 

, The d:lmps are made of s[~inless sTeel. Option ro EPDM. 1 The tubing is made of PVC. 
Separation at lab scale 
Column: XK16120 (Lei. 16 mm), 
10 em bed height. 
20ml 
Medium: Phenyl SepharoS8 6 
Fasl Flow (high sub) 
Sample: Yeast supemanlant, 
(NH4)ZSO", added 10 
0.5M 
3.00 
Loading; 450 ml sample: 
8.1 mgEGF; 
0.41 nlIJ'ml medium 
Starting buffer: 0.5 M ammomium 
sulphate, 20 mM2.00 sodium phosphate 
pH 7.0 
Sution buffer: 20 mM sodium 
phosphate pH 7.0100 Flow rate: 
Loading: 300 cnvb, 600 mIIh 
Eluiton: 60 cmlh. 120 mllh 
Purification0.00 limB: 1.5 h 
o 50 Time (min) System: BioPilot 
Separation at process scale 
eolumn: BPG 3001500 (La. 300 mm), 10 em bed heighl, 7.1 L 
Medium: Phenyl Sepharose 6 Fast Flow (high sub) 
Sample: • Yeast aupemanlant. (NH~12S04 added to 0.5 M 
Loading: SO l aample: 2.56 9 EGF: 0.36 mg/ml medium 
Starting buffer: 0.5 M ammomium sulphate. 
20 mM sodium phoSphate pH 7.0 
Elulion bUffer. 20 mM sodkJm phosphate pH 7.0 
Flow rate: 
I.oading: 300 cmIh. 2100 IJh 
Eluiron: 60 cmIh. 42 LIh 
Purification time: 1.5 h 
System: 8ioProcess conlroBed by UNICORN 
%8AU 
100 
3.0 
2.0 
50 
1.0 
0.0 	 o 
o 	 50 100 Time (min) 
Fig. J. Developmenr :lnu 5cal< up of a chromarogn1phi..: do",nstream 
process for the purih.:.uion of re.:ombinam EGf expre5sed as 3n extra· 
cellular procein imrn S. cerel'isi.l(!, Tile starring mareri,,1 was dnrified 
supernnranr, (Dollit'k A.1.. PN<"·SSOJl. N.T .. Se<1l1ddl,l, C. Puster 
presl!l/t,ltiol1. Crysu! Cit)'. L'S.-i. 1992.) 
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Chemical resistance 
Table 2 is a guide to the resiscance of materials to 
chemical solvents. The information has been 
complied from published material from several 
sources. Please note that the effects of a solvent 
will be more severe at htgher temperatures and 
[hac combined effects have not been taken into 
consideration. 
Individual testing 
As evidence of good manufacturing practice, all 
BPG columns are individually pressure tested and 
inspected. A test certificate accompanies each 
column delivery. 
Table 2. Chemical resistance of materials of construction. 
Acetic acid 1.7 M see note 6 Hydrochloric acid 0.1 M see noll: 6,7 
Acetonitrile 5% see note 2 Isopropyl alcohol 100% see note 2 
Acetonitrile 50% see note 3 Methanol 100% see note 2 
Acetone 10% see note 2 Nitric acid O.IM see note7 
Cyclohexane 100% see note 3 n-Propanol 100% OK 
Ethanol 100% see note 2 Sodium chloride 2M see note 2,5 
Ethyl acetate 100% see note 4 Sodium hydroxide 2M OK 
Ethylene glycol ·50% OK Trifluoroaceric acid 0.1% see note 7,8 
Glycerol 100% OK Triton X-100 100% OK 
Hexane 100% see note 2,7 Urea 8M OK 
Note 1: The res, does nor include PVC whinS. 

NOie 2: EPD~1 rubber changes d'ar·Jcrerisrics. Fur repetitive :lnd long term us{:. use FEP O-rings. 

Nore 3: Change ro FE? O·rings. polypropylene plastic resim:nce is f:lir. 

Nure 4: Poiyproylene pl:l5tic resist.1nce is gc>od/f:)ir. 

Nore 5: Can be used under norm::!! running conditions. Do nor use NaCI in storage snluliuns. Please nme thar NaCI c:ln .;"use .:orrosion on 

st:linless steel in acid soluI;uns {pH bdow 4.0). 

Nore 6: Nor long.:r [h~n 4 hours. 

Nme 7; Nor reO;:Ol11mended rl} he usc:J wirh PA nets. 

Nore 8: FEP .;h;]llges ch(lracrerisrio;:s. Usc EPDM ruhll~r. 

Overview of BPG columns 
Bed,.... Bed 
. height';" volume . Overall 
Bed Bcd with· ." 'Bed' '. Bed with dimensions 
Tube Tube Surface height height packing volume volume packing Max. Total Adaptor mc. stand 
diam. height area min. max. device min. max.. device pressure weight weight &: adaptor 
Column (mm) (mm) (em2) (em) (em) (em) '(l) (l) (l) (bar) (kg) (kg) hxdxd (c;m3 ) 
1001500 100 500 79 0 26 48 0 2.0 3.8 8 15 7 127><48x48 
1001750 100 750 79 15 41 66 2.0 3.2 5.2 8 16 7 152x48x48 
100/950 100 950 79 45 54 83 3.5 4.2 6.6 8 17 7 172x48x48 
140/500 140 500 154 0 26 48 0 4.0 7.4 6 25 11 127:o:59x59 
140/950 140 950 154 45 54 83 6.9 8.3 12.8 6 27 11 172x59x59 
a6()(SO(l1 200 500 314 0 26 48 0 8.2 15.1 6 34 13 127><59x59 
200/750 ZOO 750 314 15 41 66 7.3 12.9 10.7 6 36 13 152><59x59 
200/950 100 950 314 45 54 83 14.1 16.9 26.] 6 39 13 172><59x59 
q~~~~296 500 688 0 26 48 0 17.9 33.0 4 68 29 133x69x69 
, 296 750 688 25 41 66 17.2 28.2 45.4 4 73 29 158><69x69 
300/950 296 950 688· 45 54 83 31.0 37.2 57.1 4 78 29 178x69x69 
Ordering information 
Column Tube height SOO mm Tube beight 750 mm Tube beight 950 mm Stand 
BPG 100 18-1103-01 18-1103-01 18-1103-03 18-1031-10 

BPG 140 18-1113-08 18-1113-09 18-1031-20 

BPG200 18-]]03-11 18-1103-12 18-1103-13 18-1031-20 

BPG300 18-1103-21 18-1103-22 18-1103-23 included 

Each column ;ndllde5 :15 sr.lIlJ:Hd: 23 ~tIl1 pnlypropCI1f' tilrer ners and polypropene coarse ners, 2 damps, 1 EPD.\\ gaskets. 2 blank caps and 
O-rings in EPD\I. All srands must he ordered separarely ('..;..:epr for BrG 300. BPG 100 nand h:ls feer. while BPG 140,200 and 300 stand has 
wheels. 
"~p~re parts BPG 100 BPG 140.· BPG200 BPG 300 Qty/pk 
Flange O-ring 18-8494-01 18-1113-06 18-8489-01 18-1012-26 2 
Adaptor O-ring 18-8475-01 18-1113-10 18-0275-01 18-1012-51 2 
Support net, adapror 18-1103-04 IS-1112-99 18-0252-56 ]8-1012-53 2 
Suppon net, end-piece 18·0251-55 18-1112-98 18-0252-55 18-1012-36 2 
Nct, 10 Ilffi, adapror 18·1103·05 18-1] 13-03 18-0252-76 18-1012-55 2 
Net, 10 .um, end'plece 18-0251-77 18-1113-02 18-0252·77 18-1012-35 2 
Net, 12 pm, adapror 18-1103·06 18-1113-05 18-1104-42 18-1104-44 1 
Net, 12 IJm, end-piece 18-1104-41 18-1113-04 18·1104·43 18-11 04·45 2 
Nee, 23 pm, adapror 18-1103-ml 1s- L 113-01 18-9253-01 18-1012-54 2 
Net, 23 pm, end-piece '18-9252-01 18-1113-00 18-9254-01 18-1012-34 2 
4 
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Preparing the gel" <lJ: 
Protein G Sepharose 4 Fast Flow is supplied preswollen in 20% ethanol. Prepare II. 
a slurry by decanting the 20% ethanol solution and replace it with binding 
buffer in a ratio of 75% settled gel to 25% buffer. The binding buffer should 
not contain agents which significantly increase the viscosity. The column may be 
equilibrated with viscous buffers at reduced flow rate after packing is" 
completed.<t .' 

N 

For batch procedures remove the ethanol by washing the gel on a medium 
o porbsitY sintered glass funnel. '.'1· 
N 
01 Packing Sepharose Fast Flow gelsto 
1. 	 Equilibrate all material to the temperature at which the chromatography 
will be performed. 
<t 
2. 	 De-gas the gel slurry. 
3. 	 Eliminate air from the column dead spaces by flushing the end pieces with 
binding buffer. Make sure: no air ha~ been trapped under the column net. 
Close the column outlet with a few centimeters of hinding buffer remaining 
in the column. . 
4 . 	 Pour the slurry inro the column in one continuous motion. Pouring the 
.~ slurry down a glass rod held against the wall of the column will minimize ~ the introduction of air bubbles. . \)J 
S. 	 Immediately fiJI the remainder of rhe column with binding buffer, mount 
the column tOP piece onto the column and connect the column to a pump. 
6, 	 Open the: bottom outlet of [he column and set the pump to run at the 
desired flow rate. Ideally, Fast Flow gels are packed at a constant pressure 
not exceeding 1 bar (0.1 MPa) in XK columns. If the packing equipment 0\ does not include a pressure gauge, use a packing flow rate of at least 400 Ill' 
cmlh (15 em bed height, HOC, low viscosity buffer). 
4: 
- If the recommended pressure or flow rate cannot be obtained, use the 
U 
4: lIiaximum flow rare the pump can deliver. This should also give a 

:i 
a: reasonably well-packed gel. 

4: 
I 
0. 
Q 
Q 
I ('II "' ~ N • 
I 

N 

Q 
Note: 	 Do not exceed 75% of the packing flow rate in subsequent 
chromatographic procedures. 
7. 	 Maintain the packing flow rate for 3 bed volumes aFter a constallt bed 
height is reached. 
Using an adaptor 
Adaptors should be fitted as follows: 
1. 	 After the gel has been packed as described above, elme the column outlet 
and remove the top piece from the column. Carefully fill rhe rcst of rhe 
column with binding buffer to form an upward menisclls :If rhe top. 
2. 	 Insert the adaptor at an angle into the column, cnsurilli:! that no air is 
trapped under the net. 
1. 	 Make nil tubing connecti!)n~ ill this ,t,lgC. There 11111li111l.! II huhhlc·Free 
liquid connection between the colulllll alld the IHlml' ;"nl colulI1n l\IHI the 
sample application systelll (LV·3 or LV·4 v;llvesl. 
4. 	 Slide the plunger slowly down the en/limn sn tbar the iIi .. 'lhove rhe net and 
in the capillary tubings is disl>\;'u:eJ hy clm:llI. V,IIvcs lin the inler side of the 
column should be tUrned in all directions during this procedure to ensure 
that air is removed. 
S. 	 Lock the adaptor in position, open the column outlet and start the eluent 
flow. Pass eluent through the column at the packillg flow rate until the gel 
bed is stable. Re.position the adaptor on rhe gel surface as ltecess:HY. 
Binding .' 
IgG from most spedes binds Protein G Sepharose Fast Flow at neurr1l1 pH and 
physiological ionic strength. 
As a'general method we recommend 20 I1lM sodium phosphate, pH 7.0 as 
binding buffer. 
The binding capacity of Protein G Sepharuse 4 F:m Flow depends on the source 
of the particular immunoglobulin, see Tab/I: 3. However, the total cilpacity 
drpends upon several factors, such ilS the flow nHl' during s.lmplc application, 
the: sample concentration and billdin!; huffer. T.1hlt: J sllllws rhe tot,,1 C<lllacity 
under defined conditions for IgG from snmc spc(ics. 
~ 
Table 1. The relative binding strength of ROlycIOnall~G.from various species 
to Protein G and Protein A, as measured in a compe ilive ELISA test. 
Species 	 Protein G Protein A 
Human 
IgG, ++ ++ 
IgG ' ++ ++ 
IgG23 ++ r IgG4 ++ ++l. 	 Rabbit ++ ++
,Cow ++ + 

Horse ++ 

Goal ++ + 

Guinea pig + ++ 

Sheep ++ 

Dog + ++ 

Pig ++ ++ 

Rat-

Mouse·· + + 

Chicken 

++,. strQng binding , 
+ 	 = medium binding 
= weak or no binding 
Nole that IgO from rat binds to Prolein G copuled 10 Sepharose 4 Fast Flow. 
.. 	 IgOl from mouse binds more strongly 10 PrOIein G than to Proleln A. 
\)J Ph3rm3cia LKB rccombin:un Protein G, MW 17000 d:llton, is produced in 
;:: E coli. and contains two IgG binding regions. The albumin binding region of 
..r;.: native Protein G has been genetically deleted, thereby avoiding undesirable 
cross-reactions with albumin. 
. ......_-._--...;....--­
) 
) 
I 
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Table 2. Gel characteristics 
ligand densily: 	 -2 mg Protein G/ml drained gel 
Dynamic binding 
capacity·: -1 B mg hUman IgG/ml drained gel 
Bead structure:' 	 4% highly cross-linked agarose 
Bead size range: 	 45-165 ~m 
Mean bead size: approx. gO ~m 
Max linear flow i-ate: >1 300 cmlh al 0.05 MPs (0.5 bar) in a 
( yolum8lrlc now rale (cm'lhl ) XK 16/20 column, bed height 5 cm 
column cross-sectional area (em') 
Max operating 

backpressure: 0.1 MPa (1 bar, 14 psi) 

pH working range: 	 2-9" 
pH stability 
Long term: 3-9'" 
Cleaning-In-place: 3-9'" 
Chemical stability: 	 The IgG binding capacity and recovery was 
maintained aller storage for: 
(a) 7 days at 37°C in: 
1 M acetic acid pH 2.0, 
20 mM sodium phosphate, 1% SOS. pH 7.0, 
6 M guandine-HC1. 70% athanol. . 
(b) 	2 hours at room temperature in: 
0.1 M Hel, pH 1.0, 
.' 
B M Urea, pH 10.5, 
0.1 M Glycine-NaOH, pH 11 
PhYSical stability: 	 Negligible volume vanation due to 

changes in pH or ionic strength. 

Sanitization: 	 Sanitize the column with 70% ethanol. 
The dynamiC capacity was calculated as the amount of human IgG adsorbed 
to the gel before the flow through exceeded 1"10 of the absorbance of the in­
going solution. The capacity was determined at a linear flow rate of 30 cm/h 
and with a sample concentration of 0.92 
•• 	 Protein G may hydrolyse at low pH. 

Estimates to the best of our knowledge and our experience. 
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FEATURING 
• 	NO TRAY/NO LOADING 
• AUlOMATIC ADVANCE OF EMPTY TRAY 
WHEN WORKING TRAY IS FULL 
• NO SPLASHING OR TIPPING OF 
CONTAINERS 
• VARIABLE MACHINE SPEED TO MAlCH 
PRODUCTION RATES OF UPSTREAM 
EQUIPMENT 
. OPTIONS 
• 	AUTOMATIC MAKE-UP SYSTEM 
ENSURES AOEQUJUE VIA,L SUPPLY 
• LAMINAR FLOW HOOD ENCLOSURE 
• FEED-THROUGH CONVEYOR FOR 
PROCESSING NON-L'IOPHILIZEO VIALS 
. 
CONTAINER DIAMETER 112" (13mm) 10 2·1/2- (63.5mm) diametar Glass vials 
I 
CONWNeR HEIGHT 1-'14" (31.8mm) 11:1 4" (101.6mm) i 
TRAYlYPE Three-sided 
TIU.VSIZE 
' .. 
10'" (254mm) to 20'" (508mm) wide 
up to 36· (914mm) long 
MACHINE SPEED Up to 20 rows per mirwte 
" '" 
AIMS per minute xnumber Df vial$ 
per raNCONTAINERS PER MINUTE 
FEED Laft to right 
CONYE'tOR HEIGHT 32-1/2" (826mm) to 37" (940mm) I 
ELECTRICALS 120 V: 60 Hz; 1Ph 
, 
NET WEIGHT 625 b$ (284 kg) 
BTIS Specifications 
I 
I 
AutomatIc 'Ray Loader 
ModeI8T15 _._--­ ~,ouD
..................--.. 

MACHINE 
CONTFiOLS 
-
o H­ - - ... - - -.~- .' _...­ ....--=--­
-­
. - " •. _,,­ - ­ -J:­
SO" 
(1 270mm) l i ; 
I I 20":0 2f>" 
! LMPrY : 'NQRI(ING 
I TRAY: TRAY 
,ll:__ .-.-~, 
FULL 
TRAY 
1 
~-.'_. __ 
L 25". .1 ITRAVEl.. 
J. W 120' (3073mm) • 
TU 	 II' , 

H 
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Bench..ark SO S.ri.s 
Iyophlllz.r conllgur.­
flons include St.... 
In Place (S.I.P.), 
CI••n In Plac. (C.I.P.), 
Aulo..at.d locking 
Door, as well as a wide 
variety of optlon.1 
r.frigeratlon and 
condenser types to 
..atch any processing 
r.quir....nts. 
• For lyophilization equipment that 
meets your production expectations 
and volume requirements every time ... 
for greater flexibility and more shelf 
size configurations ... for lyophilizers 
that are designed to meet your own 
special needs, turn to VirTis. 
The VirTis Company understands 
your needs and your frustrations. We 
recognize that your requirements 
aren't like those of the guy down the 
street. And we have some answers. 
Every VirTis Benchmark lM 
lyophilizer is configured to match 
your processing and production envi­
ronment and requirements. For more 
than 42 years, VirTis has applied 
advanced lyophilization techniques 
to solve difficult product preservation 
problems. This gives us the knowl- ' 
edge and experience to meet your 
needsforecquipment, technology and 
post-sale valiga~on support... today, 
tomorrow, an:clfuto the next century. 
We're proud to support VirTis 
freeze dryers with a worldwide sales 
and service network extending to 
seventy countries and covering 
the world's largest installed base. 
Whether you're producing antibiotics, 
blood fractions, diagnostic, veterinary 
or biophannaceutical products, we 
make a lyophilization plant that 
can be configured, delivered and 
commissioned in less time and 
withfewer headaches than you 
ever thought possible. 

Benchmark Plus 
top-down hydraulic 
stoppering permits 
complete shelf stock 
closure for routine 
cleaning. Quick-change 
shelf spacing links 
make it easy to change 
the amount of useable 
shelf area and shelf 
Interdistance to 
accommodate any size 
produd ,container. 
Window.~ j. a trod.mark 01 
MJcrosoit CorporDtion. 
FIX DMACS- is a trademark 01 
lnt.llution, 
80TH PRODUCTION 
AN~ PHYSIW 
Ifyopr facility was designed 
for s1p3ller batch production, we 
help you maximize the space you 
have, by creating a unit with higher 
capacity that will fit right in. If extra 
large or small containers or variable 
production runs are part of your 
picture, our unique shelving system 
can be easily adjusted to fit. Only 
yirTis offers you a choice of economi­
calround-c~bered lyophilizers, as 
well as our unique square chambered 
jSQj configurations for maximum 
capacity. Utilizing an SQ model can 
accommodate larger runs in less 
space, or do with one machine what 
might have required two. We'll even 
build a lyophilizer designed for your 
most demanding clean area size con­
straints while being able to handle 
your process requirements. 
The VirTis industrial series 
extends from our Genesis"" SQ Series 
for pilot runs or small scale produc­
tion at 6.94 ft2 IQ,65m2} to oUI largest 
standard Benchmark Plus lyophiliza- . 
tion plant with 416 ft2 [38,6m2) 
of usable shelf area, all built with 
the same level of quality and fine 
attention to detail. 
l~h~,:, 
WORLD~STANDARD 
CONTROLlERS~JMKE 
VALIDATION SIMPLE 
,f ,:;,' , ,~ •• ~:~~;J!!/t';f::'( 
y ~~ dpn't need,~~!je'a computer: . 
genius,to take advantage of VirTis's 
advanCid contrcilsystems. We deliver 
complettf lyophiliZation control and 
documentation in a ,user-friendly envi­
ronment. : 
Our VirTuoso"" ~dMaestro"" 

lyop~jJf~tion control systems can 

handie:ev' ' .. 

. 'HT'-;"'~ery detail of your complex 
.c~tOd~Cycle with complete accuracy 
ah~ (!pll complement of safeguards. 
A Wm.~ows~~basedoperati.ng system 
coupled with the powerful Intellution 
FIX DMACS'" supervisory package 
guarantees the system is extremely 
easy to use, simplifying the process 
of meeting validation requirements. 
An Allen Bradley PLC-based system 
provides you with proven performance 
hardware for unparalleled reliability. 
An IBM PC- compatible computer, 
SVGA color monitor and color printer 
furnish clear, vibrant display, graphi­
cal trending and solid documentation , 
backed by worldwide support. 
VirTuoso and Maestro let you safely 
implement complex drying cycles 
with all the benefits of thermal treat­
ment, pressure rise and validation 
testing. Sophisticated VirTuoso cou­
pled to one of our Benchmark SQ 
or plus Series lyophilizers, easily 
automates your lyophilization and 
.' 
. 
.Left: VirTuoso and 
M..stro PLC·based 
-
.Itimate In product 
.syste.. protection. 
validation 
tloc.mentedperfor~ 
..U..,.!rr ..... lyWindows·
·;:bas.ahitellution FIX 
~",,;{\~; DMACS lIIakes·the IIIOSt 
'. ';ji~colliplex and demanding 
'~'~f'pharmaceutlcalsj9-_
proCe.sin! '-­ ,.. 
Below: 
Plus Series In one 
of lIIany possible 
(onfigurations. 
sterilization cycles, vacuum control, 
barometric end Point-'detewon, auto- . 
systems oRermaticcfdfro~t:in& el:ltt;cticeontrol and 
monitoring and aU:t~~ti~'validation 
",. "~; "l',<rZ""'" 
testing of all systemsand subsystems, 
as well as ~ccomn:iOdating steam ..... testing· 
providesterilization andc6Z;troI'of product· : 
'. 
profile <;Y21es. all malorIYs~' ,f/~Both systems include multi-level ..bsystellis. 
"~;p~~sword protection to safeguard . 
,~sensitive information and prodll:cts; 
report generatbr for hard copyd~tail- .' 
ing all aspects of your lyophilization 
cycle,~d an easy-to-use historical 
trending package with zoom control. 
An extensive defense system provides 
total product and equipment safety. 
And an inexpensive optional remote 
View package allows complete net­
work or off-site monitoring and 
control with guarded password 
protection. 
PURITY AND INTEGRITY 
THAT GO BnOND 
FDA STANDARDS 
To ensure performance that will pass 
the scrutiny of any regulatory agency, 
we build each VirTis lyophilizer to 
meet stringent 150-9001 certification 
and current good manufacturing 
practices icGMPI. Every VirTis system 
is extensively factory-tested to verify 
critical design and performance para­
meters, and we not only invite but 
encourage you to visit during manu­
facturing and final qualification testing. 
"3SY 

Abov.: Call1••tlz.d 
mid-rag. a •• chmark 
I,ophillz.rs are the 
most ft• .:"" pilot
plant and produdion 
l,ophUizers ev.r 
produced, with the 
shortest delivery ti.... 
In 'h. indus.ry_ Bulk 
and vial processing 
..odels are available 
wi'. usabl. shelf areas 
up to 48ft' (4.5..2), 
and sh.lf processing 
t...peratures INti0w 
-70"C. Ov.r 100 
available options 
suit all processing 
, r...uir....nts aad 

space constraints.. 

Right: Sa..pl. J'hief 
si..plifi.s the 
opIi..lz~tion process 
b, allo~ing ....pl. 
remova'.wit.oa' 
" . breaking' ,~~,cI•. 
\:;::2";c, 
WE WON'T ABANDON 
YOU AFTER DELIVERY 
What is your most problematic stage'· 
of installing a new system? If it's 
getting your new equipment up and "> . 
running, be assured that our Start Up 
Assistance Programs are designed 
to provide operator training after 
verification ofyour critical perfor­
mance parameters. By working 
with your engineers, operators and 
maintenance staff, we can guarantee 
a timely and efficient start-up ofyour 
system, and support for the long life 
of your equipment. 
355 
, " oUr trained field engineers assist 
YOui~alidation staff with the system 
testing and documentation required 
. during the installation qualification 
and operational qualification stages. 
., And; we'll train your staff to make 
· .. m:~house routine maintenance easier 

throughout the long life of your capi­
·.' tal investment. Validation Assistance 

Workbooks consist of an extensive 
· series of documented tests designed 
to audit system performance and 
clearly define product processing 
parameters. 
Max. Number of Shelves 6 
Max. Shelf Area: ftl (m2) 16.0(1.48) 
Shelf Interdistance at 
Max.: in (mml 1.891481 
Min. Number of Shelves 3 
Min. Shelf Area: ft2 1m2) 8.010.74) 
Shelf Interdistance at 
Min.: in (mml 4.28(108) 
Shelf Size: Width in from) 16(411 
Length in (mml 24161) 
6 
16.0(1.48) 
1.89(481 
2 
5.3(0.491 
6.68(169} 
16(41) 
241611 
6 

25.0(2.32) 

2.5(63) 

3 

12.511.16) 

5.5{1391 

20(51) 
30(76) 
6 
25.0(2.321 
2.5(63) 
2 
8.310·m 
8.512151 
20(51) 
30(76) 
I 8 
4S.014·46) 
2.16(54} 
3 
18.0(1.6n 
6.59i16n 
24(61) 
36(911 
8 
4S.0(4.46) 
2.16{541 
3 
18.0{1.6n 
6.59116n 
·24(61} 
36(91) 
15 
90.0(S.4} 
1< 
78.0( 
1.(8142) 
6 
36.0(3.341 
2.40i 
4 
24.012 
4.67(1181 
241(10) 
36(915) 
8.8{2: 
24(61 
36(91 
Refrigeration System Data SL SL SL SL SL SL I SL SL 
Standard System 
Shelf Temp °C -55 ·55 ·55 ·55 ·55 ·55 -55 ·55 
Condenser Temp °C ·70 -70 ·70 -70 ·70 ·70 ·70 -70 
Standard Condenser Capacity 
in 24 hours: liters (type) 100.0IExt., 65.01Ex20.0\Ext.) 20.0(Ext.) 34.0\Ext.} 34.0IExt.' 42.0(Ext·I 42.0\Ext.) 
Optional Condenser Capacities 
in 24 hours: liters (type) 50.O(Int.) 50.01In14.0IExt.J 14.01Ext.J I 20.0flnt.) 20.0flnt.) I 34.0IInt.1 34.0flnt.) 
65.0(Ext.) 100.0(E~64.O{Ext.J 64.0\Ext.] 
150.0(Ext.) 1S0.01b 
D 
o 
THE BENCHMARK PLUS SERIES 
WITH LOADING AND UNLOADING CART 
3 S\..o 
.0(22.3) 
30(461 
7 
2(10.41 
011091 
24{610) 
8(1220) 
LL 
·55 
-70 
I.OlExt.) 
i.OlInt.) 
I.O(En., 
1.0IExt.) 
416.0(38.61 240.0(22.42) 90.0{8.4) 
2.5(63) 1.80(46) 2.51631 1.68(421 
4 12 6 6 
48.0(4.48) 192.0(17.8) 72.016.72) 36.0(3.34) 
10.6(2701 4.351110) 10.0(255) 4.67(1181 
36(914) 2x,24(6101 36{9141 24(610) 
4811220) 2x,48{l220) 4811220) 361915) 
LL LL LL SL 
-55 -55 -55 -55 
-70 ·70 -70 -70 
120.0[Ext.1 3OD.0IExt., 220.0[Ext.l lOD.O(Ext.) 
100.0(Int.) 220.0(Int.) 2OD.O(Int.) 
220.0(Ext.) 3OD.0IExt.) 300.0(Ext.) 
3OD.0(Ext.) 450.0lExt., 450.0(Ext.) 
600.0lExt.) 600.alExt., 
50.0IInt.) 
65.0IExt.) 
150.0(Ext.) 
336.0(31.2) 168.0(15.7) 
2.40(60) 1.80(46) 2.5(63) 
4 9 4 
24.0(2.23) 144(13.4/ 48.0(4.48) 
8.8{2251 0(1171 10.6(2701 
24(610) 2x,24(610) 361914) 
36(915) 2x,48(1220) 48(1220) 
SL LL LL 
·55 -55 -55 
·70 -70 ·70 
65.0(Ext.) 220.0(Ext., 120.0(Ext.j 
50.0(Int.) 100.0IInt.) lOD.O(Int.) 
lOO.O(Ext., 120.0(Ext.) 220.0(Ext.) 
150.0(Ext.) 300.0(Ext., 300.0lExt., 
26 :W 
416.0{38.6) 240.0(22.42) 
1.80(46) 2.5(63) 
12 6 
192.0(17.81 72.016.721 
4.35(1101 10.0(255) 
2x,241610 36(9141 
2x,48(122D) 48112201 
LL u.. 
·55 ·55 
-70 ·70 
220.O(Ext.' 
220.0lInt., 200.0lInt.' 
3OD.O(Ext.) 3OD.OIExt.) 
450.0IExt., 450.0(Ext., 
600.0lExt., 6OD.O(Ext.) 
THE. BENCHMARK SO SERIES 

., 
VirTil B.nchmark 
S.rl.1 L,ophDiz-.rs 
can be conllrucl•• on 
vlrtuall, any lingl. or 
.ultipl. frame cOIlfigu· 
ralion r.qulred b, Ih. 
eusto••r, alld all are 
availabl. In .Ith.r 
square cha.....r or 
round cha.....r .0d.ll. 
CONSTRUCTED ON AMONOBLOCK FRAME 
3S1 
is optional. 
Once a unit has been 
validated and brought 
up to a full production 
schedule, VirTis 
continues to back 
up its customers. A 
worldwide network 
of sales and senice 
support provide a 
full range of post-sale 
assistance. 
Lyophilization and 
service support 
seminars, maintenance 
and performance audit 
contract programs, 
and a 24-hour hot-line 
are designed to keep 
production on schedule. 
}d~ 
'j 

>.~-,} . 
Finishes. ... ', .}j·j~'Heat1JransferSistems· 
Benchl:naIk lyop~r product" 'p' Benchmark incorporates an~extreme-
"2.', ~c _:-,,-~ .',-. "·',;;·A:;,< ;,,,.~~,*j.-.- ," ( "C:;,,;:-x 
chambers; condensers .and,product . Iy efficient silicone heat traIiSfer 
~-+~'4",;,"-"'~'~~~"~"~';i!'f ~M-~' - -,~ .. , ,' ... ' 
shelves 3ie'engmeered ofpliiiIriia: ;, system that can provide Unlform 
'~tica1'grade #4, IRA V~ue l~s f;:~ temperatures from;7.,O"C to +65"C. 
';>;~~~~J1~.;han~5'IDi~o in~h~~i~~t~~sli", ....• 7;jyvitI:.ei*~r th~:;t;'ridard manual 
::·'·'~1.~;~\l"ith welds giqun~ smpoth ~<i.fJ:ush<"'ik;t~··cOI!tr()l ,!&stem or ()Ur optional 
, --';Mirror finish ~ielectropoli;hfug'? YfrTh6s6or Maestro systems, you 
",:,,;, , cifu. easily ~hieve shelf temperature 
.... ('~, ,';. 'r" ,~\3,'~_:;~. .~' 
'~" cbntrol of +1-l"C. . 
.,'¢': -:'~~".---
".:2~:":--' r 
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Automated Controls 
For the "hands-off" operation that can 
save you time and money, Benchmark 
Plus and Benchmark SQ Series 
lyophilizers can be equipped with 
our optional VirTuoso or Maestro 
PLC-based control system. Use 
them to control every detail of 
your lyophili.zation cycle, including 
thermal treatment, precise vacuum 
control, primary and secondary 
drying, pressure rise barometric end 
point detection and validation testing 
of systems and subsystems. 
Durable Vacuum Components 
All vacuum componen~ are selected 
for long life and leak~fr~eoperation, 
with vacuum punip:.dqwri times that 
meet the most presJirii processing .. 
or product schedule. All connections 
and piping are resistant to metal azide 
formation. The optional Maestro or 
VirTuoso automated control system 
tests leak rates automatically. We can 
also equip Bencmna.rk systems with 
optional'standby vacuum pumps, 
chemidifrJsistarlt pumps, oil filtra­
tion ~androots blower packages. 
Sterili~~gn Systems 
Benc~:U:k!s optional steam steriliza­
tion system incorporates an efficient 
multi-evacuation heat-up cycle and 
sterilization system rated and docu­
mented to meet ASME vessel code 
at 25 PSIG. Higher coded pressure 
vessel ratings are available upon 
request. A rapid cool-down option 
improves turn-around time. A variety 
of optional gas sterilization systems 
are available. 
R.dundant ..anHI 
b.ckup controls 
or sop.isticat.d 
'Le-based ••to..at.d 
conlrols deliv.r 
consist.nt produd 
•••llty d.ring 
lyopbOmalloa, 
provldin•••I....llon 
of re..'d"!~,~.ppor.
'. cycles. SpeCi.r.·· 
p.ssw.~~jlrotecl.d 
r...o •• · •.••llorln. 
syst..s updato 
operators on sys.... 
status constanlly, at 
t••ir conv.nienc•• 
.BENCHMARK SQANDPLUS'SERIES .BULK DRYINGLYOPHILIZERS~?~;t. 
.Series/Bulk ., '.,14000 SQc"lu~;~~'SOOo Plus" ·.·;'''r:~j;;"'~~#~·5000 SQ~'\6000SQ; Plui~; 
Shelf Size in Imml 24x36/(610x915) I Shelf Stack: 2 -24x48 (610 x 1220] 
6 Shelf: ft2 \ro2) I dearance: in (mml 36 (3.31/4.6711181 -
- - I 
7 Shelf: ft2 (m2) I dearance: in (mml 42 (3.91/3.96 (100) i li2 (10.4114.30 1109) - -
8 Shelf: ft2 (m2) I Clearance: in (mml 48 (4.5113.43 (87) 128 (1 L9J13. 70 1941 - - ! 
9 Shelf: ft2(m2J / dearance: in (mml 54 (5.0)/3.01 (761 144 (13.41/3.25 (831 144113.4j/4.60 (1171 -
10 Shelf: ftl \ro211 Clearance: in (mm) 60 (5.6}l2.68 (68) 160 {14.9JI2.90 (731 160 (14.9)/4.11 (104) 
-
11 Shelf: ftl \ro2) I Clearance: in \rom) 66 (6.1}12.41 (611 176(16.4/12.60 (66) 176 (16.4)/3.711941 -
12 Shelf: ft2(m211 Clearance: in Imml 72 (6.7)/2.18 (551 192117.8]12.35 (601 192 (17.8)/3.38 (85) 192 (17.8)14.35 (1101 
13 Shelf: ft2 \ro2)I Clearance: in lroml 78 {7.3)/1.99 {SOl 208 {19.3]12.15 (541 208 (19.3j/3.09(78) 208 (193)/4.00 (1011 
14 Shelf: ft21m2) I Clearance: in lroml 84 (7.8)/1.82146) 224(20.8)11.95(50) 224 (20.8)/2.85 (72) 224 (20.8)/3.65 (93) 
15 Shelf: ft2 (m2) I Clearance: in lrom) 90 (8.41/1.68 (42) 240 (22.3)/1.80 (46) 240 122.3)12.64 (671 240 122.3j/3.40 186; 
16 Shelf: ft2(m211 Clearance: in lroml - - 256 (23.8)/2.45(62) 256123.8)/3.15 (80) 
17 Shelf: ftl/m21I Clearance: in (mm) - - 272 {25.31/2.29 (58) 272 (25.3)/2.95 (751 
18 Shelf: ft2(m2) I Clearance: in \roml 
- -
288 (26.8)/2.151541 288 {26.8)/2.80 (701 
19 Shelf: ft2 (m2) I Clearance: in lroml 
- -
304 (28.2)12,02151) 304 (28,2j12.60 (661 
20 Shelf: ft2 (m211 Clearance: in {roml - - 320129.7111.901481 320 (29.7)/2.45 (621 
21 Shelf: ft2 (ro211 Clearance: in (mm) 
- -
336(31.21/1,80 {461 336 (31.2)/2.30 (59) 
22 Shelf: ft2[m2) I Clearance: in froml 
- - -
352(32.7)12.2.0 (561 
23 Shelf: ftZ(m2) I Clearance: in (roml 
- -
- 368134,2}12.10 [531 
24 Shelf: ft21m211 Clearance: in (rom) 
- - -
384(35.7112.0 (50) 
25 Shelf: ftl(m211 Clearance: in \rom) 
- -
- 400 (37,21/1.90 (481 
26 Shelf: ft21m21I Clearance: in lmm) - - 416(38.6)/1.80 (46) 
Model IOmm Bulk Depth 12rom Bulk Depth 15rom Bulk Depth 20mm Bulk Depth 
Shelf Size in (=1 [Litersl ILiters) (Liters' [Liters) 
4000 SQ, 4000 Plus 
24 x 36 (610 x 9151 5.34 6.36 7.98 10.62 
5000SQ, 
14.24 16.96 21.28 28.32 
14.24 16.96 21.28 28.32 
Benchmark 4000 Plus Models Benchmark 5000 Plus Models 
Condenser Configurations Liters in 24 HoUl'SLiters in 24 HoursI (Compressor Sizing) (Compressor Sizing) 
[Condenser Area] [Condenser Area) 
Standard Internal 50 Liters 100 LitersI (One20Hp) (One 30 HpJ 
[21 Square Feet] [50 Square Feet] 
Standard Stoppering 120 Liters 
External 
65 Liter 
(One30Hp)IOne20HplI 

[60 Square Feet] 
Standard Bulk External 
[35 Square Feet] 
220 Liters100 LitersI 
trwo20 Hp)(One 20 Hpj 
I[120 Square Feet] [160 Square Feet] 
Heavy Duty External 
[60 Square Feet] 
300 Liters 450 Liters150 LitersI 
(One30Hp) trwo30Hp) trwo30Hpi 
[80 Square Feet] [160 Square Feet] [250 Square Feet] 
Extra Heavy Duty External Consult Factory 600 LitersConsult FactoryI 
(Three 30 Hpl 
[320 Square Feet] 
Benchmark 4000 SQ Benchmark 5000 SQ Benchmark 6000 SQ 
IAnd And And 
?,I.,;)C 
""'--
Ilenchmark 6000 Plus Models 

Liters in 24 Hours 

(Compressor Sizing) 
[Condenser Area) 
200 Liters 
trwo20HPI 
[100 
(Two 30 Hpl 
,;,;j;1;'XVIRTlS,BEHCHMARKSQAND PLUS SERIES STOPPERING LYOPHILIZERS .' 
..""".,~,,," 
' ~~: " ,%;.itt.~;; ":~~~~ooo,~;~'~~:~';>~~?~';>'r" 
."".";.... ~;~,,~~~ , ; '. "~if~:S.r~.sIS,~ppering::I:i:ikj~ 6000 . 
36x48 (915xI220)Shelf Size in Imml 24x36 (610x9151 36x481915x12201 
4 Shelf: ft2 (m2) 24.012.23) 48.0 (4.481 
-
10.61270)Clearance: in Imml 8.8 (225) 
5 Shelf: ft2 1m2) 60.0 (5.61)30.0 (2.79) 
8.4 1210)Clearance: in !mml 7,0 (1751 
72.0(6,72)6 Shelf: ftllm2) 72.0(6.72)36.0(3.34) 
6.8(170)Clearance: in (mm) 10.0 (255)5.7(145) 
7 Shelf: ft2 (m2) 84.0 (7.85142.0 (3.90) 84.017.85) 
5.8(145)Clearance: in (mm! 8.51215)4.81120) 
8 Shelf: ft2jm2) 96.0 (8.971 96.018.97)48.014.461 
4.9(125)Clearance: in Imm) 4.2(105) 7.31185) 
9 Shelf: ft2 (012) 108.0110.09J54.015.051 108.0 110.~~ 
4.1(110)Clearance: in Imml ( 6.41163)3.61921 
120.0 (11.211 120.0 (11.21)10 Shelf: ftllml ) 60.0 [5.61) 
3.8 [951Clearance: in (mm) 5.71145)3.3(82) 
11 Shelf: ft2 (m2) 132.0 (12.34J 132.0 (12.34)66.0 (6.171 
3.4 (851 5.1(130)Clearance: in Imm) 2.9(72) 
12 Shelf: ft2(m2) 144.0113.451 144.0 (13.45)72.0 (6.72) 
3.0(75) 4.6 (llS)Clearance: in (mml 2.6(65) 
13 Shelf: ft2(m2) 156(14.58) 156.0114.58)78.017.28) 
4.2 (lOS)2.4(60) 2.8 (701Clearance: in Imml 
168(15.70) 168.0115.70) 
2.5(631 3.9(100)Clearance: in (mml 
15 Shelf: ft2(m21 180.0 116.821-
Clearance: in (mm) 3.6[901 
16 Shelf: ft2(m2) 192 (17.941
- -
3.3 (851Clearance: in lmm) 
17 Shelf: ftl 1m2) 204(19.06)
- -
Clearance: in Imml 3.01751 
18 Shelf: ft2(m~ - 216120.18)
-
2.8(72)Clearance: in Imml 
19 Shelf: ft2 {m21 - 228.0 (2.1.3) 
Clearance: in (mml 2.6(651 
20 Shelf: ftl (m2) - 240.0 (22.42)
-
Clearance: in (mm) 2.51631 
Stoppering Model 15mm 23= 25mm 43= 52mm 
Shelf Size in !mml Dia Dia Dia Dia "Dia Dia 
4000SQ, 
24x36 2598 1050 858 540 294 198 
5000 5000 Plus 
36x x 1220) 5196 2100 1716 1080 588 396 
6000 SQ, 6000 Plus 
36 x 48 (914 x 1220) 5196 2100 1716 1080 588 396 
Generic tPA Appendix D 
Equipment Design for pumps in Separation Section 
UF1 Pump 
Pressure required at inlet of UF1 
Ib 
F:= 1825.47·FT Flow through Pump 
P :=63.72'~ Density of Water 
ft 
~ := 0.80 Pump efficiency 
Sizing the Pump: 
Size:= F. dP 
Size = 0.053 ohpP 
Power := Size Power =49.135 W 
~ 
Head :=~ Head::= 57.175oftP'g 
=40 psi 
dP :=40'psi- 14.7·psi 

dP 25.3 "Psi 

Hours per year: t := 7920·hr 
Electricity := Power·t 
Electricity =389.149 okW·hr 
3l92. 
Generic tPA Appendix D 
UF2 Pump 
Pressure required at inlet of UF2 =40 psi 
Pressure Drop over filter 
F:= 1325.~ Flow through Pump 
Ib M> :=40·psi- 14.7·psi 
p := 63.72·-;:] Density of Water 

ft 
M> = 25.3 "Psi 

11 :=0.80 Pump efficiency 

Sizing the Pump: 
. M> Hours per batch: t := 7920·hr SIze:=F·­ Size::: 0.084 ohpp 
Size 
Power:=­ Power::: 78.626 W 11 Electricity := Power·t 
M> 
Head :=­ Head::: 57,1 750ft Electricity", 622.718okW·hr 
p.g 
Generic tPA AppendixD 
MF Pump 
Assume an average pressure drop over the microfilter of 20 psi 
F := 1135.6.~ Max flow through filter 
P :=63.72'~ Density of Water 
ft 
11 :=0.80 Pump efficiency 
Sizing the Pump: 
Size:= F.M> Size 0.057 ohpP 

Power:= Size 
 Power = 53.27 W 
11 
Head :=~ Head = 45.198oft 
P'g 
Pressure Drop over filter 
M> := 20'psi 
Hours per batch: t := 7920·hr 
Electricity := Power·t 
Electricity =421.901 okW·hr 
'3 lJ>'-\ 

..... 

Generic tPA Appendix D 
Impeller Power Calculations for Separation section: 
Assuming all impellers run for 7920 hrs/yr 
7920 is about 400 hrs more than the most used tank (FD Tank) 
t :=7920·hr 
Power requirements fo large tanks (4000-5000 L): 10 hp 
P large:= IO·hp 

Holduptank := P large·t UFlTank := P large·t 

4
Holduptank =5.906·10 O\CW·hr UFlTank = 5.906·\04okW·hr 
Power requirements for smaller tanks (300-500 L): 5 hp 
P small := 5 ·hp UF2Tank := P smalrt 
UF2Tank = 2.953·I04okW·hr 
Process incll!des two of each of these tanks: 
AffinityTanks := 2·P smaWt FDTanks := 2·P small· t 

AffinityTanks =5.906·I04O\CW·hr FDTanks =5.906·I04okW·hr 

ERTanks :=2·P smaIl·t MFTanks :=2·P smalrt 

ERTanks = 5.906·I04okW·hr MFTanks = 5.906·\04okW·hr 

Total := Holduptank + UFI Tank + UF2Tank + AffinityTanks + FDTanks + ERTanks + MFTanks 
Total = 3.839·105okW·hr 383900 kW"hr/yr required for Separation Impellers 
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AppendixEGeneric tPA 
Equipment Design for water purification Section 
Powerfor Pump #1 P-1 (10 Micron Filter Pump) 
Pressure Drop over the first ultrafilter: 10 psi 
Water flow through pump =9.17 gal/min = 73.55 ft"3/hr. We can calculate F by multiply flow 
rate in ft"3/hr with water density in Ib/ft"3 
lbF :=4688' Flow through Pump Pressure Drop over filter m 
Pin := 14.7 ·psi Ib p := 63.72':3 Density of Water Pout :=(10+ 14.7)·psift 
11 :=0.80 Pump efficiency AP :=P out- Pin AP::: lOopsi 
Sizing the Pump: 
Size :=F. liP Size 0.054ohp 
p 
SizePower:=­ Power::: 49.875 kg·m2·sec­3 Power = 49.875 W 
11 
Hours per batch: t := 8000·hr # of batches: 
Electricity := Power·t Electricity = 399 okW·hr 
Power for Pump #2 P-2 (Carbon Filter Pump) 
Pressure Drop over the carbon filter: 12 psi 
Water flow through pump =5 gal/min =40.1 ft"3/hr. We can calculate F by multiply flow 
rate in ft"3/hr with water density in Iblft"3 
Ib Pressure Drop over filter F := 2555'm Flow through Pump PI := 14.7·psi 
lb p := 63.72':3 Density of Water P2 :=14.7·psi+ 12'psift 
1] := 0.80 Pump efficiency 
liP 120psi 
Generic tPA AppendixE 
Sizing the Pump: 

Size := F. LlP Size;. 0.035ohp Hours per batch: t := 8000·hr 

p 

3
Power := Size Power;. 32.619 kg.m2.sec­
11 Electricity := Power·t 

Head :=~ Head:: 27.1 190ft Electricity :: 260.95 okW·hr 
p.g 
Power Pump #3 P-3 (Water Softener Pump) 
Pressure Drop over water softener: 10 psi 
Water flow through pump =20 gal/min = 160.42 ftA3/hr, We can calculate F by multiply flow 
rate in ftA3/hr with water density in Ib/ftl\3 
Ib Pressure Drop over filterF:= 10222'hr Flow through Pump 

PI := 14.7·psi 

p :=63.72'~ Density of Water P2 :=14.7·psi+ 10'psift 

1] := 0.80 Pump efficiency LlP := P 2 - P 1 

LlP:: lOops; 

Sizing the Pump: 

. LlP Hours per batch: t := 8000-hr 
Slze :=F·­ Size =0.117 ohpp 

Power := Size Power:: 108.751 kg.m2·sec-3 

TJ Electricity := Power-t 

Head :=~ Head = 22.599oft Electricity :: 870.004 okW ·hr 

p.g 
2 
3-. 0 
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Reverse Osmosis System 
The manufacturer give the power requirement for the Reverse Osmosis Pump 
3Power := 1.5·hp Power = 1.119.103 kg·m2·sec-

Hours per batch: t :=8000·hr 

Electricity := Power·t 

Electricity = 8.948.103okW ·br 
Power for the UV Light System 
From the Manufacturer, the power required for the UV lamb 
Power := 0.021 kW 
if running the light t := 8000 hr 
Electricity := Power·t 
Electricity 168 kW*hr 
3 
3 1 \ 
Generic tPA Appendix E 
Power for pump #4 P-4 (UV system pump) 
Pressure drop across the UV system : 5 psi 
Water flow through pump = 6 gal/min = 48.125 fti\3/hr, We can calculate F by multiply flow 
rate in ft"3/hr with water density in Ib/ft"3 
Ib 
F :=3066.5·nr Flow through Pump Pressure Drop over filter 
Pin:= 14.7·psi 
p :=63.72'~ Density of Water Pout :=(5 + 14.7)·psift 
11 :=0.80 Pump efficiency ,u> :=P out- Pin ,u> =50psi 
Sizing the Pump: 
Size :=F.,u> Size = O.017 ohp 
p 

3
Power := Size Power = 16.312 kg.m2·sec- Power = 16.312 W 

11 

Hours per year: t := 8000·hr 
Electricity := Power·t Electricity = !30.496okW·hr 
Power for pump #5 P-5 (0.2 micron filter pump) 

Pressure drop across the filter: 10 psi 

Water flow through pump =8 gal/min = 64.17 ft"3/hr, We can calculate F by multiply flow 
rate in ft"3/hr with water density in Ib/ft"3 
Ib 
F :=4088.7·nr Flow through Pump Pressure Drop over filter 
Pin:= 14.7·psi 

p :=63.72.1~ Density of Water 
 Pout :=( 10+ 14.7)·psift 

11 :=0.80 Pump efficiency ,u> :=P out- Pin 

4 
312 
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Generic tPA 	 Appendix E 
Sizing the Pump: 
Size:= F. M> Size =0.047ohp 
p 
Size
Power:=­ Power =43.499 W 

11 

time running t := 8000·hr per year 

Electricity := Power·t 

Electricity = 347.993 okW·hr 

Power for pump #6 P-6 

Pressure drop : 20 psi 

Water flow through pump = 5 gal/min =40.1 ftA3/hr, We can calculate F by multiply flow 
rate in ftA3/hr with water density in Ib/ftA3 
Ib 
F :=2555.4·lIT Flow through Pump 	 Pressure Drop over filter 

Pin := 14.7·psi
Ib 
p := 63.72·-:::J Density of Water 
ft 	 Pout :=(20+ 14.7)·psi 
11 :=0.80 Pump efficiency LlP :=P out- Pin 
Sizing the Pump: 
Size:= F. M> Size 0.058 ohp 

P 

Size
Power:=­ Power = 54.373 W 

11 

time running t :=8000·hr per year 

Electricity := Power·t 

Electricity = 434.985 okW ·hr 

5 
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.,,/ -",/--..COMPLETE WATER TREATMENT SYSTEM 'J J 
'-.'7 
, , '\;y.' i.--~ ,,_ C"/\ , L' , ' I v') C -,~j ./ 
AmeriWate~s complete wate'r treatment system is designed to be simple to install, 1'\11 components 
are equipped with hosing a.,d quick connects so that r.he system c<'.n be easily joined tov.ther. ()1l11 
\!.....o So t ".p f G-' FYI f Yl vi.,....t,..t 9 I ! " . L V fI 
""-WATER SOFTENER' klh.wt +YI'';'' of 'Yes;., '?), po J..p ....£; ..... ~o () f~ $ 4,537,00 

~del ~~Ui.meter initioted system. 132,000 grain capacity;.,Q I . 
~- 0 'e4 ~t' 0 I VYIJn
~ . - BO SSTEM i1;s! ~ 5&tfVJ $ 1,515.00 I, ',' 

¥odeI WTT~ 6C bac~hing carbon system. # ~ tf,v11 Y1 • dl...!. ~ 0J 

!fI oU W LT S :t't c... . D f ~
? .:1'-1 
REVERSE OSMOSIS SYSTEM* ( / '7~(;?1? ,.nit.~_ 'XR.. I:, r $ 7,434.00 ! ,;" 0 
Model IR02. 220 volt system is capable of producing up to 4,600 gallon3 per 
day. Includes two rnode14" 40 high output memDr'MleS and p9l'ticulate tiltt:r. 
( \ bOO c> L). vlA<4IAL~ ..... ' ~ HOLDINGTANKA7~1 ~~'t ¥11 7. ~b f'l1 $ 3,554.00" ;;. ,-' "",:..'" 
4000 polyethylene, horizontal holding rank, 95" dia. x 14011 high. Includes Plus freight 

inlet/outlet mercury float switch with plug in cord and ca.1i locks for easy ~on­

nection. 

REPRESSURlZATION SYSTEM $ 55;.00 ("'J::'" 

ModeJ LB·5 stainless steel pump, 115 volt. Provides flow tip to 30 GPl\L 

, -
DelO"Ylizvz... vI' Fr If''~ ,7 INVESTMENT $1',595.00 
*Product flow rate varies with temperature. All m.odels are rated at 77 degrees! 

with feed water of 1500 mg/l NaCl @ 200 PSI and pH of 7.5 

;'*Holding tank \'rill be drop shipped from the manufacturer. OUf price does 

not include freigbt. 

RECIRCULATION OPTION 
To prevent bacteria grO'\'N'th in the holding t2nk, we recommend that you keep the water 
recirculating through 211 ultra violet light system. The price fer this option is as follows: 
UV System - 7 GPM $850.00 
Relief Valve $ 82.00 
Interconnecting Piping $225.00 
Spray Ball A~sembly $260.00 
TOTAL $1417.00 
, 
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Technical Question - Your E-mail, 28 Feb 00 
Subject: Technical Question - Your E-mail, 28 Feb 00 

Date: Wed, 1 Mar 2000 09:01:35 -0600 

From: "Lewis, James" <JLewis@osmonics.com> 

To: '"kasidit@seas.upenn.edu''' <kasidit@seas.upenn.edu> 

Dear Mr. Nootong, 
Thank you for regarding Osmonics' Pleated Filter Cartridges. For 
any of our cartridges, we recommend a maximum flow rate of 5 gpm/Ten Inch 
Equivalent (TIE) length. Thus, a 20" long cartridge would have a maximum 
flow ra~e of 10 gpm. The maximum can be reduced by other factors such as 
the micron rating of the cart , the solution viscosity and available 
pressure drop. 
When we size a housing for a given filtration, typically we would include 
enough TIEs to keep the initial differential pressure at 2 psid or less. 
For the 'Flotrex-AP021 cartridge this rate would be 5 gpm. For the 
Memtrex-FE921, this rate would be about 3.5 gpm. In each case, a fluid with 
a viscosity of water was assumed. The data necessary for these calculations 
is available on ou website, osmonics.com. 
Please let us know if you have further questions. Good luck on your 
project. 
Best regards, 
Jim Lewis 
Application Engineer 
3lLP 
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Ameriwater: Water Treater Senes 
Ameri\\:'atcr" Industrial 
......... If''',,' 

Water 
Treaters 
Series 
• Softeners 
• Dealkalizers 
• Filters 
Softening 
Water softening cation sodium form resin 
Ultra high exchange capacity, better than 8% cross linked gelular, 
strongly acidic. cation exchange resin. Very good kinetics, excellent 
stability at elevated temperatures and good chemical resistance over a 
wide pH range. 
Model 
WTTS 16 
Mode 
Timer ••40 
WTMS 16 Meter 40 
WTTD 16 Meterl Alternating 40 
WTTS24 Timer IIIIUW.II 80 
WT MS 24 80Meter "l~iUII 
WTTD24 MeterlAlternating~!2f~lff!~ 80RmmiLi-~'~;-i,j&!t 
Dealkalization 
Water Dealkalization Anion Chloride Form Resin 
Very effective for the reduction of bicarbonate alkalinity. Type II gelular, 
strongly basic resin in the chloride form gives high capacity and good 
leakage characteristics. 
3" 
10f4 4119/00 11:32 PM 
WySIWyg:l! lL.OfHllp.Ji W \IV w.U.lU'-'.lJ.ny\...., ... ""'""u...., •• _ ......__ 7' __ , __ _ 
Model 
WT TS 16D 
Amenwater: Water !reater :Senes 
1IftiJ.=.,.""s'
i~ll:¥?Jlj~~!ki 
~!~:I~~1!1~li1W~!~ 
20 '~I§~PJif,wMI~i
WTMS 16D 20 ~;fh~~~l~$j
'+""""'!l!1I'I'lJHIIWY"'''''p' 40 ~"'n':::B'tlIi"'''i\g"WTMD 16D Meter ~.~I~u~~~~I~ :~1ij~!~~~,~~lii~
WTTS 24D Timer f!i~lit~ilif~~1 50 l;'ij;lfl~Kg~~i~; 
WTMS24D Meter lil!~1fi~:l:)1~1i~'~'(iF"tiH 50 Ci:gG'iff'lOO;)l:~l:iu~!j~l4l~t_}; ~A~l;.,!Jh(~h1._:;'~!~!h(;,~ 
WTMD24D Meter ~1!l.T~~1:r~ 1 00 ni:il~QIiI~ilm 
Filtration 
Activated Carbon 
Made from select grades of bituminous coal to produce a high density. 
durable granular product capable of withstanding hydraulic loading, back 
washing, and mechanical handling. Abrasion #80, Iodine #950, 
Backwash 8-10 GPM/sq.ft. 
Sediment filter Ag 
Ag granuals have irregular surface characteristics for maximum removal 
with less pressure loss. Requires less backwash water. Backwash 8-10 
GPM/sq.ft. Removal down to 15 microns. 
Manganese Greensand 
Capable of removing iron, manganese and hydrogen sulfide from water 
through oxidation and filtration. Feed of chlorine or potassium 
permanganate will continue the oxidation process. Backwash 10-12 
GPM/sq.ft. Iron limit is 15 PPM. 
MultiwMedia 
High quality quartz sand and gravel in layers provides for excellent 
particulate filtration. Backwash 10-12 GPM/sq.ft. Removal down to 20 
microns. 
Model 
WTTS 16A 
WTTS24A 
WTTS 16 C Timer 
WTTS 24 C Timer 
WTTS 16M Timer 
WTTS24M Timer 
WTTS 16G Timer 
WTTS 24 G Timer 
318 
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Ameriwater: Water Treater Senes 
One versatile system for softening, dealkalizing, and filtering applications 
The AmeriWater Water Treaters Series of equipment is designed specifically for the 
water treatment professional. We offer a variety of sizes and media to meet the needs 
of your industry. Whether you need a softener, dealkalizer, or filter, you~1I find our 
pricing to be very competitive, without sacrificing quality and durability. 
or service is 1--11d6i 
Light",eig~ corrosion resistant 1-----1 
of polyethylene. Outer shell 1---­
............---... 
........--1 full size porti ng on all 
Modular Cartridge design 
means anything you need to 
change, clean 
right up front. 
Noryl construction allo\>ls 
for easy I nstallation and 10l'lg 
service life, 
Tank inner shell constructed 
\>Iound \>lith conti nuous 
fl berglass to provide 
superior strength under 
pressures of up to 150 psi. 
All systems can be moved 
easi lyon a hand truck. 
Versatile controls avai lable 
in meter I nitiated electronic 
ti mer ,or mechanical 7-day 
timer . 
mal n flo\>l paths permits 
high service flo\>l and 
back\>lash rates, 
Ultra High CapaCity Water 
Softener Resins; provide 
superior service runs and 
longer life. 
Heavy-Duty polyethylene 
Brine Tank Illcludes brine 
\>lei I , ai r check and 
overfl 0\>1 safety shut off. 
Options include bypass or no bypass water during restoration 
and PVC or threaded brass installation adapters 
1 112" Control 
meter initiated 
2" Control with 
with 
electronic timer mechanical 
7-day timer 
Water treaters series configurations 

Water Softener or Dealkalizer Single Tank System 
.. 

30f4 411910011:32 PM 
SYBRON CHEMICALS INC. 
SYBRON CHEMICALS INC. 

BIRMINGHAM ROAD, P,O. BOX 66, BIRMINGHAM, NEW JERSEY 08011 (609) 893-1100 

IONAC C-249 is a premium quality cation exchange resin capable of meeting the most exacting requirements of both 
household and commercial water softeners and suitable for treating even potable water. Extremely low fines content, high 
operating capacity and excellent physical quality make IONAC C·249 • A PREMIUM PRODUCT AT STANDARD COST. 
IONAC C·249 is a bead·form. standard crosslinked. 

polystyrene sulfonate cation exchange resin, posses· 

sing high cation exchange capacity, combined with 

excellent stability and operating characteristics. It con­

tains a minimal amount of "fines" (-50 mesh) thus 

showing low pressure loss effects. 

u. S, Typical 
Standard Mesh Size mm Distribution 
+16 1.19 4.0 % 

-16+20 1.19-0.84 29.0 % 

-20+30 0.84-0,59 49.0 % 

-30+40 0.59-0.42 16.0 % 

-40+50 0.42-0.30 1.5 % 

- 5 0 0.30 0.5 % 

IONAC C-249 is specially manufactured to eliminate 
color throw and to assure compliance with F.D.A. 
Regulations, Para. 173;25. It has also been approved by 
the Meat Inspection Division of the U.S, Department of 
Agriculture for use in the treatment of water for meat 
packaging plants, IONAC C-249 also meets the 
stringent specifications for extractable limits set by 
the French Ministry of Health for cation exchange 
resins used in potable water supplies and for food 
industry uses. 
IONAC C·249 is supplied in the fully swollen moist 
sodium form, and its primary application (detailed in 
this bulletin) is in the softening of water, for household, 
municipal, and industrial use. 
NOTE: Similar cation exchange resins with different 
crosslinkage, ionic form, particle size distribution, or 
degrees of purity are available. 
The data included herein are based on test information obtained by Sybron Chemicals Inc. These data are believed to be reliable but do not imply 
any warranty of performance guarantee. We recommend that the user determine performance by testing on his own processing equipment. We 
assume no liability or responsibility for patent infringement resulting from the use of this product. 
360 

KEY FACTORS AFFECTING CAPACITY OF IONAC C-249 
Regenerant quantity, contact time with resin, and brine concentration 
Water flow rate during service run. 
Bed depth 
CAPACITY 
Figures 1, 2, 5 and 6 illustrate the effect of 
total dissolved solids (T.D.S.) and various 
hardness levels on operating (softening) 
capacities at different salt (NaCI) dosages. 
Figures 3 and 4 illustrate the effect of 
Sodium vs. Total Hardness on expected 
leakage. 
For clarity the Total Dissolved Solids 
(Sodium plus Total Hardness as ppm 
C a C OJ) is given as a parameter, vs. In­
fluent Hardness. To obtain TOTAL DIS­
SOLVED SOLIDS (T.D.S.): 
. Add Sodium to Total Hardness (all 
expressed as CaCO,) 
Capacity ratings and related data are based 
upon capacity break-through, i.e. end-point 
of 10% rise from the average residual 
hardness. 
FOR METRIC CONVERSIONS: 
Multiply gpm sq. ft. • 2,44 a MeIers/hr. 
Muiliply gpm cu. fl.• 8 • I/nr.1I 
Multiply PSllft.'bed •.22 • Almospher.lmlbed doplh 
Muillply Bed depth. II.• 30.48 • em 
Multiply Ib.leu. It. x 16 • Gramsll 
Multiply Kgr.leu. fl.• 2.29 • Gram. CaCO,11 
CAPACITY CALCULATION: 
U.S. gal. I regon. x Total Hardn ... (in ppm) 
• kllogralno/eu. It. 
R..ln volumo leu. It.) • 17.1 • lOGO 
Motrle convorslon 1 Kg,/cu. ft.• 2.29 gm (CaCO,) pe, Iller 01 ''''n 
(1 cu. It. a 28.3 lito,.) 
38\ 
Figure 1 

(Parameter: Total Disolved Solids, ppm) 
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(Parameter: Total Dissolved Solids, ppm) 
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Figure 4 
( Par am e t e r: Total Dissolved Solids, ppm) Figure 6 10 
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w IONAC C·249 .. C8J)acity
Q. 2212 0 (Ij) 20 Ibs. Na Cl/eu. ft.1~400 
1F I i I 
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INFLUENT HARDNESS (grains/gal. as CaCo,)INFLUENT HARDNESS (grains/gal, as CaCo,) 
For 15 and 20 lb. Salt (NaCI) regeneration, per cu. ft., no 
leakage curves are presented_ The reason for omitting 
these is that at the Total Solids and Total Hardness levels 
shown the leakage at 15 lb. of Salt is below 1.5 ppm; and 
at 20 lb. of Salt the leakage is below 0.5 ppm. 
3 6 2 
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9 @ 10 Ibs. Nli elley. ft. 
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Figure 7 (Parameter: Total Dissolved Solids ppm) 
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BACKWASH FLOW 
When lonac C-249 ion exchange resin is to be used on 
the sodium cycle for softening potable water or for 
treating water for food processing, it should be 
contracted with a minimum of 60 gallons of potable 
water per cu. ft. of resin over a period of at least 15 
minutes before being placed in service. This total 
SYBRON CHEMICALS INC. 
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FLOW RATE, U.S. gpmisq. ft. 
of water can be used in either the 
backwashing, brining or rinse portions of a normal 
regeneration cycle. When so contacted, lonac C-249 
will meet the extractive requirements of the Food 
Additives Regulations, Para. 173;25. 
SYBRON CHEMICALS INC. 
BIRMINGHAM ROAD. P.O. BOX 66, BIRMINGHAM. NEW JERSEY 08011 (609) 893·]]00 
ccl21119 
ULTRAVIOLET WATER PURIFIERS 
Principles of Operation 
;I «,-,<--".,....... 

1. Water enters the purifier and 
flows into the annular space 
between the quartz sleeve and 
the outside chamber wall. 
2. Within the chamber, water is 
exposed to intense germicidal 
ultraviolet radiation. 
3. Transformer with LED indicator light provides visual indication of 
germicidal lamp operation. 
4. Water leaving the purifier is instantly ready for use. 
.3 (d /" ,/ 
I..:~~' ~«
'G 
S:ta-l-n-k:~-:.; Stce~£1""",,""" 
Optic""j 
MinipureTM Water Purifiers are manufactured under one or more patents 

owned by Atlantic Ultraviolet Corporation. 

Minipure TM, Ster-L-Ray TM and Easy-Off™ Retainer Cap are 

trademarks of the Atlantic Ultraviolet Corporation. 
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ULTRAVIOLET WATER PURIFIERS 
I MIN-9 I 9 I 540 3/4" MPT I 29-3/8" 14-1/4,1 . 5-9/16" 
• Maximum recommended operating pressure for all purifiers is 100 PSI. 
• Pressure drop at maximum recommended flow rate is 5 PSI or less. 
o All data shown above is for 118 volt 60 Hz. Units are also available for 220 volt 50 Hz and 12 
volt DC operation. 
Minip'ure TM Water Purifiers are manufactured under one or more patents 

owned by Atlantic Ultraviolet Corporation. 

Minipure TM. Sterol-Ray TM and Easy-Off TM Retainer Cap are 

trademarks of the Atlantic Ultraviolet Corporation. 

I of 1 4/19/0011:14 PM 
... .L .... u,tJu..l"" - ......""u11J uaLa http://www.atlanticuv.comirninipure/minipure5.htm 
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ULTRAVIOLET WATER PURIFIERS 
Ster-L-Ray Lamp Data for Minipure™ Water Purifiers 
05-1119--, J_ 

_iii; .: (iiiii
. 
OS 1366 
L'•-~ 05-13i'D 
e·iiiil ,iii\)5-0097 A 
'Wattage is lamp watts only and does not include ballast loss. 
"Maximum rated output at 254 nanometers. 
All Minipure TM Water Purifiers employ genuine Sterol-Ray TM germicidal lamps that afford the 
maximum efficiency and longevity in producing the required germicidal rays. In addition to the 
obvious advantages of high efficiency and low power requirements, there is no possibility of 
the purifier overheating, as is the case with some other types. Consequently the need for 
additional equipment to combat overheating is eliminated. 
Minipure™Water Purifiers are manufactured under one or more patents 
owned by Atlantic Ultraviolet Corporation. 

Minipure TM, Sterol-Ray TM and Easy-Off™ Retainer Cap are 

trademarks of the Atlantic Ultraviolet Corporation. 
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Large Volume Models 
Large Volume Models 
Technical Data 
Cat. No. 880-110,880-120 
Cat. No. 880-110 Shown 
Standard Model - Fixed Speed 
The Series 880 is offered with choice of two fixed 
speed motors. Motors offered include a 100 rpm and 
190 rpm 3/4 hp - 115/230 volt - 60 hz - single phase 
gearhead open type. Units are mounted on a durable 
cast metal base. Available in explosion proof model 
also. Refer to chart below for flow rates, 
specifications and shipping weight. 
Dimensions: L 29" x W 17" x H 21" Cat No. 880-300 
Variflow Model ­
DC Control 
The Series 880-300 (not shown) is offered with a 220 volt single phase control to a 

geared 190 rpm DC motor. The Vari-Flow control permits accurate adjustment with 

forward and reverse capabilities. 

Dimensions: L 29" x W 17" x H 21" 

RANDOLPH 

AUSTIN CO. 

Technical Data - Series 880 - Models 
Output gpm 
Pump Flow Rate 
Speed Motor 3/4" 10 1" 10 Ship. 
Cat.#. Mode rpm. hp. Tubing Tubing wt. 
880-PHO 	Pumphead only 115 lb. 
880-110 	Std. model - 100 3/4 6 12 240 lb. 
fixed speed 
880-120 	Std. model - 190 3/4 11 21 240 lb. 
fixed speed 
880-300 Vari-:low 190 1 1/2-11 1-21 250 lb. 
speed control 
880-400 Air-motor 225 . 7 3-14 5-23.5 210 lb . 
RANDOLPH AUSTIN 

COMPANY 

10f2 4/19/0011:09 PM 
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Series 750 - Models 
Output gph 
Pump Flow Rate 
Speed Motor 5/8" ID 3/4" ID Ship. 
Cat.#. Model rpm. hp. Tubing Tubing wt. 
750-PHO 	Pumphead only 20 lb. 
750-000 	Pumphead and pulley 20 lb. 
750-100 	Std. model­ 430 1/3 390 570 65 lb. 
single phase 
motor 
750-101 	Zero-max 0-400 1/2 360 00 120 lb. 
speed control 
model 
750-200 	Explosion 430 1/3 390 570 120 lb. 
proof model 
750-201 	Expl. proof 0-400 1/2 360 470 140 lb. 
model/speed 
control 
750-332 	Vari-flow 3-125 1/4 8.2-113 12-166 66 lb. 
speed control 
model 
750-342 	Vari-flow 4-165 1/4 10-150 14.6-219 66lb. 
speed control 
model 
750-352 	Vari flow 6-250 1/4 :4-227 20-332 66 lb. 
speed control 
model 
750-362 	Vari-flow 12 500 1/4 24 454 36-662 66 lb. 
speed control 
model 
750-400 	Air drive 10-90 psi 102-390 :26-570 42 lb. 
model - ARO 
750-450 	Air drive 10 90 psi 92-288 111-544 38 lb. 
model Gast 
Back to Intermediate Volume Page 
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FLOTREXm-AP FILTERS 
POLYPROPYLENE MICROFIBER 
(0.65, " 2, 3, 5, '0. 20. AND 40~m ABSOLUTE RATINGS) 
Constructed of thermally-bonded polypropylene 
fiber media, absolute-rated Flotrex-AP (FAP) filters combine 
exceptional solids holding capacities with precise micron retention 
ratings. The FAP filters are constructed of high-purity polypropylene and are made 
with all FDA-acceptable materials. 
FAP filters are absolute-rated for air. gas and liquid filtra­
tion with low pressure drop across the wide range of 0.65 
to 40 micron. The graded sheets of melt-blown media are 
layered to provide absolute particle retention, high solids 
loading and long service life. 
The FAP filter is just one example of our strong commit­
ment to liquid, gas and air treatment. Our complete port­
folio includes filters for every stage of processing, and we 
offer custom solutions for your unique applications. 
Osmonics is your complete source for filters, housings and 
other filtration equipment. 
Whether you require an integrated solution or a single 
component for a specific application, look to Osmonics 
first. From one end of the filtration spectrum to the other, 
Osmonics has a total commitment to fluid purity. 
psi bar 
7.0 0.5 
PRESSURE DROP (AIR) 
6.0 0.4 
5.0 0.3 
3.0 0.2 
2.0 0.1 
1.0 0.05 
0 0 
0 40 80 120 160 200 ACFM 
0 1133 2265 3398 4530 5662 ALPM 
ACFM ~ Actua! Cubic Feet per Min. 
NOle; For pressures and temperatures other than 14.7 psia (0 psig) and 70'F, ACFM can be approximated with the following formula: ACfM ACFM = SCFMat 70' F and 14.7 pisa 
FAP ADVANTAGES 
• Broad chemical compatibility 
• 	 Dependable protection for 
final filters 
• 	 Efficient removal of 
Cryptosporidium and 
Giardia cysts 
• High throughput 
• High efficiency 
• Long service life 
• Absolute rating (99.9%) 
• 	 Fast rinse up to 
18 megohm 
• 	 Thermally-bonded 
polypropylene fiber media 
• All FDA-acceptable materials 
psid bar ,P_R_E_S_SU_R_E_D_R_O_P_(_W;_~_T-:ERr-1--, 
4 0.28 
3 0.21 
2 0.14 
1 0.07 
00 0 1 2 3 4 5 GPM 
o 5 10 15 20 LPM 
t 147 :1 t ]OF + 460SCFM . psis(psig + 14.7) 530 J 
SPECIFICATIONS 

Effective Filtration Area for 
10-inch Equivalent 
0.65~m - 5.0 ftl (0.45 m2) 
1~m - 5.0 ft2 (0.45 m2) 
2~m - 5.2 ft2 (0,48 m2) 
3~m - 5.2 ftl (0.48 m2) 
5~m - 6.1 ftl (0.57 m2) 
1O~m - 6.7 ft2 (0.62 ml) 
20~m - 6.9 ftl (0.64 ml) 
40~m - 7.2 ft2 (0.67 m2) 
Operational Data 
Maximum Rated Differential Pressure ­
Forward now - 60 psi (4.14 bar) 
Reverse flow - 30 psi (2.07 bar) 
Maximum Rated Operating Temperature ­
180°F (82°C) at 10 psid 
(0.69 bar) in water 
Cartridge Dimensions 
(Nominal) 
Outside diameter ­
2.75 inches (70 mm) 

Inside diameter ­
1.25 inch (31 mm) 
ORDERING INFORMATION 
Polypropylene Microfibers 
APPLICATIONS 
Flotrex-AP filters are specifically designed for pharmaceutical 
prefiltration. Typical applications include: 
Prefiltration and Final Bottled Water Final 
Chemical Filtration Filtration 
• Broad chemical • Efficient removal of 
compatibility 	 Giardia and 
Cryptosporidium 
cysts 
Prefiltration of High Throughput for 
Pharmaceuticals and Beer Filtration 
Biol~ical Fluids 
• Dependable 

protection for 

final filters 

Integrity test and particle 

retention data available on request. 

Type Absoulte Cartridge End #1 End #2 Elastomer 
Micron length Adapter Adapter Material 
Rating 
FAP 96 = 0.651Jm 1 = 10 Inch A = Open End A= Open End B = Buna-N 
01 = 1.0IJm 2 = 20 Inch Gasket Gasket E = EPOM 
02 = 2.D!Jm 3 = 30 Inch B = 120 O-Ring B = 120 O-Ring S = Silicone 
03 = 10IJm 4 = 40 Inch C = 213 O-Ring C = 213 D-Ring T = Tenon* 
05 = 5.01Jm 	 E = 222 O-Ring G= Closed End Encapsulated 
10 10.01Jrn 	 F 226 O-Ring Cap (Only in 222 and 226 Sizes) 
20 20.0jJm 	 J = 020 O-Ring H= Fin Adapter V = Viton" 
40 = 40.0jJm 	 Q= 222 O-Ring 
Stainless Steel 
Support Ring 
Z = 226 Q·Ring 
• Viton and Teflon are registered trademarks of 	 Stainless Steel 
E.I. DuPont de Nemours and Company. Inc. 	 Support Ring 
For more information call toll free in the USA (800) 848-1750 
Manufactured in the USA 
~. OSMONICS 
5951 Clearwater Drive. Minnetonka, MN 55343-8995 USA 
Phone (612) 933-2277. Fax (612) 933-0141 
http://w w w. 0 S m 0 n i c S . com () Copyr>ght 1999. 1997. 1996 Q,monics. Inc. 
Printed in USA, PIN 1161965 Rev. D 
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MEMTRExm-FE-S FILTERS 
PTFE MEMBRANE 
(0.2 pm ABSOLUTE RATING) 
Memtrex-FE-S (MFE-S) validatable sterilizing 
grade filter cartridges are designed for sterile 
venting and final filtration of pharmaceutical fluids. 
MFE-S is the sterilization (S) grade MFE 
for valication uses. This commitment to validation 
by Osmonics is based upon the FDA Guidelines that we 
"establish documented evidence of assurance that a specif­
ic process will consistently produce a product meeting its 
predetermined specification and quality attributes" (FDA 
1987). MFE-S is designed for final sterile filtration of phar­
maceutical products. 
MFE-S is designed for vent and process fluid filtration in val­
idated systems where critical fluids need absolute, aseptic 
and sterile hydrophobic or chemically resistant protection. 
A detailed Validation Guide is available from Osmonics to 
document our rigorous testing for your records 
reviews. 
The MFE-S filter is just one example of our 
commitment to the pharmaceutical industry. 
complete portfolio includes filters for every stage of pro­
cessing, and we offer custom solutions for your unique 
applications. Osmonics is your complete source for filters, 
housings and other filtration equipment. 
• Gore is a registered trademark of w,L. Gore & Associates, Inc. 
PRESSURE DROP (AIR)psid bar ,---__________--, 
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ACFM ~ A,tual Cub;, Feet per Min. 
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Note: For pressures and temperatures other than 14.7 psia (0 psig) and 70'F, ACFM can be approximated with !he following (omwla: ACfM [ (PS'9 + 14.7) :J [ 530 J 
and 
strong 
Our 
psid bar 
MFE-S ADVANTAGES 
• 	 Sterilization (S) grade MFE 
for validation uses 
• 	 High-purity Gore' 
membrane 
• High throughput 
• Meets HIMA guidelines 
• 100% integrity tested 
• Steam sterilizable 
• 	 Meets USP 23 Class VI 
Plastic Test 
• 	 Passes MEM Elution 
Cytotoxicity tested 
PRESSURE DROP (WATER) 
SPECIFICATIONS 
Effective Filtration Area for 
10-inch Equivalent 
0.21..1m - 9.0 fe (0.9 m2) 
Operational Data
• Maximum Rated Differential Pressure ­
Forward flow - 60 psi (4.14 bar) 

Reverse flow- 30 psi (2.07 bar) 

PTFE MembraneMaximum Rated Operating Temperature - APPLICATIONS 
180°F (82°C) at 10 pisd 
Memtrex-FE-S filters are specifically designed for chemical, (0.69 bar) in water 
air, gas and vent filtration. Typical applications include: 
• Integrity Test 
Pharmaceutical Vent Filtration inDiffusional Flow 60% IPA per 
Vailidation 	 Pharmaceutical10-inch Element 
• Ultra high purity Vailidated Process 0.21..1m - 10 cclmin at 13 psig (0.90 bar) 
• Broad chemical 
Sterilization 	 compatibility 
Autoclave at 250°F (121°C) ­
Acid, Base, and OxidantMaximum 10 hours FiltrationSteam-in-Place at 257°F (125°C) ­
Maximum 10 hours 

Biosafety 
Passes USP 23 Class VI 250°F (121°C) 

Plastics test passes MEM Elution 

Cytotoxicity Test 

Gravimetric Extractables 
7.7 mg per 10 inch cartridge 
Bacterial Endotoxin 
Leachate is below 0.25 EUlmL which meets 
the USP 23 limit for Water For Injection (WFI) 
ORDERING INFORMATION 
Type Absolute Cartridge End #1 End #2 Elastomer Grade 
Micron length Adapter Adapter Material 
Rating 
MFE 92 = 0.2~m 1 = 10 Inch 
2 ;; 20 Inch 
3 = 30 Inch 
4 = 40 Inch 
Q 222 O-Rin~ 
Stainless teel 
Su~port Ring
l = 22 O-Rin~ 
Stainless teel 
Support Ring 
A;;; Open End 
Gasket 
B = 120 O-Ring
C= 213 O-Ring
G Closed End 
Cap
H;;; Fin Adapter 
Silicone S Sterilizing 
Pharmaceutical 
For more information call toll free in the USA (800) 848-1750 
Manufactured in the USA 
~ OSMONICS 
5951 Clearwater Drive, Minnetonka, MN 55343-8995 USA 

Phone (612) 933·2277, Fax (612) 933·0141 

hrtp:llwww.osmonics.com 
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RO Systems &om Anrerm'ater deliver versatility and value 
IR0 open skid style RO system 
Sizes l~a[]ge from .2,000-1'5,000 GPU 
Pump pressure gauge stai nles3 
steel liquid filled for accuracy 
Filter housi ng for t--;::=====
particulate filtration 4 
Flo'W meters measure product
'Water and reject 'Water 
Skid mounted on 'Wheels for easy
maneuveri ng and mai ntenance 
I--~ 
Del uxe control panel i ncJ udes 
temperature compensated digi­
tal conductivity monitor, hour 
meter, tank level controller J 
alarm 'With silencer designed
for three phase 208/220/460
volts 'With transformer. 
Disconnect, motor protection
and motor starter 
Standard control panel.
Same features as Del uxe less 
three- phase motor starter pro­
tection. Operates. on 208/230 
SI ngle- phase that can be pI ugged
into standard 208/230 'Wall 
receptacle 
Thin film composite membrane 
4"x 40" provides superior salt 
rejection and flo'W 
IRO Model Specifications 
-.umu"an .'!4 t]" a'H.'!40 ' , tn»'!JP" a':.'40" a.r..'!J t].' ;I1II.'!J•• 
er ormance: 
Projected 
>96% >96%Rejection 
Initial 
Production 2300 11500 
(GPD)~ 
Product Flow 1.5 7.5(GPM)~ 
Recovery Rate 50-75 % 
ectnca - NOTE: The only difference between models 5 and 0 is the control panel and 
Electrical specs 
All "S" models 
Single Phase** 220Yt3;S:M.aximuIIl Amp~ 
Pump Horse 1.5Power 
All "D" models 
Three Phase** . 2~OV7_5 MaximUlll Amps 
Pump Horse 1.5Power 
em ranes: 
Size (inches) 4x40 ~j[~1!~~I~~'0B 4 x40 ~n!litttjli~g~! 4 x40 riZ:l~~~,gllulliHilll 
Quantity 1 l'i~~t,\~I~i~;;~l~fi!ffi 3 :~~~:r\~',~l~(flil~~i.~- 5 f~~~;~ll}~_glll~!f~ 
Thin Film Thin Film Type Composite.. Composite 
l,illima-G- .(!i••IIII"rl.II~\"lmIl·1l<911••''''Wl!!IlI'IlIIIJI... 
1 of3 4/19/00 10:57 PM 
, Ameriwater: IRO Systems WYSIWyg:IIOOI llUp:1! WWW .<1111C1I W4LC1."UH1I1V1HUU~..J .iHBH 
Requirements 
Max Free 
Chlorine 
Temperature 
Range 
Operating pH 
Range 
Cleaning pH 

Range 

Prefiltration 
Pressure Feed 
Range (PSIG) 
Max Fouling 
Index (SDI) 

Langelier 

Saturation Index 

ImenSlons 
Connections 

HxWxD 

(inches) 

Approx Shipping 
 492Weight (lbs) 
.. Product flow rate varies with temperature. All model capacities are rated at 77 degrees F (25 
C) with feed water of 1500 mg/L NaCI @ 200 PSI and pH of 7.5 
... 208V and 440V are also available 
Here are other AmeriWater RO systems: 
Custom designed systems 
for applications larger than 15,000 GPD 
AMERIWATER REl'ERSE OSMOSIS SYS1D1S ARE EASY TO IIAINTAIN 
4-11 
2.0 - 11.5 
5 micron 
20-80 
<3 
<0 
. . 
'33·113 degrees F (1.,45.degrees. C) 
4-11 
2.0 - 11.5 
5 micron 
20-80 20-80 
<3 <3 
<0 <0 
InletlOntlet/Jl')taiI1,l!':FPT.: 
. '-"'," ". , -: '/ 
·-:;72 x.·24;~3S).
,« '.' <,' "., '",. '-' >;;;",;, 
542 
20f3 3'1'1 4/19/00 10:57 PM 
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EarthCare 
t, (l 1;.). ,';;1. 
1:'"(1", PA 1~·1~'.'April 11.2000 
. flRllI'W4-1 :HW 
(6 t i)~,~ !:6·~j3:U 
tvlCJ,~t'l 12b': F;;\\Kasadill\ootanq 
3900 Chestnut Street 
Apt. 409 
Philadelphia, PA 19104 
RE: Research Waste\vater 
Dcar Kasadit: 
As per your prdirninary specifications, EarthCarc is pleased to submit this preliminary quotation for the 
transportation and disposal of the wastewater at LJniver!:>ily ofPennsylvaJ'ia. Material will bl:! transported to 
Gloucester County WWTP for treatment and disposal. 
Transportation and Disposal Budget $0.16 to SO.21/gallon 
600\) gal. min imum 
PH 5.5 lo 9 TSS less than 1%. BOD less than }0,000 ppm 
One hour loading and 112 hour unloading is free: .523.15 per quaJ1er hour dCmUlTa.l:;\~ \vill be charged thereafter. 
It will be the responsibility of the Customer to pay for any tank clean·outs (if nt:cessary). If a tank cleiU1:-out is 
required, then the cost plus demurrage will be charged. 
All pricing based OD facmty acceptance. Ifth~s preliminary proposal is .{cceptable, we would require a 
sample and analysis of the waste (lrnot already provided). l:pon revie\v of the ::.ample, a tinal proposal will he 
issued provided the material is acceptable, Shuuld the material arrive at the tLsposal facility not meeting lhe 
above specifications. the waste 'v\ill face possible rejection or surcharges. 
This preliminary pricing is in efft!ct for thirty (30) Uays from the date of '(his correspondence. RateS do not 
include any state, federal, or local taxes or fees. \vhich may be imposed. 
We appreciate this opportunity w assist in yow' environmental conc.erns. l.:pon agreeing to these terms and 
conditions. \ve ask for your acknowledgement in the below area provided. Should you have any questions 
regarding this transportation and disposal package. please feel free to caB 111": c.t (610) 458~9333. I look f01"\Vurd 
to servicing Jour needs in the near future. 
Very t ly yours, 
~13K~ 

athleen B. Roegner. 
